{
  "cells": [
    {
      "cell_type": "markdown",
      "id": "fa218b89",
      "metadata": {
        "id": "fa218b89"
      },
      "source": [
        "# ðŸ”¬ Fine-tune SciBERT for Resource Mention Classification\n",
        "This notebook loads your training data, formats it for SciBERT, fine-tunes the model, and saves it."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "54f0fc75",
      "metadata": {
        "id": "54f0fc75",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "10e7fae9-daea-467c-f1e2-1a161270000a"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: transformers>=4.30 in /usr/local/lib/python3.11/dist-packages (4.52.4)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (3.18.0)\n",
            "Requirement already satisfied: huggingface-hub<1.0,>=0.30.0 in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (0.33.0)\n",
            "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (2.0.2)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (24.2)\n",
            "Requirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (6.0.2)\n",
            "Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (2024.11.6)\n",
            "Requirement already satisfied: requests in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (2.32.3)\n",
            "Requirement already satisfied: tokenizers<0.22,>=0.21 in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (0.21.1)\n",
            "Requirement already satisfied: safetensors>=0.4.3 in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (0.5.3)\n",
            "Requirement already satisfied: tqdm>=4.27 in /usr/local/lib/python3.11/dist-packages (from transformers>=4.30) (4.67.1)\n",
            "Requirement already satisfied: fsspec>=2023.5.0 in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0,>=0.30.0->transformers>=4.30) (2025.3.2)\n",
            "Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0,>=0.30.0->transformers>=4.30) (4.14.0)\n",
            "Requirement already satisfied: hf-xet<2.0.0,>=1.1.2 in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0,>=0.30.0->transformers>=4.30) (1.1.3)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.11/dist-packages (from requests->transformers>=4.30) (3.4.2)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.11/dist-packages (from requests->transformers>=4.30) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests->transformers>=4.30) (2.4.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.11/dist-packages (from requests->transformers>=4.30) (2025.6.15)\n"
          ]
        }
      ],
      "source": [
        "!pip install \"transformers>=4.30\"\n",
        "!pip install --quiet datasets scikit-learn"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from google.colab import data_table\n",
        "data_table.enable_dataframe_formatter()"
      ],
      "metadata": {
        "id": "Kqib97hjGIgD"
      },
      "id": "Kqib97hjGIgD",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "id": "50051928",
      "metadata": {
        "id": "50051928"
      },
      "source": [
        "## ðŸ“¤ Upload Training CSV"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "7aca6e63",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 86
        },
        "id": "7aca6e63",
        "outputId": "81b54a6b-16b8-4200-99a4-0bd51ff109ca"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "     <input type=\"file\" id=\"files-b7847fcb-a714-450f-bf44-7a273e2f4646\" name=\"files[]\" multiple disabled\n",
              "        style=\"border:none\" />\n",
              "     <output id=\"result-b7847fcb-a714-450f-bf44-7a273e2f4646\">\n",
              "      Upload widget is only available when the cell has been executed in the\n",
              "      current browser session. Please rerun this cell to enable.\n",
              "      </output>\n",
              "      <script>// Copyright 2017 Google LLC\n",
              "//\n",
              "// Licensed under the Apache License, Version 2.0 (the \"License\");\n",
              "// you may not use this file except in compliance with the License.\n",
              "// You may obtain a copy of the License at\n",
              "//\n",
              "//      http://www.apache.org/licenses/LICENSE-2.0\n",
              "//\n",
              "// Unless required by applicable law or agreed to in writing, software\n",
              "// distributed under the License is distributed on an \"AS IS\" BASIS,\n",
              "// WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\n",
              "// See the License for the specific language governing permissions and\n",
              "// limitations under the License.\n",
              "\n",
              "/**\n",
              " * @fileoverview Helpers for google.colab Python module.\n",
              " */\n",
              "(function(scope) {\n",
              "function span(text, styleAttributes = {}) {\n",
              "  const element = document.createElement('span');\n",
              "  element.textContent = text;\n",
              "  for (const key of Object.keys(styleAttributes)) {\n",
              "    element.style[key] = styleAttributes[key];\n",
              "  }\n",
              "  return element;\n",
              "}\n",
              "\n",
              "// Max number of bytes which will be uploaded at a time.\n",
              "const MAX_PAYLOAD_SIZE = 100 * 1024;\n",
              "\n",
              "function _uploadFiles(inputId, outputId) {\n",
              "  const steps = uploadFilesStep(inputId, outputId);\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  // Cache steps on the outputElement to make it available for the next call\n",
              "  // to uploadFilesContinue from Python.\n",
              "  outputElement.steps = steps;\n",
              "\n",
              "  return _uploadFilesContinue(outputId);\n",
              "}\n",
              "\n",
              "// This is roughly an async generator (not supported in the browser yet),\n",
              "// where there are multiple asynchronous steps and the Python side is going\n",
              "// to poll for completion of each step.\n",
              "// This uses a Promise to block the python side on completion of each step,\n",
              "// then passes the result of the previous step as the input to the next step.\n",
              "function _uploadFilesContinue(outputId) {\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  const steps = outputElement.steps;\n",
              "\n",
              "  const next = steps.next(outputElement.lastPromiseValue);\n",
              "  return Promise.resolve(next.value.promise).then((value) => {\n",
              "    // Cache the last promise value to make it available to the next\n",
              "    // step of the generator.\n",
              "    outputElement.lastPromiseValue = value;\n",
              "    return next.value.response;\n",
              "  });\n",
              "}\n",
              "\n",
              "/**\n",
              " * Generator function which is called between each async step of the upload\n",
              " * process.\n",
              " * @param {string} inputId Element ID of the input file picker element.\n",
              " * @param {string} outputId Element ID of the output display.\n",
              " * @return {!Iterable<!Object>} Iterable of next steps.\n",
              " */\n",
              "function* uploadFilesStep(inputId, outputId) {\n",
              "  const inputElement = document.getElementById(inputId);\n",
              "  inputElement.disabled = false;\n",
              "\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  outputElement.innerHTML = '';\n",
              "\n",
              "  const pickedPromise = new Promise((resolve) => {\n",
              "    inputElement.addEventListener('change', (e) => {\n",
              "      resolve(e.target.files);\n",
              "    });\n",
              "  });\n",
              "\n",
              "  const cancel = document.createElement('button');\n",
              "  inputElement.parentElement.appendChild(cancel);\n",
              "  cancel.textContent = 'Cancel upload';\n",
              "  const cancelPromise = new Promise((resolve) => {\n",
              "    cancel.onclick = () => {\n",
              "      resolve(null);\n",
              "    };\n",
              "  });\n",
              "\n",
              "  // Wait for the user to pick the files.\n",
              "  const files = yield {\n",
              "    promise: Promise.race([pickedPromise, cancelPromise]),\n",
              "    response: {\n",
              "      action: 'starting',\n",
              "    }\n",
              "  };\n",
              "\n",
              "  cancel.remove();\n",
              "\n",
              "  // Disable the input element since further picks are not allowed.\n",
              "  inputElement.disabled = true;\n",
              "\n",
              "  if (!files) {\n",
              "    return {\n",
              "      response: {\n",
              "        action: 'complete',\n",
              "      }\n",
              "    };\n",
              "  }\n",
              "\n",
              "  for (const file of files) {\n",
              "    const li = document.createElement('li');\n",
              "    li.append(span(file.name, {fontWeight: 'bold'}));\n",
              "    li.append(span(\n",
              "        `(${file.type || 'n/a'}) - ${file.size} bytes, ` +\n",
              "        `last modified: ${\n",
              "            file.lastModifiedDate ? file.lastModifiedDate.toLocaleDateString() :\n",
              "                                    'n/a'} - `));\n",
              "    const percent = span('0% done');\n",
              "    li.appendChild(percent);\n",
              "\n",
              "    outputElement.appendChild(li);\n",
              "\n",
              "    const fileDataPromise = new Promise((resolve) => {\n",
              "      const reader = new FileReader();\n",
              "      reader.onload = (e) => {\n",
              "        resolve(e.target.result);\n",
              "      };\n",
              "      reader.readAsArrayBuffer(file);\n",
              "    });\n",
              "    // Wait for the data to be ready.\n",
              "    let fileData = yield {\n",
              "      promise: fileDataPromise,\n",
              "      response: {\n",
              "        action: 'continue',\n",
              "      }\n",
              "    };\n",
              "\n",
              "    // Use a chunked sending to avoid message size limits. See b/62115660.\n",
              "    let position = 0;\n",
              "    do {\n",
              "      const length = Math.min(fileData.byteLength - position, MAX_PAYLOAD_SIZE);\n",
              "      const chunk = new Uint8Array(fileData, position, length);\n",
              "      position += length;\n",
              "\n",
              "      const base64 = btoa(String.fromCharCode.apply(null, chunk));\n",
              "      yield {\n",
              "        response: {\n",
              "          action: 'append',\n",
              "          file: file.name,\n",
              "          data: base64,\n",
              "        },\n",
              "      };\n",
              "\n",
              "      let percentDone = fileData.byteLength === 0 ?\n",
              "          100 :\n",
              "          Math.round((position / fileData.byteLength) * 100);\n",
              "      percent.textContent = `${percentDone}% done`;\n",
              "\n",
              "    } while (position < fileData.byteLength);\n",
              "  }\n",
              "\n",
              "  // All done.\n",
              "  yield {\n",
              "    response: {\n",
              "      action: 'complete',\n",
              "    }\n",
              "  };\n",
              "}\n",
              "\n",
              "scope.google = scope.google || {};\n",
              "scope.google.colab = scope.google.colab || {};\n",
              "scope.google.colab._files = {\n",
              "  _uploadFiles,\n",
              "  _uploadFilesContinue,\n",
              "};\n",
              "})(self);\n",
              "</script> "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Saving training_set_sentences.full.csv to training_set_sentences.full (1).csv\n",
            "input file name: training_set_sentences.full (1).csv\n"
          ]
        }
      ],
      "source": [
        "\n",
        "from google.colab import files\n",
        "uploaded = files.upload()\n",
        "\n",
        "infile = list(uploaded.keys())[0]\n",
        "print(f\"input file name: {infile}\")"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# from google.colab import drive\n",
        "# drive.mount('/content/drive')"
      ],
      "metadata": {
        "id": "Qy3C23Qtkkxj"
      },
      "id": "Qy3C23Qtkkxj",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "id": "b3dcdc2c",
      "metadata": {
        "id": "b3dcdc2c"
      },
      "source": [
        "## ðŸ§¹ Prepare the Dataset"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 18,
      "id": "edf8c8dd",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1279
        },
        "id": "edf8c8dd",
        "outputId": "bf71077e-cd35-4f41-d1b5-c639bc316c0c"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                         paragraph_text  label matched_term\n",
              "0     The entire test is carried out in the CI engin...      0          BAR\n",
              "1     The test used three injection pressures (210 b...      0          BAR\n",
              "2     Each experimental trial was conducted with a c...      0          BAR\n",
              "3     A mechanical stirrer is a laboratory magnetic ...      0          BAR\n",
              "4     BAR + FTI therapy synergistically extended the...      0          BAR\n",
              "...                                                 ...    ...          ...\n",
              "1432  Subsequently, we constructed a protein-protein...      1       STRING\n",
              "1433  Figure S1: Melt curve analysis of the RT-qPCR ...      1       STRING\n",
              "1434  Protein-protein interactions (physical and fun...      1       STRING\n",
              "1435  The proteins visualized via String database 12...      1       STRING\n",
              "1436  (C, D) String network (String 12.0) of the sig...      1       STRING\n",
              "\n",
              "[1437 rows x 3 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-193d5e23-6222-4b51-aa17-a4c795e2c0c8\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>paragraph_text</th>\n",
              "      <th>label</th>\n",
              "      <th>matched_term</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>The entire test is carried out in the CI engin...</td>\n",
              "      <td>0</td>\n",
              "      <td>BAR</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>The test used three injection pressures (210 b...</td>\n",
              "      <td>0</td>\n",
              "      <td>BAR</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Each experimental trial was conducted with a c...</td>\n",
              "      <td>0</td>\n",
              "      <td>BAR</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>A mechanical stirrer is a laboratory magnetic ...</td>\n",
              "      <td>0</td>\n",
              "      <td>BAR</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>BAR + FTI therapy synergistically extended the...</td>\n",
              "      <td>0</td>\n",
              "      <td>BAR</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1432</th>\n",
              "      <td>Subsequently, we constructed a protein-protein...</td>\n",
              "      <td>1</td>\n",
              "      <td>STRING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1433</th>\n",
              "      <td>Figure S1: Melt curve analysis of the RT-qPCR ...</td>\n",
              "      <td>1</td>\n",
              "      <td>STRING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1434</th>\n",
              "      <td>Protein-protein interactions (physical and fun...</td>\n",
              "      <td>1</td>\n",
              "      <td>STRING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1435</th>\n",
              "      <td>The proteins visualized via String database 12...</td>\n",
              "      <td>1</td>\n",
              "      <td>STRING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1436</th>\n",
              "      <td>(C, D) String network (String 12.0) of the sig...</td>\n",
              "      <td>1</td>\n",
              "      <td>STRING</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>1437 rows Ã— 3 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-193d5e23-6222-4b51-aa17-a4c795e2c0c8')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-193d5e23-6222-4b51-aa17-a4c795e2c0c8 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-193d5e23-6222-4b51-aa17-a4c795e2c0c8');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-fd0bdea2-3d44-4f07-a5fa-1660a1cca2f1\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-fd0bdea2-3d44-4f07-a5fa-1660a1cca2f1')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-fd0bdea2-3d44-4f07-a5fa-1660a1cca2f1 button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "\n",
              "  <div id=\"id_15b8d152-4b4e-4174-8a20-8d9c27066ef0\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_15b8d152-4b4e-4174-8a20-8d9c27066ef0 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 1437,\n  \"fields\": [\n    {\n      \"column\": \"paragraph_text\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1196,\n        \"samples\": [\n          \"We show that mid-level categories (e.g., face-body) are represented at all levels of SF content, while in sub-ordinate levels (e.g., identity), only the intact stimuli are represented in IT and STS neurons.\",\n          \"https://identifiers.org/ncbi/insdc.sra:SRR31897982 [ 19 ]\",\n          \"This analysis involved mapping the lncRNAs to the Rfam database based on conserved sequences and secondary structures, following the approach outlined by Nawrocki et al.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"label\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 0,\n        \"min\": 0,\n        \"max\": 1,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          1,\n          0\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"matched_term\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 80,\n        \"samples\": [\n          \"Swiss-Prot\",\n          \"BAR\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            },
            "application/vnd.google.colaboratory.module+javascript": "\n      import \"https://ssl.gstatic.com/colaboratory/data_table/e523c247d1e24a05/data_table.js\";\n\n      const table = window.createDataTable({\n        data: [[{\n            'v': 0,\n            'f': \"0\",\n        },\n\"The entire test is carried out in the CI engine of irrigation water pumping systems under the distinct injection pressures of 210, 230, and 250 bar with respective loading conditions of 0%, 20%, 40%, 60%, 80%, and 100%.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 1,\n            'f': \"1\",\n        },\n\"The test used three injection pressures (210 bar, 230 bar, and 250 bar) with a constant compression ratio (16:1).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 2,\n            'f': \"2\",\n        },\n\"Each experimental trial was conducted with a constant compression ratio of 16:1, a constant engine speed of 1500 rpm, and varying injection pressures of 210 bar baseline, 230 bar, and 250 bar at sequential engine loads of 0%, 20%, 40%, 60%, 80%, and 100%.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 3,\n            'f': \"3\",\n        },\n\"A mechanical stirrer is a laboratory magnetic device with a spinning magnetic field that quickly spins a stir bar immersed in a liquid, churning it.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 4,\n            'f': \"4\",\n        },\n\"BAR + FTI therapy synergistically extended the lifespan by 25%, surpassing the effects of either monotherapy.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 5,\n            'f': \"5\",\n        },\n\"Mechanistically, BAR decreased the SASP and inflammatory markers (e.g., IL-6 and PAI-1), complementing the progerin-targeting effects of FTI.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 6,\n            'f': \"6\",\n        },\n\"In the publication, \\u201cMedical Error: Using Storytelling and Reflection to Impact Resident Error Response Factors,\\u201d the Figure 3 y-axis middle bar and lower bar were incorrectly labeled.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 7,\n            'f': \"7\",\n        },\n\"Demographic data, inflammatory markers, echocardiographic parameters, and blood urea nitrogen-to-albumin ratio (BAR) values were compared.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 8,\n            'f': \"8\",\n        },\n\"Logistic regression identified independent risk factors, and ROC curve analysis assessed the predictive value of BAR.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 9,\n            'f': \"9\",\n        },\n\"Myocardial injury was associated with lower ejection fraction (EF), and elevated procalcitonin, lactate, and BAR levels ( P <0.05).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 10,\n            'f': \"10\",\n        },\n\"In addition to S-BAR for FEM, the SSC platform is compatible with CMOS processes and can realize compact, integrated chips, such as wearable or implantable microacoustic sensors or actuators.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 11,\n            'f': \"11\",\n        },\n\"The genome length covered by ROH ranged from 347.5 Mb in MAR to 522.9 Mb in BAR. The other breeds had the following average values: HAF (494.9 Mb), MUR (372.3 Mb), and TPR (394.2 Mb). In Fig. 3, the average length (in kb) and number of ROH per breed are represented together through a scatter plot.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 12,\n            'f': \"12\",\n        },\n\"ROH islands were not uniformly distributed across the genome; in fact, 12 chromosomes out of the 31 contained ROH islands, with the following distribution: ECA2 (BAR), ECA3 (BAR, HAF, MUR, TPR), ECA6-7 (HAF), ECA8 (BAR, HAF), ECA10 (BAR, HAF), ECA11 (HAF), ECA13 (BAR), ECA15 (BAR, TPR), ECA16 (HAF), and ECA29 (BAR, TPR).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 13,\n            'f': \"13\",\n        },\n\"( A ) Elongated adventitious shoots were cultured in triple macroelement (3MS) medium supplemented with 0.1 mg/L BA and 0.01 mg/L NAA (bar = 1.18 cm) after 21 d; ( B ) Rooted of in vitro shoots in presence of 0.6 mg/L IBA after 21 d (bar = 1.50 cm); ( C ) Acclimatization regenerated plantlets transferred to nutrient soil after 30 d. (bar = 2.50 cm).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 14,\n            'f': \"14\",\n        },\n\"Model TB: the implants were splinted with welded titanium bar; Model PB: the implants were splinted with PEEK (Poly Ether Ether Ketone) bar.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BAR\"],\n [{\n            'v': 15,\n            'f': \"15\",\n        },\n\"We generated transcriptome read mapping data and tissue images, which were then uploaded to the Bio-Analytic Resource for Plant Biology (BAR) database, resulting in a graphic expression atlas that can be easily accessed by inputting a query gene [24].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BAR\"],\n [{\n            'v': 16,\n            'f': \"16\",\n        },\n\"The Cacao SCA eFP Browser (https://bar.utoronto.ca/efp_cacao_sca/cgi-bin/efpWeb.cgi) contains 4 views: a seed atlas, a meristem atlas, a developmental atlas, and a drought and diurnal atlas. The Cacao CCN-51 eFP Browser (https://bar.utoronto.ca/efp_cacao_ccn/cgi-bin/efpWeb.cgi) encompasses two views, a developmental atlas, and a drought and diurnal atlas. The Cacao TC eFP Browser (https://bar.utoronto.ca/efp_cacao_tc/cgi-bin/efpWeb.cgi) comprises two views, an Infected C stage Leaf Atlas (for Scavina6 and NA32 varieties [26], C stage leaves infected with Phytophtora megakarya for several timepoints) up to 72 hours (h) and a T. cacao Leaf Development Atlas (for Scavina6 and ICS-1 varieties, A-E stages leaves).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BAR\"],\n [{\n            'v': 17,\n            'f': \"17\",\n        },\n\"To make this data easily available as a resource for the community, all expression data is searchable in the Arabidopsis eFP Browser (https://bar.utoronto.ca/efp_arabidopsis/cgi-bin/efpWeb.cgi?dataSource=Gynoecium; Winter et al. 2007).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BAR\"],\n [{\n            'v': 18,\n            'f': \"18\",\n        },\n\"Based on RNA-seq data from 17 samples, a tung tree electronic fluorescent pictographic (eFP) browser (http://bar.utoronto.ca/efp_tung_tree/cgi-bin/efpWeb.cgi) was devised to permit the visualization of gene expression patterns in \\u201cabsolute\\u201d, \\u201crelative\\u201d, and \\u201ccompare\\u201d modes in these tissues using the annotated gene IDs (File S3).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BAR\"],\n [{\n            'v': 19,\n            'f': \"19\",\n        },\n\"Researchers can conveniently access these resources through the interactive ePlant browser (https://bar.utoronto.ca/eplant_eucalyptus).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BAR\"],\n [{\n            'v': 20,\n            'f': \"20\",\n        },\n\"To enable community-wide, simple, graphical representation of PopGenExpress transcript abundance data, a Web-based tool was devised, the Populus Electronic Fluorescent Pictograph (eFP) browser (Fig. 6; http://www.bar.utoronto.ca/efppop/cgi-bin/efpWeb.cgi). The Populus eFP browser is based on eFP tools for Arabidopsis and Mus musculus (Winter et al., 2007).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BAR\"],\n [{\n            'v': 21,\n            'f': \"21\",\n        },\n\"The expression levels of all Eutrema genes in this study can be visualized using a \\u201cEutrema eFP browser\\u201d at the Bio - Analytic Resource [40] (http://bar.utoronto.ca/efp_Eutrema/cgi-bin/efpWeb.cgi).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BAR\"],\n [{\n            'v': 22,\n            'f': \"22\",\n        },\n\"This RNA-Seq data is publicly available and can be queried using the BAR eFP browser, which will facilitate the study of environment- or accession-associated differences in gene expression.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BAR\"],\n [{\n            'v': 23,\n            'f': \"23\",\n        },\n\"Conceptualization: Brenda Nakitto, Felix Bongomin.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 24,\n            'f': \"24\",\n        },\n\"Data curation: Brenda Nakitto, Felix Bongomin.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 25,\n            'f': \"25\",\n        },\n\"Investigation: Brenda Nakitto, Felix Bongomin, Ingrid Ampeire, Lauryn Nsenga.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 26,\n            'f': \"26\",\n        },\n\"Concept and design: Tatiana Fernandez Trokhimtchouk, \\u00c1lvaro Morillo Cox, Diego Viteri Cevallos, Jose Samaniego, Brenda Santamaria, Vicente Pe\\u00f1aherrera\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 27,\n            'f': \"27\",\n        },\n\"Acquisition, analysis, or interpretation of data: Tatiana Fernandez Trokhimtchouk, \\u00c1lvaro Morillo Cox, Diego Viteri Cevallos, Jose Samaniego, Brenda Santamaria, Vicente Pe\\u00f1aherrera\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 28,\n            'f': \"28\",\n        },\n\"This work was supported under public notices 010/2021 (PIBIC\\u2014CNPq/UFSM; scholarship to Brenda Dutra Guterres), 003/2022 (FIPE\\u2014J\\u00daNIOR/UFSM, scholarship to Emilly Renk Mello), 002/2024 (FIPE\\u2014SENIOR/UFSM, scholarship to Anna Carolina Oliveira Machado), and financial code 001 (CAPES/PROSUP, master\\u2019s scholarship to Myllena Fernandes).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 29,\n            'f': \"29\",\n        },\n\"Concept and design: Pratik Parikh, Brenda Stanley\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 30,\n            'f': \"30\",\n        },\n\"Acquisition, analysis, or interpretation of data: Pratik Parikh, Brenda Stanley\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 31,\n            'f': \"31\",\n        },\n\"Drafting of the manuscript: Pratik Parikh, Brenda Stanley\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 32,\n            'f': \"32\",\n        },\n\"Critical review of the manuscript for important intellectual content: Pratik Parikh, Brenda Stanley\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 33,\n            'f': \"33\",\n        },\n\"Concept and design: Huber D\\u00edaz, Brenda V. Ventura Trujeque, H\\u00e9ctor A. Ancona P\\u00e9rez, Ricardo A. Mill\\u00e1n Flores\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 34,\n            'f': \"34\",\n        },\n\"Acquisition, analysis, or interpretation of data: Huber D\\u00edaz, Brenda V. Ventura Trujeque, H\\u00e9ctor A. Ancona P\\u00e9rez, Ricardo A. Mill\\u00e1n Flores\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 35,\n            'f': \"35\",\n        },\n\"Drafting of the manuscript: Huber D\\u00edaz, Brenda V. Ventura Trujeque, H\\u00e9ctor A. Ancona P\\u00e9rez, Ricardo A. Mill\\u00e1n Flores\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 36,\n            'f': \"36\",\n        },\n\"Supervision: Huber D\\u00edaz, Brenda V. Ventura Trujeque, H\\u00e9ctor A. Ancona P\\u00e9rez, Ricardo A. Mill\\u00e1n Flores\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 37,\n            'f': \"37\",\n        },\n\"\\u201cMaria Eduarda Souza Guerra 1\\u2020 , Giulia Destro 1\\u2020 , Brenda Vieira 1 , Alice S. Lima 1 , Lucio Fabio Caldas Ferraz 1 , Anders P. Hakansson 2 , Michelle Darrieux 1 , Thiago Rojas Converso 1* \\u201d.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"BRENDA\"],\n [{\n            'v': 38,\n            'f': \"38\",\n        },\n\"In this study, we obtained 2085 FE sequences from the BRENDA database and initiated with an enzyme similarity network analysis, revealing three main clusters (1-3).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 39,\n            'f': \"39\",\n        },\n\"In this study, we explored 2085 FE sequences from the BRENDA database, a well-established repository that extensively documents experimentally validated enzymes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 40,\n            'f': \"40\",\n        },\n\"2085 feruloyl esterases (FEs, EC 3.1.1.73) were retrieved from the BRENDA database ( https://www.brenda-enzymes.org/ ) and the 2085 FE sequences were retrieved based on their functional annotation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 41,\n            'f': \"41\",\n        },\n\"It was trained on a dataset comprising experimentally verified enzyme-substrate interactions from public databases, including BRENDA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 42,\n            'f': \"42\",\n        },\n\"Through retrieving characterized FEs from the BRENDA database (EC 3.1.1.73), a total of 21 characterized FEs were identified for further analysis, with 17 representative enzymes distributed across clusters.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 43,\n            'f': \"43\",\n        },\n\"For example, even though there exist about 87 k, 176 k, and 46 k entries for k cat , K m , and K i measurements, respectively, in BRENDA (Release 2022_2), many are not annotated with the corresponding enzyme sequences and/or substrate information.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 44,\n            'f': \"44\",\n        },\n\"The raw data of enzyme kinetic parameters used for curating CatPred-DB are available at BRENDA [ https://www.brenda-enzymes.org/ ] and SABIO-RK [ http://sabio.h-its.org/ ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 45,\n            'f': \"45\",\n        },\n\"The raw data of enzyme kinetic parameters used for curating CatPred-DB are available at BRENDA [ https://www.brenda-enzymes.org/ ] and SABIO-RK [ http://sabio.h-its.org/ ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SABIO-RK\"],\n [{\n            'v': 46,\n            'f': \"46\",\n        },\n\"The BRENDA database is a comprehensive repository of enzyme-related information, including curated data on substrates, products, enzyme classes, and their associated reactions.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 47,\n            'f': \"47\",\n        },\n\"A set of enzymes that either utilize the identified metabolites as substrates or are involved in their production was compiled from the BRENDA database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 48,\n            'f': \"48\",\n        },\n\"To ensure that the enzymes collected from the BRENDA database were of bacterial origin, we matched the first three digits of the EC numbers of enzymes from the 312 bacterial species in our dataset with those of the enzymes from the enzymatic reactions listed in BRENDA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 49,\n            'f': \"49\",\n        },\n\"This was carried out by pairing BRENDA enzymes that were not in the positive sets with the 154 metabolites, and then extracting an equal number of instances as in the positive set.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 50,\n            'f': \"50\",\n        },\n\"For example, based on the predictions from the BRENDA substrate model, \\u03b1-ketoglutarate, which was shown to be consumed by Aeromicrobium marinum in [ 80 ], contained 88 enzymes using it as substrate.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 51,\n            'f': \"51\",\n        },\n\"It retrieves enzyme turnover numbers from databases such as BRENDA and the system for the analysis of biochemical pathways-reaction kinetics (SABIO-RK) database (Chang et al., 2021 ; Wittig et al., 2006 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 52,\n            'f': \"52\",\n        },\n\"It retrieves enzyme turnover numbers from databases such as BRENDA and the system for the analysis of biochemical pathways-reaction kinetics (SABIO-RK) database (Chang et al., 2021 ; Wittig et al., 2006 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SABIO-RK\"],\n [{\n            'v': 53,\n            'f': \"53\",\n        },\n\"Turnover numbers for enzymes are obtained from the BRENDA database (Schomburg et al., 2004 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 54,\n            'f': \"54\",\n        },\n\"Also, the flux value of a reaction catalyzed by the enzyme i is limited by available enzyme in the cell, same as similar approaches using Equation ( 9 ), which sMOMENT, retrieves enzyme turnover number k cat , from SABIO-RK and BRENDA databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 55,\n            'f': \"55\",\n        },\n\"Also, the flux value of a reaction catalyzed by the enzyme i is limited by available enzyme in the cell, same as similar approaches using Equation ( 9 ), which sMOMENT, retrieves enzyme turnover number k cat , from SABIO-RK and BRENDA databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SABIO-RK\"],\n [{\n            'v': 56,\n            'f': \"56\",\n        },\n\"However, online databases such as the BRENDA and the SABIO-RK database provide a wealth of information about enzyme kinetics, including turnover numbers.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 57,\n            'f': \"57\",\n        },\n\"However, online databases such as the BRENDA and the SABIO-RK database provide a wealth of information about enzyme kinetics, including turnover numbers.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SABIO-RK\"],\n [{\n            'v': 58,\n            'f': \"58\",\n        },\n\"The BRENDA database represents an extensive compilation of enzyme and metabolic information derived from primary literature sources.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 59,\n            'f': \"59\",\n        },\n\"Most of the existing models utilized either manually prepared databases, or publicly available databases such as Brenda-Enzymes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 60,\n            'f': \"60\",\n        },\n\"It is trained on the Brenda-Enzymes data set.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 61,\n            'f': \"61\",\n        },\n\"To train the models, we used the Brenda-Enzymes data sets of optimal pH values collected for \\u223c3,000 (version November 2021) and for \\u223c10,000 (version March 2023) proteins with the UniProt identifiers.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 62,\n            'f': \"62\",\n        },\n\"To train the models, we used the Brenda-Enzymes data sets of optimal pH values collected for \\u223c3,000 (version November 2021) and for \\u223c10,000 (version March 2023) proteins with the UniProt identifiers.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"UniProt\"],\n [{\n            'v': 63,\n            'f': \"63\",\n        },\n\"Efficient training of next generation of electrophysiologists (EPs) to perform catheter (cath) ablation (CA) of arrhythmias is needed.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 64,\n            'f': \"64\",\n        },\n\"ARTSim incorporates innovative artificial intelligence-based techniques for digitizing and tracking the movements of a physical ablation cath in real time, thereby enabling its precise navigation within a completely virtual 3D heart (Figure 1B) generated automatically from patients\\u2019 MRI scans.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 65,\n            'f': \"65\",\n        },\n\"Success was defined by placing the cath tip within 3mm of the target (white), with force of >3g (pink) for >5sec (red).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 66,\n            'f': \"66\",\n        },\n\"Safety was considered for cath force <30g, (Figure 1C).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 67,\n            'f': \"67\",\n        },\n\"Procedure time, cath tip trajectory, and contact force >30g and >50g were acquired.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 68,\n            'f': \"68\",\n        },\n\"The study population was obtained by extraction of 38,760 assays of high-sensitivity troponins (hs) performed on 25,225 patients out of 213,340 patients admitted to the emergency departments of the University Hospital Center of Reims, France, with a coronary angiography facility (Cath Lab center) and the Hospital Center of the city of Charleville-M\\u00e9zi\\u00e8res, France, without a coronary angiography facility (No Cath Lab center), between January 1, 2018 and December 31, 2019.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 69,\n            'f': \"69\",\n        },\n\"The troponin test kit used in the center with a Cath Lab was the \\\"Elecsys\\u00ae troponin T hs\\\" test from ROCHE Diagnostics (Basel, Switzerland), which allowed determination of troponin T hs by an electrochemiluminescence method on a \\\"Cobas e602\\\" immunoassay system.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 70,\n            'f': \"70\",\n        },\n\"The troponin test kit used in the center without a Cath Lab was the \\\"ARCHITECT STAT High-Sensitivity Troponin-I\\\" from ABBOTT Laboratories (Chicago, IL, USA), which allowed determination of troponin I hs by an immunological method on an \\\"ARCHITECT iSystem\\\" immunoassay system.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 71,\n            'f': \"71\",\n        },\n\"For the No Cath Lab center, an invasive test was possible with a transfer to the Cath Lab center or a private hospital in the region.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 72,\n            'f': \"72\",\n        },\n\"*p < 0.05; Cath Lab: catheterization laboratory, SD: standard deviation, BMI: body mass index, GFR: glomerular filtration rate, NSTEMI: non-ST-segment elevation myocardial infarction, LVEF: left ventricular ejection function\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 73,\n            'f': \"73\",\n        },\n\"Masuma Pervin Mishu 1 , Cath Jackson 2 , Ann McNeill 3 , Suneela Garg 4 , Amod Borle 4 , Chetana Deshmukh 4 , M. Meghachandra Singh 4 , Nidhi Bhatnagar 4 , Ravi Kaushik 4 , Rumana Huque 5 , Fariza Fieroze 5 , Sushama Kanan 5 , SM Abdullah 5 , Laraib Mazhar 6 , Zohaib Akhter 6 , Khalid Rehman 7 , Safat Ullah 7 , Lu Han 2 , Anne Readshaw 2 , Aziz Sheikh 8 , Paramjit Gill 9 , Kamran Siddiqi 2 , Mona Kanaan 2 , Romaina Iqbal 6\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 74,\n            'f': \"74\",\n        },\n\"This study evaluated the effectiveness of scatter radiation reduction with the EggNest Complete shielding system compared to standard catheterization laboratory shielding.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 75,\n            'f': \"75\",\n        },\n\"Vertical poles with mounted radiation survey meters were positioned at six points around a catheterization laboratory imaging table where procedural staff usually stand.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 76,\n            'f': \"76\",\n        },\n\"Scatter radiation measurements were reported in \\u03bcSv/h under three radiation shielding conditions: no shielding, standard catheterization laboratory lead shielding, and the EggNest Complete system.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 77,\n            'f': \"77\",\n        },\n\"Average scatter radiation (across heights for a given position) measured in various C-arm angulations using no shielding, standard catheterization laboratory shielding, and the EggNest Complete radiation protection system (p < 0.01 for EggNest Complete measurements compared to no shielding and standard shielding in all positions).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 78,\n            'f': \"78\",\n        },\n\"mdCATH features simulations of 5,398 domains at five different temperatures, each in five replicas, therefore offering statistically relevant large-scale insights into protein structure dynamics under a multiplicity of conditions.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 79,\n            'f': \"79\",\n        },\n\"This extensive and homogeneously-collected dataset of all-atom molecular dynamics simulations fills a critical void in the available molecular datasets by offering a rich, diverse, and physiologically relevant array of protein domain dynamics, enabling systematic, proteome-wide studies into protein thermodynamics, folding, and kinetics. It is possible to exploit mdCATH for learning data-driven (e.g. neural network-based) potentials17, also thanks to the inclusion, unique to our knowledge, of instantaneous forces derived from a state-of-the-art all-atom force field.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 80,\n            'f': \"80\",\n        },\n\"To address this critical gap, we introduce mdCATH, a dataset generated through an extensive set of all-atom molecular dynamics simulations of a diverse and representative collection of protein domains\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 81,\n            'f': \"81\",\n        },\n\"High quality data. To ensure the highest accuracy, mdCATH utilizes state-of-the-art force fields, code, and computational resources.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CATH\"],\n [{\n            'v': 82,\n            'f': \"82\",\n        },\n\"2020 ), CATH ( Sillitoe et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 83,\n            'f': \"83\",\n        },\n\"Domain embeddings are compared against a library of precomputed structure embeddings from structure databases such as the CATH database, and the top k nearest neighbours (measured by cosine distance) are returned, with further validation using TM-align to confirm hits.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 84,\n            'f': \"84\",\n        },\n\"These three output heads of the network predict logits for the class (C), architecture (A), and topology (T) level classifications in CATH.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 85,\n            'f': \"85\",\n        },\n\"Training the network on the different levels of the CATH hierarchy in parallel, where the C and CA labels are effectively acting as auxiliary losses, reduces overfitting and gives a more robust final embedding.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 86,\n            'f': \"86\",\n        },\n\"The training set comprised 31 885 domains, which are the S30 non-redundant subset of domains in the CATH 4.3 release.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 87,\n            'f': \"87\",\n        },\n\"Here, we introduce mdCATH, a dataset focused on providing extensive all-atom MD-derived dynamics for most protein domains in the CATH classification system\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 88,\n            'f': \"88\",\n        },\n\"Comprehensive coverage of structural features. mdCATH provides molecular dynamics information across 5,398 protein domains from the CATH classification system. This extensive coverage ensures a broad representation of the proteome, making the dataset valuable for a wide range of research applications in drug discovery.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 89,\n            'f': \"89\",\n        },\n\"We built the dataset on the basis of the domain definitions provided by the CATH database\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 90,\n            'f': \"90\",\n        },\n\"CATH, a publicly available resource maintained by the Orengo group, provides a set of domains clustered by general architecture according to the class, architecture, topology, and homologous superfamily hierarchy\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 91,\n            'f': \"91\",\n        },\n\"We started from 14,433 non-homologous domains at the S20 (20%) homology level in CATH release 4.2.0.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 92,\n            'f': \"92\",\n        },\n\"Next, we excluded all the structures whose backbone was non-contiguous, e.g. due to unresolved regions in the original experimental structures; we also excluded sequences containing non-standard amino acids (also absent from CATH model files).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 93,\n            'f': \"93\",\n        },\n\"CATH ( https://www.cathdb.info ) is a structural classification database that assigns domains to the structures in the Protein Data Bank (PDB) and AlphaFold Protein Structure Database (AFDB) and adds layers of biological information, including homology and functional annotation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 94,\n            'f': \"94\",\n        },\n\"CATH ( https://www.cathdb.info ) is a structural classification database that assigns domains to the structures in the Protein Data Bank (PDB) and AlphaFold Protein Structure Database (AFDB) and adds layers of biological information, including homology and functional annotation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 95,\n            'f': \"95\",\n        },\n\"CATH ( https://www.cathdb.info ) is a structural classification database that assigns domains to the structures in the Protein Data Bank (PDB) and AlphaFold Protein Structure Database (AFDB) and adds layers of biological information, including homology and functional annotation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"AlphaFold\"],\n [{\n            'v': 96,\n            'f': \"96\",\n        },\n\"CATH ( https://www.cathdb.info ) is a structural classification database developed in 1997 ( 1 ), that assigns domains to the structures available in the PDB ( 2 ) and the AlphaFold Protein Structure Database (AFDB) ( 3 ) and adds layers of biological information, including homology and functional annotation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 97,\n            'f': \"97\",\n        },\n\"CATH ( https://www.cathdb.info ) is a structural classification database developed in 1997 ( 1 ), that assigns domains to the structures available in the PDB ( 2 ) and the AlphaFold Protein Structure Database (AFDB) ( 3 ) and adds layers of biological information, including homology and functional annotation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 98,\n            'f': \"98\",\n        },\n\"CATH ( https://www.cathdb.info ) is a structural classification database developed in 1997 ( 1 ), that assigns domains to the structures available in the PDB ( 2 ) and the AlphaFold Protein Structure Database (AFDB) ( 3 ) and adds layers of biological information, including homology and functional annotation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"AlphaFold\"],\n [{\n            'v': 99,\n            'f': \"99\",\n        },\n\"Protein structures are segmented into their constituent domains (semi-independently folding globular units) for classification in CATH, using semi-automated approaches ( 6 )].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 100,\n            'f': \"100\",\n        },\n\"Furthermore, our suite of protein structure comparison tools and associated workflow, used for homologue detection and verification (SSAP ( 11 ), CATHEDRAL ( 6 )), has been expanded to include the publicly available state-of-the-art tools namely Foldseek ( 12 ) and Foldseek-TMalign ( 12 ), developed by the Steinegger group and Merizo-search ( 13 ), developed by the Jones group.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 101,\n            'f': \"101\",\n        },\n\"( 25 ) we recently applied our in-house Chainsaw algorithm ( 7 ) to segment protein structures in the PDB not yet classified in CATH.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 102,\n            'f': \"102\",\n        },\n\"The CATH protein structure classification database classifies in its 4.3 release over half a million protein domain structures in 6631 superfamilies, where each superfamily contains domains that are descendants of a common evolutionary ancestor.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 103,\n            'f': \"103\",\n        },\n\"Therefore, we cautiously compare our DeepUrfold results to a well-established system, like CATH, with the awareness that these are two conceptually different approaches to representing and describing protein structure relationships and, thus, the protein universe.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 104,\n            'f': \"104\",\n        },\n\"Somewhat counterintuitively, we deem weaker values of our comparison metrics (e.g., less similarity to CATH) as providing stronger support for the Urfold model of protein structure.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 105,\n            'f': \"105\",\n        },\n\"Because we have no ground truth for the Urfold view of protein structure similarities (and the resultant protein universe), we applied cluster comparison metrics to evaluate each SBM community, both in a self-contained manner and as referred against the original CATH clusterings.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 106,\n            'f': \"106\",\n        },\n\"Given that these CATH categories were established using protein structures, this analysis strongly suggests that the sequence embedding produced by the developed S-PLM exhibits an inherent awareness of protein structures, surpassing the other two PLMs in effectively distinguishing proteins with diverse structural characteristics.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 107,\n            'f': \"107\",\n        },\n\"Using pretrained weights, we assessed these models on CATH domains with known protein structures.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 108,\n            'f': \"108\",\n        },\n\"Secondly, compared to other PLMs that only use sequences, S-PLM shows impressive awareness of protein structures, as evidenced by its superior performance in clustering CATH domains and enzyme clustering tasks.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 109,\n            'f': \"109\",\n        },\n\"By evaluating them with pretrained weights on the CATH domains with known protein structures (Figure S2 , Supporting Information), the Swin-Transformer (swinv2-tiny-patch4-window8-256) was finally applied because it enables more effective feature extraction from the contact map representation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 110,\n            'f': \"110\",\n        },\n\"In brief, we used the CATH hierarchy (v4.3) which classifies 3D protein structures at the four levels Class (most distantly related pairs), Architecture, Topology and Homologous superfamily (most similar pairs).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 111,\n            'f': \"111\",\n        },\n\"Various databases and methods exist for assigning domains in experimental and computationally predicted protein structures, including CATH, SCOP2, and Pfam ( Andreeva et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 112,\n            'f': \"112\",\n        },\n\"Various databases and methods exist for assigning domains in experimental and computationally predicted protein structures, including CATH, SCOP2, and Pfam ( Andreeva et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SCOP\"],\n [{\n            'v': 113,\n            'f': \"113\",\n        },\n\"Various databases and methods exist for assigning domains in experimental and computationally predicted protein structures, including CATH, SCOP2, and Pfam ( Andreeva et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Pfam\"],\n [{\n            'v': 114,\n            'f': \"114\",\n        },\n\"We collect data from the protein structure classification database CATH.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 115,\n            'f': \"115\",\n        },\n\"Due to the lack of a canonical training set specifically for the TS50 test dataset, we follow the approach of [ 23 , 25 , 79 ] and remove 435 protein structure data similar to TS50 from the training dataset of CATH v4.2 as a new training set.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 116,\n            'f': \"116\",\n        },\n\"The curated domain annotations in databases such as CATH provide a rich source of signal for training deep learning methods to segment protein structures into their constituent domains.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 117,\n            'f': \"117\",\n        },\n\"Recently, it has been reported that the structure of pathogen-secreted proteins can be predicted using AlphaFold2 or other tools and annotated by protein structure databases such as PDB, CATH, and SCOP [ 23 , 44 , 45 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CATH\"],\n [{\n            'v': 118,\n            'f': \"118\",\n        },\n\"Recently, it has been reported that the structure of pathogen-secreted proteins can be predicted using AlphaFold2 or other tools and annotated by protein structure databases such as PDB, CATH, and SCOP [ 23 , 44 , 45 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 119,\n            'f': \"119\",\n        },\n\"Recently, it has been reported that the structure of pathogen-secreted proteins can be predicted using AlphaFold2 or other tools and annotated by protein structure databases such as PDB, CATH, and SCOP [ 23 , 44 , 45 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SCOP\"],\n [{\n            'v': 120,\n            'f': \"120\",\n        },\n\"Confidence in institutions is a key predictor of civic honesty, yet evidence shows that this relationship varies across contexts and individuals.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 121,\n            'f': \"121\",\n        },\n\"We hypothesised that for individuals high in PDO, confidence in institutions could backfire and be linked to the rejection of civic honesty.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 122,\n            'f': \"122\",\n        },\n\"For Asian American young adults, along with other racially minoritized groups, it is possible that racial discrimination may heighten their awareness of social and racial inequities and subsequently inspire civic action (Wong et al., 2011 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 123,\n            'f': \"123\",\n        },\n\"The Sociopolitical Development Theory (Watts et al., 2003 ) argues that racial discrimination can strengthen understanding of racial injustice and encourage civic action from the affected individuals (Hope & Jagers, 2014 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 124,\n            'f': \"124\",\n        },\n\"For example, perceptions of inequity or experiences of discrimination increased involvement in civic activities among Asian Americans (Lui et al., 2022 ; Park et al., 2024 ; Wong et al., 2011 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 125,\n            'f': \"125\",\n        },\n\"Community-level health partnerships are key not just for crisis response, but also for challenging divisive and exclusionary forms of citizenship, service delivery, and governance, and for building more just and emancipatory models of civic identity, social welfare, and state-society relations\\u2014health workers being potential agents of revolutionary change.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 126,\n            'f': \"126\",\n        },\n\"In a context where decades of conflict and structural violence had crystallised divisive and exclusionary models of civic identity, service delivery, and governance, new partnerships between former MoHS and ECBHO health workers were particularly significant.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 127,\n            'f': \"127\",\n        },\n\"It then details research findings, showing: how social welfare systems in Myanmar historically (re)produced divisive and exclusionary ideas of civic identity; how health workers from different systems have established new partnerships and solidarity since the 2021 coup; how experiences of and responses to suffering have been crucial to building solidarity and moral community; and how the latter has contributed to processes of revolutionary change by (re)shaping constructions of civic identity, social welfare, and governance \\u2018from below\\u2019.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 128,\n            'f': \"128\",\n        },\n\"GAS also correlated with significant societal benefits, including reduced harassment (OR = 0.693; P = 0.0078) and increased civic participation (OR = 1.339; P = 0.0005).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 129,\n            'f': \"129\",\n        },\n\"Our results are consistent with similar studies that have examined the relationships between civic engagement and breast and cervical cancer screening, as well as religious service attendance and cancer screening ( Moudatsou et al., 2014 ; Hill et al., 2006 ; Salmoirago-Blotcher et al., 2011 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 130,\n            'f': \"130\",\n        },\n\"The development of the PCC NCRA went through a multistep process that started from the identification of key stakeholders in cancer research in the Philippines including representatives of national government agencies, specialty cancer centers and training institutions, academe and research institutions, civic society and professional organizations, and development partners.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 131,\n            'f': \"131\",\n        },\n\"In the Philippines, the National Cancer Research Agenda sought to diversify stakeholders in its design, including civic and professional organizations such as CARE Ph and CerviQ.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"CIViC\"],\n [{\n            'v': 132,\n            'f': \"132\",\n        },\n\"This study evaluates GPT-4o, Llama 3.1, and Qwen 2.5 in classifying genetic variants from the OncoKB and CIViC databases, as well as a real-world dataset derived from FoundationOne CDx reports.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 133,\n            'f': \"133\",\n        },\n\"Stability analysis across 100 iterations revealed greater consistency with the CIViC system than with OncoKB.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 134,\n            'f': \"134\",\n        },\n\"This study evaluates GPT-4o, Llama 3.1, and Qwen 2.5 in classifying genetic variants from the OncoKB and CIViC databases, as well as a real-world dataset derived from FoundationOne CDx reports.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"OncoKB\"],\n [{\n            'v': 135,\n            'f': \"135\",\n        },\n\"Stability analysis across 100 iterations revealed greater consistency with the CIViC system than with OncoKB.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"OncoKB\"],\n [{\n            'v': 136,\n            'f': \"136\",\n        },\n\"This is exemplified by the OncoKB and CIViC databases, which rely on specialized committees and expert crowdsourcing, respectively 8 , 9 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 137,\n            'f': \"137\",\n        },\n\"We instructed the LLMs to classify genetic variants using the CIViC classification system, following the system prompts detailed in Supplementary Table 3 (Variant classification (CIViC level of evidence system)\\u2014Basic prompt).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 138,\n            'f': \"138\",\n        },\n\"Other widely used frameworks include the ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT), the OncoKB level of evidence classification, and the Clinical Interpretation of Variants in Cancer (CIViC) evidence levels 5 , 8 - 10 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 139,\n            'f': \"139\",\n        },\n\"Other widely used frameworks include the ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT), the OncoKB level of evidence classification, and the Clinical Interpretation of Variants in Cancer (CIViC) evidence levels 5 , 8 - 10 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"OncoKB\"],\n [{\n            'v': 140,\n            'f': \"140\",\n        },\n\"The statistics also indicate that RCT reports and registered trials cover a much higher number of populations and interventions than guidelines and CIViC because the integrated clinical trial data is not limited to cancer patients.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 141,\n            'f': \"141\",\n        },\n\"Interventions Interventions Therapies Total 129,119 5,631,219 1,543,754 6273 Unique CUIs 15,852 68,738 3994 418 Currently, the database includes (1) digital clinical guidelines extracted from the content management system (CMS) of the German Guideline Program in Oncology (GGPO), (2) abstracts and metadata of randomized controlled trials (RCTs) from PubMed , (3) registered clinical trials from ClinicalTrials.gov , as well as (4) curated assertions from CIViC , as a precision oncology knowledge base (POKB) for the clinical classification of cancer variants.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 142,\n            'f': \"142\",\n        },\n\"Alternatives to CIViC include OncoKB 49 , My Cancer Genome 50 , and Jax-Ckb 51 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 143,\n            'f': \"143\",\n        },\n\"Alternatives to CIViC include OncoKB 49 , My Cancer Genome 50 , and Jax-Ckb 51 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"OncoKB\"],\n [{\n            'v': 144,\n            'f': \"144\",\n        },\n\"Table 1 Differences between the individual MTBs in terms of structure and remuneration in the USA, Japan, Germany, Finland, Denmark and Italy USA Japan Germany Finland Denmark Italy Structure Decentralized, variable by institution Centralized, in large hospitals Integrated into the healthcare system National network of cancer centers Advisory, national network of cancer centers Regionalized, network of cancer centers Remuneration Private insurance, various models National health insurance, fixed fees Statutory health insurance, flat rates per case Public financing, uniform fees Public health insurance, fixed fees Regional health services, mixed financing Evidence levels - C-CAT levels NCT levels (Heidelberg, Augsburg) - Own ESCAT, OncoKB Tools cBioPortal ClinVar, OncoKB, gnomAD, COSMIC, CIViC cBioPortal/MIRACUM-Pipe (Augsburg, Freiburg), Knowledge Connector (Augsburg, Heidelberg) - Locally populated knowledge databases OncoKB Meetings Bi-monthly (MTB) Weekly Weekly Weekly (+ ad hoc) Bi-weekly/Weekly Weekly-monthly C-Cat center for cancer genomics and advanced therapeutics, NCT national center for tumor diseases, ESCAT european society for medical oncology scale for clinical actionability of molecular targets, COSMIC catalogue of somatic mutations in cancer, CIViC clinical interpretation of variants in cancer\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 145,\n            'f': \"145\",\n        },\n\"C-Cat center for cancer genomics and advanced therapeutics, NCT national center for tumor diseases, ESCAT european society for medical oncology scale for clinical actionability of molecular targets, COSMIC catalogue of somatic mutations in cancer, CIViC clinical interpretation of variants in cancer\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 146,\n            'f': \"146\",\n        },\n\"Table 3 An overview of knowledge databases including their access methods, updates, and the number of entries Database Developer/Institution Access Entries Maintenance OncoKB Memorial Sloan Kettering Cancer Center https://www.oncokb.org/ > 7500 variants Regular (06/2024) ClViC WUSM, St. Louis https://civicdb.org/ > 3500 variants Regular (06/2024) Ensembl EBI https://www.ensembl.org/ > 10 million variants (structural) Regular (05/2024) Reactome OICR, NYULMC, EMBL-EBI https://reactome.org/ > 2700 human pathways Regular (06/2024) My Cancer Genome Vanderbilt-Ingram Cancer Center https://www.mycancergenome.org/ > 16,800 biomarkers No update since 2021 TARGET Dana-Farber Cancer Institute Commercial platform > 135 manually curated genes Regular GDKD Fred Hutchinson Cancer Research Center, Seattle Not public > 700 gene-drug interactions Not updated since 2015 ClinVar NCBI https://www.ncbi.nlm.nih.gov/clinvar > 1.5 million variants Regular BRCA Exchange ENIGMA consortium https://brcaexchange.org/ > 27,400 BRCA 1/2 variants Regular (01/2024) GnomAD ExAC https://gnomad.broadinstitute.org/ > 730,947 exomes/ > 76,215 genomes Regular (05/2024) NCBI SNP Database NCBI https://www.ncbi.nlm.nih.gov/snp/ > 2 billion submitted SNP Regular WUSM Washington University School of Medicine, NCBI National Center for Biotechnology Information, EBI European Bioinformatics Institute, OICR Ontario Institute for Cancer Research, NYULMC New York University Langone Medical Center, EMBL European Molecular Biology Laboratory, ExAC Exome Aggregation Consortium\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 147,\n            'f': \"147\",\n        },\n\"Clinical Interpretation of Variants in Cancer (CIViC) is an expert-led and crowd-sourced knowledge base that provides clinical interpretation of cancer variants developed and maintained by the Washington University School of Medicine St. Louis (WUSM).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 148,\n            'f': \"148\",\n        },\n\"as meta and data files (TSV) MIRACUM-Pipe: processing of aligned omics data variant calling, annotation/ analysis OncoKB CiVIC MyCancerGenome Visualization reports https://.cbioportal.org [ 70 , 71 ] KC SNVs, indel, CNV, SV, gSmVs, Fusion, RNA, etc.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 149,\n            'f': \"149\",\n        },\n\"Databases are separated into three categories described in methods (left column) Name of database Site Category 1 MyCancerGenome www.mycancergenome.org OncoKB www.oncokb.org/ VICC Variant Interpretation of Cancer Consortium https://search.cancervariants.org CIViC https://civicdb.org/welcome Personalized Cancer Therapy (MD Anderson) https://pct.mdanderson.org/ The Jackson Laboratory Clinical Knowledgebase (JAX) https://ckb.jax.org Catalog of Somatic Mutations in Cancer (COSMIC): Cancer gene census https://cancer.sanger.ac.uk/census Category 2 Precision Medicine Knowledgebase https://pmkb.weill.cornell.edu Molecular Match, Inc https://www.molecularmatch.com/solutions/mmportal-clinical-decision-support.html cBioPortal for cancer genomics https://www.cbioportal.org GCD Data Portal https://portal.gdc.cancer.gov/ BBG Lab - Cancer Genome Interpreter/Cancer Biomarker Database https://www.cancergenomeinterpreter.org/home and https://www.cancergenomeinterpreter.org/biomarkers Caterogy 3 Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer https://mitelmandatabase.isb-cgc.org/ Cancer Therapeutic Drug Portal https://portals.broadinstitute.org/ctrp.v2.1/ Cancer Cell Line Encyclopedia (CCLE) in Depmap Portal https://depmap.org/portal/ intOGen https://www.intogen.org/ DriverDBv4 http://driverdb.bioinfomics.org/ European Variation Archive https://www.ebi.ac.uk/eva GTEX portal https://gtexportal.org/home/gene DoCM and DGIdb http://docm.info and https://www.dgidb.org Tumor Portal http://www.tumorportal.org/ Genecards https://www.genecards.org Cancer Driver Log https://candl.osu.edu Genomics of drug sensitivity https://www.cancerrxgene.org/\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 150,\n            'f': \"150\",\n        },\n\"The consortium gathers data from several well-known sources focused on somatic variants in cancer, including CIViC, JAX-CKB, MMatch, OncoKB, and PMKB.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 151,\n            'f': \"151\",\n        },\n\"The consortium gathers data from several well-known sources focused on somatic variants in cancer, including CIViC, JAX-CKB, MMatch, OncoKB, and PMKB.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"OncoKB\"],\n [{\n            'v': 152,\n            'f': \"152\",\n        },\n\"The consortium gathers data from several well-known sources focused on somatic variants in cancer, including CIViC, JAX-CKB, MMatch, OncoKB, and PMKB.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PMKB\"],\n [{\n            'v': 153,\n            'f': \"153\",\n        },\n\"Clinical Interpretation of Variants in Cancer (CIViC) ( https://civicdb.org/welcome ) is an open-source platform designed to provide a comprehensive resource for the clinical interpretation of cancer genome alterations hosted by Washington University [ 15 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 154,\n            'f': \"154\",\n        },\n\"The portal provides links to external resources like COSMIC (Catalogue of Somatic Mutations in Cancer) and CIViC (Clinical Interpretation of Variants in Cancer), which offer further information on clinical significance, targeted therapies, and other relevant data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 155,\n            'f': \"155\",\n        },\n\"The portal provides links to external resources like COSMIC (Catalogue of Somatic Mutations in Cancer) and CIViC (Clinical Interpretation of Variants in Cancer), which offer further information on clinical significance, targeted therapies, and other relevant data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 156,\n            'f': \"156\",\n        },\n\"It also annotates alterations that serve as biomarkers for response to cancer therapies by integrating information from multiple databases, including OncoKB, the Cancer Biomarkers Database, the Variant Interpretation for Cancer Consortium (VICC), and CIViC.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 157,\n            'f': \"157\",\n        },\n\"Variant calling software Illumina BaseSpace sequence hub CLC genomics workbench partek flow Varsome clinical Customisable pipeline a \\u2714 \\u2714 \\u2714 \\u2716 Tertiary analysis (filtering, annotation, classification) Basic b \\u2716 \\u2714 \\u2714 \\u2714 Custom Database \\u2716 \\u2716 \\u2714 \\u2716 VEP \\u2716 \\u2716 \\u2714 \\u2716 SnpEff \\u2716 \\u2716 \\u2714 \\u2716 ACMG/AMP \\u2716 \\u2716 \\u2716 \\u2714 CADD \\u2716 \\u2716 \\u2716 \\u2714 cBioportal \\u2716 \\u2716 \\u2716 \\u2714 CIViC \\u2716 \\u2716 \\u2716 \\u2714 CKB \\u2716 \\u2716 \\u2716 \\u2714 ClinGen \\u2716 \\u2716 \\u2716 \\u2714 Clinvar \\u2716 \\u2716 \\u2716 \\u2714 COSMIC \\u2716 \\u2716 \\u2716 \\u2714 dbSNP \\u2716 \\u2716 \\u2716 \\u2714 FATHMM \\u2716 \\u2716 \\u2716 \\u2714 OMIM \\u2716 \\u2716 \\u2716 \\u2714 PharmGKB \\u2716 \\u2716 \\u2716 \\u2714 PMKB \\u2716 \\u2716 \\u2716 \\u2714 VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 158,\n            'f': \"158\",\n        },\n\"VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CIViC\"],\n [{\n            'v': 159,\n            'f': \"159\",\n        },\n\"VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinGen\"],\n [{\n            'v': 160,\n            'f': \"160\",\n        },\n\"VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinVar\"],\n [{\n            'v': 161,\n            'f': \"161\",\n        },\n\"VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"OMIM\"],\n [{\n            'v': 162,\n            'f': \"162\",\n        },\n\"VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"dbSNP\"],\n [{\n            'v': 163,\n            'f': \"163\",\n        },\n\"VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 164,\n            'f': \"164\",\n        },\n\"VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PharmGKB\"],\n [{\n            'v': 165,\n            'f': \"165\",\n        },\n\"VEP, Variant Effect Predictor; SnpEff, SNP effect; ACMG, American College of Medical Genetics and Genomics; AMP, Association for Molecular Pathology; CADD, Combined Annotation Dependent Depletion; CIViC, Clinical Interpretation of Variants in Cancer; CKB, Clinical Knowledgebase; ClinGen, Clinical Genome Resource; Clinvar, Archive of interpretations of clinically relevant variants; COSMIC, Catalogue of Somatic Mutations in Cancer; dbSNP, Single Nucleotide Polymorphism database; FATHMM, Functional analysis through hidden Markov models; OMIM, Online Mendelian Inheritance in Man; PharmGKB, Pharmacogenomics Knowledge Base; PMKB, Precision Medicine Knowledge Base.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PMKB\"],\n [{\n            'v': 166,\n            'f': \"166\",\n        },\n\"As Galactic Cosmic Radiation (GCR) can convert inorganic materials to organic materials and might allow radiolysis-powered life, life in some form or fashion could be expected on many planets in the Milky Way.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 167,\n            'f': \"167\",\n        },\n\"Our planet\\u2019s geomagnetic field acts as a protective shield from primary cosmic rays, while the atmosphere generates secondary cosmic rays through spallation events when primary cosmic rays collide with atmospheric nuclei.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 168,\n            'f': \"168\",\n        },\n\"In deep space, primary cosmic rays can convert inorganic materials to organic materials, such as amino acids, which are the basic building blocks of biochemistry.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 169,\n            'f': \"169\",\n        },\n\"Some scientists have speculated that radiolysis-powered life, similar to Candidatus Desulforudis audaxviator , may be possible due to the effects of galactic cosmic rays.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 170,\n            'f': \"170\",\n        },\n\"Given this astonishing revelation, it appears possible that life based on radiolysis induced by cosmic rays could exist in outer space [ 4 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 171,\n            'f': \"171\",\n        },\n\"The COSMIC-19 study was registered with clinicaltrials.gov (registration: NCT04581031, date of registration: Oct 6th 2020).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 172,\n            'f': \"172\",\n        },\n\"In this context, we conducted the COSMIC-19 (continuous signs monitoring in Covid-19) study which evaluated a suite of WVSSs in hospitalised patients with Covid-19.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 173,\n            'f': \"173\",\n        },\n\"The COSMIC-19 study was registered with clinicaltrials.gov (registration: NCT04581031, date of registration: Oct 6th 2020).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 174,\n            'f': \"174\",\n        },\n\"The COSMIC-19 dataset is available on request subject to appropriate information governance and data sharing agreements.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 175,\n            'f': \"175\",\n        },\n\"The COSMIC-19 study was registered with clinicaltrials.gov (registration: NCT04581031, registered 4th May 2020).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 176,\n            'f': \"176\",\n        },\n\"Galactic cosmic radiation (GCR) is a naturally occurring environmental radiation that originates from outer space.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 177,\n            'f': \"177\",\n        },\n\"Therefore, commercial flight passengers (flyers) are exposed to elevated levels of cosmic radiation while flying onboard commercial aircraft.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 178,\n            'f': \"178\",\n        },\n\"Although the recent COVID-19 pandemic, which began in early 2020, is believed to have significantly affected public exposure to cosmic radiation, this impact is yet to be quantified.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 179,\n            'f': \"179\",\n        },\n\"Based on the official records of Japanese flyers, their annual per-capita doses (APCDs) of cosmic radiation exposure on international and domestic flights were calculated using the established code JISCARD EX over a 7-year period from 2014 to 2020 (including the first year of the pandemic).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 180,\n            'f': \"180\",\n        },\n\"During travel using commercial aircraft, flight passengers (flyers) and aircraft crews are exposed to elevated levels of galactic cosmic radiation (GCR) originating from outer space.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 181,\n            'f': \"181\",\n        },\n\"The concern for these adverse effects intensifies if we consider that the UVB solar radiation is combined with secondary cosmic radiation (SCR) components, such as protons and muons, as well as terrestrial gamma rays.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 182,\n            'f': \"182\",\n        },\n\"This research aims to delve into the intricate interplay between cosmic and solar radiation on earth at the cellular level, focusing on their synergistic effects on human cell biology.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 183,\n            'f': \"183\",\n        },\n\"Understanding the impact of combined radiation exposures is crucial for assessing the health risks posed to humans if the ozone layer is partially depleted, with structural and functional damages inflicted by combined cosmic and UVB exposure.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 184,\n            'f': \"184\",\n        },\n\"In parallel, cosmic ray protons at ground level exhibit a broad and relatively flat energy distribution spanning from 0.01 MeV to 100 MeV, as shown in Figure 1 (dashed red line) [ 22 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 185,\n            'f': \"185\",\n        },\n\"Secondary cosmic proton and muon spectra at an altitude of 75 m and a cut-off rigidity of 2.89 GV is as well shown in Figure 1 , as simulated with the EXPACS program [ 23 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"COSMIC\"],\n [{\n            'v': 186,\n            'f': \"186\",\n        },\n\"For COSMIC-based SNP sets, we selected autosomal SNPs annotated as nonsynonymous, stop-gain, and stop-loss ClinVar database annotations [ 35 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 187,\n            'f': \"187\",\n        },\n\"For COSMIC-based SNP sets, we selected autosomal SNPs annotated as nonsynonymous, stop-gain, and stop-loss ClinVar database annotations [ 35 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinVar\"],\n [{\n            'v': 188,\n            'f': \"188\",\n        },\n\"The selected SNPs in each COSMIC and HFI variant set are listed in Supplementary Table 4.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 189,\n            'f': \"189\",\n        },\n\"for age, tumor grade, and tumor stage) were performed using the Wilcoxon rank-sum test in a one-vs-all configuration on clusters with > 5% of samples within a cohort and COSMIC or HFI setting, with Bonferroni correction and p adj < 0.05 significance level.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 190,\n            'f': \"190\",\n        },\n\"We first generated the trait-specific clusterings of each cohort, namely BRCA, COAD, KIRC, LIHC, LUAD, LUSC, OV, PAAD, PRAD, and READ, using all nonsynonymous SNPs within different sets of COSMIC genes known to have germline association with each cancer type (Methods, Supplementary Table 3).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 191,\n            'f': \"191\",\n        },\n\"Upon dynamically clustering based on trait-specific regions\\u2014herein cancer type-specific germline COSMIC genes, a number of visual patterns emerge.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 192,\n            'f': \"192\",\n        },\n\"[ 34 ], who examined molecular data in cell lines from 4 tumor categories from the Catalogue of Somatic Mutations in Cancer (COSMIC) project at the Sanger Institute [ 120 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 193,\n            'f': \"193\",\n        },\n\"Additionally, we have utilized the Expert Curation of Genes list ( https://cancer.sanger.ac.uk/cosmic/curation ) from the COSMIC database [ 55 ], which is a meticulously curated compilation of genes that are somatically mutated and implicated in human cancers.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 194,\n            'f': \"194\",\n        },\n\"The Expert Curation of Genes list ( https://cancer.sanger.ac.uk/cosmic/curation ) is from the COSMIC database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 195,\n            'f': \"195\",\n        },\n\"To provide an overview of the most recurrent and relevant findings, the top 10 most significantly mutated genes from each histology were intersected with the COSMIC Tier 1 Cancer Gene Census and used to create an Oncoplot (Fig.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 196,\n            'f': \"196\",\n        },\n\"Top 10 most significantly mutated genes from robust regression in each histology subtype intersected with the COSMIC Tier 1 gene list ( A ) shows the high mutation frequency of TP53 across all histology subtypes and histology-specific mutations like KIT .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 197,\n            'f': \"197\",\n        },\n\"Top 10 most significantly mutated genes from robust regression in each histology subtype intersected with the COSMIC Tier 1 gene list ( A ) shows the high mutation frequency of TP53 across all histology subtypes and histology-specific mutations like KIT .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 198,\n            'f': \"198\",\n        },\n\"Interestingly, the frequency of somatic mutations in these cancer-associated genes was significantly higher in metastatic tumors compared to primary tumors (median mutations in COSMIC Tier 1 genes 3 vs. 2, Wilcoxon Rank Sum p < 0.001).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 199,\n            'f': \"199\",\n        },\n\"Top 10 most significant genes from robust regression were selected for each histology subtype and intersected with COSMIC Tier 1 genes to identify cancer-related genes 24 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 200,\n            'f': \"200\",\n        },\n\"The 723 genes, obtained from Catalogue Of Somatic Mutations In Cancer (COSMIC) ( Tate et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 201,\n            'f': \"201\",\n        },\n\"Validated SNVs were examined against one cancer (COSMIC) and two non-cancer (human germline and CRISPR-Cas 9 knockout of human DNA repair genes) mutational signature databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 202,\n            'f': \"202\",\n        },\n\"Then, we used three existing mutational signature datasets to identify signatures that explained the observed de novo SNV spectrum: (1) the cancer-derived Catalogue of Somatic Mutations in Cancer (COSMIC, v3.3) composed of 60 Single Base Substitutions (SBS) signatures with both known and unknown etiologies 17 ; (2) the germline-specific dataset comprising 14 SBS signatures with proposed etiologies 19 ; and (3) the dataset from targeted CRISPR-Cas9-based KO of DNA repair genes in hiPSCs cell lines with nine SBS mutational signatures 22 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 203,\n            'f': \"203\",\n        },\n\"A few studies 8 , 12 have used mutational signature analyses of de novo SNVs obtained from human families; these studies limited their analyses to COSMIC signatures to reconstruct the observed mutation spectrum.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 204,\n            'f': \"204\",\n        },\n\"During refitting, the extracted signature obtained by SigProfilerExtractor was used as the input for signature decomposition using several published SNV mutational signature sets: (1) the Catalog of Somatic Mutations in Cancer (COSMIC) 17 ( https://cancer.sanger.ac.uk/signatures/sbs/ ) version 3.3.1 (2780 WGS from PCAWG); (2) the mutational signatures from human germline identified in the TOPMed cohort 19 ; and, (3) the SNVs mutational signatures identified using KO of human DNA repair genes via targeted CRISPR-Cas9 method in isogeneic hiPSCs 22 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 205,\n            'f': \"205\",\n        },\n\"IDH1/2 mutation was an independent predictor (HR = 0.52; 95% CI, 0.29-0.94; P = 0.02) after adjusting for confounding factors including age, gender, cancer type, drug type, tumor mutation burden (TMB), POLE mutation, TP53 mutation, BRCA1/2 mutation, Catalog of Somatic Mutations in Cancer (COSMIC) reference signatures SBS7a, SBS10b, and SBS30.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 206,\n            'f': \"206\",\n        },\n\"2 Catalog of Somatic Mutations in Cancer (COSMIC) reference signatures associated with IDH mutation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COSMIC\"],\n [{\n            'v': 207,\n            'f': \"207\",\n        },\n\"DFAST, DDBJ Fast Annotation and Submission Tool.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 208,\n            'f': \"208\",\n        },\n\"(GTC20076) have been deposited in DDBJ ( https://www.ddbj.nig.ac.jp/index.html ) under the accession number AP039366 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 209,\n            'f': \"209\",\n        },\n\"RNA sequencing data have been deposited at the DDBJ under accession number PRJDB20100.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 210,\n            'f': \"210\",\n        },\n\"RNA sequencing data in this study have been deposited at the DDBJ ( https://www.ddbj.nig.ac.jp ) under accession number PRJDB20100.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 211,\n            'f': \"211\",\n        },\n\"BAOK01000001 and BAOK01000002 in DDBJ/EMBL/GenBank (Shoguchi et al., 2013 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 212,\n            'f': \"212\",\n        },\n\"BAOK01000001 and BAOK01000002 in DDBJ/EMBL/GenBank (Shoguchi et al., 2013 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 213,\n            'f': \"213\",\n        },\n\"The released project(s) is available on the DDBJ BioProject listing page.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 214,\n            'f': \"214\",\n        },\n\"The released project(s) is available on the DDBJ BioProject listing page.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioProject\"],\n [{\n            'v': 215,\n            'f': \"215\",\n        },\n\"https://ddbj.nig.ac.jp/resource/bioproject/PRJDB17212 The released project(s) are also available at the NCBI BioProject under Accession number PRJDB17212.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 216,\n            'f': \"216\",\n        },\n\"https://ddbj.nig.ac.jp/resource/bioproject/PRJDB17212 The released project(s) are also available at the NCBI BioProject under Accession number PRJDB17212.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 217,\n            'f': \"217\",\n        },\n\"https://ddbj.nig.ac.jp/resource/bioproject/PRJDB17212 The released project(s) are also available at the NCBI BioProject under Accession number PRJDB17212.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioProject\"],\n [{\n            'v': 218,\n            'f': \"218\",\n        },\n\"The data in GenBank and the collaborating databases, ENA and DDBJ, are submitted by investigators to one of the three databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 219,\n            'f': \"219\",\n        },\n\"The data in GenBank and the collaborating databases, ENA and DDBJ, are submitted by investigators to one of the three databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 220,\n            'f': \"220\",\n        },\n\"The data in GenBank and the collaborating databases, ENA and DDBJ, are submitted by investigators to one of the three databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 221,\n            'f': \"221\",\n        },\n\"The DDBJ Fast Annotation and Submission Tool ( 12 ) predicted 2,807 coding sequences, nine ribosomal RNAs, 52 transfer RNAs, and one CRISPR sequence.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 222,\n            'f': \"222\",\n        },\n\"DRA, DDBJ Sequence Read Archive.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 223,\n            'f': \"223\",\n        },\n\"Raw sequence data for GTC20076 have been deposited in the DDBJ/Sequence Read Archive under accession numbers DRR631455 and DRR631456 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 224,\n            'f': \"224\",\n        },\n\"This draft genome research has been cited at DDBJ/ENA/GenBank with accession number JBHIKZ000000000 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 225,\n            'f': \"225\",\n        },\n\"This draft genome research has been cited at DDBJ/ENA/GenBank with accession number JBHIKZ000000000 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 226,\n            'f': \"226\",\n        },\n\"This draft genome research has been cited at DDBJ/ENA/GenBank with accession number JBHIKZ000000000 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 227,\n            'f': \"227\",\n        },\n\"This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank with the following accession number JBFUXV000000000 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 228,\n            'f': \"228\",\n        },\n\"This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank with the following accession number JBFUXV000000000 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 229,\n            'f': \"229\",\n        },\n\"This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank with the following accession number JBFUXV000000000 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 230,\n            'f': \"230\",\n        },\n\"The whole-genome sequence has been deposited at DDBJ/ENA/GenBank under the accession number CP135236 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 231,\n            'f': \"231\",\n        },\n\"The whole-genome sequence has been deposited at DDBJ/ENA/GenBank under the accession number CP135236 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 232,\n            'f': \"232\",\n        },\n\"The whole-genome sequence has been deposited at DDBJ/ENA/GenBank under the accession number CP135236 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 233,\n            'f': \"233\",\n        },\n\"We deposited raw read sequences obtained in this study in GenBank/DDBJ/EMBL (BioProject no.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 234,\n            'f': \"234\",\n        },\n\"We deposited raw read sequences obtained in this study in GenBank/DDBJ/EMBL (BioProject no.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 235,\n            'f': \"235\",\n        },\n\"We deposited raw read sequences obtained in this study in GenBank/DDBJ/EMBL (BioProject no.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 236,\n            'f': \"236\",\n        },\n\"We deposited raw read sequences obtained in this study in GenBank/DDBJ/EMBL (BioProject no.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioProject\"],\n [{\n            'v': 237,\n            'f': \"237\",\n        },\n\"The genome assembly has been deposited in DDBJ/ENA/GenBank under the accession number JBDPZO000000000 78 , and NGDC under the GSA accession CRA015002 79 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 238,\n            'f': \"238\",\n        },\n\"The genome assembly has been deposited in DDBJ/ENA/GenBank under the accession number JBDPZO000000000 78 , and NGDC under the GSA accession CRA015002 79 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 239,\n            'f': \"239\",\n        },\n\"The genome assembly has been deposited in DDBJ/ENA/GenBank under the accession number JBDPZO000000000 78 , and NGDC under the GSA accession CRA015002 79 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 240,\n            'f': \"240\",\n        },\n\"The objective of this study is to explore whether metagenomic next-generation sequencing (mNGS) and Epithelial Neutrophil Activating Peptide-78 (ENA-78) assays in the amniotic fluid (AF) of patients with preterm labor (PTL) could be employed for diagnosing intra-amniotic infection/inflammation (IAI/I) and predict the outcomes of emergency cerclage in women with cervical insufficiency(CI).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 241,\n            'f': \"241\",\n        },\n\"AF samples from 40 patients were subjected to PTL were subjected to mNGS and microbial culture to diagnose intra-amniotic infection known as microbial invasion of the amniotic cavity (MIAC); ELISA was used to analyze ENA-78 levels for prediction of intra-amniotic inflammation (IAI).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 242,\n            'f': \"242\",\n        },\n\"Pregnancy outcomes were compared, the predictive performance of mNGS and ENA-78 were assessed to evaluate the efficacy of emergency cervical cerclage.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 243,\n            'f': \"243\",\n        },\n\"AF ENA-78 levels were significantly higher in IAI patients than in non-IAI/I patients.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 244,\n            'f': \"244\",\n        },\n\"ENA-78 demonstrated certain accuracy in identifying IAI, with sensitivity and specificity of 73.3% and 100%, respectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 245,\n            'f': \"245\",\n        },\n\"We tried to enhance the performance of the AST by also considering multiple parameters, the best performing of which (i.e., Na at 120 min, namely at the end of the AST - eNa) was selected and combined with other variables through logistic regression models.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 246,\n            'f': \"246\",\n        },\n\"aNa was defined as follows: aNa = eNa - (k*V2), with eNa being the sodium value (measured in mmol/L) at the end of the AST, V2 being the second considered variable and k a model-specific coefficient derived from the linear regression model (Table 4 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 247,\n            'f': \"247\",\n        },\n\"Table 4 Logistic regression models created with glm function (see methods) and derivation of an adjusted sodium value (aNa): sodium value at the end of the arginine stimulation test (eNa) was combined with a second predicting variable (V2).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 248,\n            'f': \"248\",\n        },\n\"** PPHS = 1 if the signal is present and PPHS = 0 if the signal is absent V2 Linear regression model* Derived formula for adjusted Na (aNa) k value aNa cut-off for AVP-D Copeptin peak after arginine stimulation (CP) Y = (24.0*eNa)- (15.2*CP) - 3336.7 aNa = (Y + 3336.7)/24 = = eNa - (0.63*CP) 0.63 mmol/pmol \\u2265 139 mmol/L Urinary osmolarity at the end of arginine stimulation test (eUOsm) Y = (90.9*eNa)- (0.7*eUOsm) - 12515.2 aNa = (Y + 12515.2)/90.9 = = eNa - (0.007*eUOsm) 0.007 mmol/mOsm \\u2265 138 mmol/L Presence of posterior pituitary hyperintense signal in T1 images** (PPHS) Y = (43.6*eNa)- (43.6*PPHS) - 6122.6 aNa=(Y + 6122.6)/43.6 = = eNa - (1*PPHS) 1 mmol/L \\u2265 140 mmol/L\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 249,\n            'f': \"249\",\n        },\n\"Logistic regression models created with glm function (see methods) and derivation of an adjusted sodium value (aNa): sodium value at the end of the arginine stimulation test (eNa) was combined with a second predicting variable (V2).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 250,\n            'f': \"250\",\n        },\n\"However, the effect of PVP on renal functions remains unknown.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 251,\n            'f': \"251\",\n        },\n\"We investigated the acute administration of low MW of PVP on renal functions and whether it produces a toxic effect on the kidney.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 252,\n            'f': \"252\",\n        },\n\"Renal clearance experiments were performed in rats and showed PVP infusion elicited significant diuretic and natriuretic effects.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 253,\n            'f': \"253\",\n        },\n\"Urine volume, absolute (ENa), and fractional (FENa) Na + excretion were significantly increased.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 254,\n            'f': \"254\",\n        },\n\"In T1D, rats were treated with Enalapril (Ena) or Losartan (Los) for six weeks, whereas T2D animals received high-dose (HD) or low-dose (LD) Ena for 8 weeks.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 255,\n            'f': \"255\",\n        },\n\"Results: Diabetic hearts exhibited reduced contractile performance that was improved by RAS inhibition both in vivo (ejection fraction (%): T1D model: Control: 79 \\u00b1 7, T1D: 54 \\u00b1 11, T1D + Ena: 65 \\u00b1 10, T1D + Los: 69 \\u00b1 10, n = 18, 18, 15, 10; T2D model: Control: 73 \\u00b1 8, T2D: 52 \\u00b1 6, T2D + LDEna: 62 \\u00b1 8, T2D + HDEna: 76 \\u00b1 8, n = 9, 8, 6, 7) and ex vivo (+dPressure/dt max (mmHg/s): T1D model: Control: 2532 \\u00b1 341, T1D: 2192 \\u00b1 208, T1D + Ena: 2523 \\u00b1 485, T1D + Los: 2643 \\u00b1 455; T2D model: Control: 2514 \\u00b1 197, T2D: 1930 \\u00b1 291, T2D + LDEna: 2311 \\u00b1 289, T2D + HDEna: 2614 \\u00b1 268).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 256,\n            'f': \"256\",\n        },\n\"Analysis of Ca 2+ i transients showed impaired Ca 2+ i release and removal dynamics and increased diastolic Ca 2+ i levels in both models that were restored by Ena and Los treatments.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 257,\n            'f': \"257\",\n        },\n\"We observed a decrease in sarcoendoplasmic reticulum Ca 2+ -ATPase2a (SERCA2a) expression, accompanied by a compensatory increase in 16Ser-phosphorylated phospholamban (P-PLB) in T2D that was prevented by both LD and HD Ena (expression level (% of Control): SERCA2a: T2D: 36 \\u00b1 32, T2D + LDEna: 112 \\u00b1 32, T2D + HDEna: 106 \\u00b1 30; P-PLB: T2D: 557 \\u00b1 156, T2D + LDEna: 129 \\u00b1 38, T2D + HDEna: 108 \\u00b1 42; n = 4, 4, 4).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 258,\n            'f': \"258\",\n        },\n\"RAS inhibition with Ena or Los mitigates these disturbances independent of blood pressure effects, underlining their importance in managing diabetic heart failure.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 259,\n            'f': \"259\",\n        },\n\"The data can be accessed at https://www.ebi.ac.uk/ena/browser/view/PRJEB86263 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 260,\n            'f': \"260\",\n        },\n\"The next-generation sequencing data set associated with this study is available in the European Nucleotide Archive (ENA) under the accession number ERP169623, project PRJEB86263.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 261,\n            'f': \"261\",\n        },\n\"The European Nucleotide Archive (ENA, https://www.ebi.ac.uk/ena ), maintained at the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) provides freely accessible services, both for deposition of, and access to, open nucleotide sequencing data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 262,\n            'f': \"262\",\n        },\n\"The European Nucleotide Archive( 1 ) (ENA; https://www.ebi.ac.uk/ena ) was established in the early 1980s.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 263,\n            'f': \"263\",\n        },\n\"The ENA database is a founding member of the International Nucleotide Sequence Data Collaboration (INSDC) ( 3 ), a long-standing global data exchange initiative.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 264,\n            'f': \"264\",\n        },\n\"The ENA engages with the scientific community, together with our partners in the National Institutes of Health-National Library of Medicine (NIH-NLM) National Center for Biotechnology (NCBI) ( 4 ) in the United States and the Research Organization of Information and Systems (ROIS) DNA DataBank of Japan (DDBJ) ( 5 ), as trusted custodians of freely available public nucleotide sequence data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 265,\n            'f': \"265\",\n        },\n\"The ENA engages with the scientific community, together with our partners in the National Institutes of Health-National Library of Medicine (NIH-NLM) National Center for Biotechnology (NCBI) ( 4 ) in the United States and the Research Organization of Information and Systems (ROIS) DNA DataBank of Japan (DDBJ) ( 5 ), as trusted custodians of freely available public nucleotide sequence data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 266,\n            'f': \"266\",\n        },\n\"The ENA engages with the scientific community, together with our partners in the National Institutes of Health-National Library of Medicine (NIH-NLM) National Center for Biotechnology (NCBI) ( 4 ) in the United States and the Research Organization of Information and Systems (ROIS) DNA DataBank of Japan (DDBJ) ( 5 ), as trusted custodians of freely available public nucleotide sequence data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 267,\n            'f': \"267\",\n        },\n\"Since its foundation, the ENA has developed into a globally critical data platform for the coordination of nucleotide data, and is used in over 90% of the world's countries.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 268,\n            'f': \"268\",\n        },\n\"ERR14252058; European Nucleotide Archive (ENA)].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 269,\n            'f': \"269\",\n        },\n\"The data generated in the present study may be found in the European Nucleotide Archive (ENA), under accession no.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 270,\n            'f': \"270\",\n        },\n\"Figure 1 Design and screening of ENA-ASO candidates that target human MAPT exon 10 (A) Schematic diagram of human MAPT exon 10 and the flanking intronic regions with the ENA-ASO annealing sites indicated by lines over the complementary sequence.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 271,\n            'f': \"271\",\n        },\n\"(A) Schematic diagram of human MAPT exon 10 and the flanking intronic regions with the ENA-ASO annealing sites indicated by lines over the complementary sequence.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 272,\n            'f': \"272\",\n        },\n\"Based on the antisense potencies and diversity of targeted sequences, three ENA-modified ASOs (EN-02, 03, and 06) that induced skipping of MAPT exon 10 in vitro were arbitrarily chosen for in vivo screening.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 273,\n            'f': \"273\",\n        },\n\"We compared the in vitro efficiency of tau splicing among four ENA-modified ASOs (EN-Ctrl, EN-03, EN-05, and EN-06) and four MOE-modified ASOs (MO-Ctrl, MO-03, MO-05, and MO-06) targeting the same sequences.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ENA\"],\n [{\n            'v': 274,\n            'f': \"274\",\n        },\n\"To assess potential artifacts in the quality of GISAID data, we performed an initial exploratory analysis of raw sequencing reads obtained via the European Nucleotide Archive (ENA).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 275,\n            'f': \"275\",\n        },\n\"To assess potential artifacts in the quality of GISAID data, we performed an initial exploratory analysis of raw sequencing reads obtained via the European Nucleotide Archive (ENA).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GISAID\"],\n [{\n            'v': 276,\n            'f': \"276\",\n        },\n\"For GISAID data, genomes were placed on a tree dated to the survey date (15 June 2022), while for ENA data, consensus sequences inferred through our pipeline were placed on a tree dated to the last input record (11 March 2022).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 277,\n            'f': \"277\",\n        },\n\"For GISAID data, genomes were placed on a tree dated to the survey date (15 June 2022), while for ENA data, consensus sequences inferred through our pipeline were placed on a tree dated to the last input record (11 March 2022).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GISAID\"],\n [{\n            'v': 278,\n            'f': \"278\",\n        },\n\"b) ENA dataset (3-fold random subset), with lineages assigned running pangolin v4.3 on consensus sequences reconstructed from read mappings (see Materials and methods ), as no lineage metadata is provided in database records.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 279,\n            'f': \"279\",\n        },\n\"To evaluate the reliability of GISAID-derived data, we compared its consensus sequences to corresponding raw reads from the ENA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 280,\n            'f': \"280\",\n        },\n\"To evaluate the reliability of GISAID-derived data, we compared its consensus sequences to corresponding raw reads from the ENA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GISAID\"],\n [{\n            'v': 281,\n            'f': \"281\",\n        },\n\"We also extend our acknowledgment to all contributors and submitters of raw reads hosted by the ENA and other members of the International Nucleotide Sequence Database Collaboration, which are also integral to this study.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 282,\n            'f': \"282\",\n        },\n\"The F. fastidiosum SGP1 and F. nucleatum ATCC 25586 genome sequences, corresponding gene annotations, and the raw read data are available in GenBank/ENA under BioProject accession number PRJEB82993 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 283,\n            'f': \"283\",\n        },\n\"The genome sequence data of strain 22-10884_313#20 has been deposited at ENA under accession number GCA_964417475.1 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 284,\n            'f': \"284\",\n        },\n\"The raw data are deposited in the European Nucleotide Archive (ENA) database under study accession PRJEB77885 42 with accession numbers of Illumina DNA short reads (ERR14104108), RNA (ERR14104109), Hi-C short reads (ERR14104110) and PacBio reads (ERR14104112).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 285,\n            'f': \"285\",\n        },\n\"Data from single cell experiments (17) were previously deposited to ENA (https://www.ebi.ac.uk/ena): PRJEB20144 (WGS) and PRJEB20143 (RNA).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 286,\n            'f': \"286\",\n        },\n\"All sequence data from patient 499 (20) samples were previously deposited into the EGA Sequence Read Archive (https://ega-archive.org) under accession number EGAS00001000942.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"EGA\"],\n [{\n            'v': 287,\n            'f': \"287\",\n        },\n\"RNA sequencing data from patient A21 (19) were previously deposited into the EGA Sequence Read Archive under accession number EGAS00001001659.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"EGA\"],\n [{\n            'v': 288,\n            'f': \"288\",\n        },\n\"Background: The 2022 European Society of Cardiology/European Respiratory Society (ESC/ERS) pulmonary hypertension guidelines recommend initial combination of endothelin receptor antagonist (ERA) and phosphodiesterase type-5 inhibitor (PDE5i) in patients with pulmonary arterial hypertension (PAH) at low to intermediate risk without cardiopulmonary comorbidities.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"ERA\"],\n [{\n            'v': 289,\n            'f': \"289\",\n        },\n\"These datasets comprise vast phylogenetic and taxonomic diversity from closely related species to all taxa currently represented on NCBI SRA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 290,\n            'f': \"290\",\n        },\n\"The datasets made available in this data descriptor include the following: (1) newly sequenced and expert-curated low-coverage whole genome sequencing for species in the flowering plant clade Malpighiales, spanning divergences from closely related species to families, and with samples labeled at species, genus and family levels (2) species-level datasets for plants, animals, fungi and bacteria obtained from the literature, and samples labeled at the species level or below (3) a dataset including all eukaryotic families from the NCBI SRA, labeled at the family level and (4) a dataset with all taxa available from the NCBI SRA, labeled with their complete taxonomic classification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 291,\n            'f': \"291\",\n        },\n\"For example, neither conventional barcodes or Skmer can be applied to all taxa on NCBI SRA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 292,\n            'f': \"292\",\n        },\n\"To test shallow-level classification at species or lower taxonomic ranks, we compiled four datasets from publicly available genome skimming data from the NCBI SRA using NCBI Entrez.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 293,\n            'f': \"293\",\n        },\n\"NCBI BioProject Database\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 294,\n            'f': \"294\",\n        },\n\"https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1206793 [ 18 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 295,\n            'f': \"295\",\n        },\n\"https://identifiers.org/ncbi/insdc.sra:SRR31897982 [ 19 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 296,\n            'f': \"296\",\n        },\n\"FASTQ files from Illumina sequencing are available in the NCBI Gene Expression Omnibus.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCBI\"],\n [{\n            'v': 297,\n            'f': \"297\",\n        },\n\"FASTQ files from Illumina sequencing are available in the NCBI Gene Expression Omnibus.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Gene Expression Omnibus\"],\n [{\n            'v': 298,\n            'f': \"298\",\n        },\n\"The final 16 data sets of raw FASTQ data and FeatureCount table were deposited in the NCBI Gene Expression Omnibus (accessible on https://identifiers.org/geo:GSE287646 ) and listed in Table 1 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCBI\"],\n [{\n            'v': 299,\n            'f': \"299\",\n        },\n\"The final 16 data sets of raw FASTQ data and FeatureCount table were deposited in the NCBI Gene Expression Omnibus (accessible on https://identifiers.org/geo:GSE287646 ) and listed in Table 1 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Gene Expression Omnibus\"],\n [{\n            'v': 300,\n            'f': \"300\",\n        },\n\"The raw RNA sequencing results for this publication are available from the NCBI Gene Expression Omnibus and are accessible through GEO Series accession number GSE287646 ( http://identifiers.org/geo:GSE287646 , [ 28 ]).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCBI\"],\n [{\n            'v': 301,\n            'f': \"301\",\n        },\n\"The raw RNA sequencing results for this publication are available from the NCBI Gene Expression Omnibus and are accessible through GEO Series accession number GSE287646 ( http://identifiers.org/geo:GSE287646 , [ 28 ]).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Gene Expression Omnibus\"],\n [{\n            'v': 302,\n            'f': \"302\",\n        },\n\"The raw RNA sequencing results for this publication are available from the NCBI Gene Expression Omnibus and are accessible through GEO Series accession number GSE287646 ( http://identifiers.org/geo:GSE287646 , [ 28 ]).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 303,\n            'f': \"303\",\n        },\n\"Species Family Source Bombyx mori Bombycidae NCBI (GCF_000151625.1) Carposina sasakii Carposinidae NCBI (GCA_014607495.2) Chilo suppressalis Crambidae NCBI (GCA_902850365.2) Cnaphalocrocis medinalis Crambidae NCBI (GCA_014851415.1) Diatraea saccharalis Crambidae NCBI (GCA_918026875.4) Heortia vitessoides Crambidae NCBI (GCA_020976665.1) Ostrinia furnacalis Crambidae NCBI (GCA_041937195.1) Parotis chlorochroalis Crambidae This study Arctia plantaginis Erebidae NCBI (GCA_902825455.1) Ectropis grisescens Geometridae NCBI (GCA_017562165.1) Operophtera brumata Geometridae NCBI (GCA_932527245.1) Dendrolimus punctatus Lasiocampidae NCBI (GCA_012273795.1) Helicoverpa armigera Noctuidae NCBI (GCF_002156985.1) Heliothis virescens Noctuidae NCBI (GCA_002382865.2) Spodoptera litura Noctuidae NCBI (GCF_002706865.2) Trichoplusia ni Noctuidae NCBI (GCF_003590095.1) Danaus plexippus Nymphalidae NCBI (GCF_018135715.1 Kallima inachus Nymphalidae 10.5061/dryad.8w9ghx3gt Papilio bianor Papilionidae NCBI (GCA_040363705.1) Pieris napi Pieridae NCBI (GCF_905475465.1) Zerene cesonia Pieridae NCBI (GCF_012273895.1) Plutella xylostella Plutellidae NCBI (GCF_932276165.1) Ephestia elutella Pyralidae NCBI (GCA_018467065.1) Antheraea pernyi Saturniidae NCBI (GCA_015888305.1) Manduca sexta Sphingidae NCBI (GCF_014839805.1) Cydia pomonella Tortricidae NCBI (GCF_033807575.1)\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 304,\n            'f': \"304\",\n        },\n\"Bombyx mori Bombycidae NCBI (GCF_000151625.1)\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 305,\n            'f': \"305\",\n        },\n\"Carposina sasakii Carposinidae NCBI (GCA_014607495.2)\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 306,\n            'f': \"306\",\n        },\n\"The predicted PCGs were functionally annotated using BLAST v2.9.0 (E-value = 1E-05) [ 29 ] against the public protein databases, namely the KEGG [ 30 ], GO [ 31 ], NR ( https://ftp.ncbi.nlm.nih.gov/ ), Swiss-Prot ( http://www.expasy.ch/sprot ), InterPro [ 32 ], and KOG ( https://ftp.ncbi.nih.gov/pub/COG/KOG/ ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCBI\"],\n [{\n            'v': 307,\n            'f': \"307\",\n        },\n\"The predicted PCGs were functionally annotated using BLAST v2.9.0 (E-value = 1E-05) [ 29 ] against the public protein databases, namely the KEGG [ 30 ], GO [ 31 ], NR ( https://ftp.ncbi.nlm.nih.gov/ ), Swiss-Prot ( http://www.expasy.ch/sprot ), InterPro [ 32 ], and KOG ( https://ftp.ncbi.nih.gov/pub/COG/KOG/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 308,\n            'f': \"308\",\n        },\n\"The predicted PCGs were functionally annotated using BLAST v2.9.0 (E-value = 1E-05) [ 29 ] against the public protein databases, namely the KEGG [ 30 ], GO [ 31 ], NR ( https://ftp.ncbi.nlm.nih.gov/ ), Swiss-Prot ( http://www.expasy.ch/sprot ), InterPro [ 32 ], and KOG ( https://ftp.ncbi.nih.gov/pub/COG/KOG/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 309,\n            'f': \"309\",\n        },\n\"The predicted PCGs were functionally annotated using BLAST v2.9.0 (E-value = 1E-05) [ 29 ] against the public protein databases, namely the KEGG [ 30 ], GO [ 31 ], NR ( https://ftp.ncbi.nlm.nih.gov/ ), Swiss-Prot ( http://www.expasy.ch/sprot ), InterPro [ 32 ], and KOG ( https://ftp.ncbi.nih.gov/pub/COG/KOG/ ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCBI\"],\n [{\n            'v': 310,\n            'f': \"310\",\n        },\n\"The predicted PCGs were functionally annotated using BLAST v2.9.0 (E-value = 1E-05) [ 29 ] against the public protein databases, namely the KEGG [ 30 ], GO [ 31 ], NR ( https://ftp.ncbi.nlm.nih.gov/ ), Swiss-Prot ( http://www.expasy.ch/sprot ), InterPro [ 32 ], and KOG ( https://ftp.ncbi.nih.gov/pub/COG/KOG/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Swiss-Prot\"],\n [{\n            'v': 311,\n            'f': \"311\",\n        },\n\"The predicted PCGs were functionally annotated using BLAST v2.9.0 (E-value = 1E-05) [ 29 ] against the public protein databases, namely the KEGG [ 30 ], GO [ 31 ], NR ( https://ftp.ncbi.nlm.nih.gov/ ), Swiss-Prot ( http://www.expasy.ch/sprot ), InterPro [ 32 ], and KOG ( https://ftp.ncbi.nih.gov/pub/COG/KOG/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 312,\n            'f': \"312\",\n        },\n\"The predicted PCGs were functionally annotated using BLAST v2.9.0 (E-value = 1E-05) [ 29 ] against the public protein databases, namely the KEGG [ 30 ], GO [ 31 ], NR ( https://ftp.ncbi.nlm.nih.gov/ ), Swiss-Prot ( http://www.expasy.ch/sprot ), InterPro [ 32 ], and KOG ( https://ftp.ncbi.nih.gov/pub/COG/KOG/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KOG\"],\n [{\n            'v': 313,\n            'f': \"313\",\n        },\n\"https://identifiers.org/ncbi/insdc.sra:SRR25056968\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 314,\n            'f': \"314\",\n        },\n\"https://identifiers.org/ncbi/insdc.sra:SRR25056968\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 315,\n            'f': \"315\",\n        },\n\"https://identifiers.org/ncbi/insdc.sra:SRR25056969\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 316,\n            'f': \"316\",\n        },\n\"https://identifiers.org/ncbi/insdc.sra:SRR25056969\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 317,\n            'f': \"317\",\n        },\n\"The data described in this Data note can be freely accessed on NCBI under Bioproject ID PRJNA656383.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 318,\n            'f': \"318\",\n        },\n\"The data described in this Data note can be freely accessed on NCBI under Bioproject ID PRJNA656383.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioProject\"],\n [{\n            'v': 319,\n            'f': \"319\",\n        },\n\"Data file 1 Raw WGS long reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12489157 ) [ 13 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 320,\n            'f': \"320\",\n        },\n\"Data file 1 Raw WGS long reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12489157 ) [ 13 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 321,\n            'f': \"321\",\n        },\n\"Data file 2 Raw Hi-C reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12605950 ) [ 14 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 322,\n            'f': \"322\",\n        },\n\"Data file 2 Raw Hi-C reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12605950 ) [ 14 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 323,\n            'f': \"323\",\n        },\n\"Data file 3 Raw illumina HiSeq reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12443991 ) [ 15 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 324,\n            'f': \"324\",\n        },\n\"Data file 3 Raw illumina HiSeq reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12443991 ) [ 15 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 325,\n            'f': \"325\",\n        },\n\"As part of developing varKoder , a new method of DNA-based taxonomic identification based on low-coverage genomic reads 1 (i.e., genome skimming), we have created a number of curated datasets for organisms spanning different taxonomic ranks and phylogenetic depths, from closely related populations, species, to all taxa represented on the NCBI Sequence Read Archive (SRA, https://www.ncbi.nlm.nih.gov/sra/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 326,\n            'f': \"326\",\n        },\n\"As part of developing varKoder , a new method of DNA-based taxonomic identification based on low-coverage genomic reads 1 (i.e., genome skimming), we have created a number of curated datasets for organisms spanning different taxonomic ranks and phylogenetic depths, from closely related populations, species, to all taxa represented on the NCBI Sequence Read Archive (SRA, https://www.ncbi.nlm.nih.gov/sra/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 327,\n            'f': \"327\",\n        },\n\"Table 1 Overview of data files/data sets Label Name of data file/data sets File types (file extension) Data repository and identifier (DOI or accession number) Data file 1 Data analysis workflow PDF Figshare: 10.6084/m9.figshare.28802672 [ 16 ] Data file 2 Antimicrobial resistance profile PDF Figshare: 10.6084/m9.figshare.28805720 [ 17 ] Data file 3 Klebsiella quasipneumoniae I1-1, I1-3, I5-2, and I5-3 NCBI BioProject No file format NCBI BioProject Database https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1206793 [ 18 ] Data file 4 Klebsiella quasipneumoniae I1-1 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897982 https://identifiers.org/ncbi/insdc.sra:SRR31897982 [ 19 ] Data file 5 Klebsiella quasipneumoniae I1-3 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897981 https://identifiers.org/ncbi/insdc.sra:SRR31897981 [ 20 ] Data file 6 Klebsiella quasipneumoniae I5-2 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897980 https://identifiers.org/ncbi/insdc.sra:SRR31897980 [ 21 ] Data file 7 Klebsiella quasipneumoniae I5-3 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897979 https://identifiers.org/ncbi/insdc.sra:SRR31897979 [ 22 ] Data file 8 Klebsiella quasipneumoniae I1-1, I1-3, I5-2, and I5-3 NCBI BioSample No file format NCBI BioSample https://www.ncbi.nlm.nih.gov/biosample?LinkName=bioproject_biosample_all%26;from_uid=1206793 [ 23 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 328,\n            'f': \"328\",\n        },\n\"Table 1 Overview of data files/data sets Label Name of data file/data sets File types (file extension) Data repository and identifier (DOI or accession number) Data file 1 Data analysis workflow PDF Figshare: 10.6084/m9.figshare.28802672 [ 16 ] Data file 2 Antimicrobial resistance profile PDF Figshare: 10.6084/m9.figshare.28805720 [ 17 ] Data file 3 Klebsiella quasipneumoniae I1-1, I1-3, I5-2, and I5-3 NCBI BioProject No file format NCBI BioProject Database https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1206793 [ 18 ] Data file 4 Klebsiella quasipneumoniae I1-1 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897982 https://identifiers.org/ncbi/insdc.sra:SRR31897982 [ 19 ] Data file 5 Klebsiella quasipneumoniae I1-3 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897981 https://identifiers.org/ncbi/insdc.sra:SRR31897981 [ 20 ] Data file 6 Klebsiella quasipneumoniae I5-2 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897980 https://identifiers.org/ncbi/insdc.sra:SRR31897980 [ 21 ] Data file 7 Klebsiella quasipneumoniae I5-3 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897979 https://identifiers.org/ncbi/insdc.sra:SRR31897979 [ 22 ] Data file 8 Klebsiella quasipneumoniae I1-1, I1-3, I5-2, and I5-3 NCBI BioSample No file format NCBI BioSample https://www.ncbi.nlm.nih.gov/biosample?LinkName=bioproject_biosample_all%26;from_uid=1206793 [ 23 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Sequence Read Archive\"],\n [{\n            'v': 329,\n            'f': \"329\",\n        },\n\"Table 1 Overview of data files/data sets Label Name of data file/data sets File types (file extension) Data repository and identifier (DOI or accession number) Data file 1 Data analysis workflow PDF Figshare: 10.6084/m9.figshare.28802672 [ 16 ] Data file 2 Antimicrobial resistance profile PDF Figshare: 10.6084/m9.figshare.28805720 [ 17 ] Data file 3 Klebsiella quasipneumoniae I1-1, I1-3, I5-2, and I5-3 NCBI BioProject No file format NCBI BioProject Database https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1206793 [ 18 ] Data file 4 Klebsiella quasipneumoniae I1-1 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897982 https://identifiers.org/ncbi/insdc.sra:SRR31897982 [ 19 ] Data file 5 Klebsiella quasipneumoniae I1-3 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897981 https://identifiers.org/ncbi/insdc.sra:SRR31897981 [ 20 ] Data file 6 Klebsiella quasipneumoniae I5-2 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897980 https://identifiers.org/ncbi/insdc.sra:SRR31897980 [ 21 ] Data file 7 Klebsiella quasipneumoniae I5-3 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897979 https://identifiers.org/ncbi/insdc.sra:SRR31897979 [ 22 ] Data file 8 Klebsiella quasipneumoniae I1-1, I1-3, I5-2, and I5-3 NCBI BioSample No file format NCBI BioSample https://www.ncbi.nlm.nih.gov/biosample?LinkName=bioproject_biosample_all%26;from_uid=1206793 [ 23 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioProject\"],\n [{\n            'v': 330,\n            'f': \"330\",\n        },\n\"Table 1 Overview of data files/data sets Label Name of data file/data sets File types (file extension) Data repository and identifier (DOI or accession number) Data file 1 Data analysis workflow PDF Figshare: 10.6084/m9.figshare.28802672 [ 16 ] Data file 2 Antimicrobial resistance profile PDF Figshare: 10.6084/m9.figshare.28805720 [ 17 ] Data file 3 Klebsiella quasipneumoniae I1-1, I1-3, I5-2, and I5-3 NCBI BioProject No file format NCBI BioProject Database https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1206793 [ 18 ] Data file 4 Klebsiella quasipneumoniae I1-1 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897982 https://identifiers.org/ncbi/insdc.sra:SRR31897982 [ 19 ] Data file 5 Klebsiella quasipneumoniae I1-3 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897981 https://identifiers.org/ncbi/insdc.sra:SRR31897981 [ 20 ] Data file 6 Klebsiella quasipneumoniae I5-2 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897980 https://identifiers.org/ncbi/insdc.sra:SRR31897980 [ 21 ] Data file 7 Klebsiella quasipneumoniae I5-3 Illumina raw sequence fastq NCBI Sequence Read Archive SRR31897979 https://identifiers.org/ncbi/insdc.sra:SRR31897979 [ 22 ] Data file 8 Klebsiella quasipneumoniae I1-1, I1-3, I5-2, and I5-3 NCBI BioSample No file format NCBI BioSample https://www.ncbi.nlm.nih.gov/biosample?LinkName=bioproject_biosample_all%26;from_uid=1206793 [ 23 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioSample\"],\n [{\n            'v': 331,\n            'f': \"331\",\n        },\n\"Table 1 Overview of data files/data sets Label Name of data file/data set File types (file extension) Data repository and identifier (DOI or accession number) Data files 1 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; http://identifiers.org/geo:GSM8749322 [ 12 ] Data files 2 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; http://identifiers.org/geo:GSM8749326 [ 13 ] Data files 3 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; http://identifiers.org/geo:GSM8749330 [ 14 ] Data files 4 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749334 [ 15 ] Data files 5 Raw sequence reads for senescent MSCs MmC+/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749324 [ 16 ] Data files 6 Raw sequence reads for senescent MSCs MmC+/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749328 [ 17 ] Data files 7 Raw sequence reads for senescent MSCs MmC+/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749332 [ 18 ] Data files 8 Raw sequence reads for senescent MSCs MmC+/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749336 [ 19 ] Data files 9 Raw sequence reads for MSCs treated with GDF11 MmC-/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749323 [ 20 ] Data files 10 Raw sequence reads for MSCs treated with GDF11 MmC-/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749327 [ 21 ] Data files 11 Raw sequence reads for MSCs treated with GDF11 MmC-/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749331 [ 22 ] Data files 12 Raw sequence reads for MSCs treated with GDF11 MmC-/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749335 [ 23 ] Data files 13 Raw sequence reads for senescent MSCs treated with GDF11 MmC+/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM87493325 [ 24 ] Data files 14 Raw sequence reads for senescent MSCs treated with GDF11 MmC+/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749329 [ 25 ] Data files 15 Raw sequence reads for senescent MSCs treated with GDF11 MmC+/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749333 [ 26 ] Data files 16 Raw sequence reads for senescent MSCs treated with GDF11 MmC+/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749337 [ 27 ] Data file 17 FeatureCount table Table (.txt.gz) NCBI GEO; http://identifiers.org/geo:GSE287646 [ 28 ]\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCBI\"],\n [{\n            'v': 332,\n            'f': \"332\",\n        },\n\"Table 1 Overview of data files/data sets Label Name of data file/data set File types (file extension) Data repository and identifier (DOI or accession number) Data files 1 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; http://identifiers.org/geo:GSM8749322 [ 12 ] Data files 2 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; http://identifiers.org/geo:GSM8749326 [ 13 ] Data files 3 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; http://identifiers.org/geo:GSM8749330 [ 14 ] Data files 4 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749334 [ 15 ] Data files 5 Raw sequence reads for senescent MSCs MmC+/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749324 [ 16 ] Data files 6 Raw sequence reads for senescent MSCs MmC+/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749328 [ 17 ] Data files 7 Raw sequence reads for senescent MSCs MmC+/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749332 [ 18 ] Data files 8 Raw sequence reads for senescent MSCs MmC+/GDF11- FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749336 [ 19 ] Data files 9 Raw sequence reads for MSCs treated with GDF11 MmC-/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749323 [ 20 ] Data files 10 Raw sequence reads for MSCs treated with GDF11 MmC-/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749327 [ 21 ] Data files 11 Raw sequence reads for MSCs treated with GDF11 MmC-/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749331 [ 22 ] Data files 12 Raw sequence reads for MSCs treated with GDF11 MmC-/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749335 [ 23 ] Data files 13 Raw sequence reads for senescent MSCs treated with GDF11 MmC+/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM87493325 [ 24 ] Data files 14 Raw sequence reads for senescent MSCs treated with GDF11 MmC+/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749329 [ 25 ] Data files 15 Raw sequence reads for senescent MSCs treated with GDF11 MmC+/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749333 [ 26 ] Data files 16 Raw sequence reads for senescent MSCs treated with GDF11 MmC+/GDF11+ FASTQ files (.fastq.gz) NCBI GEO; https://identifiers.org/geo:GSM8749337 [ 27 ] Data file 17 FeatureCount table Table (.txt.gz) NCBI GEO; http://identifiers.org/geo:GSE287646 [ 28 ]\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 333,\n            'f': \"333\",\n        },\n\"Data files 1 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; http://identifiers.org/geo:GSM8749322 [ 12 ]\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCBI\"],\n [{\n            'v': 334,\n            'f': \"334\",\n        },\n\"Data files 1 Raw sequence reads for control MSCs MmC-/GDF11- FASTQ files (.fastq.gz) NCBI GEO; http://identifiers.org/geo:GSM8749322 [ 12 ]\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 335,\n            'f': \"335\",\n        },\n\"Potential contaminants were screened using blastn (BLAST + v2.11) 25 against the NCBI nucleotide database, and sequences shorter than 1,000 bp and non-target sequences were filtered using BlobToolKit environment 26 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 336,\n            'f': \"336\",\n        },\n\"The raw sequence data of Illumina, transcriptome, Hi-C, and PacBio can be found under identification numbers CRR1371036-CRR1371040 57 - 61 for NGDC and SRP506446 62 for NCBI, the whole genome sequence assembly can be found under identification numbers GWHFIDL00000000.1 63 as well as deposited in the NCBI assembly with the accession number GCA_047302205.1 64 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 337,\n            'f': \"337\",\n        },\n\"Table 1 Overview of all data files/data sets Labe Name of data file/data set File types (file extension) Data repository and identifier (DOI or accession number) Data file 1 Raw short MGI sequencing reads Fasta file (.fastq) NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056966 [ 33 ] Data file 2 Raw long HiFi sequencing reads Fasta file (.fastq) NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056964 [ 34 ] Data file 3 Raw Hi-C sequencing reads Fasta file (.fastq) NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056965 [ 35 ] Data file 4 Raw RNA-seq reads for seven tissues Fasta file (.fastq) NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056967 https://identifiers.org/ncbi/insdc.sra:SRR25056968 https://identifiers.org/ncbi/insdc.sra:SRR25056969 https://identifiers.org/ncbi/insdc.sra:SRR25056970 https://identifiers.org/ncbi/insdc.sra:SRR25056971 https://identifiers.org/ncbi/insdc.sra:SRR25056972 https://identifiers.org/ncbi/insdc.sra:SRR25056973 [ 36 ] Data file 5 Supplementary of the genome pdf file (.pdf) Figshare, 10.6084/m9.figshare.23651262 [ 37 ] Data file 6 Assembled genome Fasta file (.fasta) NCBI GenBank, https://identifiers.org/ncbi/insdc.gca:GCA_030549335.1 [ 38 ] Data file 7 Predicted gene Gff3 file (.gff) Figshare, 10.6084/m9.figshare.23635401 [ 39 ] Data file 8 Predicted gene-CDS CDS file (.cds) Figshare, 10.6084/m9.figshare.23635401 [ 39 ] Data file 9 Predicted gene-Protein Protein file (.pep) Figshare, 10.6084/m9.figshare.23635401 [ 39 ] Data file 10 Gene annotation using KEGG, GO, InterPro, Swiss-Prot, NR, and KOG databases Annotation file (.html) Figshare, 10.6084/m9.figshare.23635401 [ 39 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 338,\n            'f': \"338\",\n        },\n\"Table 1 Overview of all data files/data sets Labe Name of data file/data set File types (file extension) Data repository and identifier (DOI or accession number) Data file 1 Raw short MGI sequencing reads Fasta file (.fastq) NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056966 [ 33 ] Data file 2 Raw long HiFi sequencing reads Fasta file (.fastq) NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056964 [ 34 ] Data file 3 Raw Hi-C sequencing reads Fasta file (.fastq) NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056965 [ 35 ] Data file 4 Raw RNA-seq reads for seven tissues Fasta file (.fastq) NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056967 https://identifiers.org/ncbi/insdc.sra:SRR25056968 https://identifiers.org/ncbi/insdc.sra:SRR25056969 https://identifiers.org/ncbi/insdc.sra:SRR25056970 https://identifiers.org/ncbi/insdc.sra:SRR25056971 https://identifiers.org/ncbi/insdc.sra:SRR25056972 https://identifiers.org/ncbi/insdc.sra:SRR25056973 [ 36 ] Data file 5 Supplementary of the genome pdf file (.pdf) Figshare, 10.6084/m9.figshare.23651262 [ 37 ] Data file 6 Assembled genome Fasta file (.fasta) NCBI GenBank, https://identifiers.org/ncbi/insdc.gca:GCA_030549335.1 [ 38 ] Data file 7 Predicted gene Gff3 file (.gff) Figshare, 10.6084/m9.figshare.23635401 [ 39 ] Data file 8 Predicted gene-CDS CDS file (.cds) Figshare, 10.6084/m9.figshare.23635401 [ 39 ] Data file 9 Predicted gene-Protein Protein file (.pep) Figshare, 10.6084/m9.figshare.23635401 [ 39 ] Data file 10 Gene annotation using KEGG, GO, InterPro, Swiss-Prot, NR, and KOG databases Annotation file (.html) Figshare, 10.6084/m9.figshare.23635401 [ 39 ]\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Sequence Read Archive\"],\n [{\n            'v': 339,\n            'f': \"339\",\n        },\n\"NCBI Sequence Read Archive, https://identifiers.org/ncbi/insdc.sra:SRR25056967\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 340,\n            'f': \"340\",\n        },\n\"Table 1 Overview of data files and data sets Label Name of data file/data set File types (file extension) Data repository and identifier (DOI or accession number) Data file 1 Raw WGS long reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12489157 ) [ 13 ] Data file 2 Raw Hi-C reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12605950 ) [ 14 ] Data file 3 Raw illumina HiSeq reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12443991 ) [ 15 ] Data file 4 Raw ISO-seq reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR31179476 ) [ 16 ] Data file 5 Full length transcripts consensus sequencing Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12489156 ) [ 17 ] Data file 6 Genome survey Text file (.txt) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 7 Assembled genome Fasta file (.fasta) NCBI ( https://identifiers.org/ncbi/insdc.gca:GCA_019677235.1 ) [ 19 ] Data file 8 BUSCO assessment of the assembly Text file (.txt) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 9 Merqury spectra-cn plot Portable network graphics (.png) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 10 Genome synteny and collinearity analysis Portable document format(.pdf) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 11 Predicted gene Spreadsheet(.xlsx) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 12 Predicted genes - nucleotide sequences Fasta file (.fasta) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 13 Predicted genes - translated sequences Fasta file (.fasta) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 14 Gene annotation using GO, interPro a, KEGG, NR, Swissprot, TrEMBL.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 341,\n            'f': \"341\",\n        },\n\"Table 1 Overview of data files and data sets Label Name of data file/data set File types (file extension) Data repository and identifier (DOI or accession number) Data file 1 Raw WGS long reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12489157 ) [ 13 ] Data file 2 Raw Hi-C reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12605950 ) [ 14 ] Data file 3 Raw illumina HiSeq reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12443991 ) [ 15 ] Data file 4 Raw ISO-seq reads Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR31179476 ) [ 16 ] Data file 5 Full length transcripts consensus sequencing Fastq file (.fastq.gz) NCBI ( https://identifiers.org/ncbi/insdc.sra:SRR12489156 ) [ 17 ] Data file 6 Genome survey Text file (.txt) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 7 Assembled genome Fasta file (.fasta) NCBI ( https://identifiers.org/ncbi/insdc.gca:GCA_019677235.1 ) [ 19 ] Data file 8 BUSCO assessment of the assembly Text file (.txt) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 9 Merqury spectra-cn plot Portable network graphics (.png) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 10 Genome synteny and collinearity analysis Portable document format(.pdf) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 11 Predicted gene Spreadsheet(.xlsx) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 12 Predicted genes - nucleotide sequences Fasta file (.fasta) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 13 Predicted genes - translated sequences Fasta file (.fasta) Figshare (10.6084/m9.figshare.26391472.v2) [ 18 ] Data file 14 Gene annotation using GO, interPro a, KEGG, NR, Swissprot, TrEMBL.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Sequence Read Archive\"],\n [{\n            'v': 342,\n            'f': \"342\",\n        },\n\"The raw Illumina sequencing data for genome survey were deposited in the Sequence Read Archive at NCBI under accession number SRR30106271 75 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 343,\n            'f': \"343\",\n        },\n\"The raw Illumina sequencing data for genome survey were deposited in the Sequence Read Archive at NCBI under accession number SRR30106271 75 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Sequence Read Archive\"],\n [{\n            'v': 344,\n            'f': \"344\",\n        },\n\"The raw Illumina sequencing data for genome assembly were deposited in the Sequence Read Archive at NCBI under accession number SRR30106270 76 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 345,\n            'f': \"345\",\n        },\n\"The raw Illumina sequencing data for genome assembly were deposited in the Sequence Read Archive at NCBI under accession number SRR30106270 76 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Sequence Read Archive\"],\n [{\n            'v': 346,\n            'f': \"346\",\n        },\n\"Hi-C sequencing data were deposited in the Sequence Read Archive at NCBI under accession number SRR30106263 77 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 347,\n            'f': \"347\",\n        },\n\"Hi-C sequencing data were deposited in the Sequence Read Archive at NCBI under accession number SRR30106263 77 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Sequence Read Archive\"],\n [{\n            'v': 348,\n            'f': \"348\",\n        },\n\"Nanopore sequencing raw data were deposited in the Sequence Read Archive at NCBI under accession number SRR30106264 78 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 349,\n            'f': \"349\",\n        },\n\"Nanopore sequencing raw data were deposited in the Sequence Read Archive at NCBI under accession number SRR30106264 78 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Sequence Read Archive\"],\n [{\n            'v': 350,\n            'f': \"350\",\n        },\n\"RNA-seq data were deposited in the Sequence Read Archive at NCBI under accession numbers SRR30106257-62 79 - 84 , SRR30106265-69 85 - 89 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 351,\n            'f': \"351\",\n        },\n\"RNA-seq data were deposited in the Sequence Read Archive at NCBI under accession numbers SRR30106257-62 79 - 84 , SRR30106265-69 85 - 89 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Sequence Read Archive\"],\n [{\n            'v': 352,\n            'f': \"352\",\n        },\n\"The sequence data of the study isolates were submitted to NCBI GenBank to obtain specific access numbers.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 353,\n            'f': \"353\",\n        },\n\"The sequence data of the study isolates were submitted to NCBI GenBank to obtain specific access numbers.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 354,\n            'f': \"354\",\n        },\n\"Then, multiple sequence alignment analysis, phylogenetic tree analysis, and homology sequence identity were performed using MEGA-11 Software and NCBI-Viewer to identify significant identity between the study local B. bronchiseptica isolates and the NCBI-BLAST B. bronchiseptica isolates/strains.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 355,\n            'f': \"355\",\n        },\n\"[TABLE-CAPTION] Homology sequence identity (%) of local and NCBI-BLAST B. bronchiseptica isolates.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 356,\n            'f': \"356\",\n        },\n\"The 16 S rRNA partial nucleotide sequence was compared with those available in the GenBank databases by using the BLAST tool (blastn) ( https://blast.ncbi.nlm.nih.gov/Blast.cgi ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 357,\n            'f': \"357\",\n        },\n\"This paper constructs three bi-class multi-relational heterogeneous graphs based on real-world data, and it proposes a semantic and relation aware neural network model (SRA-BMHN) designed for bi-class multi-relational heterogeneous graphs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 358,\n            'f': \"358\",\n        },\n\"These datasets comprise vast phylogenetic and taxonomic diversity from closely related species to all taxa currently represented on NCBI SRA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 359,\n            'f': \"359\",\n        },\n\"These datasets comprise vast phylogenetic and taxonomic diversity from closely related species to all taxa currently represented on NCBI SRA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 360,\n            'f': \"360\",\n        },\n\"The datasets made available in this data descriptor include the following: (1) newly sequenced and expert-curated low-coverage whole genome sequencing for species in the flowering plant clade Malpighiales, spanning divergences from closely related species to families, and with samples labeled at species, genus and family levels (2) species-level datasets for plants, animals, fungi and bacteria obtained from the literature, and samples labeled at the species level or below (3) a dataset including all eukaryotic families from the NCBI SRA, labeled at the family level and (4) a dataset with all taxa available from the NCBI SRA, labeled with their complete taxonomic classification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 361,\n            'f': \"361\",\n        },\n\"For example, neither conventional barcodes or Skmer can be applied to all taxa on NCBI SRA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 362,\n            'f': \"362\",\n        },\n\"To test shallow-level classification at species or lower taxonomic ranks, we compiled four datasets from publicly available genome skimming data from the NCBI SRA using NCBI Entrez.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 363,\n            'f': \"363\",\n        },\n\"This study introduces two innovative coupled models\\u2014SRA-SVR and SRA-MLPR\\u2014to enhance runoff prediction by leveraging the strengths of statistical and deep learning approaches.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 364,\n            'f': \"364\",\n        },\n\"Stepwise Regression Analysis (SRA) was employed to effectively handle high-dimensional data and multicollinearity, ensuring that only the most influential predictive variables were retained.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 365,\n            'f': \"365\",\n        },\n\"The results show that: (1) Compared to baseline single models, the SRA-MLPR model reduced RMSE (from 798.47 to 594.45) by 26% and MAPE (from 34.79 to 22.90%) by 34%, while achieving an NSE (from 0.67 to 0.76) improvement of 13%, particularly excelling in extreme runoff scenarios.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 366,\n            'f': \"366\",\n        },\n\"(2) The inclusion of teleconnection indices not only enriched the predictive feature set but also improved model stability, with the SRA-MLPR demonstrating enhanced capability in capturing latent nonlinear relationships.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 367,\n            'f': \"367\",\n        },\n\"To address these challenges, researchers have explored variable selection and dimensionality reduction techniques, such as stepwise regression analysis (SRA) 25 and wavelet analysis 26 , to improve computational efficiency and prediction accuracy.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 368,\n            'f': \"368\",\n        },\n\"This predominant pattern involved the IMA bifurcating into the left colic artery (LCA) and a common trunk for both the superior rectal artery (SRA) and the sigmoid artery (SA), with a pooled prevalence of 46.09%.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 369,\n            'f': \"369\",\n        },\n\"Then, it continues as the superior rectal artery (SRA) in the sigmoid mesocolon's root [ 34 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 370,\n            'f': \"370\",\n        },\n\"LCA- left colic artery, SA- sigmoid artery, SRA- superior rectal artery, ALCA- accessory left colic artery, ALA- ascending lumbar artery\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 371,\n            'f': \"371\",\n        },\n\"LCA- left colic artery, SA- sigmoid artery, SRA- superior rectal artery, ALCA- accessory left colic artery, ALA- ascending lumbar artery\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 372,\n            'f': \"372\",\n        },\n\"The predominant pattern involved the IMA bifurcation into the LCA and a common trunk for the SRA and SA, showcasing a pooled prevalence of 46.09% ( 95% CI: 39.54-52.71% ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 373,\n            'f': \"373\",\n        },\n\"(C) Selective microcatheter angiography of the superior rectal artery (SRA) via a 2.8-Fr microcatheter reveals no active contrast extravasation (arrows).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 374,\n            'f': \"374\",\n        },\n\"(D) Postembolization angiography of the SRA via a 2.8-Fr microcatheter demonstrates marked flow reduction (arrows) following administration of 350-560\\u2005\\u03bcm GS.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 375,\n            'f': \"375\",\n        },\n\"Subsequent angiography revealed atherosclerotic occlusion of the right internal iliac artery (RIIA) ( Figure 2(B) ), with no active bleeding from the SRA ( Figure 2(C) ) or LIRA ( Figure 2(D) ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 376,\n            'f': \"376\",\n        },\n\"(C) Selective microcatheter angiography of the SRA identifies no contrast extravasation (arrows).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 377,\n            'f': \"377\",\n        },\n\"Given inadequate bowel preparation and hemodynamic instability, emergency angiography was performed, revealing contrast extravasation from the left terminal branch of superior rectal artery (LT-SRA) ( Figure 3(A) ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SRA\"],\n [{\n            'v': 378,\n            'f': \"378\",\n        },\n\"As nanopore sequencing technology becomes more accurate and cost-effective 2 , its adoption has surged in recent years, leading to the accumulation of over 700,000 datasets in the Sequence Read Archive (SRA) database ( https://www.ncbi.nlm.nih.gov/sra ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 379,\n            'f': \"379\",\n        },\n\"The integration of sequenced samples and clinical data from independent yet related studies from public domain databases, such as The Sequence Read Archive (SRA), has the potential to increase sample sizes and enhance the statistical power needed for more precise bioinformatic analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 380,\n            'f': \"380\",\n        },\n\"Addressing these challenges is pivotal for advancing the identification and validation of disease-specific biomarkers and improving translational research outcomes.Among other public domain databases such as Gene Expression Omnibus (GEO) 24 and The Cancer Genome Atlas (TCGA) 25 , the Sequence Read Archive (SRA) 26 is recognized as a crucial data source for biological research.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 381,\n            'f': \"381\",\n        },\n\"Addressing these challenges is pivotal for advancing the identification and validation of disease-specific biomarkers and improving translational research outcomes.Among other public domain databases such as Gene Expression Omnibus (GEO) 24 and The Cancer Genome Atlas (TCGA) 25 , the Sequence Read Archive (SRA) 26 is recognized as a crucial data source for biological research.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 382,\n            'f': \"382\",\n        },\n\"Addressing these challenges is pivotal for advancing the identification and validation of disease-specific biomarkers and improving translational research outcomes.Among other public domain databases such as Gene Expression Omnibus (GEO) 24 and The Cancer Genome Atlas (TCGA) 25 , the Sequence Read Archive (SRA) 26 is recognized as a crucial data source for biological research.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"TCGA\"],\n [{\n            'v': 383,\n            'f': \"383\",\n        },\n\"Among the various tools currently available to facilitate the access, analysis, and annotation of data and metadata from next-generation sequencing (NGS) repositories, those specifically focused on Sequence Read Archive (SRA) data operate on principles aimed at improving accessibility, enhancing metadata quality, and integrating advanced computational approaches to address the challenges inherent in large-scale biological data management.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 384,\n            'f': \"384\",\n        },\n\"This methodology was also designed to address and overcome the limitations identified in existing platforms used for accessing, analyzing, and annotating next-generation sequencing (NGS) data and metadata, particularly from the Sequence Read Archive (SRA).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 385,\n            'f': \"385\",\n        },\n\"Firstly, local databases are constructed containing all SRA metadata and Pubmed publications related to the sequences.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 386,\n            'f': \"386\",\n        },\n\"The NCBI's Sequencing Read Archive (SRA) ( Sayers et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 387,\n            'f': \"387\",\n        },\n\"To test HTSinfer's usability and accuracy, we downloaded from the Sequence Read Archive (SRA) ( Sayers et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 388,\n            'f': \"388\",\n        },\n\"As SRA does not systematically collect information on read orientation or adapter sequences, we initially focused on evaluating the agreement between the inferred and reported library sources.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 389,\n            'f': \"389\",\n        },\n\"The raw SRA data was deposited in the National Center of Biotechnology Information (NCBI) Sequence Read Archive (SRA) database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 390,\n            'f': \"390\",\n        },\n\"Data accessibility Repository name: NCBI Sequence Read Archive (SRA) Data identification number: PRJNA1177777 Direct URL to data: https://www.ncbi.nlm.nih.gov/sra/PRJNA1177777 Repository name: Mendeley Data Data identification number: DOI: 10.17632/94hhxg2vtz.1 Direct URL to data: https://data.mendeley.com/datasets/94hhxg2vtz/1 Related research article None .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 391,\n            'f': \"391\",\n        },\n\"The raw data was deposited as FASTQ files in the National Center of Biotechnology Information (NCBI) Sequence Read Archive (SRA) database under BioProject accession number PRJNA1177777 [ 6 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 392,\n            'f': \"392\",\n        },\n\"The raw data was deposited as FASTQ files in the National Center of Biotechnology Information (NCBI) Sequence Read Archive (SRA) database under BioProject accession number PRJNA1177777 [ 6 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioProject\"],\n [{\n            'v': 393,\n            'f': \"393\",\n        },\n\"Data accessibility Repository name: NCBI Sequence Read Archive (SRA) Data identification number: PRJNA1177777 Direct URL to data: https://www.ncbi.nlm.nih.gov/sra/PRJNA1177777 Repository name: Mendeley Data Data identification number: DOI: 10.17632/94hhxg2vtz.1 Direct URL to data: https://data.mendeley.com/datasets/94hhxg2vtz/1\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 394,\n            'f': \"394\",\n        },\n\"The genomic MGI DNBSEQ-T7RS sequencing data and Hi-C sequencing data were deposited in the NCBI Sequence Read Archive (SRA) database under accession No.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 395,\n            'f': \"395\",\n        },\n\"Isolate code Location and sample type Whole-genome sequence accession SRA accession number Genome size (bp) Gc (%) Filtered reads used in the assembly Mean depth (x) Contigs N50 (bp) Predicted total genes, total CDS, and total protein- coding genes a BUSCO completeness (%) Nearest genome match\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 396,\n            'f': \"396\",\n        },\n\"SRA, Sequence Read Archive.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 397,\n            'f': \"397\",\n        },\n\"Eddiemania GenBank and Sequence Read Archive (SRA) accession numbers are PQ184802 and SRR29377726 , respectively.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 398,\n            'f': \"398\",\n        },\n\"cohort of EBV-associated NPC was downloaded from Sequencing Read Archive (SRA) (accession ID: SRP035573).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 399,\n            'f': \"399\",\n        },\n\"In order to facilitate its analysis, the short read archive (SRA) SRR25309874 that contains short genomic sequences, as well as the PACBIO_SMRT SRA SRR28416710 were also used.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 400,\n            'f': \"400\",\n        },\n\"Local outlier factor (LOF) analysis can help in identifying rare or anomalous MEFV innate immunity regulator, pyrin (MEFV ) ,variants that deviate from the norm, whereas ensemble machine learning algorithms can provide a robust and accurate predictive model by combining the strengths of multiple learning algorithms 11 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Ensembl\"],\n [{\n            'v': 401,\n            'f': \"401\",\n        },\n\"Ensemble machine learning algorithms, by employing these techniques, can effectively address the challenges of balancing bias and variance 15 , 16 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Ensembl\"],\n [{\n            'v': 402,\n            'f': \"402\",\n        },\n\"Using more advanced ensemble strategies, such as machine learning or deep learning, might be superior to the heuristic intersection workflow we adopted and help to enlarge the number of SVs in the benchmark set, which is worth to be experimented.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Ensembl\"],\n [{\n            'v': 403,\n            'f': \"403\",\n        },\n\"Molecular Twin) implementing an ensemble of variable ML algorithms to accurately predict disease survival using genomic, transcriptomic, proteomic, and lipid data from adenocarcinoma patients [ 6 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Ensembl\"],\n [{\n            'v': 404,\n            'f': \"404\",\n        },\n\"Studies have shown that even the best scoring systems for rare variant detection, such as Rare Exome Variant Ensemble Learner (REVEL), fail to provide the desired predictions for variants in this gene.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Ensembl\"],\n [{\n            'v': 405,\n            'f': \"405\",\n        },\n\"The Ensembl Plants database ( Bolser et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 406,\n            'f': \"406\",\n        },\n\"We utilized the custom annotations feature provided by the ensembl variant effect predictor (VEP) [ 25 ] to annotate the gnomAD chromosome reference VCF files for functional consequences in the sORF reading frame.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 407,\n            'f': \"407\",\n        },\n\"Ensembl Variant Effect Predictor\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 408,\n            'f': \"408\",\n        },\n\"77 https://github.com/Ensembl/ensembl-vep Truvari (v4.0.0) English et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 409,\n            'f': \"409\",\n        },\n\"VEP (v112.0) McLaren et al. 77 https://github.com/Ensembl/ensembl-vep\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 410,\n            'f': \"410\",\n        },\n\"PVT1 is related to the regulation of tumors, including colorectal [ 26 ], gallbladder [ 27 ], and ovarian cancers [ 28 ]; however, the function of the PVT1-214 transcript (Ensembl ID: ENST00000522875) has rarely been reported.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 411,\n            'f': \"411\",\n        },\n\"GCA_900186335.2 ) and Ensembl 70 (release 93; https://www.ensembl.org/Eptatretus_burgeri/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 412,\n            'f': \"412\",\n        },\n\"Hagfish Hox sequences were obtained from a previous study 19 and used as queries in TBLASTN (v.2.10.1+) to find the location in the Hi-C assembly and Ensembl annotation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 413,\n            'f': \"413\",\n        },\n\"Mutation tolerance was predicted using MutationTaster (GRCh37/Ensembl 69, accessed June 14 2024), SIFT (accessed June 14 2024) and PolyPhen2 (accessed June 14, 2024), while ensemble measures of pathogenicity were estimated using CADD+ (GRCh38, v1.4) and REVEL scores (GRCh38, v1.3).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 414,\n            'f': \"414\",\n        },\n\"GO terms were downloaded for each species from Ensembl Plants.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 415,\n            'f': \"415\",\n        },\n\"The IDs of proteins and mRNAs were unified by Ensembl ID.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 416,\n            'f': \"416\",\n        },\n\"With Scaffold DIA (Proteome Software Inc., Portland, OR, USA), the spectral library was built by searching MS data in the library against the mouse Ensembl release 97 database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 417,\n            'f': \"417\",\n        },\n\"Arrows indicate the two contrasted isoforms identified by Ensembl transcript IDs, with the upward arrow for the \\u201cswitched-up\\u201d isoform (ENSMUST00000047664.16) featuring a shorter open reading frame (ORF) with the absence of intrinsically disordered regions (IDRs), and the downward arrow for the \\u201cswitched-down\\u201d isoform (ENSMUST00000159747.9) preserving a longer ORF with IDRs.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 418,\n            'f': \"418\",\n        },\n\"The ncRNA dataset was retrieved from Ensembl build 75, which was previously used in the published study [ 8 ] that identified hundreds of non-canonical ORFs using ribosome profiling and mass-spectrometry.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 419,\n            'f': \"419\",\n        },\n\"A pipeline used data on 16 grass full genomes from Ensembl Plants to generate 13 312 highly conserved, universal groups of grass protein-coding genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 420,\n            'f': \"420\",\n        },\n\"Numbers of fully sequenced genomes from Ensembl Plants release 56 used and not used in the pipeline and from NCBI for validation are shown for each taxon.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 421,\n            'f': \"421\",\n        },\n\"Ensembl, Phytozome) group genes by evolutionary relationships, i.e.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 422,\n            'f': \"422\",\n        },\n\"2016 ) release 56 ( https://feb2023-plants.ensembl.org/ ), which was used as the source of sequence and ortholog information, has fully sequenced genomes of grasses in four of the main taxa of core grasses ( Fig.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 423,\n            'f': \"423\",\n        },\n\"We extracted 12,017 human MEFV gene variants from the Ensembl database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 424,\n            'f': \"424\",\n        },\n\"Ensembl is an open-source bioinformatics project designed to organize biological data systematically, focusing on the sequences of large-scale genomes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 425,\n            'f': \"425\",\n        },\n\"Gene annotation of this assembly on Ensembl identified 23,728 protein-coding genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 426,\n            'f': \"426\",\n        },\n\"The Alnus glutinosa genome assembly (GCA_958979055.1) was annotated at the European Bioinformatics Institute (EBI) on Ensembl Rapid Release.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 427,\n            'f': \"427\",\n        },\n\"The resulting annotation includes 36,650 transcribed mRNAs from 23,728 protein-coding and 4,860 non-coding genes ( Table 2 ; https://rapid.ensembl.org/Alnus_glutinosa_GCA_958979055.1/Info/Index ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 428,\n            'f': \"428\",\n        },\n\"The Ensembl Genebuild annotation system ( Aken et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 429,\n            'f': \"429\",\n        },\n\", 2016 ) was used to generate annotation for the Alnus glutinosa assembly (GCA_958979055.1) in Ensembl Rapid Release at the EBI.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 430,\n            'f': \"430\",\n        },\n\"The \\u03b2-defensin 2 (MZ198754) from seabass was used for BLASTp in Genomicus and allowed us to find an orthologous gene in gilthead seabream genome, defb2 gene (ENSSAUG00010026539, Ensembl (Barroso et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 431,\n            'f': \"431\",\n        },\n\"The gene information and structure were retrieved from Ensembl Gene .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 432,\n            'f': \"432\",\n        },\n\"Table 1 Accession numbers of defb genes, mRNAs, proteins, and primers in gilthead seabream (Ensembl, NCBI) \\u03b2-Defensin name Gene mRNA Protein Primer defb1 ENSSAUG00010014090 ENSSAUT00010034981 (FM158209, NCBI) ENSSAUP00010033200 F-CCCCAGTCTGAGTGGAGTGT R-AATGAGACACGCAGCACAAG defb2 ENSSAUG00010026539 ENSSAUT00010069764 ENSSAUP00010066624 F-TTCTCCTGATGCTCGCAGTC R-ACCGTGATGACCAACGATGT\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 433,\n            'f': \"433\",\n        },\n\"Accession numbers of defb genes, mRNAs, proteins, and primers in gilthead seabream (Ensembl, NCBI)\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 434,\n            'f': \"434\",\n        },\n\"This used 129 fish genomes from a common ancestor Actinopterygii (~ 386 Mya) and low-coverage genomes were removed; these assembly genomes can be found in Ensembl .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 435,\n            'f': \"435\",\n        },\n\"Using Ensembl [ 22 ] Release 113, phenotype associations were identified for 30 genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 436,\n            'f': \"436\",\n        },\n\"Further analysis of Ensembl Release 113 revealed Gene Ontology (GO) terms for 99 genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 437,\n            'f': \"437\",\n        },\n\"For the genes we obtained the coding blocks from the most recent Ensembl Release GTF file.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Ensembl\"],\n [{\n            'v': 438,\n            'f': \"438\",\n        },\n\"We hypothesized that part of this variability may be attributed to the influence of the geo-sociocultural context.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 439,\n            'f': \"439\",\n        },\n\"In this study, we aimed to compare the longitudinal determinants of empathy in four cohorts of medical students from two distinct geo-sociocultural backgrounds.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 440,\n            'f': \"440\",\n        },\n\"The determinants of empathy were significantly modulated by the geo-sociocultural context.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 441,\n            'f': \"441\",\n        },\n\"Additionally, a recent review of the literature suggests that changes in empathic dispositions over the course of medical training might be determined by geo-sociocultural characteristics, such as language and whether a culture is more individualistic or collectivistic [ 32 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 442,\n            'f': \"442\",\n        },\n\"This study aimed to investigate the determinants of empathy in medical students at the start and after four years of training, within two geo-sociocultural contexts.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 443,\n            'f': \"443\",\n        },\n\"A hypergeometric test assessed the over-representation of GO terms and KEGG pathways.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 444,\n            'f': \"444\",\n        },\n\"To elucidate differentially expressed genes, we obtained the SIMD-associated dataset GSE79962 from the GEO database.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GEO\"],\n [{\n            'v': 445,\n            'f': \"445\",\n        },\n\"The adjusted P -value was assessed to correct for false positive results in the GEO datasets.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 446,\n            'f': \"446\",\n        },\n\"Therefore, the datasets, including GSE21257 ( n = 52), GSE33382 ( n = 82), GSE16091 ( n = 34), GSE126209 (including complete RNA-seq data from 5 adjacent normal tissue [N] and 6 tumor tissue [T]) and GSE42352 (including 3 osteoblasts [OBs], 12 mesenchymal stem cells [MSCs] and 19 OS cell lines [OSs]) were acquired from the GEO using the \\u201cGEOquery\\u201d (version 2.66.0) R package.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 447,\n            'f': \"447\",\n        },\n\"The GSE21257 and GSE16091 were integrated to form the GEO-OS cohort.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 448,\n            'f': \"448\",\n        },\n\"Firstly, univariate-COX (uni-COX) regression analysis was performed on the TARGET-OS and GEO-OS datasets to identify the prognostic related genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 449,\n            'f': \"449\",\n        },\n\"And to investigate the expression differences of PSIP1 between OS tissues/cells and normal tissues/cells, we selected GEO datasets that included more than three tumor tissues/cells and adjacent normal tissues or cell lines, ensuring the statistical validity of the analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 450,\n            'f': \"450\",\n        },\n\"First, the GWAS data predominantly represent European populations, while the GEO data primarily originate from Asia and the United States, which may limit the applicability of the findings to other ethnic groups.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 451,\n            'f': \"451\",\n        },\n\"The datasets generated and analyzed in this study are available in the IEU Open GWAS Project [ https://gwas.mrcieu.ac.uk/ ], GeneCards Database [ https://www.genecards.org/ ], and GEO Database [ https://www.ncbi.nlm.nih.gov/geo/ ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 452,\n            'f': \"452\",\n        },\n\"The datasets generated and analyzed in this study are available in the IEU Open GWAS Project [ https://gwas.mrcieu.ac.uk/ ], GeneCards Database [ https://www.genecards.org/ ], and GEO Database [ https://www.ncbi.nlm.nih.gov/geo/ ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GeneCards\"],\n [{\n            'v': 453,\n            'f': \"453\",\n        },\n\"Four GEO datasets (GSE79962, GSE267388, GSE229925, GSE229298) were analyzed using Limma and WGCNA to identify overlapping genes from differentially expressed genes (DEGs), cuproptosis-related DEGs (DE-CRGs), and module-associated genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 454,\n            'f': \"454\",\n        },\n\"All datasets are publicly available on the GEO database, supporting transparency and reproducibility.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 455,\n            'f': \"455\",\n        },\n\"All datasets were retrieved from the GEO database ( https://www.ncbi.nlm.nih.gov/geo/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 456,\n            'f': \"456\",\n        },\n\"In this study, we applied bioinformatics methods using the GEO database to identify key copper toxicity-related genes, PDHB and DLAT, which are significantly associated with sepsis-induced myocardial dysfunction (SIMD).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 457,\n            'f': \"457\",\n        },\n\"This study retrieved AD data sets from the GEO database to identify palmitoylation-associated genes (PRGs).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 458,\n            'f': \"458\",\n        },\n\"Since the GEO database is a public resource, this study required no ethical approval.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 459,\n            'f': \"459\",\n        },\n\"Data for GSE5281 and GSE29378 can be downloaded from the GEO public database ( https://www.ncbi.nlm.nih.gov/geo/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 460,\n            'f': \"460\",\n        },\n\"The dataset of gene expression profiling for PAH (GSE113439) was downloaded from the gene expression omnibus (GEO) database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 461,\n            'f': \"461\",\n        },\n\"We conducted a gene expression profiling analysis of pulmonary arterial hypertension (GSE113439) using the gene expression omnibus (GEO) database ( www.ncbi.nlm.nih.gov/geo/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 462,\n            'f': \"462\",\n        },\n\"All microarray data were downloaded from the GEO database ( http://www.ncbi.nih.gov/geo ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 463,\n            'f': \"463\",\n        },\n\"Microarray data were downloaded from the GEO database ( http://www.ncbi.nih.gov/geo ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 464,\n            'f': \"464\",\n        },\n\"To develop and validate the RGPSM, we collected Gene Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo/ ) datasets based on the following criteria: (1) Samples were pathologically diagnosed as OS; (2) The datasets had complete prognostic information and RNA-seq data [ 22 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 465,\n            'f': \"465\",\n        },\n\"And to investigate the expression differences of PSIP1 between OS tissues/cells and normal tissues/cells, we selected GEO datasets that included more than three tumor tissues/cells and adjacent normal tissues or cell lines, ensuring the statistical validity of the analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 466,\n            'f': \"466\",\n        },\n\"Oligonucleotides and other sequence-based reagents qPCR primers mNe tin Forward TAAAAGCTCCAAGGGCCACTC Reverse GATTCTTCCCCGACGCAACC mSPP1 Forward CTGGCTGAATTCTGAGGGACTA Reverse TGAGATGGGTCAGGCACCA mFra-2 Forward ACGCTCACATCCCTACAGTC Reverse CGGATTCGACGCTTCTCCT mCSF1R primer Qiagen QT01055810 m-TGF-b Qiagen QT00145250 mFPR2 mIL-6 mCol1A1 Forward: ACGAGTCACACCGGAACTTG Reverse: TGGGGTGGAGGGAGTTTACA Qiagen QT00171514 QT00098875 Human 18S Qiagen QT00199367 Human CCL2 Qiagen QT00212730 Human IL8 Qiagen QT00000322 Chemicals, enzymes and other reagents D,L-homocysteine Sigma-Aldrich Liberase TH Sigma-Aldrich DNase1 Sigma-Aldrich Hyaluronidase Type 1-S Sigma-Aldrich Collagenase A Sigma-Aldrich Histopaque 1077 Sigma-Aldrich CD14 positive selection kit Miltenyi Biotech C5a R&D Cyclosporin H Alexis Biochemicals WRW4 Bachem HALT phosphatase inhibitors Thermo Scientific Immobilon Forte Western HRP Substrate Millipore Software IAAA database galaxy.ustc.edu.cn/IAAA/dataset/bulkRNA/ LabChart v8 ADInstruments FlowJo V10 Becton, Dickinson & Company Bio-Plex Manager Bio-Rad ImageJ ImageJ.net GraphPad PRISM v8 GraphPad Software Imaris Oxford Instruments Other materials C43, Agonist Merck Millipore BMS986235, Agonist Bristol Myers Squibb Vevo-3100 imaging system Fujifilm Visualsonics ProCyte Idexx Europe B.V., Netherlands CODA blood pressure monitor Kent Scientific AttuneNxT ThermoFisher BD FACSymphony BD BD LSRFortessa BD Mouse creatinine Assay Kit Crystal Chem High Performance Assays, elk Grove, USA AST-ELISA Abcam Ab263882 Luminex panels Millipore Sigma, Bio-Techne MHSTCMAG-70K, MCYTOMAG-70K, MECY2MAG-73K, MTH17MAG-47K FLEXMAP 3D instrument Luminex ThermoFisher Scientific Homocysteine ELISA ELK biotechnology ELK8718 Precellys Lysing kit Bertin Technologies Precellys homogenizer Bertin Technologies RNeasy Fibrous Tissue mini kit Qiagen Nanodrop 2000 ThermoFisher RevertAid First Strand cDNA synthesis kit ThermoFisher QuantStudio 5 RT PCR, 384 well block ThermoFisher Primers Qiagen (Hprt1), Merck (Nestin) xCELLigence DP system Agilent Attune Cytpix Invitrogen Azure 400 CCD system Azure Biosystems Multiphoton laser scanning microscope Leica Nikon CSU-W1 SoRa spinning disk confocal microscope Nikon Databases Database/Dataset URL/Access IAAA database galaxy.ustc.edu.cn/IAAA/dataset/bulkRNA/ Gene Expression Omnibus dataset for GSE90081 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90081 Gene Expression Omnibus dataset for GSE66573 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66573 Gene Expression Omnibus dataset for GSE66763 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66763 Gene Expression Omnibus dataset for GSE77598 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77598 Gene Expression Omnibus dataset for GSE112057 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112057 Gene Expression Omnibus dataset for GSE122459 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122459 Gene Expression Omnibus dataset for GSE123786 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE123786 Gene Expression Omnibus dataset for GSE125977 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE125977 Author year dataset title dataset URL database and identifier Author(s) Year Dataset Title Dataset URL Database and Identifier Shchetynsky K et al 2017 Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90081 GEO GSE90081 Spurlock III CF et al 2015 Defective structural RNA processing in relapsing-remitting multiple sclerosis https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66573 GEO GSE66573 Cao Y et al 2015 Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66763 GEO GSE66763 Binder MD et al 2016 Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77598 GEO GSE77598 Mo A et al 2018 Whole Blood Transcriptome Profiling in Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112057 GEO GSE112057 Tokuyama M et al 2018 SLE PBMC RNA-seq https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122459 GEO GSE122459 Catapano M et al 2020 Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE123786 GEO GSE123786 Parkes JE et al 2020 MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE125977 GEO GSE125977\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 467,\n            'f': \"467\",\n        },\n\"( C ) Chemokine gene expression in human cardiac fibroblasts (HCF), where Ct values were normalised using 18S as a housekeeping gene and fold change was calculated relative to the geometric mean of the HCF co-cultured with vehicle control M1-like macrophages.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 468,\n            'f': \"468\",\n        },\n\"Gene Expression Omnibus dataset for GSE90081 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE90081\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 469,\n            'f': \"469\",\n        },\n\"Gene expression data from the GEO database were used to examine three vitiligo subtypes\\u2014segmental vitiligo (SV), non-segmental vitiligo (NSV), and generalized vitiligo (GV).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 470,\n            'f': \"470\",\n        },\n\"The authors would like to express their gratitude to the GEO (Gene Expression Omnibus) database for providing the dataset used in this study.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 471,\n            'f': \"471\",\n        },\n\"The datasets analysed during the current study are available in the National Center for Biotechnology Information Gene Expression Omnibus (NCBI-GEO) under accession number GSE149670, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE149670 [ 15 ], number GSE69291, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69291 [ 21 ] and number GSE160266, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160266 [ 22 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 472,\n            'f': \"472\",\n        },\n\"Gene expression data sets related to \\\"Alzheimer's Disease\\\" were retrieved from the GEO database to identify key genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 473,\n            'f': \"473\",\n        },\n\"The sc-RNA-Seq data presented in this study has been deposited in NCBI's Gene Expression Omnibus (GEO): https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE232839 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 474,\n            'f': \"474\",\n        },\n\"Materials and methods: In this study, we analyzed datasets sourced from the Gene Expression Omnibus (GEO) database, and identified shared genes of IBD and psoriasis through differential expression analysis and weighted gene co-expression network analysis (WGCNA).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 475,\n            'f': \"475\",\n        },\n\"In this study, we first screened IBD and psoriasis datasets from GEO, conducted differential gene expression analysis and WGCNA, and identified AQP9 as a shared diagnostic gene using three machine learning methods.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 476,\n            'f': \"476\",\n        },\n\"We integrated RNA expression data and clinical information from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases to explore the associations between metabolism-related gene expression and TNBC prognosis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 477,\n            'f': \"477\",\n        },\n\"We integrated RNA expression data and clinical information from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases to explore the associations between metabolism-related gene expression and TNBC prognosis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"TCGA\"],\n [{\n            'v': 478,\n            'f': \"478\",\n        },\n\"Since our last report in 2019, we have continued to acquire these classical types of expression data; developed a searchable index of RNA-Seq and microarray experiments that allows users to quickly and reliably find specific mouse expression studies in ArrayExpress ( https://www.ebi.ac.uk/arrayexpress/ ) and GEO ( https://www.ncbi.nlm.nih.gov/geo/ ); and expanded GXD to include RNA-Seq data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 479,\n            'f': \"479\",\n        },\n\"Understanding how graphene oxide (GO) interacts with cells is crucial for its safe and efficient biomedical applications.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 480,\n            'f': \"480\",\n        },\n\"Here, we examined the uptake of thin GO sheets with distinct lateral dimensions in 13 cell lines: 8 cancer (HeLa, A549, PC3, DU-145, LNCaP, SW-480, SH-SY5Y, U87-MG) and 5 non-cancer (BEAS-2B, NIH/3T3, PNT-2, HaCaT, 293T), using confocal microscopy, transmission electron microscopy, and flow cytometry.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 481,\n            'f': \"481\",\n        },\n\"Our results reveal a striking difference in GO uptake: non-cancer cells internalized GO efficiently, while in cancer cells, GO predominantly interacted with the plasma membrane, showing minimal to no internalization.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 482,\n            'f': \"482\",\n        },\n\"Comparison to other nanomaterials (polystyrene beads and graphene flakes) confirmed that cancer cells internalize materials similarly to non-cancer cells, indicating GO-specific interactions.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 483,\n            'f': \"483\",\n        },\n\"We identified that GO\\u2019s thinness plays important role in this differential uptake.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 484,\n            'f': \"484\",\n        },\n\"To simultaneously trigger ICD, we incorporated 2D graphene oxide (GO) engineered with optimized physicochemical properties to induce robust ICD under near-infrared irradiation.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 485,\n            'f': \"485\",\n        },\n\"Our in vitro and in vivo experiments demonstrated that the combined treatment of capsaicin and GO not only enhanced cancer cell killing but also promoted immune cell infiltration and potentiated anti-tumor immunity, leading to significant tumor suppression.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 486,\n            'f': \"486\",\n        },\n\"Concurrent Pyroptosis and ICD Induction via Cap/GO Synergy Enhances Anti-Tumor Immunity.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 487,\n            'f': \"487\",\n        },\n\"The Cap/GO complex combines ROS-mediated pyroptosis (via Cap) with ICD activation (via GO under NIR irradiation), fostering an immunological tumor microenvironment.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 488,\n            'f': \"488\",\n        },\n\"Additionally, we engineered graphene oxide (GO) variants with different sizes (~500, ~1000, and ~1500 nm) and surface modifications (C=O content of ~5%, ~10%, and ~15%) to identify the most effective formulation for inducing ICD upon 808 nm irradiation.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 489,\n            'f': \"489\",\n        },\n\"In this study, graphene oxide (GO) and GO@MXene non-spherical hydrogels were prepared by introducing different ions, and their adsorption effects on methylene blue (MB) were discussed to determine their feasibility in water treatment.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 490,\n            'f': \"490\",\n        },\n\"The GO and GO@MXene hydrogels crosslinked with Ca 2+ demonstrated superior MB adsorption performance compared to those prepared with K + and Al 3+ , achieving 85.2% and 85.8% MB removal efficiencies within 9 hours, respectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 491,\n            'f': \"491\",\n        },\n\"Furthermore, our study demonstrated that Ca 2+ -crosslinked GO and GO@MXene hydrogels exhibit excellent selective adsorption of cationic dyes, achieving MB removal efficiencies of 96.6% and 98.3% in mixed dye systems, respectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 492,\n            'f': \"492\",\n        },\n\"1-5 In recent years, GO, as a two-dimensional carbon nanomaterial, has received extensive attention from the scientific community for its unique structure and properties.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 493,\n            'f': \"493\",\n        },\n\"6-9 GO hydrogel is a three-dimensional structure composed of GO cross-linked by self-assembly.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 494,\n            'f': \"494\",\n        },\n\"The present work reports an innovative modification of graphene oxide (GO) using air nanobubbles (NBs).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 495,\n            'f': \"495\",\n        },\n\"FTIR analyses confirmed the rise in oxygenated functional groups, mostly C-O entities, which improved the surface reactivity of GO@NBs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 496,\n            'f': \"496\",\n        },\n\"XRD confirmed the increase in crystallinity as well as greater crystal size in GO@NBs, while SAXS confirmed the structural integrity as well as material porosity.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 497,\n            'f': \"497\",\n        },\n\"Air NBs, therefore, impact the physicochemical properties of GO extensively and reveal significant opportunities for energy storage, catalysis, and remediation.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 498,\n            'f': \"498\",\n        },\n\"Graphene oxide (GO), the two-dimensional oxidized derivative of graphene, comprises a hexagonal lattice of carbon molecules adorned with functional oxygen groups in the form of hydroxyl, epoxy, carbonyl, and carboxyl units.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 499,\n            'f': \"499\",\n        },\n\"The following abbreviations are used in this manuscript: Pd Pseudogymnoascus destructans BCS Bathocuproinedisulfonic acid GO Gene ontology FDR False discovery rate DEG Differentially Expressed Gene RNA Ribonucleic acid SOD Superoxide dismutase CTR Copper transporter BLP Bim1-like protein CRC Copper-Responsive Gene Cluster MFS Major facilitator superfamily HSP Heat shock protein SC-Ura Synthetic Complete Medium minus Uracil CPM Counts Per Million YPD Yeast Extract Peptone Dextrose Medium\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 500,\n            'f': \"500\",\n        },\n\"Next, we conducted gene ontology analysis of the GO-upregulated DARs and DEGs in each B cell subgroup (Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 501,\n            'f': \"501\",\n        },\n\"Graves\\u2019 ophthalmopathy (GO) is an autoimmune disease that occurs concurrently with Graves\\u2019 disease, potentially leading to facial disfigurement and irreversible vision loss.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 502,\n            'f': \"502\",\n        },\n\"However, the molecular characteristics of cellular changes in the peripheral immune environment of GO patients remain unclear. This study presents a multi-omics single-cell analysis of peripheral blood from GO patients and healthy controls, revealing key molecular alterations in immune cell subpopulations.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 503,\n            'f': \"503\",\n        },\n\"The underlying causes of GO are not entirely clear, though it is generally accepted that they are linked to autoantibodies targeting the thyroid-stimulating hormone receptor (TSHR).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 504,\n            'f': \"504\",\n        },\n\"Given the enrichment of B cell activation-related pathways in the gene ontology analysis of the markers for NB3 cells (Fig. S5d), we speculated that this group of cells is abnormally activated in the context of GO\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 505,\n            'f': \"505\",\n        },\n\"To further elucidate the pathogenic pathways, we conducted gene ontology analysis of the GO-upregulated DEGs and DARs for all cell subtypes (Figs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GO\"],\n [{\n            'v': 506,\n            'f': \"506\",\n        },\n\"Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of differentially expressed genes (DEGs) were conducted using the KOBAS software (v2.1.1), with a significance threshold of P \\u2264 0.05.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 507,\n            'f': \"507\",\n        },\n\"To characterize the biological significance of walnut differentially expressed genes (DEGs) across experimental groups, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 508,\n            'f': \"508\",\n        },\n\"2 Gene Ontology (GO) enrichment analysis of walnut DGEs.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 509,\n            'f': \"509\",\n        },\n\"Gene Ontology (GO) enrichment analysis of walnut DGEs.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 510,\n            'f': \"510\",\n        },\n\"5 Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment functional analysis of Colletotrichum gloeosporioides DEGs.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 511,\n            'f': \"511\",\n        },\n\"5 Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment functional analysis of Colletotrichum gloeosporioides DEGs.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 512,\n            'f': \"512\",\n        },\n\"Gene ontology (GO) enrichment analysis revealed several biological processes and pathways associated with both indicine and taurine ancestry (Supplementary file S3 and S4 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 513,\n            'f': \"513\",\n        },\n\"The Gene Ontology (GO) enrichment analysis categorized the differentially expressed genes into three domains: \\u201ccellular components\\u201d, \\u201cmolecular functions\\u201d, and \\u201cbiological processes\\u201d.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 514,\n            'f': \"514\",\n        },\n\"Among the 171 upregulated genes in Huanghuazhan rice seedlings, the most enriched Gene Ontology (GO) terms included photosystem II oxygen-evolving complex (GO:0009654), cellular oxidative detoxification (GO:0098869), mitochondrial inner membrane (GO:0005743), chloroplast (GO:0009507), peroxidase activity (GO:0004601), peroxisomal catabolic process (GO:0042744), and cell wall biosynthesis (GO:0042546).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 515,\n            'f': \"515\",\n        },\n\"Differentially expressed genes (DEGs) with |Log2FC| \\u2265 1 and p < 0.05 were identified using Phyper and subsequently analyzed through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 516,\n            'f': \"516\",\n        },\n\"Differentially expressed genes (DEGs) with |Log2FC| \\u2265 1 and p < 0.05 were identified using Phyper and subsequently analyzed through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 517,\n            'f': \"517\",\n        },\n\"Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analysis showed that immune system pathways, immune disease pathways, and chemotaxis-related molecular function of gayal were significantly enriched, whereas T cell-related cellular component and biological process were downregulated in the gayal .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 518,\n            'f': \"518\",\n        },\n\"Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analysis showed that immune system pathways, immune disease pathways, and chemotaxis-related molecular function of gayal were significantly enriched, whereas T cell-related cellular component and biological process were downregulated in the gayal .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 519,\n            'f': \"519\",\n        },\n\"It supports COG/KOG (Clusters of Orthologous Genes), GO (Gene Ontology), and KEGG (Kyoto Encyclopedia of Genes and Genomes) annotations, and generates background frequency models from publicly available annotations for overrepresentation analysis, within a set of experimentally defined genes or proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 520,\n            'f': \"520\",\n        },\n\"It supports COG/KOG (Clusters of Orthologous Genes), GO (Gene Ontology), and KEGG (Kyoto Encyclopedia of Genes and Genomes) annotations, and generates background frequency models from publicly available annotations for overrepresentation analysis, within a set of experimentally defined genes or proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COG\"],\n [{\n            'v': 521,\n            'f': \"521\",\n        },\n\"It supports COG/KOG (Clusters of Orthologous Genes), GO (Gene Ontology), and KEGG (Kyoto Encyclopedia of Genes and Genomes) annotations, and generates background frequency models from publicly available annotations for overrepresentation analysis, within a set of experimentally defined genes or proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 522,\n            'f': \"522\",\n        },\n\"Several well-established annotation frameworks facilitate this process, including the eukaryotic-centric euKaryotic Orthologous Groups (KOG) [ 1 ], Gene Ontology (GO) [ 2 ], and Kyoto Encyclopedia of Genes and Genomes (KEGG) [ 3 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 523,\n            'f': \"523\",\n        },\n\"Several well-established annotation frameworks facilitate this process, including the eukaryotic-centric euKaryotic Orthologous Groups (KOG) [ 1 ], Gene Ontology (GO) [ 2 ], and Kyoto Encyclopedia of Genes and Genomes (KEGG) [ 3 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KOG\"],\n [{\n            'v': 524,\n            'f': \"524\",\n        },\n\"This feature identifies groups of terms that share a common ancestor within a user-defined depth in the ontology graph and retains only the most significant representative (based on p-value) from each group, leveraging the internal igraph-based GO structure in place for annotation propagation.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 525,\n            'f': \"525\",\n        },\n\"Functional enrichment analysis of DE circRNAs was performed to identify enriched Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 526,\n            'f': \"526\",\n        },\n\"Functional enrichment analysis of DE circRNAs was performed to identify enriched Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 527,\n            'f': \"527\",\n        },\n\"Functional enrichment analyses of DEGs in the ceRNA networks were performed using Gene Ontology enrichment analysis (GO; http://geneontology.org/ ) and the Kyoto Encyclopedia of Genes and Genomes (KEGG; https://www.kegg.jp/ ) databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 528,\n            'f': \"528\",\n        },\n\"Functional enrichment analyses of DEGs in the ceRNA networks were performed using Gene Ontology enrichment analysis (GO; http://geneontology.org/ ) and the Kyoto Encyclopedia of Genes and Genomes (KEGG; https://www.kegg.jp/ ) databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 529,\n            'f': \"529\",\n        },\n\"Gene ontology (GO) analysis of identified DEGs was performed to reveal enriched pathways.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 530,\n            'f': \"530\",\n        },\n\"Gene ontology (GO) enrichment analysis with biological processes terms was performed using Clue GO version 2.5.5 26 and Cluepedia version 1.5.5 27 for Cytoscape version 3.6.1 and was conducted for DEGs obtained using three pipelines.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 531,\n            'f': \"531\",\n        },\n\"The InterPro2GO mappings are comprised of the cross-references between these two resources and are the largest source of GO annotation predictions for proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 532,\n            'f': \"532\",\n        },\n\"Here, we describe the protocol by which InterPro curators integrate GO terms into the InterPro database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 533,\n            'f': \"533\",\n        },\n\"Here, we describe the protocol by which InterPro curators integrate GO terms into the InterPro database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 534,\n            'f': \"534\",\n        },\n\"We discuss the unique challenges involved in integrating specific GO terms with entries that may describe a diverse set of proteins, and we illustrate, with examples, how InterPro hierarchies reflect GO terms of increasing specificity.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 535,\n            'f': \"535\",\n        },\n\"We discuss the unique challenges involved in integrating specific GO terms with entries that may describe a diverse set of proteins, and we illustrate, with examples, how InterPro hierarchies reflect GO terms of increasing specificity.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 536,\n            'f': \"536\",\n        },\n\"We describe a revised protocol for GO mapping that enables us to assign GO terms to domains based on the function of the individual domain, rather than the function of the families in which the domain is found.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 537,\n            'f': \"537\",\n        },\n\"We also discuss how taxonomic constraints are dealt with and those cases where we are unable to add any appropriate GO terms. Expert manual annotation of InterPro entries with GO terms enables users to infer function, process or subcellular information for uncharacterized sequences based on sequence matches to predictive models.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 538,\n            'f': \"538\",\n        },\n\"We also discuss how taxonomic constraints are dealt with and those cases where we are unable to add any appropriate GO terms. Expert manual annotation of InterPro entries with GO terms enables users to infer function, process or subcellular information for uncharacterized sequences based on sequence matches to predictive models.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 539,\n            'f': \"539\",\n        },\n\"Moreover, those genes are often richly annotated using GO terms that describe gene function and that can be used to summarize the results of the genome-scale experiments.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 540,\n            'f': \"540\",\n        },\n\"However, making sense of such GO enrichment analyses may be challenging. For instance, overrepresented GO functions in a set of differentially expressed genes are typically output as a flat list, a format not adequate to capture the complexities of the hierarchical structure of the GO annotation labels\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 541,\n            'f': \"541\",\n        },\n\"We catalog their availability-Web-based or standalone, the main principles they employ in summarizing large lists of GO terms, and the visualization styles they support.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 542,\n            'f': \"542\",\n        },\n\"Instead, we show examples of their use and suggest that the choice of an appropriate visualization tool may be crucial to the utility of GO in biological discovery.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 543,\n            'f': \"543\",\n        },\n\"Since the inception of the GO annotation project, a variety of tools have been developed that support exploring and searching the GO database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 544,\n            'f': \"544\",\n        },\n\"GOrilla is a web-based application that identifies enriched GO terms in ranked lists of genes, without requiring the user to provide explicit target and background sets.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 545,\n            'f': \"545\",\n        },\n\"GOrilla employs a flexible threshold statistical approach to discover GO terms that are significantly enriched at the top of a ranked gene list.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 546,\n            'f': \"546\",\n        },\n\"Key to this success is how the GO can be used to support hypotheses or conclusions about the biology or evolution of a study system by identifying annotated functions that are overrepresented in subsets of genes of interest.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 547,\n            'f': \"547\",\n        },\n\"Graphical visualizations of such GO term enrichment results are critical to aid interpretation and avoid biases by presenting researchers with intuitive visual data summaries. Amongst current visualization tools and resources there is a lack of standalone open-source software solutions that facilitate explorations of key features of multiple lists of GO terms.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 548,\n            'f': \"548\",\n        },\n\"To address this we developed GO-Figure!, an open-source Python software for producing user-customisable semantic similarity scatterplots of redundancy-reduced GO term lists.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 549,\n            'f': \"549\",\n        },\n\"GO-Figure! offers a simple solution for command-line plotting of informative summary visualizations of lists of GO terms, designed to support exploratory data analyses and dataset comparisons.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 550,\n            'f': \"550\",\n        },\n\"Additionally, we have proposed a new model interpretation method, global sensitivity analysis (GSA), to complement the well-recognized SHapley Additive exPlanations analysis.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 551,\n            'f': \"551\",\n        },\n\"Several comparative studies have shown that GSA is a time-efficient and accurate approach for identifying crucial descriptors that contribute to model prediction, especially in the scenario where the dataset contains a substantial number of data entries with a limited set of descriptors.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 552,\n            'f': \"552\",\n        },\n\"Our models as well as GSA findings can provide useful guidance on screening library design to minimize false positives.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 553,\n            'f': \"553\",\n        },\n\"Therefore, we brought up a new protocol called Global Sensitivity Analysis (GSA), which identifies important features and assesses their impact on the model\\u2019s predictions.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 554,\n            'f': \"554\",\n        },\n\"To address this limitation, we introduced a novel approach called GSA to effectively and efficiently assess the contribution of each descriptor/feature and examine the impact of individual descriptors/features on the model\\u2019s prediction outcomes.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 555,\n            'f': \"555\",\n        },\n\"Graded sickness absence (GSA) as an alternative to full time sickness absence (FSA) has been implemented in the Nordic countries to promote return to work (RTW) and prevent disability, similar to the Fit Note in the UK.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 556,\n            'f': \"556\",\n        },\n\"However, the evidence of the effects of GSA on RTW is limited.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 557,\n            'f': \"557\",\n        },\n\"FSA is plausibly associated with more health problems than GSA.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 558,\n            'f': \"558\",\n        },\n\"The aim is to investigate if the hypothesized benefits of GSA over FSA on RTW is confounded by health in a cohort of sick listed patients referred to secondary care due to MSD.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 559,\n            'f': \"559\",\n        },\n\"Poisson regression was used to estimate the association of GSA versus FSA on RTW at 12 months after assessment, with and without adjustment for measures of symptom severity.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 560,\n            'f': \"560\",\n        },\n\"Background: Osteoporotic vertebral fractures (OVFs) often lead to poor global sagittal alignment (GSA) and reduced quality of life (QOL).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 561,\n            'f': \"561\",\n        },\n\"While pseudarthrosis and kyphotic deformities are well-known predictors of conservative treatment failure, the impact of vertebral collapse, paraspinal muscle degeneration, sarcopenia, and nutritional status on GSA remains unclear.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 562,\n            'f': \"562\",\n        },\n\"This study investigated the relationship between these factors and GSA in patients with conservatively treated OVFs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 563,\n            'f': \"563\",\n        },\n\"GSA was categorized based on the sagittal vertical axis (SVA [mm]): normal (SVA \\u2264 40), moderate (40 \\u2264 SVA \\u2264 95), and severe (SVA > 95).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 564,\n            'f': \"564\",\n        },\n\"Results: At 12 months, 22.9% of patients had severe GSA and showed significantly lower JOABPEQ gait dysfunction scores ( p = 0.01), higher ODI scores ( p < 0.01), and reduced lower lumbar lordosis ( p = 0.01).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 565,\n            'f': \"565\",\n        },\n\"99m Tc-diethylenetriaminepentaacetic acid-galactosyl-human serum albumin ( 99m Tc-GSA) is used for human liver imaging.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 566,\n            'f': \"566\",\n        },\n\"In this study, we utilized 99m Tc-GSA as a probe to detect Mycobacterium avium ( M. avium ), a major pathogen in NTM pulmonary diseases (NTM-PDs).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 567,\n            'f': \"567\",\n        },\n\"Our aim was to investigate the non-invasive detection of M. avium using 99m Tc-GSA on Single-Photon Emission Computed Tomography (SPECT).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 568,\n            'f': \"568\",\n        },\n\"Methods : The accumulation of 99m Tc-GSA in M. avium was investigated in vitro.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 569,\n            'f': \"569\",\n        },\n\"In vivo, SPECT images were obtained after the administration of 99m Tc-GSA to an M. avium thigh infection model.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 570,\n            'f': \"570\",\n        },\n\"Year Speed # of points Vertical resolution Waveform type RMSE Point-by-point reconfigurability 53 2019 78.0 GSa/s 14 pts 3 bits Triangular and trapezoid 0.1074 No 52 2019 250 GSa/s 80 pts 3 bits Square and triangular No 51 2020 50 GSa/s 10 pts 3 bits Square, sawtooth, triangular, trapezoid 0.0466 Limited 12 2020 28 GHz / / Linearly chirped / No 67 2020 11 GSa/s 40 pts 4 bits Square and sawtooth / No 54 2020 30 GS/s 3 pts / Arbitrary shape / Limited 16 2021 400 GHz 5 pts / Square pulses with different widths / No 48 2021 55 GSa/s 45 pts 3 bits Triangular / No 11 2022 43.5 Gbit/s 10 pts / Pulse sequences of different durations / No 18 2023 180 GHz 5 pts / Wavelets of different orders / No 26 2023 1.64 TSa/s 30 pts 3 bits Square, triangular, sawtooth, Gaussian 0.0791 Limited 49 2024 50 GSa/s 22 pts / Linearly chirped and 64-QAM / Limited 50 2024 15.4 GHz / / Square, triangular, sawtooth 0.0878 Limited This work 2025 1 TSa/s and higher 10400 pts 7 bits Square, triangular, sawtooth, Gaussian, chirped, OOK, PAM4, QPSK 0.0409 Full\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 571,\n            'f': \"571\",\n        },\n\"Also, during these sequences, groundwater flow rate anomalies in the GSA aquifer were detected in pre-, co- and post-seismic condition 38 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 572,\n            'f': \"572\",\n        },\n\"When performing gene set analysis (GSA), a researcher must decide on a suitable analysis strategy, including all analytical choices concerning the method, its internal parameter setting, and the preprocessing approach used to format the gene expression data as required by the selected method.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 573,\n            'f': \"573\",\n        },\n\"The study aims to systematically assess the potential of GSA for the generation of overoptimistic and thus nonreplicable results as a consequence of the exploitation of the inherent uncertainties combined with selective reporting.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 574,\n            'f': \"574\",\n        },\n\"When considering data sets with the true sample labels, our focus is therefore on the quantification of the variability in the GSA results as the consequence of parameter and data preprocessing uncertainty, rather than on overoptimism.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 575,\n            'f': \"575\",\n        },\n\"The WGS data of DH, YB, HZ and WZ buffaloes were downloaded from the genome sequence archive (GSA) under accession code CRA001463 ( https://ngdc.cncb.ac.cn/gsa/browse/CRA001463 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 576,\n            'f': \"576\",\n        },\n\"The PacBio HiFi data (CRA017575, https://bigd.big.ac.cn/gsa/browse/CRA017575 ) 36 , Hi-C data (CRA017576, https://bigd.big.ac.cn/gsa/browse/CRA017576 ) 37 , Illumina data (CRA017567, https://bigd.big.ac.cn/gsa/browse/CRA017567 ) 38 , and RNA-Seq data (CRA017577, https://bigd.big.ac.cn/gsa/browse/CRA017577 ) 39 have been deposited in the Genome Sequence Archive (GSA, https://ngdc.cncb.ac.cn/gsa ) at the National Genomic Data Center (NGDC).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 577,\n            'f': \"577\",\n        },\n\"In this study, we investigated the cell-penetrating peptide (CPP)-mediated delivery of multiple types of GSAs (e.g., double-stranded RNA (dsRNA), artificial microRNA (amiRNA), and antisense oligonucleotide (ASO)) to knock down a putative phytoene desaturase ( PDS ) gene in the invasive common reed ( Phragmites australis spp.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 578,\n            'f': \"578\",\n        },\n\"Here we designed three classes of GSAs (i.e., ASO, dsRNA, and amiRNA) to knock down the P. australis PDS gene based on the limited sequence information available at the time of this study, spanning from 2018 to 2021, in an effort to induce the photobleaching symptom in the treated P. australis plants.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 579,\n            'f': \"579\",\n        },\n\"GSA Class GSA Name Nucleic Acid Sequence (5\\u2032 \\u2192 3\\u2032)\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 580,\n            'f': \"580\",\n        },\n\"At least two major hurdles exist when applying this approach to invasive plants: (1) the design and screening of species- and gene-specific biomacromolecules (i.e., gene-silencing agents or GSAs) made of DNA, RNA, or peptides that can suppress the expression of target genes efficiently, and (2) the delivery vehicle needed to penetrate plant cell walls and other physical barriers (e.g., leaf cuticles).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GSA\"],\n [{\n            'v': 581,\n            'f': \"581\",\n        },\n\"16S rRNA sequence data in this study are available in the Genome Sequence Archive (GSA) database (GSA accession number: PRJCA038177), which can be accessed at https://bigd.big.ac.cn/gsa/browse/CRA024397 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 582,\n            'f': \"582\",\n        },\n\"The raw sequence data reported in this paper have been deposited in the Genome Sequence Archive (Genomics, Proteomics & Bioinformatics 2021) in National Genomics Data Center (Nucleic Acids Res 2022), China National Center for Bioinformation / Beijing Institute of Genomics, Chinese Academy of Sciences (GSA-Human: HRA007815) that are publicly accessible at https://ngdc.cncb.ac.cn/gsa-human.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 583,\n            'f': \"583\",\n        },\n\"The RNA-seq, circRNA-seq and PTBP1 RIP-seq data generated in this project for K562 cell line have been deposited in the Genome Sequence Archive [ 68 ] in National Genomics Data Centre [ 69 ], China National Center for Bioinformation/Beijing Institute of Genomics, Chinese Academy of Sciences (GSA-Human: HRA006344) that are publicly accessible at https://bigd.big.ac.cn/gsa-human (Shared URL: https://ngdc.cncb.ac.cn/gsa-human/browse/HRA006344) [ 70 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 584,\n            'f': \"584\",\n        },\n\"The DNBSEQ-T7 short reads, PacBio Sequel II long-reads, and Hi-C sequencing data used for the genome assembly have been deposited in the China National Center for Bioinformation Genome Sequence Archive (GSA) database with the GSA number CRA016115 44 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 585,\n            'f': \"585\",\n        },\n\"The transcriptome and full-length transcriptome (Iso-Seq) data used to assist in the annotation of the \\u2018Wanfeng\\u2019 almond genome have been deposited in the Genome Sequence Archive (GSA) database of the China National Center for Bioinformation under the GSA accession number CRA020887 48 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 586,\n            'f': \"586\",\n        },\n\"The datasets generated and/or analyzed during the current study are available in the Genome Sequence Archive (GSA) repository, 16S rRNA gene sequence: https://bigd.big.ac.cn/gsa/browse/CRA021120 (accession number: CRA021120); whole genome sequences: https://bigd.big.ac.cn/gsa/browse/CRA021105 (accession number: CRA021105).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 587,\n            'f': \"587\",\n        },\n\"The raw sequencing data were deposited in the Genome Sequence Archive (GSA) under the accession number CRA018593 [ 43 , 44 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 588,\n            'f': \"588\",\n        },\n\"The raw sequencing data were deposited in the Genome Sequence Archive (GSA) under the accession number CRA016012.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 589,\n            'f': \"589\",\n        },\n\"The raw sequencing data generated in this study have been deposited in the Genome Sequence Archive (GSA).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 590,\n            'f': \"590\",\n        },\n\"Despite the rich information in NGS data, particularly with the growing datasets from repositories like the Genome Sequence Archive (GSA) at NGDC, programmatic access to public sequencing data and metadata remains limited.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 591,\n            'f': \"591\",\n        },\n\"iSeq supports simultaneous retrieval from GSA, SRA, ENA, and DDBJ databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 592,\n            'f': \"592\",\n        },\n\"iSeq supports simultaneous retrieval from GSA, SRA, ENA, and DDBJ databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 593,\n            'f': \"593\",\n        },\n\"iSeq supports simultaneous retrieval from GSA, SRA, ENA, and DDBJ databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 594,\n            'f': \"594\",\n        },\n\"iSeq supports simultaneous retrieval from GSA, SRA, ENA, and DDBJ databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 595,\n            'f': \"595\",\n        },\n\"To address these challenges, we introduce iSeq, a tool designed to streamline the retrieval of metadata and NGS data from major databases, including GSA, SRA, ENA, and DDBJ.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 596,\n            'f': \"596\",\n        },\n\"To address these challenges, we introduce iSeq, a tool designed to streamline the retrieval of metadata and NGS data from major databases, including GSA, SRA, ENA, and DDBJ.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 597,\n            'f': \"597\",\n        },\n\"To address these challenges, we introduce iSeq, a tool designed to streamline the retrieval of metadata and NGS data from major databases, including GSA, SRA, ENA, and DDBJ.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 598,\n            'f': \"598\",\n        },\n\"To address these challenges, we introduce iSeq, a tool designed to streamline the retrieval of metadata and NGS data from major databases, including GSA, SRA, ENA, and DDBJ.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 599,\n            'f': \"599\",\n        },\n\"iSeq is a Bash script designed to efficiently fetch public sequencing data from multiple bioinformatics databases, including GSA, SRA, ENA, and DDBJ.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SRA\"],\n [{\n            'v': 600,\n            'f': \"600\",\n        },\n\"iSeq is a Bash script designed to efficiently fetch public sequencing data from multiple bioinformatics databases, including GSA, SRA, ENA, and DDBJ.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 601,\n            'f': \"601\",\n        },\n\"iSeq is a Bash script designed to efficiently fetch public sequencing data from multiple bioinformatics databases, including GSA, SRA, ENA, and DDBJ.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DDBJ\"],\n [{\n            'v': 602,\n            'f': \"602\",\n        },\n\"iSeq is a Bash script designed to efficiently fetch public sequencing data from multiple bioinformatics databases, including GSA, SRA, ENA, and DDBJ.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 603,\n            'f': \"603\",\n        },\n\"iSeq automatically detects the accession format and fetches metadata from the appropriate source, prioritizing ENA among the partner organizations of INSDC or GSA due to their extensive data availability.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 604,\n            'f': \"604\",\n        },\n\"iSeq automatically detects the accession format and fetches metadata from the appropriate source, prioritizing ENA among the partner organizations of INSDC or GSA due to their extensive data availability.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ENA\"],\n [{\n            'v': 605,\n            'f': \"605\",\n        },\n\"iSeq automatically detects the accession format and fetches metadata from the appropriate source, prioritizing ENA among the partner organizations of INSDC or GSA due to their extensive data availability.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"INSDC\"],\n [{\n            'v': 606,\n            'f': \"606\",\n        },\n\"If data are stored in GSA and the HUAWEI Cloud channel is accessible, iSeq prioritizes accessing the HUAWEI Cloud channel for its speed and reliability.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 607,\n            'f': \"607\",\n        },\n\"For the GSA database, iSeq always directly fetches compressed or BAM format data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 608,\n            'f': \"608\",\n        },\n\"To evaluate iSeq\\u2019s performance, we tested its ability to download 3000 gzip-formatted FASTQ files (\\u223c7 Terabyte of base pairs, Tbp) from GSA and 3000 SRA files (\\u223c5 Tbp) from INSDC-related databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 609,\n            'f': \"609\",\n        },\n\"To evaluate iSeq\\u2019s performance, we tested its ability to download 3000 gzip-formatted FASTQ files (\\u223c7 Terabyte of base pairs, Tbp) from GSA and 3000 SRA files (\\u223c5 Tbp) from INSDC-related databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"INSDC\"],\n [{\n            'v': 610,\n            'f': \"610\",\n        },\n\"Aspera provided the fastest download speeds for INSDC-related databases, while AXEL achieved comparable speeds for GSA FTP channels (Fig. 1E).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GSA\"],\n [{\n            'v': 611,\n            'f': \"611\",\n        },\n\"Aspera provided the fastest download speeds for INSDC-related databases, while AXEL achieved comparable speeds for GSA FTP channels (Fig. 1E).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"INSDC\"],\n [{\n            'v': 612,\n            'f': \"612\",\n        },\n\"Authorship contributions: GXD and SLW conceptualised and designed the study.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 613,\n            'f': \"613\",\n        },\n\"HT, BL, and GXD contributed to interpreting the results.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 614,\n            'f': \"614\",\n        },\n\"HT, BL, GXD, and SLW helped in drafting this work.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 615,\n            'f': \"615\",\n        },\n\"BL, LHQY, and GXD provided input into the analyses, and critically reviewed and modified the manuscript drafts.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 616,\n            'f': \"616\",\n        },\n\"GXD supervised the study project.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 617,\n            'f': \"617\",\n        },\n\"However, it remains unclear how much these gene-diet interactions (GxDs) affect disease risk in human populations.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 618,\n            'f': \"618\",\n        },\n\"Understanding the contribution of GxDs to variability in disease risk factors is thus critical to guide scientific effort as well as prioritize specific dietary exposures for study.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 619,\n            'f': \"619\",\n        },\n\"We set out to quantify the genome-wide contribution of GxDs to the heritability of multiple cardiometabolic risk factors across a wide range of dietary traits.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 620,\n            'f': \"620\",\n        },\n\"We conducted a genome-wide GxD interaction study for each combination of 12 cardiometabolic risk factors (e.g., lipids and glycemic traits) and 20 dietary exposures (macronutrients, micronutrients, and food groups).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 621,\n            'f': \"621\",\n        },\n\"GxD contributions to heritability (mean of 0.1% variance explained across all diet-trait pairs) were much lower than those from genetic main effects (mean of 16.8% variance explained).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 622,\n            'f': \"622\",\n        },\n\"The conserved GxD signature is highlighted with a red bar.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 623,\n            'f': \"623\",\n        },\n\"Red box indicates GxD signature; highlighted amino acids with \\u226550% of residues identical to the consensus residue.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 624,\n            'f': \"624\",\n        },\n\"The ICOPa and ICOPb proteins had no other detectable domains but contained three amino acid residues, called the GxD signature ( Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 625,\n            'f': \"625\",\n        },\n\"Because the GxD signature in WSD motif-containing proteins was proposed to mediate interactions with ISWI1 in diverse eukaryotes ( Aravind and Iyer 2012 ), we assessed whether this signature is needed to form the ISWI1-ICOP complex.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 626,\n            'f': \"626\",\n        },\n\"ICOPa and ICOPb have two GxDs ( Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 627,\n            'f': \"627\",\n        },\n\"Such 'gene-by-diet', or GxD, interactions have been shown to explain, in great part, why a dietary recommendation that is beneficial for one demographic may be ineffective or even deleterious in another [ 7 - 9 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 628,\n            'f': \"628\",\n        },\n\"Personalized nutritional guidelines are therefore one promising solution to addressing obesity, though constructing such guidelines will require a continued effort towards establishing an in-depth understanding of GxD effects as well as their epigenetic and transcriptomic bases.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 629,\n            'f': \"629\",\n        },\n\"Despite the clear importance of identifying GxD interactions governing health effects in humans, there are many limitations to studying GxD in human cohorts [ 10 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 630,\n            'f': \"630\",\n        },\n\"Here we have designed a new experimental paradigm in which we identify GxD changes in gene expression and DNA methylation in a cohort of genetically diverse mouse strains, apply the pathway analysis from those studies to inform a literature-based selection of a predicted strain-specific drug intervention, and assess the molecular and phenotypic consequences of this intervention in a strain-specific manner ( Fig 1A and 1B ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"GXD\"],\n [{\n            'v': 631,\n            'f': \"631\",\n        },\n\"Here, we present an overview of the core data types represented in MGI and highlight recent enhancements to the resource with a focus on new data and functionality for MGD and GXD.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 632,\n            'f': \"632\",\n        },\n\"Here, we present an overview of the core data types represented in MGI and highlight recent enhancements to the resource with a focus on new data and functionality for MGD and GXD.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 633,\n            'f': \"633\",\n        },\n\"Both MGD and GXD have been recognized as Global Core Biodata Resources, meeting the criteria of the Global Biodata Coalition for high scientific quality, value, and usage ( https://globalbiodata.org/what-we-do/global-core-biodata-resources/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 634,\n            'f': \"634\",\n        },\n\"Both MGD and GXD have been recognized as Global Core Biodata Resources, meeting the criteria of the Global Biodata Coalition for high scientific quality, value, and usage ( https://globalbiodata.org/what-we-do/global-core-biodata-resources/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 635,\n            'f': \"635\",\n        },\n\"The Mouse Genome Database (MGD) and the Gene Expression Database (GXD) are core MGI databases that share data and system architecture.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 636,\n            'f': \"636\",\n        },\n\"The Mouse Genome Database (MGD) and the Gene Expression Database (GXD) are core MGI databases that share data and system architecture.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 637,\n            'f': \"637\",\n        },\n\"2021 ) and the Gene Expression Database (GXD) ( Finger et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 638,\n            'f': \"638\",\n        },\n\"GXD curates and integrates expression data from different mouse strains and mutants, with a particular emphasis on endogenous gene expression during mouse development.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 639,\n            'f': \"639\",\n        },\n\"Because tissue-specific interactions in mice are unavailable in the current STITCH version, the basal murine hepatic gene expression of the STITCH proteins was queried in the Mouse Genome Informatics (MGI) Gene eXpression Database (GXD) (v6.22) (Baldarelli et al., 2021 ) with assay type: RNA-seq, sex: male, strain: C57BL/6J, and structure: liver.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 640,\n            'f': \"640\",\n        },\n\"Out of the 361 proteins in the PDI network, 11 protein entries were not identified in MGI GXD, leaving 350 proteins for basal hepatic expression analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 641,\n            'f': \"641\",\n        },\n\"Basal hepatic expression, based on Mouse Genome Informatics Gene eXpression Database (MGI GXD) RNA-seq data, was annotated with node borders wherein solid line indicates expected expression while dotted line indicates not.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 642,\n            'f': \"642\",\n        },\n\"The Mouse Genome Database (MGD) and the Gene Expression Database (GXD) are MGI\\u2019s two major knowledgebases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 643,\n            'f': \"643\",\n        },\n\"The Mouse Genome Database (MGD) and the Gene Expression Database (GXD) are MGI\\u2019s two major knowledgebases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 644,\n            'f': \"644\",\n        },\n\"2021 ), Gene Expression Database (GXD) (Baldarelli et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 645,\n            'f': \"645\",\n        },\n\"The mouse Gene Expression Database (GXD) collects and integrates different types of gene expression information, with a focus on endogenous gene expression in wild-type and mutant mice.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 646,\n            'f': \"646\",\n        },\n\"Because GXD is an integral component of the larger MGI system, its expression data are combined with the genetic, functional, and phenotypic data collected by MGD.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 647,\n            'f': \"647\",\n        },\n\"Because GXD is an integral component of the larger MGI system, its expression data are combined with the genetic, functional, and phenotypic data collected by MGD.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 648,\n            'f': \"648\",\n        },\n\"For many years, GXD has collected mouse developmental expression data from RNA in situ hybridization, immunohistochemistry, in situ reporter (knock-in) RT-PCR, northern blot, and western blot experiments (Finger et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 649,\n            'f': \"649\",\n        },\n\"The Gene Expression Database (GXD; www.informatics.jax.org/expression.shtml ) is an extensive and well-curated community resource of mouse developmental gene expression information.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 650,\n            'f': \"650\",\n        },\n\"For many years, GXD has collected and integrated data from RNA in situ hybridization, immunohistochemistry, RT-PCR, northern blot, and western blot experiments through curation of the scientific literature and by collaborations with large-scale expression projects.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 651,\n            'f': \"651\",\n        },\n\"Since our last report in 2019, we have continued to acquire these classical types of expression data; developed a searchable index of RNA-Seq and microarray experiments that allows users to quickly and reliably find specific mouse expression studies in ArrayExpress ( https://www.ebi.ac.uk/arrayexpress/ ) and GEO ( https://www.ncbi.nlm.nih.gov/geo/ ); and expanded GXD to include RNA-Seq data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 652,\n            'f': \"652\",\n        },\n\"Since our last report in 2019, we have continued to acquire these classical types of expression data; developed a searchable index of RNA-Seq and microarray experiments that allows users to quickly and reliably find specific mouse expression studies in ArrayExpress ( https://www.ebi.ac.uk/arrayexpress/ ) and GEO ( https://www.ncbi.nlm.nih.gov/geo/ ); and expanded GXD to include RNA-Seq data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ArrayExpress\"],\n [{\n            'v': 653,\n            'f': \"653\",\n        },\n\"Since our last report in 2019, we have continued to acquire these classical types of expression data; developed a searchable index of RNA-Seq and microarray experiments that allows users to quickly and reliably find specific mouse expression studies in ArrayExpress ( https://www.ebi.ac.uk/arrayexpress/ ) and GEO ( https://www.ncbi.nlm.nih.gov/geo/ ); and expanded GXD to include RNA-Seq data.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GEO\"],\n [{\n            'v': 654,\n            'f': \"654\",\n        },\n\"Uniformly processed RNA-Seq data are imported from the EBI Expression Atlas and then integrated with the other types of expression data in GXD, and with the genetic, functional, phenotypic and disease-related information in Mouse Genome Informatics (MGI).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 655,\n            'f': \"655\",\n        },\n\"Uniformly processed RNA-Seq data are imported from the EBI Expression Atlas and then integrated with the other types of expression data in GXD, and with the genetic, functional, phenotypic and disease-related information in Mouse Genome Informatics (MGI).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Expression Atlas\"],\n [{\n            'v': 656,\n            'f': \"656\",\n        },\n\"The longstanding objective of GXD has been to capture and integrate different types of mouse developmental expression information, with a focus on endogenous gene expression in wild-type and mutant mice, and to make these data readily accessible to researchers via biologically- and biomedically-relevant searches.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 657,\n            'f': \"657\",\n        },\n\"2015 ) to annotate the anatomical location and developmental stage of Cre activity, thus enabling hierarchical anatomical searches and the comparison of Cre activity patterns (from the CrePortal) and expression patterns (from GXD) via interactive matrix views (described further below).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 658,\n            'f': \"658\",\n        },\n\"In addition, a new matrix view that juxtaposes the endogenous expression pattern of a gene (provided by GXD) against activity patterns for recombinases driven by that gene is now available (Fig.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 659,\n            'f': \"659\",\n        },\n\"This will require the addition of developmental stage-specific search capabilities for Cre activity at the portal, similar to the GXD Differential Expression Search interface.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 660,\n            'f': \"660\",\n        },\n\"HPA (hypopharyngeal airway area) and ULHPAW-Max (maximum upper limit hypopharyngeal airway width) account for variations in HPV (hypopharyngeal airway volume).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 661,\n            'f': \"661\",\n        },\n\"1 Upper airway landmarks on the Kinetic MRI scan: (1) Anterior nasal spine(ANS); (2) Posterior nasal spine(PNS); (3) Tip of soft palate(SPT); (4) Tip of the epiglottis(TEP); (5) Tip of the cricoid cartilage(TCC); (6) RPA; (7) RGA; (8) HPA; (9) ULRPA; (10) ULRGA; (11) ULHPA; (12) LLHPA\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 662,\n            'f': \"662\",\n        },\n\"Upper airway landmarks on the Kinetic MRI scan: (1) Anterior nasal spine(ANS); (2) Posterior nasal spine(PNS); (3) Tip of soft palate(SPT); (4) Tip of the epiglottis(TEP); (5) Tip of the cricoid cartilage(TCC); (6) RPA; (7) RGA; (8) HPA; (9) ULRPA; (10) ULRGA; (11) ULHPA; (12) LLHPA\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 663,\n            'f': \"663\",\n        },\n\"3 Upper airway landmarks on the Cephalometric radiography: (1) Anterior nasal spine(ANS); (2) Posterior nasal spine(PNS); (3) Tip of soft palate(SPT); (4) Tip of the epiglottis(TEP); (5) Tip of the cricoid cartilage(TCC); (6) RPA; (7) RGA; (8) HPA; (9) ULRPA; (10) ULRGA; (11) ULHPA; (12) LLHPA\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 664,\n            'f': \"664\",\n        },\n\"Upper airway landmarks on the Cephalometric radiography: (1) Anterior nasal spine(ANS); (2) Posterior nasal spine(PNS); (3) Tip of soft palate(SPT); (4) Tip of the epiglottis(TEP); (5) Tip of the cricoid cartilage(TCC); (6) RPA; (7) RGA; (8) HPA; (9) ULRPA; (10) ULRGA; (11) ULHPA; (12) LLHPA\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 665,\n            'f': \"665\",\n        },\n\"Additionally, we observed that the S/N ratios and mass precision of 3-hydroxypicolinic acid (3-HPA) varied significantly depending on the solvent composition and the presence of additives.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 666,\n            'f': \"666\",\n        },\n\"Also, Distler and Allsion showed that the addition of fucose to 6-aza-2-thiothymine (ATT) or 3-hydroxypicolinic acid (3-HPA) led to a reduction of fragmentation and an increase in spot homogeneity and signal intensity [ 16 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 667,\n            'f': \"667\",\n        },\n\"Typically, IMs are solid or liquid organic salts generated by mixing conventional matrices (e.g., THAP, ATT, or 3-HPA) with an organic base (e.g., pyridine, 1-methylimidazole, or butylamine) in equimolar amounts.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 668,\n            'f': \"668\",\n        },\n\"3-HPA (\\u2265 99.0%), 2,5-dihydroxybenzoic acid (2,5-DHBA) (\\u2265 99.0%), sinapinic acid (SA) (\\u2265 98%), 2,4,6-THAP (\\u2265 99.5%), \\u03b1-cyano-4-hydroxycinnamic acid (HCCA) (\\u2265 99.0%), DAC (\\u2265 99.0%), acetonitrile (ACN) (\\u2265 99.9%), butylamine (99.5%), and D-glucose (\\u2265 99.5%) were from Sigma-Aldrich (Taufkirchen, Germany).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 669,\n            'f': \"669\",\n        },\n\"In addition to testing different matrix salts (3-HPA, ATT, 2,5-DHBA, SA, HCCA, and 2,4,6-THAP), four different solvent mixtures were tested: ACN/H 2 O (1:1, vol/vol), 2-propanol/H 2 O (1:1, vol/vol), ACN/2-propanol/H 2 O (1:1:1, vol/vol), and ACN/EtOH/H 2 O (1:1:1, vol/vol).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 670,\n            'f': \"670\",\n        },\n\"Hyperphenylalaninemia (HPA) is most commonly caused by pathogenic variants in the PAH gene, but it is also caused by defects in BH4 metabolism or pathogenic variants in DNAJC12, which account for 1-3% of HPA.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 671,\n            'f': \"671\",\n        },\n\"HPA is the core biochemical abnormality of PKU, in which normal blood Phe concentrations (35-120 \\u03bcmol/l) are exceeded.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 672,\n            'f': \"672\",\n        },\n\"While most individuals with mild HPA or milder forms of PKU are responsive, only 10% of classic PKU patients respond to BH4.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 673,\n            'f': \"673\",\n        },\n\"This study retrospectively analyzes the demographic, clinical, biochemical, and molecular genetic data of HPA/PKU patients to elucidate genotype-phenotype correlations, with a particular focus on individuals of predominantly Turkish descent.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 674,\n            'f': \"674\",\n        },\n\"Clinical and demographic information, as well as the mode of HPA/PKU diagnosis\\u2014either early detection through NS or late clinical diagnosis\\u2014were documented.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 675,\n            'f': \"675\",\n        },\n\"By copolymerizing WMFAEE with hydroxypropyl acrylate (HPA), a novel photocurable elastomer was developed, which could be amenable to molding using an LCD light-curing 3D printer.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 676,\n            'f': \"676\",\n        },\n\"The resulting WMFAEE-HPA elastomer exhibits exceptional mechanical flexibility (elongation at break: 645.09%) and autonomous room-temperature self-healing properties, achieving 57.82% recovery of elongation after 24 h at 25 \\u00b0C.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 677,\n            'f': \"677\",\n        },\n\"Furthermore, the synergy between monomer chain diffusion/entanglement and dynamic hydrogen bond reorganization allows the WMFAEE-HPA system to achieve a balance of multifunctional integration.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 678,\n            'f': \"678\",\n        },\n\"By copolymerizing WMFAEE with hydroxypropyl acrylate (HPA), we embedded these dual mechanisms, i.e., hydrogen bonding and entanglement of long alkyl chains, into the polymer backbone, creating a sustainable photocurable network that unifies advanced functionalities, including room-temperature self-healing, exceptional elasticity, pressure-sensitive adhesion, thermally triggered shape memory, weldability, reprocessability, and biodegradability.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 679,\n            'f': \"679\",\n        },\n\"The WMFAEE-HPA elastomer represents the first multifunctional 3D-printable material with self-healing capability derived from WCO, surpassing the mechanical and functional constraints of prior systems like EWOMA.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 680,\n            'f': \"680\",\n        },\n\"This review summarises the existing findings and underscores the necessity for future investigations into intervention strategies to improve physical and psychological wellbeing targeting at HPA axis dysregulation for the betterment of psychological wellbeing and human health.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 681,\n            'f': \"681\",\n        },\n\"Psychiatric conditions are often linked to dysfunction of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The Endocannabinoid System (ECS) plays a significant role in stress and anxiety and interacts with the HPA axis.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 682,\n            'f': \"682\",\n        },\n\"ACTH stimulates the release of glucocorticoids from the adrenal cortex\\u2014cortisol in humans and corticosterone in rodents\\u2014which initiate downstream actions for stress response and feedback control of the HPA axis [ 9 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 683,\n            'f': \"683\",\n        },\n\"With growing interest in the use of FAAH inhibitors as a new treatment avenue for psychiatric conditions associated with HPA axis dysfunction and recent human clinical trials [ 41 - 43 ], understanding the effects of FAAH inhibition on HPA axis function is increasingly important.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 684,\n            'f': \"684\",\n        },\n\"Rodent studies offer the opportunity to enhance our understanding of HPA response to FAAH inhibition as this topic has been more extensively studied in this population compared to the relatively sparse literature in humans.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 685,\n            'f': \"685\",\n        },\n\"As there is a link between prolonged stress and alterations in the ECS and HPA axis, this could lead or contribute to the development of anxiety conditions in humans.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 686,\n            'f': \"686\",\n        },\n\"Our findings are consistent with human evidence of recalibration/normalization of HPA axis function during adolescence in children that switch from adverse/deprived environments to supportive adoptive families.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 687,\n            'f': \"687\",\n        },\n\"Research across several species (e.g., rodents, nonhuman primates (NHPs), and humans) suggests that chronic stress can affect both the baseline, stress-induced response and the negative feedback functions of the HPA axis [ 5 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 688,\n            'f': \"688\",\n        },\n\"Protein sequence alignment between OhpA (CYP116B2 homologue from C. pinatubonensis JMP134) and CYP116B234 revealed a 65% sequence identity, with all 18 active site residues fully conserved.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 689,\n            'f': \"689\",\n        },\n\"Proteomic analysis (SWATH-MS) of cell lysates from R. globerulus grown on 2-HPA or phenylalanine revealed distinct protein expression profiles.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 690,\n            'f': \"690\",\n        },\n\"Opioid-induced hypothalamic-pituitary-adrenal (HPA) axis suppression is thought to occur through the inhibition of corticotropin-releasing hormone (CRH) via central G protein-coupled opioid receptors.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 691,\n            'f': \"691\",\n        },\n\"Moreover, the evaluation of HPA axis hormones has been used to assess training status, performance degree [ 15 , 16 , 17 , 18 , 19 , 20 ], and overtraining syndrome of athletic horses [ 12 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ], sport humans [ 9 , 29 ], and, specifically, Standardbreds\\u2019 performance [ 30 , 31 , 32 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"HPA\"],\n [{\n            'v': 692,\n            'f': \"692\",\n        },\n\"For this purpose, we utilized the Human Protein Atlas (HPA) (Uhl\\u00e9n et al., 2015 ), a unique and highly valuable data resource providing immunogen information for their in-house produced polyclonal antibodies.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 693,\n            'f': \"693\",\n        },\n\"The selection of the immunogens reported in the HPA already incorporates important factors including limited sequence similarity to the human proteome and the absence of transmembrane regions and signal peptides (Berglund, Andrade, et al., 2008 ; Berglund, Bj\\u00f6rling, et al., 2008 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 694,\n            'f': \"694\",\n        },\n\"To allow analysis of the properties of protein fragments suitable to be used as immunogens, the HPA was mined for relevant information regarding in-house antibodies, most importantly their performance success across three different antibody-based applications and their respective immunogens.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 695,\n            'f': \"695\",\n        },\n\"The HPA antibodies cover 80.79% of the human proteome (Figure 1a ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 696,\n            'f': \"696\",\n        },\n\"Validated HPA antibodies cover more than 80% of the human proteome.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 697,\n            'f': \"697\",\n        },\n\"Visualization of the protein sequence lengths of covered and not covered proteins indicated a subset of smaller proteins for which no HPA antibodies are available (Figure 1c).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 698,\n            'f': \"698\",\n        },\n\"A possible reason is that the immunogen selection algorithm applied for HPA antibody generation (Berglund, Bj\\u00f6rling, et al., 2008) was not able to find a protein fragment with low enough sequence identity to the human proteome in these short proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 699,\n            'f': \"699\",\n        },\n\"We described how the \\u201cstringency\\u201d is based on the \\u201cReliability\\u201d column from HPA\\u2019s data describing how certain HPA is of the staining result.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 700,\n            'f': \"700\",\n        },\n\"Other gene list tools such as Enrichr, which query multiple databases for associations, have not incorporated the HPA protein cell expression dataset into their tools 4.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 701,\n            'f': \"701\",\n        },\n\"There are other R packages used to incorporate and query HPA data such as hpar 5, which allows for easy loading and querying of version controlled data and HPAnalyze 6 which has powerful visualization tools for protein levels.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 702,\n            'f': \"702\",\n        },\n\"We introduce HPAStainR ( https://32tim32.shinyapps.io/HPAStainR/), a Bioconductor R package and Shiny app developed to query the cell staining database of the HPA\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 703,\n            'f': \"703\",\n        },\n\"HPAStainR is customizable, allowing the user the ability to include cancer or normal tissue data, change the HPA confidence levels, toggle the identification of what proteins from the list were detected, generate a p-value for how many cell type specific proteins are counted for a given cell type, and allow the downloading of the output as a comma separated (csv) file.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 704,\n            'f': \"704\",\n        },\n\"As a result, there are some caveats in the HPA data that should be noted. The distribution of how many proteins are histologically scored in each of the 137 cell types varies in HPA, such that not all results are equal.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 705,\n            'f': \"705\",\n        },\n\"Access of the HPA data is mainly via web-based interface allowing views of individual proteins, which may not be optimal for data analysis of a gene set, or automatic retrieval of original images.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 706,\n            'f': \"706\",\n        },\n\"HPAanalyze is an R package for retrieving and performing exploratory analysis of data from HPA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 707,\n            'f': \"707\",\n        },\n\"HPAanalyze provides functionality for importing data tables and xml files from HPA, exporting and visualizing data, as well as downloading all staining images of interest.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 708,\n            'f': \"708\",\n        },\n\"The Human Protein Atlas (HPA) is a comprehensive resource for exploration of the human proteome which contains a vast amount of proteomics and transcriptomics data generated from antibody-based tissue micro-array profiling and RNA deep-sequencing [1-7].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 709,\n            'f': \"709\",\n        },\n\"Starting from version 4.0, the HPA includes subcellular localization profiles based on confocal images of immunofluorescent, stained cells.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 710,\n            'f': \"710\",\n        },\n\"Data from the HPA are freely available via proteinatlas.org, allowing scientists to access and incorporate the data into their research.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 711,\n            'f': \"711\",\n        },\n\"HPAanalyze allows users to quickly import data tables and xml files from HPA and provides a visual summary of the data. All staining images available in HPA can also be downloaded.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 712,\n            'f': \"712\",\n        },\n\"The HPA project provides data via two main mechanisms: Full datasets in the form of downloadable compressed Tab-Separated Value (TSV) files are available as well as individual entries in Extensible Markup Language (XML), Resource Description Framework (RDF), and TSV formats.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 713,\n            'f': \"713\",\n        },\n\"Protein expression data for genes were obtained from the Human Protein Atlas (HPA, https://www.proteinatlas.org).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 714,\n            'f': \"714\",\n        },\n\"IHC protocols in the HPA involve antibody-based staining of tissue microarrays, ensuring high reproducibility.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 715,\n            'f': \"715\",\n        },\n\"Additionally, single-cell RNA sequencing (scRNA-seq) data from the HPA were analyzed to assess gene expression in specific cell types, focusing on mucosal surfaces, particularly the lung and eye. This integrated approach highlighted the role of these molecules in mucosal immunity.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HPA\"],\n [{\n            'v': 716,\n            'f': \"716\",\n        },\n\"We then construct our schemes using the BHM method and couple it, for increased accuracy, with an implicit-explict (IMEX) time stepping formulation.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 717,\n            'f': \"717\",\n        },\n\"In Section 3 , we introduce the CS, BHM, and IMEX approaches for solving the CH equation.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 718,\n            'f': \"718\",\n        },\n\"IMEX methods can be understood as time-stepping techniques that are useful after a splitting has taken place in a given model equation.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 719,\n            'f': \"719\",\n        },\n\"IMEX schemes are known to preserve the energy decreasing property of original formulations (CS and BHM splittings) while increasing the temporal accuracy [ 23 , 24 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 720,\n            'f': \"720\",\n        },\n\"Our schemes given by (3.3) and (3.10) can be represented in the following form (3.14) u t = \\u03a8 U n + 1 + \\u03a6 U n , which are then suitable for an implicit-explicit (IMEX) Runge-Kutta (RK) time-stepping technique [ 25 , 26 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 721,\n            'f': \"721\",\n        },\n\"The customs import and export (IMEX) data used in this study is the value of customs IMEX goods, calculated based on domestic source/destination statistics, classified according to the Harmonized Commodity Description and Coding System (HS).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 722,\n            'f': \"722\",\n        },\n\"The concordance of customs IMEX data to IRIO is shown in Table 1 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 723,\n            'f': \"723\",\n        },\n\"In practical applications, it is essential to preprocess the customs IMEX data annually.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 724,\n            'f': \"724\",\n        },\n\"The first step involves merging the customs IMEX data at the IO sector level based on the correspondence between the IO sector and the customs commodity code.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 725,\n            'f': \"725\",\n        },\n\"Table 1 A summary of the concordance of customs IMEX data to IRIO.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 726,\n            'f': \"726\",\n        },\n\"Twenty minutes later, vehicle [phosphate-buffered saline (PBS) only], IMEX (1 \\u00d7 10 10 particles in 100\\u2005\\u00b5L PBS), yREX3 (400\\u2005ng with DharmaFECT), or scrambled sequence (400\\u2005ng with DharmaFECT) were injected into the left ventricle (LV) cavity during aortic cross-clamp to achieve intracoronary delivery, for 20\\u2005s. 18 For intravenous injection, yREX3 (400\\u2005ng with DharmaFECT in 50\\u2005\\u00b5L) was injected in the retro-bulbar space.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 727,\n            'f': \"727\",\n        },\n\"Immortalized human CDCs secrete cardioprotective EVs (IMEX, 14 Figure 1A ) that, when isolated using ultrafiltration, are \\u223c100-300\\u2005nm in diameter by light scattering [nanosight tracking analysis (NTA): Figure 1B ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 728,\n            'f': \"728\",\n        },\n\"21 RNA sequencing of an equivalent particle number (as measured by NTA) of imCDCs and primary CDCs (less cardioprotective by comparison 14 ) from the same donor identified generally comparable RNA distributions, but the cargo of their secreted EVs differed significantly: CDC-EVs had a higher proportion of tRNAs and micro RNAs (miRs), while IMEX were enriched in ribosomal RNAs and hairpin RNAs (see Supplementary data online , Figure S1A and B ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 729,\n            'f': \"729\",\n        },\n\"The observed discrepancies in the distribution of different RNA classes between IMEX and primary CDC-EVs likely reflect the activation of beta-catenin in the parent cells of the IMEX, a genetic engineering step that enhanced therapeutic potency.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 730,\n            'f': \"730\",\n        },\n\"Characterization of extracellular vesicles from therapeutically enhanced cardiac stromal cells (IMEX).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 731,\n            'f': \"731\",\n        },\n\"Perhaps the most successful (in terms of accuracy) operator-split method published to date is the discontinuous Galerkin implicit-explicit (DG-IMEX) scheme proposed by McClarren et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 732,\n            'f': \"732\",\n        },\n\"Our method is based on a convex-invariant, asymptotic-preserving IMEX approach that is second-order accurate in streaming limit, wherein the transport terms are handled explicitly, while the matter-radiation interacting part is treated implicitly and locally , eliminating the need for non-local implicit terms in iteration.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 733,\n            'f': \"733\",\n        },\n\"Then, in Section 3 , we present the IMEX scheme.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 734,\n            'f': \"734\",\n        },\n\"Before describing our proposed solution, however, we pause to discuss another possible approach that is somewhat close to ours in spirit: the DG-IMEX method of McClarren et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 735,\n            'f': \"735\",\n        },\n\"We first describe our overall strategy for the full RHD system in Section 3.1 , then the IMEX scheme we use for the radiation subsystem in Section 3.2 , and finally our method for carrying out each IMEX stage in Section 3.3 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IMEx\"],\n [{\n            'v': 736,\n            'f': \"736\",\n        },\n\"A similar issue faced the field of protein networks more than 20 years ago, and the major providers of protein-protein interactions (PPIs) congregated as the International Molecular Exchange Consortium (IMEx) in order to develop a common file format to represent protein-interaction data, and common guidelines [ 40 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 737,\n            'f': \"737\",\n        },\n\"Nowadays, the IMEx Consortium is recognized as a Core Data Resource for both Elixir ( https://elixir-europe.org/ , accessed on 2 January 2025) and Global Core Biodata ( https://globalbiodata.org/what-we-do/global-core-biodata-resources/ accessed on 2 January 2025) and provides non-redundant interaction data presented in full details and described using controlled vocabulary terms.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 738,\n            'f': \"738\",\n        },\n\"Although it is mainly focused on protein interactions, in recent years, the IntAct database [ 72 ], which is part of the IMEx Consortium, has collected ncRNA interactions, following the same criteria used for protein networks [ 65 , 73 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 739,\n            'f': \"739\",\n        },\n\"According to the IMEx criteria, to permit its annotation in the interaction database, the binding of a microRNA to its target must be demonstrated at the experimental level.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 740,\n            'f': \"740\",\n        },\n\"Both the IMEx consortium and the GO consortium have started to propose terms for lncRNAs annotation, but the coverage is still very limited [ 102 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 741,\n            'f': \"741\",\n        },\n\"MatrixDB, a member of the International Molecular Exchange consortium (IMEx), is a curated interaction database focused on interactions established by extracellular matrix (ECM) constituents including proteins, proteoglycans, glycosaminoglycans and ECM bioactive fragments.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 742,\n            'f': \"742\",\n        },\n\"MatrixDB is one of the services of the French node of ELIXIR ( https://elixir-europe.org/about-us/who-we-are/nodes/france ), and an active member of the International Molecular Exchange (IMEx) consortium ( https://www.imexconsortium.org/ ) ( 6 ), which is a Global Core Biodata Resource ( https://globalbiodata.org ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 743,\n            'f': \"743\",\n        },\n\"Interaction data available in MatrixDB are manually curated from the literature via the curation interface of the IntAct database ( 7 ) following the IMEx curation rules ( 8 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 744,\n            'f': \"744\",\n        },\n\"The new interaction dataset (release 4.0) comprises experimentally-supported interactions manually curated from publications by MatrixDB, and interactions involving at least one ECM component imported from IntAct (release 2024-02) ( 7 ), and other databases of the IMEx consortium ( 6 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 745,\n            'f': \"745\",\n        },\n\"High-confidence computationally predicted protein-protein interactions (151 132) from the Integrated Interaction Database ( 9 ), a member of the IMEx consortium, were added to MatrixDB.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 746,\n            'f': \"746\",\n        },\n\"Physical interactions can be queried in multiple databases, including the International Molecular Exchange Consortium (IMEx) database [ 10 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 747,\n            'f': \"747\",\n        },\n\"A list of all nodes in the present network (input list and first interactors) was used to query the IMEx database again to identify second interactors and interactions among first interactors.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 748,\n            'f': \"748\",\n        },\n\"One of the main limitations of this study is that the generation of the PPI network heavily relies on interaction data retrieved from available databases, such as IMEx, in the context of this work.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 749,\n            'f': \"749\",\n        },\n\"The following abbreviations are used in this manuscript: array-CGH Array-comparative genomic hybridization ASD Autism spectrum disorder CNV Copy number variant ER Enrichment ratio FDR False discovery rate GWAS Genome-wide association studies HGNC Human Genome Nomenclature Committee HUPO-PSI Human Proteome Organization Proteomics Standards Initiative IMEx International Molecular Exchange Consortium KEGG Kyoto Encyclopedia of Genes and Genomes NDD Neurodevelopmental disorder ORA Over-representation analysis PPI Protein-Protein Interaction PSICQUIC Proteomics Standard Initiative Common QUery InterfaCe SFARI Simons Foundation Autism Research Initiative VUS Variant of uncertain significance WebGestalt WEB-based GEne SeT AnaLysis Toolkit\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 750,\n            'f': \"750\",\n        },\n\"The following abbreviations are used in this manuscript: array-CGH Array-comparative genomic hybridization ASD Autism spectrum disorder CNV Copy number variant ER Enrichment ratio FDR False discovery rate GWAS Genome-wide association studies HGNC Human Genome Nomenclature Committee HUPO-PSI Human Proteome Organization Proteomics Standards Initiative IMEx International Molecular Exchange Consortium KEGG Kyoto Encyclopedia of Genes and Genomes NDD Neurodevelopmental disorder ORA Over-representation analysis PPI Protein-Protein Interaction PSICQUIC Proteomics Standard Initiative Common QUery InterfaCe SFARI Simons Foundation Autism Research Initiative VUS Variant of uncertain significance WebGestalt WEB-based GEne SeT AnaLysis Toolkit\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 751,\n            'f': \"751\",\n        },\n\"The following abbreviations are used in this manuscript: array-CGH Array-comparative genomic hybridization ASD Autism spectrum disorder CNV Copy number variant ER Enrichment ratio FDR False discovery rate GWAS Genome-wide association studies HGNC Human Genome Nomenclature Committee HUPO-PSI Human Proteome Organization Proteomics Standards Initiative IMEx International Molecular Exchange Consortium KEGG Kyoto Encyclopedia of Genes and Genomes NDD Neurodevelopmental disorder ORA Over-representation analysis PPI Protein-Protein Interaction PSICQUIC Proteomics Standard Initiative Common QUery InterfaCe SFARI Simons Foundation Autism Research Initiative VUS Variant of uncertain significance WebGestalt WEB-based GEne SeT AnaLysis Toolkit\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"HGNC\"],\n [{\n            'v': 752,\n            'f': \"752\",\n        },\n\"The protein-protein interaction (PPI) networks of cHDEGs were constructed with two databases STRING v11.5 [ 71 ] and IMEx [ 72 ], separately to identify cHKGs.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 753,\n            'f': \"753\",\n        },\n\"Protein-protein interaction (PPI) networks were constructed using IMEx Interactome and the STRING database within the NetworkAnalyst 3.0 platform to examine the functional relationships among the common genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 754,\n            'f': \"754\",\n        },\n\"Protein-protein interaction (PPI) networks were constructed using IMEx Interactome and the STRING database within the NetworkAnalyst 3.0 platform to examine the functional relationships among the common genes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 755,\n            'f': \"755\",\n        },\n\"The protein-protein interaction (PPI) network was constructed using the IMEx Interactome and STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) database within the NetworkAnalyst 3.0 platform ( https://www.networkanalyst.ca/ ) [ 20 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 756,\n            'f': \"756\",\n        },\n\"The protein-protein interaction (PPI) network was constructed using the IMEx Interactome and STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) database within the NetworkAnalyst 3.0 platform ( https://www.networkanalyst.ca/ ) [ 20 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 757,\n            'f': \"757\",\n        },\n\"IMEx Interactome utilizes literature-curated comprehensive data from InnateDB, while STRING is a database that provides details on predicted and known protein-protein connections, including direct (physical) and indirect (functional) interactions [ 21 , 22 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 758,\n            'f': \"758\",\n        },\n\"IMEx Interactome utilizes literature-curated comprehensive data from InnateDB, while STRING is a database that provides details on predicted and known protein-protein connections, including direct (physical) and indirect (functional) interactions [ 21 , 22 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InnateDB\"],\n [{\n            'v': 759,\n            'f': \"759\",\n        },\n\"IMEx Interactome utilizes literature-curated comprehensive data from InnateDB, while STRING is a database that provides details on predicted and known protein-protein connections, including direct (physical) and indirect (functional) interactions [ 21 , 22 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 760,\n            'f': \"760\",\n        },\n\"The use of IMEx Interactome and STRING on NetworkAnalyst 3.0 allowed for the comprehensive analysis of the PPI network, which is expected to provide insights into the functional relationships and interactions between the proteins of interest, thereby enhancing the understanding of the underlying biological processes and potential molecular mechanisms.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 761,\n            'f': \"761\",\n        },\n\"The use of IMEx Interactome and STRING on NetworkAnalyst 3.0 allowed for the comprehensive analysis of the PPI network, which is expected to provide insights into the functional relationships and interactions between the proteins of interest, thereby enhancing the understanding of the underlying biological processes and potential molecular mechanisms.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 762,\n            'f': \"762\",\n        },\n\"In addition, using the International Molecular Exchange Consortium (IMEx) protein interactions database, the previously reported 20 associated genes and CKS1B was used in NetworkAnalyst ( https://www.networkanalyst.ca/ ) to establish the protein-protein interaction at a generic level.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IMEx\"],\n [{\n            'v': 763,\n            'f': \"763\",\n        },\n\"The majority of cystine uroliths occur in intact male dogs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 764,\n            'f': \"764\",\n        },\n\"In this case-control study, odds ratios and 95% confidence intervals (CIs) were calculated to identify breeds where the proportion of intact males with cystine uroliths was higher than that of intact males without cystine uroliths.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 765,\n            'f': \"765\",\n        },\n\"The proportions of intact males forming cystine uroliths before 12, 24, and 36 months of age were calculated.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 766,\n            'f': \"766\",\n        },\n\"Across 60 breeds, the median proportion of male cystine urolith formers that were intact was 98% (range, 40%-100%).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 767,\n            'f': \"767\",\n        },\n\"When compared with dogs without cystine uroliths, intact males were overrepresented in cystine urolith formers in all breeds except 8 (Akita, Belgian Malinois, Brussels Griffon, Cane Corso, Coonhound, Newfoundland, Scottish Terrier, and Silky Terrier).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 768,\n            'f': \"768\",\n        },\n\"The absence of subordinate representation in both LSF and HSF compared to intact stimuli further implies that full SF content is essential for fine-category processing.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 769,\n            'f': \"769\",\n        },\n\"To examine the effect of SF content on categorical representation at multiple levels, the responses of IT and STS neurons to various visual stimuli in three levels of abstraction and three levels of SF content (i.e., intact, high, and low) are recorded.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 770,\n            'f': \"770\",\n        },\n\"We show that mid-level categories (e.g., face-body) are represented at all levels of SF content, while in sub-ordinate levels (e.g., identity), only the intact stimuli are represented in IT and STS neurons.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 771,\n            'f': \"771\",\n        },\n\"We found that, as in the neurophysiological data, super-ordinate categorization can be done in HSF similar to intact, while LSF decreases the performance.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 772,\n            'f': \"772\",\n        },\n\"Three SFs are defined: low SF (LSF), intact, and high SF (HSF).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 773,\n            'f': \"773\",\n        },\n\"Abstract figure legend Locomotor electromyographic (EMG) activity of hindlimb muscles of intact and spinal cats reveals muscle synergies and suggests organization of spinal locomotor networks.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 774,\n            'f': \"774\",\n        },\n\"spinal cats) have revealed up to seven muscle groups that are activated together in the walking cycle and are generally similar to the groups during intact locomotion (Desrochers et al., 2019 ; Higgin et al., 2020 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 775,\n            'f': \"775\",\n        },\n\"Specifically, in both spinal and intact cats, there are muscle activity burst groups comprising either flexor or extensor muscles and some of these groups contain muscles operating at different joints (Desrochers et al., 2019 ; Harnie et al., 2021 ; Higgin et al., 2020 ; Klishko et al., 2021 ; Krouchev et al., 2006 ; Markin et al., 2012 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 776,\n            'f': \"776\",\n        },\n\"One to two weeks after electrode implantation, we collected data in the intact state for 4-6 weeks.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 777,\n            'f': \"777\",\n        },\n\"In three experimental conditions of two cats (HA, intact state, speeds 0.7 and 1.0 m/s and SA, intact state, speed 1.0 m/s; Table 1 ) the quality of signal was low, and we were unable to reliably identify muscle bursts.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 778,\n            'f': \"778\",\n        },\n\"The removal of either the calyx or corolla generally reduced floral temperatures compared to intact flowers.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 779,\n            'f': \"779\",\n        },\n\"The floral temperatures of a calyx-removed flower and an adjacent intact flower at the same stage, as well as the ambient temperature, were recorded simultaneously.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 780,\n            'f': \"780\",\n        },\n\"At the Fallen stage, two adjacent withered flowers without corollas were selected, with one serving as the intact control (CK) and the other subjected to calyx removal.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 781,\n            'f': \"781\",\n        },\n\"The temperatures inside the intact calyx and partly removed calyx, and the ambient temperature behind an adjacent leaf were recorded simultaneously.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 782,\n            'f': \"782\",\n        },\n\"At each stage, the floral temperatures of an intact flower, an adjacent corolla-removed flower, and the ambient temperature were recorded simultaneously.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 783,\n            'f': \"783\",\n        },\n\"We found that insulin like growth factor binding protein 5 (Igfbp5) was strongly expressed within the infarction core, but barely in the intact hemisphere (Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 784,\n            'f': \"784\",\n        },\n\"4 B, C; number of interactions: stroke / intact: +104%, stroke / ibz: +71%: interaction strength: stroke / intact: +95%; ibz / intact + 104%).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 785,\n            'f': \"785\",\n        },\n\"By contrast, cells derived from the ibz and intact tissue exhibited a lower number of predicted interactions especially among non-neural cell populations such as Imm, Vasc, Per, IC and Olig compared to corresponding cell types from stroke-injured tissue (Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 786,\n            'f': \"786\",\n        },\n\"In stroke-affected tissue, Glut and Asc, particularly as senders, display significantly increased interactions, with IC also showing heightened communication compared to intact tissue.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 787,\n            'f': \"787\",\n        },\n\"For instance, stroke tissue showed enhanced communication via the COLLAGEN, PTPR, PTN, NEGR, LAMININ, CNTN and CADM pathways, involving multiple cell types that either did not participate or exhibited only minimal signaling interactions in intact tissue (Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 788,\n            'f': \"788\",\n        },\n\"Our findings highlight the role of SWD in the primary infestation of intact grape berries and underscore the importance of considering interspecific interactions when interpreting results based on fly emergence from field-collected fruits.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 789,\n            'f': \"789\",\n        },\n\"Moreover, when intact berries were treated as pooled samples, thus allowing interactions among larvae developing in different berries, the proportion of the emerging SWD flies was significantly lower.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 790,\n            'f': \"790\",\n        },\n\"Furthermore, when berries were pooled (placing multiple intact fruits in close proximity and allowing potential interactions between larvae), MTD emergence became even more dominant.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 791,\n            'f': \"791\",\n        },\n\"Even among intact berries, pooling appeared to influence larval emergence, likely due to post-harvest microenvironmental changes such as increased humidity, microbial activity, or subtle skin weakening, which may have allowed limited larval movement or indirect species interactions.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 792,\n            'f': \"792\",\n        },\n\"Gene expression analysis revealed that the podocyte-associated proteins ( NPHS1 , NPHS2 , and PODXL ) were downregulated following PAN injection, and their expression was maintained in the PAN-MSC group similar to the intact group, indicating a protective effect of MSCs at the molecular level.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 793,\n            'f': \"793\",\n        },\n\"The protein expression of LHR in mammary tumor tissues was elevated in spayed dogs compared to intact female dogs ( Table 6 ), particularly in the HS ( p < 0.05).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 794,\n            'f': \"794\",\n        },\n\"Interestingly, the protein expression trend of FSHR was opposite to that of LHR, as FSHR expression increased in the mammary tumors of intact female dogs, although no significant difference was observed ( Table 6 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 795,\n            'f': \"795\",\n        },\n\"Table 1 Baseline characteristics of Swi/Snf-deficient ECAs Parameters Total ( n = 604) Swi/Snf-intact ( n = 568) Swi/Snf-deficient ( n = 36) P Age (years) 0.151 Median (range) 47.5(19-78) 47(19-78) 50(35-67) Family history of cancer, n (%) 0.269 Absent 544(90.1) 514(90.5) 30(83.3) Present 60(9.9) 54(9.5) 6(16.7) FIGO stage, n (%) 0.154 I 438(72.5) 416(73.2) 22(61.1) II 71(11.8) 67(11.8) 4(11.1) III 87(14.4) 77(13.6) 10(27.8) 0.041 IV 8(1.3) 8(1.4) 0(0) Tumor size (cm) < 0.001 Median (range) 2.650(0.2-8.5) 2.5(0.2-8.5) 3.5(1-7.5) Surgical margin, n (%) 0.323 Negative 575(95.2) 539(94.9) 36(100) Positive 29(4.8) 29(5.1) 0(0) Parametrium invasion, n (%) 0.908 Absent 581(96.2) 547(96.3) 34(94.4) Present 23(3.8) 21(3.7) 2(5.6) Stromal invasion level, n (%) 0.131 < 1/3 172(28.5) 167(29.4) 5(13.9) 1/3 \\u2212 2/3 173(28.6) 160(28.2) 13(36.1) 0.046 > 2/3 259(42.9) 241(42.4) 18(50.0) LVI, n (%) 0.133 Absent 389(64.4) 370(65.1) 19(52.8) Present 215(35.6) 198(34.9) 17(47.2) LNM, n (%) 0.037 Negative 484(80.1) 460(81.0) 24(66.7) Positive 120(19.9) 108(19.0) 12(33.3) MMR status < 0.001 Proficient 592(98.0) 564(99.3) 28(77.8) Deficient 12(2.0) 4(0.7) 8(22.2) P16 < 0.001 Negative 67(11.1) 50(8.8) 17(47.2) Positive 537(88.9) 518(91.2) 19(52.8) Ki-67 0.405 Median (range) 36.67(0-95) 40.00(0-95) 31.67(0-85) Major classification 0.015 HPVA 558(92.4) 529(93.1) 29(80.6) NHPVA 46(7.6) 39(6.9) 7(19.4) Tumor subtype Usual type 477(79.0) 455(80.1) 22(61.1) 0.007 ISMC 42(7.0) 37(6.5) 5(13.8) 0.177 Mucinous NOS 20(3.3) 18(3.2) 2(5.5) 0.767 Intestinal 18(3.0) 18(3.2) 0(0) 0.563 Signet-ring cell 1(0.1) 1(0.1) 0(0) 1 Gastric type 37(6.1) 31(5.5) 6(16.8) 0.018 Clear cell 9(1.5) 8(1.4) 1(2.8) 0.427 ( n = 558) ( n = 529) ( n = 29) Silva pattern 0.007 A 70(12.5) 70(13.2) 0(0) B 107(19.2) 105(19.8) 2(6.9) C 381(68.3) 354(67.0) 27(93.1) FIGO, International Federation of Gynaecology and Obstetrics; LVI, lymph vascular invasion; LNM, lymph node metastasis; NHPVA, not human papillomavirus-associated adenocarcinoma, HPVA, human papillomavirus-associated adenocarcinoma; ISMC, invasive Stratified Mucin-producing Carcinoma; MMR, mismatch repair Protein.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 796,\n            'f': \"796\",\n        },\n\"Table 4 Univariate and multivariate Cox regression analysis of overall survival in 604 ECAs Clinicopathology Variables Univariate COX Multivariate COX HR (95%CI) P HR (95%CI) P Swi/Snf (intact/deficiency) 2.101 (1.054-4.188) 0.035 18.451 (1.098-309.957) 0.043 Tumor size (< 2.65/\\u22652.65 cm) 3.481 (2.131-5.684) < 0.001 2.196 (1.294-3.727) 0.004 LNM (positive/negative) 6.604 (4.315-10.107) < 0.001 4.243 (2.183-8.247) < 0.001 MMR (deficiency/proficiency) 2.5 (0.790-7.913) 0.119 7.139 (1.568-32.501) 0.011 Subtype (gastric-type/non-gastric-type) 6.208 (3.724-10.349) < 0.001 4.248 (2.436-7.409) < 0.001 ARID1A (intact/deficient) 1.69 (0.685-4.166) 0.255 SMARCA2 (intact/deficient) 1.664 (0.526-5.263) 0.386 SMARCA4 (intact/deficient) 2.913 (0.920-9.217) 0.069 Age (< 48/\\u226548years) 1.356 (0.890-2.065) 0.156 Family history of cancer (absent/present) 0.804 (0.371-1.74) 0.58 FIGO (I-II /III-IV) 5.182 (3.314-8.105) < 0.001 Surgical margin (positive/negative) 4.138 (2.247-7.621) < 0.001 Parametrium invasion (absent/present) 4.753 (2.524-8.949) < 0.001 Stromal invasion level (< 1/3/\\u22651/3) 4.174 (2.018-8.634) < 0.001 LVI (absent/present) 3.039 (1.985-4.652) < 0.001 PD-L1 CPS (\\u2265 1/<1) 0.973 (0.637-1.487) 0.901 HR, Hazard ratio; CI, confidence interval; LNM, lymph node metastasis; MMR represents Mismatch Repair Protein; FIGO, International Federation of Gynaecology and Obstetrics; LVI, lympho-vascular invasion; CPS, combined positive score.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 797,\n            'f': \"797\",\n        },\n\"Moreover, the peptide stereocomplex cross-links imbue proteolytic stability, with nearly 80% of conjugates remaining intact after a 1 h incubation with Proteinase K, compared to just \\u223c40% of the l -conjugates.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"IntAct\"],\n [{\n            'v': 798,\n            'f': \"798\",\n        },\n\"Our HI-union-SI consists of 2196 structural PPIs among 1705 Swiss-Prot proteins, while our IntAct-SI consists of 5499 structural PPIs among 4006 Swiss-Prot proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 799,\n            'f': \"799\",\n        },\n\"Our HI-union-SI consists of 2196 structural PPIs among 1705 Swiss-Prot proteins, while our IntAct-SI consists of 5499 structural PPIs among 4006 Swiss-Prot proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Swiss-Prot\"],\n [{\n            'v': 800,\n            'f': \"800\",\n        },\n\"Missense and nonsense mutations were mapped onto the Swiss-Prot proteins in the HI-union-SI and IntAct-SI using mRNA to protein mappings from RefSeq (O'Leary et al., 2016 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 801,\n            'f': \"801\",\n        },\n\"Missense and nonsense mutations were mapped onto the Swiss-Prot proteins in the HI-union-SI and IntAct-SI using mRNA to protein mappings from RefSeq (O'Leary et al., 2016 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RefSeq\"],\n [{\n            'v': 802,\n            'f': \"802\",\n        },\n\"Missense and nonsense mutations were mapped onto the Swiss-Prot proteins in the HI-union-SI and IntAct-SI using mRNA to protein mappings from RefSeq (O'Leary et al., 2016 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Swiss-Prot\"],\n [{\n            'v': 803,\n            'f': \"803\",\n        },\n\"Mutations were mapped onto the HI-union-SI and IntAct-SI using protein accession mappings and sequences from RefSeq (O'Leary et al., 2016 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 804,\n            'f': \"804\",\n        },\n\"Mutations were mapped onto the HI-union-SI and IntAct-SI using protein accession mappings and sequences from RefSeq (O'Leary et al., 2016 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RefSeq\"],\n [{\n            'v': 805,\n            'f': \"805\",\n        },\n\"(a) Table presenting the numbers and percentages of dbSNP non-pathogenic and ClinVar Mendelian disease-causing quasi-null and nonsense mutations distributed across either the first half or last half of the proteins in the HI-union-SI (blue) and IntAct-SI (green).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 806,\n            'f': \"806\",\n        },\n\"(b) Table displaying the minimum and maximum AFs of dbSNP quasi-null and nonsense variants in proteins within the HI-union-SI (blue) and IntAct-SI (green).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 807,\n            'f': \"807\",\n        },\n\"We generated a combined reference PPI library retrieving interactions from multiple sources, including BioGRID (Oughtred et al, 2021), IID (Kotlyar et al, 2022), IntAct (Orchard et al, 2014), and STRING (Szklarczyk et al, 2023).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 808,\n            'f': \"808\",\n        },\n\"We generated a combined reference PPI library retrieving interactions from multiple sources, including BioGRID (Oughtred et al, 2021), IID (Kotlyar et al, 2022), IntAct (Orchard et al, 2014), and STRING (Szklarczyk et al, 2023).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioGRID\"],\n [{\n            'v': 809,\n            'f': \"809\",\n        },\n\"We generated a combined reference PPI library retrieving interactions from multiple sources, including BioGRID (Oughtred et al, 2021), IID (Kotlyar et al, 2022), IntAct (Orchard et al, 2014), and STRING (Szklarczyk et al, 2023).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IID\"],\n [{\n            'v': 810,\n            'f': \"810\",\n        },\n\"We generated a combined reference PPI library retrieving interactions from multiple sources, including BioGRID (Oughtred et al, 2021), IID (Kotlyar et al, 2022), IntAct (Orchard et al, 2014), and STRING (Szklarczyk et al, 2023).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 811,\n            'f': \"811\",\n        },\n\"For this, we mined BioGRID (Oughtred et al, 2021), IID (downloaded on the 11.05.2021) (Kotlyar et al, 2022), IntAct (Orchard et al, 2014) (downloaded on the 11.09.2023) and STRING v12 (Szklarczyk et al, 2023).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 812,\n            'f': \"812\",\n        },\n\"For this, we mined BioGRID (Oughtred et al, 2021), IID (downloaded on the 11.05.2021) (Kotlyar et al, 2022), IntAct (Orchard et al, 2014) (downloaded on the 11.09.2023) and STRING v12 (Szklarczyk et al, 2023).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioGRID\"],\n [{\n            'v': 813,\n            'f': \"813\",\n        },\n\"For this, we mined BioGRID (Oughtred et al, 2021), IID (downloaded on the 11.05.2021) (Kotlyar et al, 2022), IntAct (Orchard et al, 2014) (downloaded on the 11.09.2023) and STRING v12 (Szklarczyk et al, 2023).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IID\"],\n [{\n            'v': 814,\n            'f': \"814\",\n        },\n\"For this, we mined BioGRID (Oughtred et al, 2021), IID (downloaded on the 11.05.2021) (Kotlyar et al, 2022), IntAct (Orchard et al, 2014) (downloaded on the 11.09.2023) and STRING v12 (Szklarczyk et al, 2023).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 815,\n            'f': \"815\",\n        },\n\"IntAct was filtered to contain only human proteins in combination with the method identifiers: \\u201cMI:0006\\u201d, \\u201cMI:0007\\u201d, \\u201cMI:0019\\u201d, \\u201cMI:0096\\u201d, \\u201cMI:0114\\u201d, and \\u201cMI:0676\\u201d.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 816,\n            'f': \"816\",\n        },\n\"Protein interaction data in the neXtProt human protein knowledgebase and IntAct database showed that two protein kinases, CDK9 and PRKDC, might interact with METTL3\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 817,\n            'f': \"817\",\n        },\n\"Protein interaction data in the neXtProt human protein knowledgebase and IntAct database showed that two protein kinases, CDK9 and PRKDC, might interact with METTL3\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"neXtProt\"],\n [{\n            'v': 818,\n            'f': \"818\",\n        },\n\"Our model was robust for predicting PPIs from BioGrid\\u2014the Biological General Repository for Interaction Datasets28 (Supplementary Fig. 7A-D) and from IntAct\\u2014the EMBL-EBI Molecular Interaction Database29 (Supplementary Fig. 7E-H); functional interactions from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database30 (Supplementary Fig. 8); and protein complex co-occurrence from CORUM31 (Supplementary Fig. 9A-D), and IntAct Complex29 (Supplementary Fig. 9E-H) databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"IntAct\"],\n [{\n            'v': 819,\n            'f': \"819\",\n        },\n\"Our model was robust for predicting PPIs from BioGrid\\u2014the Biological General Repository for Interaction Datasets28 (Supplementary Fig. 7A-D) and from IntAct\\u2014the EMBL-EBI Molecular Interaction Database29 (Supplementary Fig. 7E-H); functional interactions from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database30 (Supplementary Fig. 8); and protein complex co-occurrence from CORUM31 (Supplementary Fig. 9A-D), and IntAct Complex29 (Supplementary Fig. 9E-H) databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioGrid\"],\n [{\n            'v': 820,\n            'f': \"820\",\n        },\n\"Our model was robust for predicting PPIs from BioGrid\\u2014the Biological General Repository for Interaction Datasets28 (Supplementary Fig. 7A-D) and from IntAct\\u2014the EMBL-EBI Molecular Interaction Database29 (Supplementary Fig. 7E-H); functional interactions from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database30 (Supplementary Fig. 8); and protein complex co-occurrence from CORUM31 (Supplementary Fig. 9A-D), and IntAct Complex29 (Supplementary Fig. 9E-H) databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 821,\n            'f': \"821\",\n        },\n\"Our model was robust for predicting PPIs from BioGrid\\u2014the Biological General Repository for Interaction Datasets28 (Supplementary Fig. 7A-D) and from IntAct\\u2014the EMBL-EBI Molecular Interaction Database29 (Supplementary Fig. 7E-H); functional interactions from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database30 (Supplementary Fig. 8); and protein complex co-occurrence from CORUM31 (Supplementary Fig. 9A-D), and IntAct Complex29 (Supplementary Fig. 9E-H) databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Kyoto Encyclopedia of Genes and Genomes\"],\n [{\n            'v': 822,\n            'f': \"822\",\n        },\n\"Our model was robust for predicting PPIs from BioGrid\\u2014the Biological General Repository for Interaction Datasets28 (Supplementary Fig. 7A-D) and from IntAct\\u2014the EMBL-EBI Molecular Interaction Database29 (Supplementary Fig. 7E-H); functional interactions from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database30 (Supplementary Fig. 8); and protein complex co-occurrence from CORUM31 (Supplementary Fig. 9A-D), and IntAct Complex29 (Supplementary Fig. 9E-H) databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"CORUM\"],\n [{\n            'v': 823,\n            'f': \"823\",\n        },\n\"In a first experiment we have benchmarked our implementation against the tools InterProc [43] and Sting [22].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"InterPro\"],\n [{\n            'v': 824,\n            'f': \"824\",\n        },\n\"InterProc and Sting are each unable to find nearly 40% of the bounds (i.e., supports), meaning they report an infinite reach-space in the corresponding directions.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"InterPro\"],\n [{\n            'v': 825,\n            'f': \"825\",\n        },\n\"In these instances, InterProc (owing to limitations related to widening) and Sting (owing to the absence of tight polyhedral, inductive invariants) are unable to infer finite bounds at all.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"InterPro\"],\n [{\n            'v': 826,\n            'f': \"826\",\n        },\n\"Home healthcare is mostly a complex endeavour because interprofessional collaboration is often challenging\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"InterPro\"],\n [{\n            'v': 827,\n            'f': \"827\",\n        },\n\"The project interprof HOME aims to develop an interprofessional person-centred care concept for people receiving home care in a multistep approach.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"InterPro\"],\n [{\n            'v': 828,\n            'f': \"828\",\n        },\n\"Resilient AMS strategies in place pre-pandemic included positive hospital wide AMS culture (organization); system-wide AMS programs (organization); decentralized antimicrobial stewardship (organization); strong interprofessional relationships (organization & person); infectious disease involvement (person); protocols to facilitate pharmacist autonomy (organization & tools and technology) and automated tools to facilitate AMS program activities (tools and technology).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"InterPro\"],\n [{\n            'v': 829,\n            'f': \"829\",\n        },\n\"Gene clusters were then annotated with anvi-run-pfams, which draws on the Pfam (now InterPro) database ( 20 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 830,\n            'f': \"830\",\n        },\n\"In this study, we analyzed the phylogenetic tree using all DyP-type peroxidase sequences available in the InterPro database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 831,\n            'f': \"831\",\n        },\n\"Further enrichment analyses of the 42 genes identified significant overrepresentation of the terms \\u201ctoxin catabolic process\\u201d, \\u201cglutathione metabolism\\u201d ( Figure 2 D), \\u201cinterpro-ipr004046 (glutathione S-transferase, C-terminal)\\u201d, and \\u201cgst\\u201d ( Figure 2 E).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"InterPro\"],\n [{\n            'v': 832,\n            'f': \"832\",\n        },\n\"Gene mRNA Number Percent (%) Number Percent (%) Total 24,730 100 24,730 100 Annotated 24,642 99.64 24,642 99.64 NR 24,598 99.47 24,598 99.47 SwissProt 21,214 85.78 21,214 85.78 TrEMBL 24,582 99.4 24,582 99.4 KOG 19,641 79.42 19,641 79.42 TF 6,183 25 6,183 25 InterPro 23,404 94.64 23,404 94.64 GO 17,696 71.56 17,696 71.56 KEGG_ALL 24,549 99.27 24,549 99.27 KEGG_KO 16,540 66.88 16,540 66.88 Pfam 22,038 89.11 22,038 89.11 Unannotated 88 0.36 88 0.36\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 833,\n            'f': \"833\",\n        },\n\"Gene mRNA Number Percent (%) Number Percent (%) Total 24,730 100 24,730 100 Annotated 24,642 99.64 24,642 99.64 NR 24,598 99.47 24,598 99.47 SwissProt 21,214 85.78 21,214 85.78 TrEMBL 24,582 99.4 24,582 99.4 KOG 19,641 79.42 19,641 79.42 TF 6,183 25 6,183 25 InterPro 23,404 94.64 23,404 94.64 GO 17,696 71.56 17,696 71.56 KEGG_ALL 24,549 99.27 24,549 99.27 KEGG_KO 16,540 66.88 16,540 66.88 Pfam 22,038 89.11 22,038 89.11 Unannotated 88 0.36 88 0.36\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 834,\n            'f': \"834\",\n        },\n\"To annotate the functional roles of these protein sequences, we employed several databases: NCBI nonredundant protein (NR), INTERPRO, Swiss-Prot40 (http://www.gpmaw.com/html/swiss-prot.html), TrEMBL (http://www.uniprot.org), eukaryotic orthologous groups of proteins (KOG) (https://ftp.ncbi.nih.gov/pub/COG/KOG/), Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/), Pfam and TF databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 835,\n            'f': \"835\",\n        },\n\"To annotate the functional roles of these protein sequences, we employed several databases: NCBI nonredundant protein (NR), INTERPRO, Swiss-Prot40 (http://www.gpmaw.com/html/swiss-prot.html), TrEMBL (http://www.uniprot.org), eukaryotic orthologous groups of proteins (KOG) (https://ftp.ncbi.nih.gov/pub/COG/KOG/), Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/), Pfam and TF databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Swiss-Prot\"],\n [{\n            'v': 836,\n            'f': \"836\",\n        },\n\"To annotate the functional roles of these protein sequences, we employed several databases: NCBI nonredundant protein (NR), INTERPRO, Swiss-Prot40 (http://www.gpmaw.com/html/swiss-prot.html), TrEMBL (http://www.uniprot.org), eukaryotic orthologous groups of proteins (KOG) (https://ftp.ncbi.nih.gov/pub/COG/KOG/), Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/), Pfam and TF databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"TrEMBL\"],\n [{\n            'v': 837,\n            'f': \"837\",\n        },\n\"To annotate the functional roles of these protein sequences, we employed several databases: NCBI nonredundant protein (NR), INTERPRO, Swiss-Prot40 (http://www.gpmaw.com/html/swiss-prot.html), TrEMBL (http://www.uniprot.org), eukaryotic orthologous groups of proteins (KOG) (https://ftp.ncbi.nih.gov/pub/COG/KOG/), Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/), Pfam and TF databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COG\"],\n [{\n            'v': 838,\n            'f': \"838\",\n        },\n\"To annotate the functional roles of these protein sequences, we employed several databases: NCBI nonredundant protein (NR), INTERPRO, Swiss-Prot40 (http://www.gpmaw.com/html/swiss-prot.html), TrEMBL (http://www.uniprot.org), eukaryotic orthologous groups of proteins (KOG) (https://ftp.ncbi.nih.gov/pub/COG/KOG/), Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/), Pfam and TF databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 839,\n            'f': \"839\",\n        },\n\"To annotate the functional roles of these protein sequences, we employed several databases: NCBI nonredundant protein (NR), INTERPRO, Swiss-Prot40 (http://www.gpmaw.com/html/swiss-prot.html), TrEMBL (http://www.uniprot.org), eukaryotic orthologous groups of proteins (KOG) (https://ftp.ncbi.nih.gov/pub/COG/KOG/), Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/), Pfam and TF databases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Pfam\"],\n [{\n            'v': 840,\n            'f': \"840\",\n        },\n\"Gene sequences were compared with the KEGG, Swiss-Prot, TrEMBL, KOG, and NR databases using DIAMOND v2.0.1442 with an E-value threshold of 1e-5.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 841,\n            'f': \"841\",\n        },\n\"Gene sequences were compared with the KEGG, Swiss-Prot, TrEMBL, KOG, and NR databases using DIAMOND v2.0.1442 with an E-value threshold of 1e-5.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Swiss-Prot\"],\n [{\n            'v': 842,\n            'f': \"842\",\n        },\n\"Gene sequences were compared with the KEGG, Swiss-Prot, TrEMBL, KOG, and NR databases using DIAMOND v2.0.1442 with an E-value threshold of 1e-5.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"TrEMBL\"],\n [{\n            'v': 843,\n            'f': \"843\",\n        },\n\"Gene sequences were compared with the KEGG, Swiss-Prot, TrEMBL, KOG, and NR databases using DIAMOND v2.0.1442 with an E-value threshold of 1e-5.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"COG\"],\n [{\n            'v': 844,\n            'f': \"844\",\n        },\n\"InterPro 23,404 94.64 23,404 94.64\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 845,\n            'f': \"845\",\n        },\n\"c , d , Heatmaps of tissue-specific functional modalities selected based on the enrichment scores using InterPro ( c ) and KEGG ( d ) pathway analyses.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 846,\n            'f': \"846\",\n        },\n\"c , d , Heatmaps of tissue-specific functional modalities selected based on the enrichment scores using InterPro ( c ) and KEGG ( d ) pathway analyses.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 847,\n            'f': \"847\",\n        },\n\"Next, we used InterPro and KEGG classification to analyze these cell-type-specific transcriptome profiles and discovered distinct functional features for each cell type.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 848,\n            'f': \"848\",\n        },\n\"b and c , Heatmaps showing tissue-specific functional modalities based on Roux et al.\\u2019s scRNA-seq data 21 , represented by the enrichment score based on KEGG ( b ) and InterPro ( c ) pathway terms.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 849,\n            'f': \"849\",\n        },\n\"b and c , Heatmaps showing tissue-specific functional modalities based on Roux et al.\\u2019s scRNA-seq data 21 , represented by the enrichment score based on KEGG ( b ) and InterPro ( c ) pathway terms.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 850,\n            'f': \"850\",\n        },\n\"The InterPro term \\u2018F-box_dom\\u2019 is represented in gray, indicating no expression for all seven genes in this term in the Roux et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 851,\n            'f': \"851\",\n        },\n\"Interpro analysis of His-EsxB treated cells\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 852,\n            'f': \"852\",\n        },\n\"Interpro analysis of His-PPE68 treated cells\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 853,\n            'f': \"853\",\n        },\n\"[TABLE-CAPTION] Interpro analysis of His-EsxB treated cells\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 854,\n            'f': \"854\",\n        },\n\"Interpro Nucleotide-binding, alpha-beta plait 12 7.70E \\u2212 09\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 855,\n            'f': \"855\",\n        },\n\"Interpro Type II keratin 5 3.30E \\u2212 06\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 856,\n            'f': \"856\",\n        },\n\"The DEGs of His-EsxB or His-PPE68-treated groups were entered into the Gene Ontology (GO) (Young et al. 2010) and Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http://www.genome.jp/kegg/) for functional enrichment analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GOC\"],\n [{\n            'v': 857,\n            'f': \"857\",\n        },\n\"The DEGs of His-EsxB or His-PPE68-treated groups were entered into the Gene Ontology (GO) (Young et al. 2010) and Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http://www.genome.jp/kegg/) for functional enrichment analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 858,\n            'f': \"858\",\n        },\n\"Each variant shares the same amino-terminal segment and central coiled-coil region (with InterPro signature IPR025153/Ead_Ea22).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 859,\n            'f': \"859\",\n        },\n\"An InterPro signature (IPR007539/DUF551) is unique to the Ea22 V2 variant.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 860,\n            'f': \"860\",\n        },\n\"The green- and magenta-colored regions are signature sequences in the InterPro database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 861,\n            'f': \"861\",\n        },\n\"The green- and magenta-colored regions are signature sequences in the InterPro database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 862,\n            'f': \"862\",\n        },\n\"We detected 1,425 gene clusters among all genomes using the Anvi'o metagenomics suite and classified the clusters into protein families according to the Pfam database (now InterPro) ( 19 - 21 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 863,\n            'f': \"863\",\n        },\n\"Furthermore, the sequence identity of TrpP to the mentioned transporters is rather low (17-22%) and with current blast search tools (NCBI BLAST) or searches in protein family databases (Interpro) we did not get any similar proteins that have transporter function.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 864,\n            'f': \"864\",\n        },\n\"According to Interpro, TrpP belongs to the SdpI/YhfL protein family whose members are annotated as membrane proteins of unknown function, l -tryptophan permease or SdpI/YhfL family proteins [ 39 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 865,\n            'f': \"865\",\n        },\n\"While some N 2 -fixing organisms contain an ATP-dependent cage-like Mo storage protein ( 20 ), most utilize members of the molbindin family ( 21 - 23 ), which bind the oxyanion within the transport-associated oligonucleotide/oligosaccharide binding type 1 domain (TOBE; InterPro domain IPR005116, Pfam domain PF03459).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 866,\n            'f': \"866\",\n        },\n\"Both Tub and Mop contain the same recognizable InterPro domain approximately 70 amino acids in length, termed the TOBE domain that binds either tungstate or molybdate depending on the protein and the physiological conditions.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 867,\n            'f': \"867\",\n        },\n\"We used InterPro to search for other domains contained within the TOBE domain-containing proteins, and this revealed 16 unique InterPro domain architectures (DAs).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 868,\n            'f': \"868\",\n        },\n\"These were used to categorize the TOBE domain-containing proteins into groups likely to have physiologically related functions ( Table S5 ) and to compare them with all TOBE domain-containing proteins found in InterPro ( Table S6 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 869,\n            'f': \"869\",\n        },\n\"This flow chart illustrates the relationships between species representatives, member genomes, associated proteins, and InterPro domain architectures (DAs) in the UHGG collection.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 870,\n            'f': \"870\",\n        },\n\"To identify nsSNPs that are located in the conserved domains of the PD-1 protein, the InterPro tool [ 52 ] ( https://www.ebi.ac.uk/interpro/ , accessed on 1 February 2024) was used.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 871,\n            'f': \"871\",\n        },\n\"InterPro is an integrated database that comprises several member databases, such as the immunoglobulin-like domain, immunoglobulin V-set domain, and immunoglobulin subtype, to identify the protein motifs and domains.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 872,\n            'f': \"872\",\n        },\n\"Structural and functional analysis of the PD-1 protein domain was conducted through the InterPro tool.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 873,\n            'f': \"873\",\n        },\n\"To determine the localization of these variants within the PD-1 protein, we mapped the nsSNPs to the specific domains of PD-1 using the InterPro program.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 874,\n            'f': \"874\",\n        },\n\"In the present study, we performed a phylogenetic analysis of DyP-type peroxidases using all the sequences included in the InterPro entry, DyP-type peroxidase family (IPR006314), from the InterPro database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 875,\n            'f': \"875\",\n        },\n\"All amino acid sequences included in an InterPro entry, DyP-type peroxidase family (IPR006314), of the InterPro database were retrieved (25,475 sequences as of 17 February 2022).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 876,\n            'f': \"876\",\n        },\n\"To perform phylogenetic analysis of DyP-type peroxidases, the regions matching DyP-type peroxidase family of the InterPro entry were extracted from each sequence.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 877,\n            'f': \"877\",\n        },\n\"We performed a comprehensive phylogenetic analysis using all amino acid sequences included in an InterPro entry, DyP-type peroxidase family (IPR006314) (25,475 sequences as of 17 February 2022).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 878,\n            'f': \"878\",\n        },\n\"The integrity of the identified UGP protein sequences was further verified using InterPro ( http://www.ebi.ac.uk/interpro/search/sequence/ , accessed on 18 May 2024) [ 46 ] and SMART ( http://smart.Embl-heidelberg.de/ , accessed on 18 May 2024) [ 47 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 879,\n            'f': \"879\",\n        },\n\"T542 is located in a region identified as belonging to a shared protein family named FANCAA (beyond amino acid position 448) ( http://pfam.xfam.org/ ; https://www.ebi.ac.uk/interpro/ ; Supplemental Figure 1D and Supplemental Figure 3A ), but not in a known functional motif or domain.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 880,\n            'f': \"880\",\n        },\n\"T542 is located in a region identified as belonging to a shared protein family named FANCAA (beyond amino acid position 448) ( http://pfam.xfam.org/ ; https://www.ebi.ac.uk/interpro/ ; Supplemental Figure 1D and Supplemental Figure 3A ), but not in a known functional motif or domain.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Pfam\"],\n [{\n            'v': 881,\n            'f': \"881\",\n        },\n\"FAAP100 shares homology with a conserved protein family termed FANCAA (Pfam protein families database; http://pfam.xfam.org/ ; https://www.ebi.ac.uk/interpro/ ), which is widely represented in FAAP100 of all vertebrate species ( Supplemental Figure 14 , A and B).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 882,\n            'f': \"882\",\n        },\n\"FAAP100 shares homology with a conserved protein family termed FANCAA (Pfam protein families database; http://pfam.xfam.org/ ; https://www.ebi.ac.uk/interpro/ ), which is widely represented in FAAP100 of all vertebrate species ( Supplemental Figure 14 , A and B).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Pfam\"],\n [{\n            'v': 883,\n            'f': \"883\",\n        },\n\"Protein family searches and analyses were performed using InterPro.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"InterPro\"],\n [{\n            'v': 884,\n            'f': \"884\",\n        },\n\"To address this, our study integrated data from SILVA, NCBI, and LPSN databases, extracting V3-V4 region sequences and supplementing them with 16S rRNA sequences from 1,082 human gut samples.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 885,\n            'f': \"885\",\n        },\n\"The seed sequences were sourced from two authoritative databases: LPSN (List of Prokaryotic names with Standing in Nomenclature) and the NCBI (National Center for Biotechnology Information) RefSeq database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 886,\n            'f': \"886\",\n        },\n\"For the LPSN database, all species and subspecies listed on the LPSN website 1 were considered ( Parte et al., 2020 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 887,\n            'f': \"887\",\n        },\n\"The 16S rRNA gene reference sequences for each of the selected species and subspecies ( n =\\u202f16,713) were downloaded from their respective LPSN webpages.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 888,\n            'f': \"888\",\n        },\n\"For that reason, the List of Prokaryotic names with Standing in Nomenclature (LPSN) presented the etymology of the name as N.L.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 889,\n            'f': \"889\",\n        },\n\"n. Marivivens , living in the sea ( https://lpsn.dsmz.de/search?word=Marivivens , accessed 27 March 2025), assigning the masculine or the feminine gender to the generic name.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 890,\n            'f': \"890\",\n        },\n\"LPSN gives both adjectival epithets as N.L.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 891,\n            'f': \"891\",\n        },\n\"( https://lpsn.dsmz.de/species/marivivens-donghaensis and https://lpsn.dsmz.de/species/marivivens-geojensis , accessed 27 March 2025).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 892,\n            'f': \"892\",\n        },\n\"A phylogenetic tree constructed with 14 Anaerococcus species from the LPSN indicated that AH8042_DFU013_CI05 is evolutionarily distinct from other known Anaerococcus species ( Fig.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 893,\n            'f': \"893\",\n        },\n\"This study aimed to elucidate the anti-biofilm properties of L. plantarum and L. rhamnosus cell-free supernatants (LPSN and LRSN, respectively) on S. pyogenes biofilms grown in vitro in supplemented minimal medium.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"LPSN\"],\n [{\n            'v': 894,\n            'f': \"894\",\n        },\n\"When planktonic or biofilm S. pyogenes were exposed to LPSN or LRSN , S. pyogenes survival was reduced significantly in a concentration-dependent manner, and the effect was more pronounced on preformed biofilms.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"LPSN\"],\n [{\n            'v': 895,\n            'f': \"895\",\n        },\n\"Enzymatic digestion of LPSN and LRSN suggested that glycolipid compounds might cause the antimicrobial effect.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"LPSN\"],\n [{\n            'v': 896,\n            'f': \"896\",\n        },\n\"Adding lactic acid to S. pyogenes 5448 cell-free spent medium adjusted to pH 4.5 (GASSN-LA) to a concentration comparable to the one present in L. plantarum and L. rhamnosus cell-free supernatants (LPSN and LRSN) in MRS (140 mM) showed a significant reduction of viable S. pyogenes 5448 recovered from 72-hour-old biofilms, albeit lower than with MRS-derived LPSN or LRSN ( Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"LPSN\"],\n [{\n            'v': 897,\n            'f': \"897\",\n        },\n\"Lactic acid concentration and biofilm treatment with 5% LPSN or LRSN grown in different growth media.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"LPSN\"],\n [{\n            'v': 898,\n            'f': \"898\",\n        },\n\"In its current release Bac Dive shows data on 20 060 type strains, covering 98% of the 20 510 validly described species ( https://lpsn.dsmz.de/text/numbers ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 899,\n            'f': \"899\",\n        },\n\"The increase in type strain coverage in Bac Dive from just 81% in 2021 to 98% in 2024 could be achieved through improved data exchange with one of its sister databases, the List of Prokaryotic names with Standing in Nomenclature (LPSN) ( 10 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 900,\n            'f': \"900\",\n        },\n\"The increase in type strain coverage in Bac Dive from just 81% in 2021 to 98% in 2024 could be achieved through improved data exchange with one of its sister databases, the List of Prokaryotic names with Standing in Nomenclature (LPSN) ( 10 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BacDive\"],\n [{\n            'v': 901,\n            'f': \"901\",\n        },\n\"Data from LPSN is no longer only used to keep Bac Dive up to date on correct prokaryotic nomenclature, but also to add all type strains of newly described species to the database in a timely manner.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 902,\n            'f': \"902\",\n        },\n\"Data from LPSN is no longer only used to keep Bac Dive up to date on correct prokaryotic nomenclature, but also to add all type strains of newly described species to the database in a timely manner.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BacDive\"],\n [{\n            'v': 903,\n            'f': \"903\",\n        },\n\"Accessions for GenBank genome assemblies and 16S rRNA gene sequences are now routinely collected by going through current accession lists downloaded from the NCBI FTP server and programmatically matching them to Bac Dive strains via culture collection numbers and species names, also considering all synonyms known in LPSN and the NCBI taxonomy ( 15 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 904,\n            'f': \"904\",\n        },\n\"Accessions for GenBank genome assemblies and 16S rRNA gene sequences are now routinely collected by going through current accession lists downloaded from the NCBI FTP server and programmatically matching them to Bac Dive strains via culture collection numbers and species names, also considering all synonyms known in LPSN and the NCBI taxonomy ( 15 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GenBank\"],\n [{\n            'v': 905,\n            'f': \"905\",\n        },\n\"Accessions for GenBank genome assemblies and 16S rRNA gene sequences are now routinely collected by going through current accession lists downloaded from the NCBI FTP server and programmatically matching them to Bac Dive strains via culture collection numbers and species names, also considering all synonyms known in LPSN and the NCBI taxonomy ( 15 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BacDive\"],\n [{\n            'v': 906,\n            'f': \"906\",\n        },\n\"The databases not only include the established Core data resources BRENDA ( 18 ), SILVA ( 19 ) and LPSN ( 10 ), but also newly established databases like StrainInfo ( https://straininfo.dsmz.de ), Media Dive ( 20 ) and Phage Dive ( 21 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 907,\n            'f': \"907\",\n        },\n\"The databases not only include the established Core data resources BRENDA ( 18 ), SILVA ( 19 ) and LPSN ( 10 ), but also newly established databases like StrainInfo ( https://straininfo.dsmz.de ), Media Dive ( 20 ) and Phage Dive ( 21 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 908,\n            'f': \"908\",\n        },\n\"The databases not only include the established Core data resources BRENDA ( 18 ), SILVA ( 19 ) and LPSN ( 10 ), but also newly established databases like StrainInfo ( https://straininfo.dsmz.de ), Media Dive ( 20 ) and Phage Dive ( 21 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 909,\n            'f': \"909\",\n        },\n\"Nomenclature information was obtained from LPSN (available at https://lpsn.dsmz.de ) [ 17 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 910,\n            'f': \"910\",\n        },\n\"Non-redundant ASVs database: A specialized V3-V4 regions (positions 341-806) ASVs database was created by integrating data from SILVA, NCBI, LPSN, and 1,082 human gut samples, providing precise data for bacterial species identification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 911,\n            'f': \"911\",\n        },\n\"Non-redundant ASVs database: A specialized V3-V4 regions (positions 341-806) ASVs database was created by integrating data from SILVA, NCBI, LPSN, and 1,082 human gut samples, providing precise data for bacterial species identification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 912,\n            'f': \"912\",\n        },\n\"Non-redundant ASVs database: A specialized V3-V4 regions (positions 341-806) ASVs database was created by integrating data from SILVA, NCBI, LPSN, and 1,082 human gut samples, providing precise data for bacterial species identification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 913,\n            'f': \"913\",\n        },\n\"The genus Anaerococcus, first proposed in 2001 with Anaerococcus prevotii as its type species ( 1 ), comprises 15 validly described species of gram-positive, strictly anaerobic bacteria listed in the LPSN (List of Prokaryotic Names with Standing in Nomenclature) ( 2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 914,\n            'f': \"914\",\n        },\n\"The genome was also submitted to the Type (Strain) Genome Server (TYGS) in tandem with the List of Prokaryotic names coupled to the Standing in Nomenclature (LPSN) [ 53 ], followed by preparing phylogenetic trees in MEGA12 [ 54 ] to confirm phylogenetic relationships among other bacteria.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 915,\n            'f': \"915\",\n        },\n\"Of all the public databases that contain nomenclature information on prokaryotes, the List of Prokaryotic Names with Standing in Nomenclature database (LPSN, lpsn.dsmz.de) is recommended for information on the names of prokaryotic taxa, including their nomenclatural history and their current status: validly published or effectively published (names published in a recognized scientific printed and/or electronic publication but conditions for validation not yet fulfilled), legitimate (in accordance with the Rules of the ICNP) or illegitimate (contrary to the Rules of the ICNP), correct name, synonym, basonym (the original name of a new combination), etc 28 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 916,\n            'f': \"916\",\n        },\n\"The names of prokaryotes in NCBI Taxonomy are curated to best align with the authoritative nomenclature defined by the List of Prokaryotic Names with Standing in Nomenclature (LPSN) [ 6 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 917,\n            'f': \"917\",\n        },\n\"( 2009 ) of the order Microbacteriales (Salam et al., 2020 ) and currently contains >130 species with validly published names ( https://lpsn.dsmz.de/genus/microbacterium ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 918,\n            'f': \"918\",\n        },\n\"The order Hyphomicrobiales of the class Alphaproteobacteria consists of 38 families encompassing 152 valid genera according to the List of Prokaryotic names with Standing in Nomenclature (LPSN; accessed 2 January 2024).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 919,\n            'f': \"919\",\n        },\n\"For the five housekeeping genes, we constructed individual datasets containing sequences generated in the current study, as well as those for the type strains of known species as listed on the List of Prokaryotes with Standing in Nomenclature (LPSN, available at https://lpsn.dsmz.de/ , accessed on 15th September 2023) that captures all Mesorhizobium type strains irrespective of their names\\u2019 valid publication (Euz\\u00e9by 1997 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 920,\n            'f': \"920\",\n        },\n\"This tool was designed to work for a wide range of prokaryotes and is the first example of an automated reconciliation of NCBI\\u2019s Taxonomy database with that of the List of Prokaryotic names with Standing in Nomenclature (LPSN).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 921,\n            'f': \"921\",\n        },\n\"This tool was designed to work for a wide range of prokaryotes and is the first example of an automated reconciliation of NCBI\\u2019s Taxonomy database with that of the List of Prokaryotic names with Standing in Nomenclature (LPSN).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 922,\n            'f': \"922\",\n        },\n\"Since its establishment in 1997 by Professor Jean Euz\\u00e9by, the List of Prokaryotic names with Standing in Nomenclature (LPSN) has served the microbiological community by providing a centralized resource containing the most up-to-date taxonomic information for both Archaea and Bacteria ( 15-18 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 923,\n            'f': \"923\",\n        },\n\"However, reliance on the text files available for download at the LPSN has significantly reduced the ability of PHANTASM to accurately work with cyanobacterial genomes as the cyanobacterial nomenclature is largely omitted from the file.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 924,\n            'f': \"924\",\n        },\n\"To ascertain good coverage of microbes, taxonomy databases for viruses, bacteria and fungi have been added, namely the International Committee on Taxonomy of Viruses (ICTV) [ 8 ], List of Prokaryotic names with Standing in Nomenclature (LPSN) [ 9 ] and MycoBank [ 10 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 925,\n            'f': \"925\",\n        },\n\"The GTDB\\u2019s standardized bacterial taxonomy, utilized by GTDBtk, combines the genus Spirillospora with several species that are traditionally classified under the genus Actinomadura in NCBI and LPSN (Approved Lists) [ 6 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 926,\n            'f': \"926\",\n        },\n\"Searching the List of Prokaryotic names with Standing in Nomenclature (LPSN) [ 36 ] and deleting low abundant microbiome, we included some possible families (Comamonadaceae, Cystobacteraceae, Enterobacteriaceae, Mycobacteriaceae, Paenibacillaceae and Peptostreptococcaceae) and genus ( Mycobacterium , Paenibacillus , Peptoclostridium , Saccharomonospora , Salmonella and Alicyclobacillus ) in following analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 927,\n            'f': \"927\",\n        },\n\"A major change regarding the selection of taxon names for inclusion in LPSN is the addition of names that are not validly published ( Candidatus names and other names), as well as of names of Cyanobacteria validly published under the ICN (International Code of Nomenclature for algae, fungi and plants), in anticipation of the recent changes to the ICNP ( 29 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 928,\n            'f': \"928\",\n        },\n\"Since every member of the class Cyanobacteria found in our samples belonged to the Nostocaceae family, we renamed the Cyanobacteriales order to Nostocales, following LPSN.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 929,\n            'f': \"929\",\n        },\n\"3) Endotoxemia-induced kidney inflammation was assessed 24 h after the administration of 5 mg/kg IP bacterial lipopolysaccharide (LPS, Sigma) (LPS nephropathy, LPSN).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 930,\n            'f': \"930\",\n        },\n\"The interface also creates links to articles for the respective taxon on three other public resources: Wikipedia ( https://en.wikipedia.org/ ; accessed 2024/02/02), the List of Prokaryotic names with Standing in Nomenclature (LPSN) [27] , and the Bacterial and Viral Bioinformatics Resource Center (BV-BRC) [26] .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 931,\n            'f': \"931\",\n        },\n\"Several classifications to circumscribe this family are available in major resources, such as those provided by the List of Prokaryotic names with Standing in Nomenclature (LPSN), NCBI Taxonomy, Genome Taxonomy Database (GTDB), and Bergey\\u2019s Manual of Systematics of Archaea and Bacteria (BMSAB), with some degree of disagreement between them.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 932,\n            'f': \"932\",\n        },\n\"Several classifications to circumscribe this family are available in major resources, such as those provided by the List of Prokaryotic names with Standing in Nomenclature (LPSN), NCBI Taxonomy, Genome Taxonomy Database (GTDB), and Bergey\\u2019s Manual of Systematics of Archaea and Bacteria (BMSAB), with some degree of disagreement between them.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GTDB\"],\n [{\n            'v': 933,\n            'f': \"933\",\n        },\n\"As of July 2023, it comprises 168 species with validly published names (according to the LPSN) that share the following features: Gram-stain-negative, non-endospore-forming rods or coccoid cells, chemo-organotrophic, aerobic or facultatively anaerobic, catalase-positive and oxidase-variable, and halophilic or halotolerant bacteria ( Ventosa et al., 2021b ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"LPSN\"],\n [{\n            'v': 934,\n            'f': \"934\",\n        },\n\"In this study, we aimed to determine the effect of various mammographic technologies on the in vivo mean glandular doses (MGDs) that are received in clinical settings.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 935,\n            'f': \"935\",\n        },\n\"Methods : The MGDs and applied acquisition parameters from 194,608 mammograms, acquired employing AEC using different digital mammography systems (GE, Siemens, and two different models of Hologic), were retrospectively collected.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 936,\n            'f': \"936\",\n        },\n\"The potential variation in MGD resulting from different technologies (system and target/filter combination) was assessed employing the Kruskal-Wallis test, followed by Dunn\\u2019s post hoc.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 937,\n            'f': \"937\",\n        },\n\"The trend line of these parameters in addition to the MGD and source-to-breast distance were also plotted and compared.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 938,\n            'f': \"938\",\n        },\n\"As the CBT increases, the MGD increases with different degrees, rates, and patterns across systems due to differences in AEC strategies.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 939,\n            'f': \"939\",\n        },\n\"Changes in visual function in individuals with meibomian gland dysfunction (MGD), which is commonly associated with evaporative DED, have not been well studied.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 940,\n            'f': \"940\",\n        },\n\"This study evaluated best-corrected visual acuity (BCVA) and reading speed in individuals with and without MGD.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 941,\n            'f': \"941\",\n        },\n\"In a 22-day, prospective, noninterventional, multicenter (three sites) clinical study (NCT01979887), eligible adults (age \\u226540 years with no uncontrolled ocular or systemic disease other than MGD) were classified into one of three cohorts (non-MGD, mild/moderate MGD, and severe MGD) based on meibum quality scores, ocular symptom scores, and Schirmer test results.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 942,\n            'f': \"942\",\n        },\n\"Mean BCVA was 89.9, 88.3, and 82.7 letters in the non-MGD, mild/moderate MGD, and severe MGD cohorts, respectively (p= 0.046 severe vs mild/moderate MGD; p= 0.094 severe MGD vs non-MGD).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 943,\n            'f': \"943\",\n        },\n\"Mean IReST reading speed was slower in the severe MGD cohort (146.0 words/min) than in the non-MGD (164.2 words/min) and mild/moderate MGD (167.8 words/min) cohorts, and the difference between the mild/moderate and severe MGD cohorts was significant (p= 0.046).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 944,\n            'f': \"944\",\n        },\n\"Patient demographics, preoperative laboratory measurements, and RRs were compared between patients with single-gland disease (SGD) versus multigland disease (MGD).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 945,\n            'f': \"945\",\n        },\n\"Patient demographics, preoperative laboratory measurements, and RRs were compared between patients with single-gland disease (SGD) versus multigland disease (MGD).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 946,\n            'f': \"946\",\n        },\n\"Of 2368 patients included, 1585 (66.9%) patients had SGD, and 783 (33.1%) had MGD.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 947,\n            'f': \"947\",\n        },\n\"Of 2368 patients included, 1585 (66.9%) patients had SGD, and 783 (33.1%) had MGD.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 948,\n            'f': \"948\",\n        },\n\"Patients with SGD had higher median (IQR) RRs than the MGD group (0.8 [0.5-1.3] vs 0.4 [0.3-0.7], P <.001).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 949,\n            'f': \"949\",\n        },\n\"However, these radiologic studies could be inaccurate in localizing disease or distinguishing between single-gland disease (SGD) and multigland disease (MGD).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 950,\n            'f': \"950\",\n        },\n\"However, these radiologic studies could be inaccurate in localizing disease or distinguishing between single-gland disease (SGD) and multigland disease (MGD).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 951,\n            'f': \"951\",\n        },\n\"5 MGD typically presents with smaller lesions that are often difficult to identify on imaging.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 952,\n            'f': \"952\",\n        },\n\"Objective: This research seeks to investigate the effects of preoperative intense pulsed light with manual meibomian expression (IPL-MGX) on the refractive accuracy of cataract surgery on dry eyes with meibomian gland dysfunction (MGD-related dry eyes).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 953,\n            'f': \"953\",\n        },\n\"Methods: Fifty-six MGD-related dry eye cases planned for cataract surgery were analyzed.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 954,\n            'f': \"954\",\n        },\n\"Conclusions: Preoperative IPL-MGX considerably improved the predicted postoperative refraction accuracy in patients with MGD-related dry eye undergoing cataract surgery.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 955,\n            'f': \"955\",\n        },\n\"These conditions can also be caused by meibomian gland dysfunction (MGD)-related dry eyes [ 15 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 956,\n            'f': \"956\",\n        },\n\"MGD was defined as abnormal meibum composition and secretion [ 19 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 957,\n            'f': \"957\",\n        },\n\"Dyslipidemia and obesity have been shown to be associated with MGD in adults and obesity mouse model [ 3 , 22 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 958,\n            'f': \"958\",\n        },\n\"The therapeutic efficacy of the ROSI-loaded MN patch (ROSI-MN) was evaluated in a high-fat diet (HFD)-induced MGD mouse model, showing improved outcomes compared to oral administration.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 959,\n            'f': \"959\",\n        },\n\"We have delineated a mouse model of atrophic meibomian Gland Dysfunction (MGD).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 960,\n            'f': \"960\",\n        },\n\"MGD-4 and MGD-28 showed high specificity for tumor cells reflected by the minimal antiproliferative activity against primary B cells isolated from healthy individuals, however, a more relevant humanized mouse model (e.g., CRBN I391V mice) could be utilized to evaluate the toxicity and side effects of our degraders in preclinical studies.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 961,\n            'f': \"961\",\n        },\n\"30-32 , 41 In a transgenic mouse model, deficiency in Cyp4f39 , a gene encoding a fatty acid \\u03c9-hydroxylase, resulted in decreased levels of C16:1 OAHFAs, cholesteryl OAHFAs, and wax diesters in the meibomian glands, as well as obstruction of the orifices of the meibomian glands, a decrease in tear film breakup time, and corneal epithelial damage indicative of MGD and DED.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 962,\n            'f': \"962\",\n        },\n\"As wax esters make up approximately 43 % of the human tear film lipids and they are dysregulated in patients with MGD [ 25 , 26 ], the use of the Awat2 KO mouse model to study EDED is promising.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 963,\n            'f': \"963\",\n        },\n\"Importantly, the Awat2 KO mouse described in this study seems to better recapitulate many of the features of moderate to advanced MGD and EDED in humans due to its less severe ocular surface phenotype [ 23 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 964,\n            'f': \"964\",\n        },\n\"The Awat2 KO mouse model generally recapitulates the clinical disease seen in human patients with MGD and EDED, but there have been no mutations in Awat2 identified to date that have been associated with MGD/EDED in humans.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 965,\n            'f': \"965\",\n        },\n\"Thus, the few phenotypic differences between the Awat2 KO mouse model and humans with MGD and EDED could be unique to this genetic deficiency and the specific responses to the loss of Awat2 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 966,\n            'f': \"966\",\n        },\n\"However, despite these differences, the Awat2 KO mouse represents a promising model for the human condition as it exemplifies the main clinical features of human patients with MGD and EDED.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 967,\n            'f': \"967\",\n        },\n\"As described above, we have devised a novel mouse model of OMGD with robust ductal obstruction and acinar atrophy shortly after genetic deletion of Fgfr2 in Krt5 + MG progenitor cells.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 968,\n            'f': \"968\",\n        },\n\"This inducible Krt5Fgfr2 CKO - TAM transgenic mouse model of OMGD is readily reversible upon discontinuing TAM induction.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 969,\n            'f': \"969\",\n        },\n\"This study investigated the effects of UPM on MG dysfunction (MGD) in rodent models.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 970,\n            'f': \"970\",\n        },\n\"89 , 90 In addition, the NF-\\u03baB and MAPK pathways played an etiological role in inflammatory MGD induced by hyperglycemia 37 and hyperlipidemia in rodent models.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 971,\n            'f': \"971\",\n        },\n\"We previously reported that this sclerotic GVHD mouse model mimics MGD and blepharitis with the depletion of MG acini, pathological fibrosis, and infiltration of inflammatory cells, as observed in patients with cGVHD 30 , 31 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 972,\n            'f': \"972\",\n        },\n\"Overall, the successful establishment of a mouse model of ARMGD phenotype was confirmed.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 973,\n            'f': \"973\",\n        },\n\"Many mouse models have also shown that hyperlipidemia is associated with MGD [ 46 , 47 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 974,\n            'f': \"974\",\n        },\n\"Previous mouse studies have reported an increased incidence of MGD in mice with altered lipid abnormalities [ 47 , 48 ], but whether this translates to humans needs to be carefully examined.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 975,\n            'f': \"975\",\n        },\n\"Although a lot of literature on rodent MGD models exists, a comprehensive review on rabbit animal models is lacking.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 976,\n            'f': \"976\",\n        },\n\"They have been successfully used to generate several animal models of MGD like rabbit epinephrine-induced MGD,[ 46 , 47 ] primate polychlorinated biphenyl-induced MGD,[ 46 ] and the rhino mouse genetic MGD models.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"MGD\"],\n [{\n            'v': 977,\n            'f': \"977\",\n        },\n\"The Mouse Genome Database (MGD) and the Gene Expression Database (GXD) are MGI\\u2019s two major knowledgebases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 978,\n            'f': \"978\",\n        },\n\"The Mouse Genome Database (MGD) and the Gene Expression Database (GXD) are MGI\\u2019s two major knowledgebases.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GXD\"],\n [{\n            'v': 979,\n            'f': \"979\",\n        },\n\"A comprehensive list of oncogenes and tumor suppressor genes was obtained by querying the Mouse Genome Database (MGD) [57], which collects data on mouse genes, their functions, phenotypes and mouse models of human disease.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 980,\n            'f': \"980\",\n        },\n\"The Mouse Genome Database (MGD) (http://www.informatics.jax.org) one component of a community database resource for the laboratory mouse, a key model organism for interpreting the human genome and for understanding human biology.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 981,\n            'f': \"981\",\n        },\n\"MGD strives to provide an extensively integrated information resource with experimental details annotated from both literature and on-line genomic data sources.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 982,\n            'f': \"982\",\n        },\n\"MGD curates and presents the consensus representation of genotype (sequence) to phenotype information including highly detailed information about genes and gene products.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 983,\n            'f': \"983\",\n        },\n\"MGD collaborates with other bioinformatics groups to curate a definitive set of information about the laboratory mouse.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 984,\n            'f': \"984\",\n        },\n\"MGD contains information on mouse genes, genetic markers and genomic features as well as information on molecular segments (probes, primers, cDNA clones, BACs and YACs) mutant phenotypes, comparative mapping data, graphical displays of linkage, cytogenetic and physical maps, experimental mapping data, as well as strain distribution patterns for recombinant inbred strains (RIs) and cross haplotypes\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 985,\n            'f': \"985\",\n        },\n\"These lists were originally extracted from the corresponding organism specific databases, Saccharomyces Genome Database (SGD) [13] and Mouse Genome Database (MGD) [14].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 986,\n            'f': \"986\",\n        },\n\"These lists were originally extracted from the corresponding organism specific databases, Saccharomyces Genome Database (SGD) [13] and Mouse Genome Database (MGD) [14].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 987,\n            'f': \"987\",\n        },\n\"We use the MGD human homologues information to interconvert mouse and human gene names. We maintain local copies of these conversion tables because nearly all queries require that gene nomenclature problems be solved.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MGD\"],\n [{\n            'v': 988,\n            'f': \"988\",\n        },\n\"CLL11 ( ClinicalTrials.gov identifier: NCT01010061) is an international, multicentric, open-label, randomized phase 3 study.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 989,\n            'f': \"989\",\n        },\n\"CLL11 ( ClinicalTrials.gov identifier: NCT01010061) is an international, multicentric, open-label, randomized phase 3 study.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 990,\n            'f': \"990\",\n        },\n\"Of the patients who had received G-Clb or R-Clb as part of the CLL11 study, a subset of n = 35 was further followed up in a national registry of the German CLL Study Group ( ClinicalTrials.gov identifier: NCT02863692) after the end of the study in August 2017.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 991,\n            'f': \"991\",\n        },\n\"Of the patients who had received G-Clb or R-Clb as part of the CLL11 study, a subset of n = 35 was further followed up in a national registry of the German CLL Study Group ( ClinicalTrials.gov identifier: NCT02863692) after the end of the study in August 2017.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 992,\n            'f': \"992\",\n        },\n\"ClinicalTrials.gov , identifier NCT06644794.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 993,\n            'f': \"993\",\n        },\n\"ClinicalTrials.gov , identifier NCT06644794.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 994,\n            'f': \"994\",\n        },\n\"Results may be reported to clinicaltrials.gov, as required.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 995,\n            'f': \"995\",\n        },\n\"The primary outcome is the change in urine albumin-creatinine ratio after 6 months of treatment with finerenone (nsMRA) and empagliflozin (SGLT2i) in combination compared with each drug alone (ClinicalTrials.gov ID NCT05254002) [ 45 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 996,\n            'f': \"996\",\n        },\n\"The primary outcome is the change in urine albumin-creatinine ratio after 6 months of treatment with finerenone (nsMRA) and empagliflozin (SGLT2i) in combination compared with each drug alone (ClinicalTrials.gov ID NCT05254002) [ 45 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 997,\n            'f': \"997\",\n        },\n\"The SUGARNSALT study (ClinicalTrials.gov ID NCT06217302) aims to provide efficacy and safety data to seek US Food and Drug Administration (FDA) approval of sotagliflozin for the prevention of kidney function decline in individuals with type 1 diabetes and diabetic kidney disease (DKD).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 998,\n            'f': \"998\",\n        },\n\"The SUGARNSALT study (ClinicalTrials.gov ID NCT06217302) aims to provide efficacy and safety data to seek US Food and Drug Administration (FDA) approval of sotagliflozin for the prevention of kidney function decline in individuals with type 1 diabetes and diabetic kidney disease (DKD).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 999,\n            'f': \"999\",\n        },\n\"ClinicalTrials.gov (ID NCT05965544).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1000,\n            'f': \"1000\",\n        },\n\"ClinicalTrials.gov (ID NCT05965544).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1001,\n            'f': \"1001\",\n        },\n\"ClinicalTrials.gov served as the primary data source for this review.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1002,\n            'f': \"1002\",\n        },\n\"Data from http://clinicaltrials.gov as of November 10, 2023.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1003,\n            'f': \"1003\",\n        },\n\"Secondly, the completeness and quality of data extracted from ClinicalTrials.gov may vary, potentially impacting the reliability of findings.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1004,\n            'f': \"1004\",\n        },\n\"The data from ClinicalTrials.gov provide a foundational resource for advancing HD management.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1005,\n            'f': \"1005\",\n        },\n\"The study complied with the Declaration of Helsinki, was approved by the university ethics committee (project number: 18-059), and was registered on clinicaltrials.gov (NCT05153694).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1006,\n            'f': \"1006\",\n        },\n\"The study complied with the Declaration of Helsinki, was approved by the university ethics committee (project number: 18-059), and was registered on clinicaltrials.gov (NCT05153694).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1007,\n            'f': \"1007\",\n        },\n\"The study was conducted in accordance with the ethical standards of the Declaration of Helsinki, approved by the university ethics committee (project number: 18-059) and registered on clinicaltrials.gov (NCT05153694).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1008,\n            'f': \"1008\",\n        },\n\"The study was conducted in accordance with the ethical standards of the Declaration of Helsinki, approved by the university ethics committee (project number: 18-059) and registered on clinicaltrials.gov (NCT05153694).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1009,\n            'f': \"1009\",\n        },\n\"The study is registered at ClinicalTrials.gov (ID: NCT06644794) in 15 October 2024.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1010,\n            'f': \"1010\",\n        },\n\"The study is registered at ClinicalTrials.gov (ID: NCT06644794) in 15 October 2024.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1011,\n            'f': \"1011\",\n        },\n\"The current study is approved by the Advarra IRB (#Pro00064749) and registered at Clinicaltrials.gov (Identifier: NCT05735587).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1012,\n            'f': \"1012\",\n        },\n\"The current study is approved by the Advarra IRB (#Pro00064749) and registered at Clinicaltrials.gov (Identifier: NCT05735587).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1013,\n            'f': \"1013\",\n        },\n\"The study was registered at Clinicaltrials.gov (Identifier: NCT05735587).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1014,\n            'f': \"1014\",\n        },\n\"The study was registered at Clinicaltrials.gov (Identifier: NCT05735587).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1015,\n            'f': \"1015\",\n        },\n\"All individuals enrolled in the Berries and Steps study are offered an opportunity to enroll in a sub-study called Berries, Bugs and the Blues that is funded by the USDA (2022-09412), approved by the Advarra IRB (#Pro00068528), and registered at Clinicaltrials.gov (Identifier: NCT05817383).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1016,\n            'f': \"1016\",\n        },\n\"All individuals enrolled in the Berries and Steps study are offered an opportunity to enroll in a sub-study called Berries, Bugs and the Blues that is funded by the USDA (2022-09412), approved by the Advarra IRB (#Pro00068528), and registered at Clinicaltrials.gov (Identifier: NCT05817383).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1017,\n            'f': \"1017\",\n        },\n\"ClinicalTrials.gov, Registration number: NCT06284941, Retrospectively registered, Date of registration: February 04, 2024.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1018,\n            'f': \"1018\",\n        },\n\"This randomized clinical trial was approved by the Ethics Committee of Taizhou Jiangyan Hospital of Traditional Chinese Medicine in April 2023 (ethics number: KY 2023-001-001; registered on May 05, 2023) and registered at clinicaltrials.gov (registration number: NCT06284941; registered on February 04, 2024).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1019,\n            'f': \"1019\",\n        },\n\"The aggregates formed by pathogenic proteins have been reported to sequester other cellular factors and cause dysfunction and impairment of the sequestered components [ 17 , 18 , 19 ], which is implicated in the pathologies of NDDs [ 20 , 21 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1020,\n            'f': \"1020\",\n        },\n\"Such accumulation of the pathogenic proteins into inclusions leads to the loss of essential function or gain of toxic function of the sequestered proteins, which may influence the biological processes or pathways, eventually aggravate the aggregation-related protein pathologies (proteinopathies) and accelerate the disease progression [ 23 , 24 , 26 , 27 , 56 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1021,\n            'f': \"1021\",\n        },\n\"The NTD of TDP-43 exhibits multiple forms of oligomerization that are critical for proper physiological functions [ 62 , 63 , 64 , 65 , 66 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1022,\n            'f': \"1022\",\n        },\n\"Given the important functions of TDP-43 in RNA and protein homeostasis, it is unsurprising that the structural damages and dysfunction of TDP-43 may easily alter cellular homeostasis and cause severe neurological diseases.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1023,\n            'f': \"1023\",\n        },\n\"The TDP-43 proteinopathies may also result in the impairment of nucleocytoplasmic transport (NCT) [ 132 , 133 , 134 ] and axonal transport [ 81 , 135 ], induction of the endoplasmic reticulum and oxidative stresses [ 136 , 137 , 138 ], apoptosis [ 139 , 140 ], dysfunction of mitochondrion [ 141 , 142 , 143 ] and also deregulation of protein quality control system (such as UPS and autophagy) [ 144 , 145 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1024,\n            'f': \"1024\",\n        },\n\"Childhood trauma refers to adverse life events experienced during childhood, including various types of abuse or neglect, and severe family dysfunction [ 1 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1025,\n            'f': \"1025\",\n        },\n\"Previous studies have found that childhood trauma is closely related to a higher incidence of mental disorders and poorer social functioning in adulthood [ 3 - 5 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1026,\n            'f': \"1026\",\n        },\n\"These factors may amplify the effects of childhood trauma on emotional disorders, creating distinct patterns compared to other populations.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1027,\n            'f': \"1027\",\n        },\n\"The R package \\u201cNetwork Comparison Test (NCT)\\u201d was used to compare networks with and without childhood trauma [ 49 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1028,\n            'f': \"1028\",\n        },\n\"The NCT is a permutation test that compares the difference between two networks through 1,000 iterations [ 50 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1029,\n            'f': \"1029\",\n        },\n\"Functional studies show that FUS-TFCP2 blocks myogenic differentiation, induces transcription of ALK and truncated TERT, and inhibits DNA repair.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1030,\n            'f': \"1030\",\n        },\n\"Here, the authors use multi-omics analyses and functional and mechanistic investigations to characterize TFCP2-rearranged RMS - including cases with FUS/EWSR1-TFCP2 fusions - across two precision oncology programs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1031,\n            'f': \"1031\",\n        },\n\"TFCP2 has been linked to Alzheimer\\u2019s disease and the expression of HIV genes and acts as an oncogene in hepatocellular carcinoma, pancreatic ductal adenocarcinoma, and breast cancer but exerts a tumor-suppressive function in melanoma 13 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1032,\n            'f': \"1032\",\n        },\n\"This corresponded to the fusion of the transcriptional activation domain and part of the first RGG1 domain of FUS or part of the transcriptional activation domain of EWSR1 with all functional domains of TFCP2 (Supplementary Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1033,\n            'f': \"1033\",\n        },\n\"However, the processing of A\\u03b2 is complex, involving multiple cleavages of the APP transmembrane domain (TMD) by the membrane-embedded \\u03b3-secretase complex, resulting in A\\u03b2 peptides through two distinct pathways: C99\\u2192A\\u03b249\\u2192A\\u03b246\\u2192A\\u03b243\\u2192A\\u03b240 and C99\\u2192A\\u03b248\\u2192A\\u03b245\\u2192A\\u03b242\\u2192A\\u03b238 ( Figure 1A ; Takami et al., 2009 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1034,\n            'f': \"1034\",\n        },\n\"Similarly, we found that six PSEN1 FAD-mutant \\u03b3-secretase complexes show reduced processive proteolytic function ( Devkota et al., 2024 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1035,\n            'f': \"1035\",\n        },\n\"Consequently, the observed deficiencies in A431E and A434T can be attributed to the disruption of these crucial structural and functional elements.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1036,\n            'f': \"1036\",\n        },\n\"Consistent with this idea, true loss of function of \\u03b3-secretase\\u2014due to dominant mutations in PSEN1 and other components of the protease complex that lead to nonsense-mediated decay (i.e.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1037,\n            'f': \"1037\",\n        },\n\"In this context, \\u03b3-secretase activators that rescue stalled E-S complexes offer a promising therapeutic strategy by potentially rescuing deficient proteolytic function and thereby reducing levels of stalled E-S complexes, without over-activating cleavage of other substrates (which are limited by prior rate-determining ectodomain shedding) ( Wolfe, 2024 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1038,\n            'f': \"1038\",\n        },\n\"Currently approved BRAF inhibitors are potent against class I BRAF V600 mutants, which function as monomers.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1039,\n            'f': \"1039\",\n        },\n\"Our data indicate that FUS/EWSR1-TFCP2-positive sarcoma is a distinct disease entity that does not fit the pattern of genetically silent fusion-driven sarcomas and provide insight into potential therapeutic vulnerabilities that may inform clinical decision-making in this difficult-to-treat sarcoma subtype.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1040,\n            'f': \"1040\",\n        },\n\"A phase II trial of neoadjuvant pembrolizumab and dabrafenib plus trametinib for patients with BRAF V600E-mutated ATC is nearing completion (NCT04675710).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1041,\n            'f': \"1041\",\n        },\n\"AIC100 is an ICAM-1-directed CAR-T cell and a phase I trial of AIC100 for poorly differentiated TC and ATC is now underway (NCT05530754).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1042,\n            'f': \"1042\",\n        },\n\"They can include other APIs with distinct pharmaceutical activities and clinical uses, or common chemical substances without independent medicinal applications.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1043,\n            'f': \"1043\",\n        },\n\"Larotrectinib-treated pediatric patients with sarcoma in the SCOUT (ClinicalTrials.gov identifier: NCT02637687 ) phase I/II study and NAVIGATE (ClinicalTrials.gov identifier: NCT02576431 ) phase II basket trial formed the analytic cohort; the trial designs were previously published.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1044,\n            'f': \"1044\",\n        },\n\"Larotrectinib-treated pediatric patients with sarcoma in the SCOUT (ClinicalTrials.gov identifier: NCT02637687 ) phase I/II study and NAVIGATE (ClinicalTrials.gov identifier: NCT02576431 ) phase II basket trial formed the analytic cohort; the trial designs were previously published.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1045,\n            'f': \"1045\",\n        },\n\"The EPI-VITRAKVI study (ClinicalTrials.gov identifier: NCT05236257 ) compared results from the larotrectinib SCOUT trial with external historical controls treated with chemotherapy.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1046,\n            'f': \"1046\",\n        },\n\"The EPI-VITRAKVI study (ClinicalTrials.gov identifier: NCT05236257 ) compared results from the larotrectinib SCOUT trial with external historical controls treated with chemotherapy.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1047,\n            'f': \"1047\",\n        },\n\"Clinical data such as liver function, fibrosis markers, presence of esophageal varices, presence of a portosystemic shunt, and liver volume were compared.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1048,\n            'f': \"1048\",\n        },\n\"Abbreviations: BET, bromodomain and extraterminal domain; CDK4/6, cyclin-dependent kinases 4/6; CTLA4, cytotoxic T-lymphocyte associated protein 4; ET, essential thrombocythemia; FEDR, fedratinib; JAKi, JAK inhibitors; LOXL2, lysyl oxidase homolog 2; mAb, monoclonal antibody; MDM2, mouse double minute 2; MF, myelofibrosis; MMB, momelotinib; NCT, national clinical trial; PI3K, phosphoinositide 3-kinase; PIM, proviral integration site for Moloney murine leukemia virus; RUX, ruxolitinib; SVR35%, spleen volume reduction \\u2265 35%; TSS50%, total symptom score reduction \\u2265 50%; XPO1, exportin 1.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1049,\n            'f': \"1049\",\n        },\n\"The combination of ERK inhibitor rineterkib and RUX was tested in a phase I/II open platform ADORE study (NCT04097821); unfortunately, the trial was interrupted.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1050,\n            'f': \"1050\",\n        },\n\"Consequently, the phase III trial TRANSFORM-1 (NCT04472598) evaluated navitoclax plus RUX compared with placebo plus RUX in JAKi-na\\u00efve patients, whereas the phase III TRANSFORM-2 (NCT04468984) enrolled RUX relapsed/refractory MF to navitoclax and RUX combination versus BAT.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1051,\n            'f': \"1051\",\n        },\n\"The phase III BOREAS trial is ongoing and evaluates the efficacy and safety of navtemadlin versus BAT for TP53 wild-type MF patients relapsed/refractory to JAKi (NCT03662126); patients are randomized 2:1 to receive navtemadlin monotherapy 240 mg once daily (day 1-7/28-day cycle) or BAT (JAKi were excluded).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1052,\n            'f': \"1052\",\n        },\n\"To date, selinexor at the dose of 60 mg is under investigation as monotherapy in patients with JAK inhibitor-na\\u00efve MF and moderate thrombocytopenia in the phase II SENTRY-2 (NCT05980806) and in combination with RUX in the phase III randomized, placebo-controlled, SENTRY (NCT04562389) trial.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1053,\n            'f': \"1053\",\n        },\n\"Minimal hepatic encephalopathy (MHE) patients do not exhibit obvious clinical or neurological symptoms and can only be detected through neuropsychological methods to identify deficits in their neurocognitive functions [ 3 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"NCT\"],\n [{\n            'v': 1054,\n            'f': \"1054\",\n        },\n\"Currently, a Phase 2 trial in BJI (NCT03723551) is enrolling patients to be treated for 3-6 weeks with afabicin or standard of care (SoC).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1055,\n            'f': \"1055\",\n        },\n\"For example, sonidegib (a hedgehog pathway inhibitor approved in 2015 for locally advanced basal cell carcinoma) demonstrated an ORR of 58% by BICR vs. 71% by investigator in the pivotal Phase 2 BOLT trial (NCT01327053) [ 10 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1056,\n            'f': \"1056\",\n        },\n\"A discrepancy of 13% between these two different assessments may seem inconsequential; however, it is noteworthy that cancer therapies have been granted FDA approval based on even lower response rates (for example, the 2018 approval of the immune checkpoint inhibitor nivolumab for small cell lung cancer was supported by an ORR of 12% in the Phase 1/2 CheckMate-032 trial [NCT01928394]) [ 11 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1057,\n            'f': \"1057\",\n        },\n\"The trials\\u2019 NCT numbers, phase, masking, and primary endpoint (BICR-assessed vs. investigator-assessed) were also extracted.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1058,\n            'f': \"1058\",\n        },\n\"These were treated as independent comparisons (designated by the National Clinical Trial [NCT] number and year, followed by \\u201ca\\u201d, \\u201cb\\u201d, etc.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1059,\n            'f': \"1059\",\n        },\n\"For example, a recent press release reported the results of the Phase 2 KEYNOTE-695 trial (NCT03132675), which evaluated TAVO\\u2122-EP (an interleukin 12 encoding plasmid delivered by intratumoral electroporation) in combination with pembrolizumab for the treatment of patients with unresectable or metastatic melanoma [ 34 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1060,\n            'f': \"1060\",\n        },\n\"Mechanism of action Selnoflast ISRCTN 10520571 CHIP, CAD, and CRP of \\u22652 mg/L 1 No NLRP3 inflammasome inhibitor Canakinumab NCT 05641831 CCUS with VAF of \\u226510% 2 Yes, as secondary end point IL-1\\u03b2 blockade Enasidenib NCT 05102370 IDH2 -mutated CCUS 1 No IDH2 inhibitor Ivosidenib NCT05030441 IDH1 -mutant CCUS 2 No IDH1 inhibitor Curcumin NCT 06063486 CCUS, low-risk MDS and MPN 2 No Pleiotropic IV ascorbic acid NCT 03418038 TET2 -mutated CCUS 2 No TET2 cofactor Oral ascorbic acid NCT 03682029 CCUS, low-risk MDS and MPN 2 No TET2 cofactor Statins NCT 05483010 CCUS, low-risk MDS 2 No Pleiotropic CAD, coronary artery disease; CRP, C-reactive protein; IDH1/2, isocitrate dehydrogenase 1/2; ISRCTN, International Standard Randomised Controlled Trial Number; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm; NCT, National Clinical Trial; TET1/2, ten-eleven translocation 1/2.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1061,\n            'f': \"1061\",\n        },\n\"The impact evaluation has been registered with the Registry for International Development Impact Evaluations (RIDIE-STUDY-ID-58261b2f46876) and the Indian Council of Medical Research (ICMR) National Clinical Trials Registry of India (CTRI/2016/11/007482).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1062,\n            'f': \"1062\",\n        },\n\"Participants were recruited using a multipronged approach, including (1) flyers distributed to gyms, community centers, grocery stores, and health and wellness clinics throughout Raleigh, Durham, and Chapel Hill, North Carolina; (2) study details posted on Research Match, a national clinical trials registry that matches participants to studies; (3) social media posts on Twitter, Facebook, and Nextdoor; and (4) contact with participants who were ineligible for other studies but showed interest in similar behavioral studies.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1063,\n            'f': \"1063\",\n        },\n\"This clinical trial was approved by the institutional ethics committee of Morioka Municipal Hospital (H30-1), here in accordance with the Declaration of Helsinki and the National Clinical Trials Registry (UMIN000033830) before patient recruitment.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1064,\n            'f': \"1064\",\n        },\n\"of the study/trial: This study was also registered to national clinical trials registry (UMIN000033830) prior to initiation of patient recruitment.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1065,\n            'f': \"1065\",\n        },\n\"All trials were registered with ClinicalTrials.gov and if applicable, the South African National Clinical Trials Registry and the Pan African Clinical Trials Registry.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1066,\n            'f': \"1066\",\n        },\n\"South African National Clinical Trials Registry: DOH-27-0215-4796, trial registration initiated prior to 2015-02-09 and achieved on 2015-02-09.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1067,\n            'f': \"1067\",\n        },\n\"South African National Clinical Trials Registry: DOH-27-0715-4894, 2014-10-07.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1068,\n            'f': \"1068\",\n        },\n\"South African National Clinical Trials Registry: DOH-27-1015-5117.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1069,\n            'f': \"1069\",\n        },\n\"South African National Clinical Trials Registry: DOH-27-0715-4917.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1070,\n            'f': \"1070\",\n        },\n\"The study was approved by the University of Health Sciences Turkey, \\u0130stanbul Prof. Dr. Cemil Ta\\u015fc\\u0131o\\u011flu City Hospital Local Ethics Committee (approval number: 27, date: 23.01.2023) and registered with the National Clinical Trials Registry under NCT06211894.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1071,\n            'f': \"1071\",\n        },\n\"The study was approved by the University of Health Sciences Turkey, \\u0130stanbul Prof. Dr. Cemil Ta\\u015fc\\u0131o\\u011flu City Hospital Local Ethics Committee (approval number: 27, date: 23.01.2023) and registered with the National Clinical Trials Registry under NCT06211894.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1072,\n            'f': \"1072\",\n        },\n\"This study was enrolled in the National Clinical Trials Registry (CTRI/2019/09/021104) and reported following the preferred reporting items for randomized trials in endodontics 2020 guidelines.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1073,\n            'f': \"1073\",\n        },\n\"The South African National Clinical Trials Registry number for the parent study is NCT02915016.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1074,\n            'f': \"1074\",\n        },\n\"The South African National Clinical Trials Registry number for the parent study is NCT02915016.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1075,\n            'f': \"1075\",\n        },\n\"The protocol was approved by the Institutional Review Board at the University of Southern California and registered with the US National Clinical Trials Registry ( NCT02217709 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1076,\n            'f': \"1076\",\n        },\n\"The protocol was approved by the Institutional Review Board at the University of Southern California and registered with the US National Clinical Trials Registry ( NCT02217709 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1077,\n            'f': \"1077\",\n        },\n\"The study protocol is registered on the South African National Clinical Trials Registry (Trial Number: DOH-27-072021-7413).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1078,\n            'f': \"1078\",\n        },\n\"Patients with histologically documented advanced (unresectable) locoregional HNSCC who were candidates for concurrent CRT were recruited in a physician-led clinical trial, registered with Cuban National Clinical Trials Registry (Trial ID: RPCEC00000241).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1079,\n            'f': \"1079\",\n        },\n\"The protocol was registered in the National Clinical Trials Registry (NCT03243383) and approved by the Temple University Institutional Review Board (#24306).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1080,\n            'f': \"1080\",\n        },\n\"The protocol was registered in the National Clinical Trials Registry (NCT03243383) and approved by the Temple University Institutional Review Board (#24306).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCT\"],\n [{\n            'v': 1081,\n            'f': \"1081\",\n        },\n\"1 , 2 , 3 To ensure the transparency and reliability of clinical trial research, the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) created a national clinical trials registry and results database (ClinicalTrials.gov) in 2000.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"National Clinical Trials Registry\"],\n [{\n            'v': 1082,\n            'f': \"1082\",\n        },\n\"1 , 2 , 3 To ensure the transparency and reliability of clinical trial research, the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) created a national clinical trials registry and results database (ClinicalTrials.gov) in 2000.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"ClinicalTrials.gov\"],\n [{\n            'v': 1083,\n            'f': \"1083\",\n        },\n\"The PANTHER trial is a phase III multicentre randomised clinical trial, aimed to evaluate the efficacy of dose-dense versus standard adjuvant chemotherapy in early high-risk breast cancer (EHRBC) ( 1 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1084,\n            'f': \"1084\",\n        },\n\"The primary outcome of the PANTHER trial was BCRFS, defined as time from randomization to the first local-, regional- or distant breast cancer recurrence or death due to breast cancer or last date of follow-up if no event has occurred.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1085,\n            'f': \"1085\",\n        },\n\"The PANTHER trial provides valuable insights into the benefits of tailored dose-dense chemotherapy.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1086,\n            'f': \"1086\",\n        },\n\"The PANTHER study showed that the use of dose-dense chemotherapy was associated with a 20% improvement in BCRFS, a 22% improvement in EFS, defined as time from randomization to the first of the events breast cancer recurrence of any type, contralateral breast cancer, other malignancy or any cause of death, and a 21% improvement in distant disease-free survival (DDFS) [hazard ratio (HR) 0.80, 95% confidence interval (CI): 0.65-0.98; HR 0.78, 95% CI: 0.65-0.94; HR 0.79, 95% CI: 0.64-0.94, respectively] compared to the standard adjuvant chemotherapy group.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1087,\n            'f': \"1087\",\n        },\n\"Additionally, the PANTHER trial indicated a 1.5% absolute increase in 10-year OS with dose-dense chemotherapy (16.6%) compared to the control arm (15.1%), although this difference was not statistically significant (HR 0.82, 95% CI: 0.65-1.04).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1088,\n            'f': \"1088\",\n        },\n\"This study describes the development and validation of a real-time PCR-based laboratory-developed assay (LDA) on the Panther Fusion system for the simultaneous detection of Aspergillus fumigatus (AF) and Pneumocystis jirovecii (PJ) in bronchoalveolar lavage fluid (BALF) samples.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1089,\n            'f': \"1089\",\n        },\n\"Rigorous optimization ensured compatibility with the automated workflow of the Panther Fusion system, which addresses challenges such as BALF viscosity and fungal DNA recovery.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1090,\n            'f': \"1090\",\n        },\n\"The fully automated Panther Fusion system (Hologic, San Diego, CA, USA) for nucleic acid extraction and polymerase chain reaction (PCR), with its Open Access functionality, enables the adaptation of molecular-based assays for various targets, including influenza A virus subtyping [ 5 ], tickborne diseases [ 6 ], measles [ 7 ], clade II human mpox virus [ 8 ], and macrolide-associated mutations in Mycoplasma genitalium [ 9 ], alongside in vitro diagnostic (IVD) assays [ 10 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1091,\n            'f': \"1091\",\n        },\n\"In line with these efforts to leverage existing molecular infrastructures, such as SARS-CoV-2 testing platforms [ 11 ], to detect other critical pathogens, our assay builds on this approach by adapting the Panther Fusion system for the dual detection of A. fumigatus and P. jirovecii .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1092,\n            'f': \"1092\",\n        },\n\"This study describes the development and validation of an LDA using real-time PCR on the Panther Fusion system, marking its first application for the detection of fungal pathogens.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1093,\n            'f': \"1093\",\n        },\n\"We prospectively evaluated its clinical performance against three reference rRT-PCR tests: Hologic Panther Fusion, Roche Cobas, and CDC 2019-nCoV RT-PCR Diagnostic Panel.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1094,\n            'f': \"1094\",\n        },\n\"For 1,630 cases of symptomatic and asymptomatic subjects suspected of COVID-19, where all three rRT-PCR methods were evaluable, CDC test results differed the most, with 144 discordant results with Roche and 119 with Panther rRT-PCR tests.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1095,\n            'f': \"1095\",\n        },\n\"Roche and Panther test results differed in 67 cases.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1096,\n            'f': \"1096\",\n        },\n\"We conducted a multicenter study to estimate the clinical positive percentage agreement (PPA) and negative percentage agreement (NPA) of the Abbott ID NOW\\u2122 COVID-19 2.0 assay against qualitative results from three rRT-PCR in vitro diagnostic tests, used as a reference to determine the Patient Infected Status (PIS): Hologic Panther Fusion SARS-CoV-2 Assay, Roche cobas SARS-CoV-2, and CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR Diagnostic Panel.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1097,\n            'f': \"1097\",\n        },\n\"The workflow in the central lab processed the eluted UTM swab samples on three comparator laboratory rRT-PCR in vitro diagnostic tests: Hologic Panther Fusion SARS-CoV-2 Assay, Roche cobas SARS-CoV-2, and CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR Diagnostic Panel, according to the manufacturer\\u2019s instructions for use, before adjudicating infection status.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1098,\n            'f': \"1098\",\n        },\n\"This protocol elucidates the methodology used in the development of a fully automated real-time polymerase chain reaction (qPCR)-based test, using the Panther Fusion \\u00ae Open Access TM functionality, for the detection of Streptococcus agalactiae in pregnant women, using selectively enriched rectovaginal swabs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1099,\n            'f': \"1099\",\n        },\n\"Subsequently, the process was manually optimized using a CFX96 Dx analyzer, whose technical specifications and performance are homologous to that of the final platform (Panther Fusion \\u00ae ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1100,\n            'f': \"1100\",\n        },\n\"Unlike Panther Fusion \\u00ae , the CFX96 Dx does not require excess volumes of reagents, samples, and evaluation materials (dead volume) to accommodate potential robotic handling-associated imprecisions.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1101,\n            'f': \"1101\",\n        },\n\"\\u2022 Analytical and clinical validation of the qPCR-based LDT developed on an open-access functionality (Open Access TM ) of an automated in vitro diagnostic platform, Panther Fusion \\u00ae (Hologic).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1102,\n            'f': \"1102\",\n        },\n\"Protocol to develop a qPCR-based laboratory-developed test (LDT) for detecting Streptococcus agalactiae using the Panther Fusion \\u00ae Open Access TM system.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1103,\n            'f': \"1103\",\n        },\n\"PANTHER 18.0 bioinformatics tools ( https://www.pantherdb.org/ ) was used to perform protein classification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1104,\n            'f': \"1104\",\n        },\n\"C Abundance ratio (HG-C/NG) represented on the Y axis for relevant proteins classified under Gene ontology-Biological process \\u201cBone growth\\u201d and \\u201cBone mineralization\\u201d, using PANTHER 18.0 bioinformatics tools.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1105,\n            'f': \"1105\",\n        },\n\"Using PANTHER 18.0 bioinformatic tools, a comprehensive protein classification was conducted, providing an overview of the functionality of the proteome (Fig.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1106,\n            'f': \"1106\",\n        },\n\"However, PANTHER was unable to classify 1,958 proteins (Fig.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1107,\n            'f': \"1107\",\n        },\n\"Cellular components and biological functions were determined by Gene Ontology (GO) Panther analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1108,\n            'f': \"1108\",\n        },\n\"Cellular components and biological functions were determined by Gene Ontology (GO) Panther analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Gene Ontology\"],\n [{\n            'v': 1109,\n            'f': \"1109\",\n        },\n\"Cellular components and biological functions were determined by Gene Ontology (GO) Panther analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 1110,\n            'f': \"1110\",\n        },\n\"Using GO Panther analysis, we analyzed each group of proteins to see if there were any significant enrichments in cellular components or biological processes ( Figure S4 and Tables S5 , S6 , S7 , and S8 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1111,\n            'f': \"1111\",\n        },\n\"Using GO Panther analysis, each list of unique proteins was searched if there was a statistically significant number associated with a particular cellular component or biological process.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1112,\n            'f': \"1112\",\n        },\n\"For the group of uniquely depleted proteins identified in SDC ( Figure 6 D) and EasyPep samples ( Figure 6 E), our GO panther analysis showed a statistically significant depletion in the expected amount of representation of the listed biological processes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1113,\n            'f': \"1113\",\n        },\n\"In-depth look at homogenization strategy differences in digestion methods; direct comparison of the hydrophobicity of unique proteins and peptides identified by digestion methods; direct comparison of the isoelectric point and molecular weight of unique proteins and peptides identified by digestion methods; GO Panther cellular component analysis using unique protein lists from digestion methods; and direct comparison of digestion methods using volcano plots ( PDF )\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1114,\n            'f': \"1114\",\n        },\n\"Using GO Panther analysis, we analyzed each group of proteins to see if there were any significant enrichments in cellular components or biological processes ( Figure S4 and Tables S5 , S6 , S7 , and S8 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 1115,\n            'f': \"1115\",\n        },\n\"Using GO Panther analysis, each list of unique proteins was searched if there was a statistically significant number associated with a particular cellular component or biological process.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 1116,\n            'f': \"1116\",\n        },\n\"For the group of uniquely depleted proteins identified in SDC ( Figure 6 D) and EasyPep samples ( Figure 6 E), our GO panther analysis showed a statistically significant depletion in the expected amount of representation of the listed biological processes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 1117,\n            'f': \"1117\",\n        },\n\"In-depth look at homogenization strategy differences in digestion methods; direct comparison of the hydrophobicity of unique proteins and peptides identified by digestion methods; direct comparison of the isoelectric point and molecular weight of unique proteins and peptides identified by digestion methods; GO Panther cellular component analysis using unique protein lists from digestion methods; and direct comparison of digestion methods using volcano plots ( PDF )\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 1118,\n            'f': \"1118\",\n        },\n\"These proteins were then submitted to two online bioinformatics resources, the PANTHER online tool (v.17.0) with a GO biological process annotation [ 23 ] and the STRING database (v.11.0b; https://version-11-0b.string-db.org/ ; accessed on 10 December 2020) [ 24 ] in order to determine functional significance and biological pathways for protein-protein interactions ( Table S2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1119,\n            'f': \"1119\",\n        },\n\"These proteins were then submitted to two online bioinformatics resources, the PANTHER online tool (v.17.0) with a GO biological process annotation [ 23 ] and the STRING database (v.11.0b; https://version-11-0b.string-db.org/ ; accessed on 10 December 2020) [ 24 ] in order to determine functional significance and biological pathways for protein-protein interactions ( Table S2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 1120,\n            'f': \"1120\",\n        },\n\"Using the PANTHER (v.17.0) and STRING (v.11.0b) databases, several distinct pathways were found to be associated with these two sets of significant proteins ( Table S2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1121,\n            'f': \"1121\",\n        },\n\"Using the PANTHER (v.17.0) and STRING (v.11.0b) databases, several distinct pathways were found to be associated with these two sets of significant proteins ( Table S2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1122,\n            'f': \"1122\",\n        },\n\"The STRING analysis identified enriched biological processes that were highly consistent with the PANTHER analysis when considering the decreased proteins in abundance ( Table S2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1123,\n            'f': \"1123\",\n        },\n\"The STRING analysis identified enriched biological processes that were highly consistent with the PANTHER analysis when considering the decreased proteins in abundance ( Table S2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1124,\n            'f': \"1124\",\n        },\n\"For the proteins detected at higher levels, in contrast to the STRING analysis, the oxidation-reduction pathway was not enriched in the PANTHER analysis ( Table S2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1125,\n            'f': \"1125\",\n        },\n\"For the proteins detected at higher levels, in contrast to the STRING analysis, the oxidation-reduction pathway was not enriched in the PANTHER analysis ( Table S2 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1126,\n            'f': \"1126\",\n        },\n\"Based on the combined results of the STRING and PANTHER analyses, we opted to focus on ribosomal biogenesis to represent the set of downregulated proteins and lipid metabolism to represent the proteins upregulated by the siLIN28B treatment.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1127,\n            'f': \"1127\",\n        },\n\"Comparative analyses of LACD genes from IMPC and established human CD genes from IC3D included protein interactions (STRING), biological processes (PANTHER), and molecular pathways (KEGG).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1128,\n            'f': \"1128\",\n        },\n\"Comparative analyses of LACD genes from IMPC and established human CD genes from IC3D included protein interactions (STRING), biological processes (PANTHER), and molecular pathways (KEGG).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1129,\n            'f': \"1129\",\n        },\n\"Comparative analyses of LACD genes from IMPC and established human CD genes from IC3D included protein interactions (STRING), biological processes (PANTHER), and molecular pathways (KEGG).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 1130,\n            'f': \"1130\",\n        },\n\"19 This analysis was conducted using established bioinformatics tools: Platform for Analysis of Sceiad (PLAE) was used to identify gene expression of human orthologs in the cornea, the Search Tool for the Retrieval of interacting Genes/Proteins (STRING) within the Cytoscape platform (version 3.10.2) was used to analyze protein-protein interactions, Protein Analysis THrough Evolutionary Relationships (PANTHER) was used to compare and contrast biological processes, and Kyoto Encyclopedia of Genes and Genomes (KEGG) within the Database for Annotation, Visualization, and Integrated Discovery website (DAVID) was used to assess whether candidate and established human CD genes were known to be involved in cellular pathways or signaling cascades.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1131,\n            'f': \"1131\",\n        },\n\"19 This analysis was conducted using established bioinformatics tools: Platform for Analysis of Sceiad (PLAE) was used to identify gene expression of human orthologs in the cornea, the Search Tool for the Retrieval of interacting Genes/Proteins (STRING) within the Cytoscape platform (version 3.10.2) was used to analyze protein-protein interactions, Protein Analysis THrough Evolutionary Relationships (PANTHER) was used to compare and contrast biological processes, and Kyoto Encyclopedia of Genes and Genomes (KEGG) within the Database for Annotation, Visualization, and Integrated Discovery website (DAVID) was used to assess whether candidate and established human CD genes were known to be involved in cellular pathways or signaling cascades.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1132,\n            'f': \"1132\",\n        },\n\"19 This analysis was conducted using established bioinformatics tools: Platform for Analysis of Sceiad (PLAE) was used to identify gene expression of human orthologs in the cornea, the Search Tool for the Retrieval of interacting Genes/Proteins (STRING) within the Cytoscape platform (version 3.10.2) was used to analyze protein-protein interactions, Protein Analysis THrough Evolutionary Relationships (PANTHER) was used to compare and contrast biological processes, and Kyoto Encyclopedia of Genes and Genomes (KEGG) within the Database for Annotation, Visualization, and Integrated Discovery website (DAVID) was used to assess whether candidate and established human CD genes were known to be involved in cellular pathways or signaling cascades.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 1133,\n            'f': \"1133\",\n        },\n\"19 This analysis was conducted using established bioinformatics tools: Platform for Analysis of Sceiad (PLAE) was used to identify gene expression of human orthologs in the cornea, the Search Tool for the Retrieval of interacting Genes/Proteins (STRING) within the Cytoscape platform (version 3.10.2) was used to analyze protein-protein interactions, Protein Analysis THrough Evolutionary Relationships (PANTHER) was used to compare and contrast biological processes, and Kyoto Encyclopedia of Genes and Genomes (KEGG) within the Database for Annotation, Visualization, and Integrated Discovery website (DAVID) was used to assess whether candidate and established human CD genes were known to be involved in cellular pathways or signaling cascades.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"DAVID\"],\n [{\n            'v': 1134,\n            'f': \"1134\",\n        },\n\"PANTHER represents the effect on the protein function as \\u201cProbably Benign\\u201d, \\u201cPossibly Damaging\\u201d, \\u201cProbably Damaging\\u201d comparing the entered protein sequence with that in the PANTHER protein library.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1135,\n            'f': \"1135\",\n        },\n\"Results: Through enrichment databases including the KEGG, GO, Reactome, and PANTHER, we identified 76 metabolism-related DEGs and performed protein-protein interaction (PPI) network analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1136,\n            'f': \"1136\",\n        },\n\"Results: Through enrichment databases including the KEGG, GO, Reactome, and PANTHER, we identified 76 metabolism-related DEGs and performed protein-protein interaction (PPI) network analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 1137,\n            'f': \"1137\",\n        },\n\"Results: Through enrichment databases including the KEGG, GO, Reactome, and PANTHER, we identified 76 metabolism-related DEGs and performed protein-protein interaction (PPI) network analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Reactome\"],\n [{\n            'v': 1138,\n            'f': \"1138\",\n        },\n\"Results: Through enrichment databases including the KEGG, GO, Reactome, and PANTHER, we identified 76 metabolism-related DEGs and performed protein-protein interaction (PPI) network analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 1139,\n            'f': \"1139\",\n        },\n\"PANTHER enrichment analysis highlighted that Cd-induced DEGs may be involved in cytoskeletal regulation by Rho GTPase, insulin/IGF pathway-mitogen-activated protein kinase kinase/MAP kinase cascade, and the nicotinic acetylcholine receptor signaling pathway.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PANTHER\"],\n [{\n            'v': 1140,\n            'f': \"1140\",\n        },\n\"In this study, we uncover the main changes inside the PdB driving the impact on health and well-being from the residents' perceptions in a neighbourhood of Barcelona.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PDB\"],\n [{\n            'v': 1141,\n            'f': \"1141\",\n        },\n\"Most changes inside the PdB were perceived as positive for health by all the groups.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PDB\"],\n [{\n            'v': 1142,\n            'f': \"1142\",\n        },\n\"Pla de Barris (Neighbourhood Plan\\u2014hereinafter, PdB) is a council-led wide-ranging urban regeneration programme for the most vulnerable neighbourhoods of Barcelona city.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PDB\"],\n [{\n            'v': 1143,\n            'f': \"1143\",\n        },\n\"Studies have shown, on one side, that the PdB programme has improved sustainable local partnerships in the process of implementation; and on the other side, that has allowed improvements in specific health indicators (e.g.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PDB\"],\n [{\n            'v': 1144,\n            'f': \"1144\",\n        },\n\"However, these studies have failed to illuminate how and to which population group affected the changes driving by the PdB.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PDB\"],\n [{\n            'v': 1145,\n            'f': \"1145\",\n        },\n\"Additionally, we used ADFRsuite 1.03 to convert all processed small molecules and receptor proteins into the PDBQT format for docking with AutoDock Vina 1.2.3 docking.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PDB\"],\n [{\n            'v': 1146,\n            'f': \"1146\",\n        },\n\"Both protein and drug were converted to the PDBQT files using AutoDock CrankPep package software 41 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"PDB\"],\n [{\n            'v': 1147,\n            'f': \"1147\",\n        },\n\"Lys868, Asp1046, Cys919, and Glu885 are recognized as the critical residues on the VEGFR2 kinase domain (PDB ID: 3EWH ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1148,\n            'f': \"1148\",\n        },\n\"3D and 2D interaction diagrams of the campesterol with their acceptor VEGFR1 (PDB: 3HNG) and \\u03b3-sitosterol with their acceptor VEGFR1 (PDB-3HNG).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1149,\n            'f': \"1149\",\n        },\n\"By binding to specific sites within the pore or near the extracellular vestibule, inhibitors like 1PBC (PDB ID: 7ZK3 19 ) obstruct the ion conduction pathway.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1150,\n            'f': \"1150\",\n        },\n\"(C-F) Binding capacity of isorhamnetin and predicted hub regulatory targets, including NFE2L2 (PDB ID: 7X5E), VEGFR (PDB ID: 1FLT), ZNF24 (PDB ID: 3LHR), and ATM (PDB ID: 7SIC ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1151,\n            'f': \"1151\",\n        },\n\"(A) Crystal structure of the bacterial helicase PcrA (PDB 3PJR ) bound to ATP (orange) and DNA (gray).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1152,\n            'f': \"1152\",\n        },\n\"The asymmetric units of B a- (PDB: 7MTX ), Cj- (PDB: 5URQ ) and Clp IMPDH (PDB: 5UWX ) contained 8, 8, and 4 active sites, respectively.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1153,\n            'f': \"1153\",\n        },\n\"Green: A110 (PDB: 4MYA ); orange: C91 (PDB: 4MY9 ); deep blue: D67 (PDB: 4QM1 ); beige: P32 (PDB: 4MYX ); cyan: Q21 (PDB: 4MY8 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1154,\n            'f': \"1154\",\n        },\n\"Key interactions of compound 12 ( Figure 6 D and Figure 7 D) with SRC (PDB: 3F3V) include hydrogen bonding with an ylidene nitrogen atom in the hydrazone fragment (negatively charged Asp404) and the secondary amino group (hydrophobic Met341).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1155,\n            'f': \"1155\",\n        },\n\"The crystal structures of the Nrf2/NFE2L2, VEGFR, ZNF24, and ATM proteins used for docking were obtained from the protein data bank (PDB), which is accessible at https://www.rcsb.org/.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1156,\n            'f': \"1156\",\n        },\n\"The PDB IDs for the 4 proteins are 7X5E 1FLT, 3LHR, and 7SIC, respectively.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1157,\n            'f': \"1157\",\n        },\n\"Acknowledgments: We thank the providers of the protein structures in the PDB database (Sengoku et al 28 , Wiesmann et al 27 , Volkman et al., and Warren et al 30 ), and to the providers of the microarray of PAH in the GEO database (Mura et al 16 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1158,\n            'f': \"1158\",\n        },\n\"12 Here, we systematically survey and compare the structural mechanism of ligands bound to helicases in the Protein Data Bank (PDB) to gain insight into the structural chemistry of enzyme inhibition and inform future efforts in helicase drug design.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1159,\n            'f': \"1159\",\n        },\n\"7 - 14 The structural determinants for the selectivity for bacterial over mammalian IMPDHs are revealed in the many E\\u00b7IMP\\u00b7I crystal structures of IMPDHs from Bacillus anthracis ( Ba ), Campylobacter jejuni ( Cj ), Cryptosporidium parvum ( Cp ), Clostridium perfringens ( Clp ), and Mycobacterium tuberculosis ( Mtb ) deposited in the Protein Data Bank (PDB).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1160,\n            'f': \"1160\",\n        },\n\"Therefore, we included receptor tyrosine kinases EGFR (PDB: 1M17, 4HJO, 1XKK), VEGFR (PDB: 4AGD, 4ASD, 3EWH), HER2 (PDB: 3RCD, 3PPO), non-receptor tyrosine kinases SCR (PDB: 1A07, 3F3V), ACK-1 (PDB: 5ZXB), and serine/threonine protein kinases (STPKs) BRAF (PDB: 4RZV, 7MOU), MEK (PDB: 4U7Z, 7MOY), and CDK5 (PDB: 1UNL) that are frequently overactivated or mutated in these cancer types.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1161,\n            'f': \"1161\",\n        },\n\"The structures of target proteins EGFR (PDB: 1M17, 4HJO, 1XKK), VEGFR (PDB: 4AGD, 4ASD, 3EWH), HER2 (PDB: 3RCD, 3PPO), BRAF (PDB: 4RZV, 7MOU), MEK (PDB: 4U7Z, 7MOY), SCR (PDB: 1A07, 3F3V), and CDK5 (PDB: 1UNL) were retrieved from the Protein Data Bank (PDB) [ 72 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1162,\n            'f': \"1162\",\n        },\n\"The target proteins were prepared using the Protein Preparation Wizard [ 73 ], involving removal of water molecules that do not form hydrogen bonds, completion of absent loops from the PDB file, and addition of hydrogen atoms absent in the structure of target protein.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1163,\n            'f': \"1163\",\n        },\n\"34 - 36 The three-dimensional (3D) structures from PubChem were used to prepare the ligands and the Open Babel GUI (Graphical user interface) was used to convert them to the Protein Data bank (PDB) format.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1164,\n            'f': \"1164\",\n        },\n\"37 Auto Dock version 4.2 was used for protein (PDB ID: 3EWH ) that was downloaded from the Research Collaboratory for Structural Bioinformatics (RCSB) PDB optimization through the removal of water and other atoms, the addition of a polar hydrogen group, and then the assignment of Kollman energy.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1165,\n            'f': \"1165\",\n        },\n\"The calcium-bound structure of TMEM16A (PDB ID: 5OYB) and the TMEM16A with the known pore-blocker 1PBC (PDB ID: 7ZK3) were used as protein receptors for molecular docking.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1166,\n            'f': \"1166\",\n        },\n\"The TMEM16A (PDB ID: 7ZK3) in complex with 1PBC was used as protein receptors for MD simulations.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1167,\n            'f': \"1167\",\n        },\n\"TMEM16A in both states obtained from the Protein Data Bank (PDB code: 5OYB 20 and 7ZK3 19 ) was used as a receptor.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1168,\n            'f': \"1168\",\n        },\n\"Atomic coordinates and structure factors were deposited to Protein Data bank (PDB) under the accession codes: Nsp15-E266Q-P2 1 ( 9MRU ), Nsp15-E266Q-P6 3 ( 9MRY ), WT-P2 1 ( 9MRW ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1169,\n            'f': \"1169\",\n        },\n\"The N-terminal domain sequence of C. albicans Als3 protein was derived from the crystal structure (PDB code: 4LE8), covering residues 18-316 [ 27 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1170,\n            'f': \"1170\",\n        },\n\"The first step, the PatchDock module, generates initial complex PDB files of receptor proteins and miniproteins, which have not yet been optimized for binding.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1171,\n            'f': \"1171\",\n        },\n\"Because ESMFold resets the origin and orientation of the PDB file during prediction, we realigned the miniprotein PDB files with the original complex PDB files from the initial PatchDock results.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"PDB\"],\n [{\n            'v': 1172,\n            'f': \"1172\",\n        },\n\"Simultaneous targeting of RGD and FA receptors on breast carcinoma could improve the diagnostic outcome of breast cancer patients.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1173,\n            'f': \"1173\",\n        },\n\"In this study, we have designed and synthesized an FA-RGD heteromeric targeting vector, with both RGD and FA motifs, in one single molecule for positron emission tomography (PET) diagnostic imaging of breast carcinoma.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1174,\n            'f': \"1174\",\n        },\n\"Aoa-FA-RGD peptide conjugate was radiolabeled efficiently with [ 18 F]FDG, resulting in high labeling efficiency (\\u2265 85%).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1175,\n            'f': \"1175\",\n        },\n\"The Aoa-FA-RGD peptide conjugate showed the nanomolar affinity (\\u2264 51 nM) to the TNBC MDA-MB-231 cell line.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1176,\n            'f': \"1176\",\n        },\n\"In the MDA-MB-231 xenografts model, [ 18 F]FDG-Aoa-FA-RGD peptide conjugate exhibited efficient clearance from the blood and excretion predominantly by the renal pathway (~ 56% ID), possibly due to its hydrophilic nature.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1177,\n            'f': \"1177\",\n        },\n\"To make these nanoparticles better at finding tumors, we added ARGD peptides to their surfaces.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1178,\n            'f': \"1178\",\n        },\n\"Our research showed that these RGD-MXene nanoconjugates have excellent targeting accuracy and can eradicate tumors very effectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1179,\n            'f': \"1179\",\n        },\n\"RGD peptides, which bind to integrin \\u03b1 v \\u03b2 3 , offer a promising avenue for selectively targeting tumor cells.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1180,\n            'f': \"1180\",\n        },\n\"RGD peptides can bind to integrin receptors on the cell surface, and certain integrins identify RGD motifs in proteins and bind to these peptides, enabling cell adhesion and communication [ 25 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1181,\n            'f': \"1181\",\n        },\n\"The extracellular domain of integrin \\u03b1 v \\u03b2 3 is bent or folded in the inactive state to prevent binding, whereas in the on state to which the RGD peptide is bound, the extracellular domain appears straight without being bent.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1182,\n            'f': \"1182\",\n        },\n\"The complex was conjugated with an integrin-targeting peptide c(RGDfC) to afford a tumour-targeting conjugate (1-RGD) for bioimaging and photoactivated therapy.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1183,\n            'f': \"1183\",\n        },\n\"An RGD-free analogue (2) was also prepared for comparison studies.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1184,\n            'f': \"1184\",\n        },\n\"Interestingly, the IEDDA cycloaddition reaction of the S , S -tetrazine-containing conjugate 1-RGD and complex 2 with (1 R ,8 S ,9 s )-bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN-OH) led to significant emission enhancement.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1185,\n            'f': \"1185\",\n        },\n\"Table 1 Primers used for construction of the recombinant PRRSV rGD-EGFP, rGD-mCherry, or rGD-mCherry-EGFP infectious clones Number Primer Sequence 1 EGFP-F ATGGTGAGCAAGGGCGAGGAGCT 2 EGFP-R TCACTTGTACAGCTCGTCCATGCC 3 7U-TRS6-EGFP-F ATTTAAAT GTTCCGCGGCAAC CCCT TTAACC AGAGTTTCAGCGGAACG ATGGTGAGCAAGGGCGAGGAGCTGTTC 4 7U-EGFP-R TGCCAGCCCA ACGCGT TCACTTGTACAGCTCGTCCATGC 5 GD-Fragment A-F TAAGGAGCAGT GTTTAAAC TGCTAGCCGCCAGCGG 6 GD-Fragment A-R AAATTCATGCTGAGGGTGATGCTGTGGCGCGGATCAGACG 7 GD-Fragment B-F ACGCGT TGGGCTGGCATTCTTTGGCACC 8 GD-Fragment B-R ATGCCCAGGT CGGACCG CGAGGAGGTGGAGATGCCA 9 mCherry-F ATGGTGAGCAAGGGCGAGGAGG 10 mCherry-R CTTGTACAGCTCGTCCATGCCGCC 11 12-mCherry-F CCTGAATTGAA ATTTAAAT ATGGTGAGCAAGGGCGAGGAGG 12 12-mCherry-TRS-R GGTTAAAGGGGTTGCCGCGGAAC ACGCGT TCACTTGTACAGCTCGTCCATGCCGCCGGT 13 GD-Fragment C-F CTGACTAAGGAGCAGT GTTTAAAC TGCTAGCCGCCAGCGG 14 GD-Fragment C-R ATTTAAATTTCAATTCAGGCCTAAAGTTGGTTCAATGACAGGGC 15 GD-Fragment D-F CGGCAACCCCTTTAACCAGAGTTTCAGCGGAACGATGAAATGGGGTCTATGCAAAGCC 16 GD-Fragment D-R ATGCCCAGGT CGGACCG CGAGGAGGTGGAGATGCCA 17 JD-EGFP-F CTGTTCACCGGGGTGGTGCCCAT 18 JD-EGFP-R AGTGATCCCGGCGGCGGTCACGAA 19 JD-mCherry-F ACATGGCCATCATCAAGGAGTTC 20 JD-mCherry-R ATGCCGCCGGTGGAGTGGCGGC Note: the bold position indicates the endonuclease recognition sequence; the underlined part indicates the homology arm sequence\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1186,\n            'f': \"1186\",\n        },\n\"Primers used for construction of the recombinant PRRSV rGD-EGFP, rGD-mCherry, or rGD-mCherry-EGFP infectious clones\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1187,\n            'f': \"1187\",\n        },\n\"The rescued virus was named rGD-EGFP, rGD-mCherry, and rGD-mCherry-EGFP, respectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1188,\n            'f': \"1188\",\n        },\n\"rGD-EGFP, rGD-mCherry, rGD-mCherry-EGFP, or rGD were infected on MARC-145 cells for 36 h at a multiplicity of infection (MOI) of 1.0.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1189,\n            'f': \"1189\",\n        },\n\"PRRSV rGD served as a positive control.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1190,\n            'f': \"1190\",\n        },\n\"For instance, integrin subtypes such as integrin \\u03b1v\\u03b26 and RGD-binding integrins like \\u03b1v\\u03b23 play distinct roles in cell-matrix adhesion and mechanotransduction 22 , 23 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1191,\n            'f': \"1191\",\n        },\n\"Specifically, integrin \\u03b1v\\u03b26 requires a higher tension of approximately 200 pN to activate cell spreading 24 , a requirement that starkly contrasts with the lower, cell type-independent threshold of around 40 pN needed for RGD-binding integrins 25 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1192,\n            'f': \"1192\",\n        },\n\"SKOV-3 cell proliferation curves in two hydrogels PNA and PNA-RGD (450 nm).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1193,\n            'f': \"1193\",\n        },\n\"Unlike common iridium( iii ) complexes, excitation of conjugate 1-RGD and complex 2 resulted in weak emission and negligible singlet oxygen ( 1 O 2 ) generation due to the quenching effect of the tetrazine unit.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1194,\n            'f': \"1194\",\n        },\n\"Upon continuous light irradiation, the S , S -tetrazine moiety in conjugate 1-RGD and complex 2 underwent efficient photodissociation, yielding thiocyanate (3) and amide (4) complexes as photoproducts with increased emission intensities and enhanced 1 O 2 generation efficiencies.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1195,\n            'f': \"1195\",\n        },\n\"When functionalized with two different subtype-specific peptidomimetic ligands\\u2014RGD for \\u03b1v\\u03b23 and RTDLDSLRT (referred to as RTD) for \\u03b1v\\u03b26\\u2014distinct cell migration patterns were observed after 4 days under various force application parameters.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1196,\n            'f': \"1196\",\n        },\n\"When functionalized with two different subtype-specific peptidomimetic ligands\\u2014RGD for \\u03b1v\\u03b23 and RTDLDSLRT (referred to as RTD) for \\u03b1v\\u03b26\\u2014distinct cell migration patterns were observed after 4 days under various force application parameters.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1197,\n            'f': \"1197\",\n        },\n\"It has been reported that RGD concentrations ranging between 25 \\u03bcM and 3.5 mM support 3D cell adhesion and spreading in 3D hydrogels 5 , 31 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1198,\n            'f': \"1198\",\n        },\n\"The MPN@K6-RGD/OGP/Ang coating not only supported the early adhesion and migration, late osteogenesis and mineralization of BMSCs, but also promoted the adhesion, migration and vascularization of HUVECs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1199,\n            'f': \"1199\",\n        },\n\"The trifunctional peptide coating (MPN@K6 - RGD/OGP/Ang) constructed in this paper has a mild preparation process, is biologically safe, facilitates large-scale production, has a positive effect on bone tissue repair, and has a great potential for clinical application in orthopedic and dental implants.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1200,\n            'f': \"1200\",\n        },\n\"For example, arginine-glycine-aspartate (RGD) has been widely used to enhance cell adhesion and migration [ 18 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1201,\n            'f': \"1201\",\n        },\n\"Furthermore, dual-peptides coatings were obtained with the help of the designed hexalysine (K6) linked OGP and RGD polypeptides with promoted osseointegration, comparing to single peptide functionalized implant [ 22 , 23 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1202,\n            'f': \"1202\",\n        },\n\"Herein, using the platform concept described above, we present K6 linked respectively with three distinct functional peptides onto the MPNs, including RGD peptide for cellular adhesion and migration, OGP peptide that promotes osteogenic differentiation of BMSCs, and the peptide SVVYGLR that promotes angiogenesis ( Scheme 1 a).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1203,\n            'f': \"1203\",\n        },\n\"On the one hand, the grafting of the RGD sequence into the hydrogel could significantly improve cell proliferation in this system; on the other hand, it led to an earlier appearance of DOX drug resistance.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"RGD\"],\n [{\n            'v': 1204,\n            'f': \"1204\",\n        },\n\"The Rat Genome Database (RGD) created a COVID-19 Disease Portal to leverage information from the scientific literature.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1205,\n            'f': \"1205\",\n        },\n\"Our analysis confirms the role of the immune system in COVID-19 pathogenesis as shown by substantial enrichment of immune system related Gene Ontology terms. The information in RGD's COVID-19 disease portal can generate new hypotheses to potentiate novel therapies and prevention of acute and long-term complications of COVID-19.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1206,\n            'f': \"1206\",\n        },\n\"The Rat Genome Database (RGD) PhenoMiner tool has provided the first step in this effort by standardizing and integrating data from individual studies.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1207,\n            'f': \"1207\",\n        },\n\"Our work, mainly utilizing data curated in RGD, involves the following key steps: (i) we developed a meta-analysis pipeline to automatically integrate data from heterogeneous sources and to produce expected ranges (standardized phenotype ranges) for different strains and phenotypes under different experimental conditions; (ii) we created tools to visualize expected ranges for individual strains and strain groups.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1208,\n            'f': \"1208\",\n        },\n\"The RGD (rgd.mcw.edu) is the most comprehensive data repository and informatics platform for the laboratory rat (18). RGD curates and integrates data from published literature, individual research projects as well as the PhysGen Program for Genomic Application (19) and the NBRP Rat Phenome Project in Japan (14).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1209,\n            'f': \"1209\",\n        },\n\"To better curate and query comprehensive experimental data from heterogeneous data sources, RGD initiated the PhenoMiner project (https://rgd.mcw.edu/rgdweb/phenominer/home.jsp) (20). Video tutorials about how to effectively use this database are described on RGD website (https://rgd.mcw.edu/wg/home/rgd_rat_community_videos/rgd-tool-and-website-videos/), and updates on new tools were described in the accompanying paper by Wang et al. (20) in this issue.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1210,\n            'f': \"1210\",\n        },\n\"Therefore, the motivation for our work is to take advantage of the substantial volume of quantitative phenotype data in the RGD to establish expected ranges for different rat strains.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1211,\n            'f': \"1211\",\n        },\n\"The continued expansion and success of these ontologies has facilitated the integration of more than 60,000 records into the RGD PhenoMiner database. In addition, new applications of these ontologies, such as annotation of Quantitative Trait Loci (QTL), have been added at the sites actively using them, including RGD and the Animal QTL Database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1212,\n            'f': \"1212\",\n        },\n\"New terms and expansions to the ontologies continue to be added as a result of active curation efforts at RGD and the Animal QTL database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1213,\n            'f': \"1213\",\n        },\n\"These ontologies are freely available for download and use from the NCBO BioPortal website at http://bioportal.bioontology.org/ontologies/1583 (CMO), http://bioportal.bioontology.org/ontologies/1584 (MMO), and http://bioportal.bioontology.org/ontologies/1585 (XCO), or from the RGD ftp site at ftp://rgd.mcw.edu/pub/ontology/.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1214,\n            'f': \"1214\",\n        },\n\"RGD has substantially expanded its use of the CMO, MMO, and XCO for integration of complex datasets in the PhenoMiner project.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1215,\n            'f': \"1215\",\n        },\n\"Easy access to consolidated results across rat strains and experiments is now available in the RGD PhenoMiner tool [30]. Results for a single strain can be accessed directly in PhenoMiner or from the strain phenotype profile section, labelled \\u201cPhenotype Values via PhenoMiner\\u201d, on the RGD strain report page.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1216,\n            'f': \"1216\",\n        },\n\"The authors would like to acknowledge the contributions of the RGD curation team at the Medical College of Wisconsin and the staff and informatics team at Washington University. This project is funded in part by R01HL094271, R01HL094286, and R01HL064541.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"RGD\"],\n [{\n            'v': 1217,\n            'f': \"1217\",\n        },\n\"In total protein-coding genes, 13,788 of them were found to relate with the CYP superfamily, while only 2,659 genes were searched after controlling E -value less than 1e \\u22125 ( Supplementary Table 4 ), and 1,733 protein-coding genes were annotated as transporter proteins in the TCDB ( Supplementary Table 5 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rfam\"],\n [{\n            'v': 1218,\n            'f': \"1218\",\n        },\n\"(b) Active TEs of eight superfamilies in 119 species.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rfam\"],\n [{\n            'v': 1219,\n            'f': \"1219\",\n        },\n\"The heatmap shows the active TE copies of the eight superfamilies (Copia, Gypsy, hAT, CACTA, PIF-Harbinger, Mutator, Tc1_Mariner and Helitron) from the innermost to the outermost layers.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rfam\"],\n [{\n            'v': 1220,\n            'f': \"1220\",\n        },\n\"(c) Active TEs of eight superfamilies in seven crop populations.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rfam\"],\n [{\n            'v': 1221,\n            'f': \"1221\",\n        },\n\"Among the six Class II TE superfamilies, Helitron demonstrate the highest level of activity.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rfam\"],\n [{\n            'v': 1222,\n            'f': \"1222\",\n        },\n\"Among the two Class I TE superfamilies, the Gypsy superfamily shows higher activity compared to the Copia superfamily.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rfam\"],\n [{\n            'v': 1223,\n            'f': \"1223\",\n        },\n\"3.3.2 [ 38 ] and to the Rfam database ver.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1224,\n            'f': \"1224\",\n        },\n\"Transcripts lacking coding potential according to the results of three of the five cited programs (CPAT score < 0.78; CPC2 score < 0; Feelnc score < 0.558; CNCI and PLEK index = \\u201cnoncoding\\u201d), with low similarity to protein domains in the Pfam database (e-value > 10 \\u22123 ) and lacking alignments to the Rfam database records, were referred to in the subsequent analysis stages.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1225,\n            'f': \"1225\",\n        },\n\"Including the cis-regulatory element not only serves as a counterpoint against other gene classes in Rfam\\u2019s hierarchy [ 40 ] but also enables baseline benchmarking, validating our model\\u2019s efficacy.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1226,\n            'f': \"1226\",\n        },\n\"The \\u2019cmfetch\\u2019 function retrieves covariance models from the complete Rfam database, and \\u2019cmsearch\\u2019 matches these models against a genome.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1227,\n            'f': \"1227\",\n        },\n\"We accessed the Rfam Public MySQL Database (version 14.9) to obtain RNA type-associated family lists [ 54 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1228,\n            'f': \"1228\",\n        },\n\"Four CM files were generated using the complete Rfam covariance model (CM) and these lists using cmfetch, with one file dedicated to each RNA type.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1229,\n            'f': \"1229\",\n        },\n\"We utilized cmsearch with the Rfam curators\\u2019 selected gathering cut-off (GA) value [ 55 ] for sequence extraction of RNA types from a given genome.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1230,\n            'f': \"1230\",\n        },\n\"Noncoding RNA predictions were conducted using tRNAscan-SE v1.3.1 ( http://lowelab.ucsc.edu/tRNAscan-SE/ ) to predict tRNAs and RNAmmer v1.2 ( https://services.healthtech.dtu.dk/services/RNAmmer-1.2/ ) to predict rRNAs, and the rest of noncoding RNA predictions were predicted in Rfam database ( https://rfam.org/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1231,\n            'f': \"1231\",\n        },\n\"This analysis involved mapping the lncRNAs to the Rfam database based on conserved sequences and secondary structures, following the approach outlined by Nawrocki et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1232,\n            'f': \"1232\",\n        },\n\"Gene prediction was performed with Prokka v1.14.15 26 and the following parameters were used for genome assembly annotation: --compliant --genus [Genus] --usegenus --rfam --evalue 0.0001.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1233,\n            'f': \"1233\",\n        },\n\"This paper introduces major improvements, including the expansion of Rfamseq to 26\\u2005106 genomes, a 76% increase, incorporating the latest UniProt reference proteomes and additional viral genomes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1234,\n            'f': \"1234\",\n        },\n\"This paper introduces major improvements, including the expansion of Rfamseq to 26\\u2005106 genomes, a 76% increase, incorporating the latest UniProt reference proteomes and additional viral genomes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"UniProt\"],\n [{\n            'v': 1235,\n            'f': \"1235\",\n        },\n\"Rfam is freely available at https://rfam.org .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1236,\n            'f': \"1236\",\n        },\n\"The Rfam database, a widely used repository of non-coding RNA families, has undergone significant updates in release 15.0.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1237,\n            'f': \"1237\",\n        },\n\"These updates significantly expand Rfam\\u2019s coverage and improve annotation quality, reinforcing its critical role in RNA research, genome annotation and the development of machine learning models.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1238,\n            'f': \"1238\",\n        },\n\"The Rfam database was established in 2002 ( 1 ) in order to provide a central repository of non-coding RNA (ncRNA) families for genomic annotations.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1239,\n            'f': \"1239\",\n        },\n\"With this new information, we have produced new covariance models (CMs), two of which are available at the Rfam database [ 14 ], and demonstrated their utility for tmRNA gene search.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1240,\n            'f': \"1240\",\n        },\n\"Three automated tmRNA-finding tools were applied to batches of genomes: (i) Aragorn v. 1.2.40 [ 22 ], (ii) five tmRNA CMs from Rfam [ 14 ] (RF00023, RF01849, RF01850, RF01851, and RF02544), applied using Infernal v. 1.1.2 [ 23 ], and (iii) BLASTN [ 24 ] against the then-current version of our tmRNA database, as managed by our software Rfind [ 25 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1241,\n            'f': \"1241\",\n        },\n\"After the latest major update batch, an additional phase of tmRNA finding was undertaken for bacterial taxa with low tmRNA gene yields, choosing candidates based on Rfam data (in the above work, candidates had been selected based on Aragorn or BLASTN data only).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1242,\n            'f': \"1242\",\n        },\n\"For each of the 4590 genomes in these taxa where tmRNA had not yet been identified, a single top candidate tmRNA sequence was taken based on the best Rfam hit for the genome.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1243,\n            'f': \"1243\",\n        },\n\"We took advantage of the diversity of new tmRNA genes discovered in this work to update the Rfam tmRNA CMs.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1244,\n            'f': \"1244\",\n        },\n\"We used GeneMarkS v4.32 [ 21 ] to predict the coding sequences and tRNAscan-SE, Barrnap v0.9, and Rfam to identify transfer RNA, ribosomal RNA, and other non-coding RNA, respectively [ 22 , 23 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1245,\n            'f': \"1245\",\n        },\n\"In its most recent release, Rfam has discarded its BLAST filters.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1246,\n            'f': \"1246\",\n        },\n\"Eric was looking for Rfam families with the biggest increase in number of putative detected homologs.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1247,\n            'f': \"1247\",\n        },\n\"These benchmarks are named the Rfam-ome and Rfam-cliques datasets.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1248,\n            'f': \"1248\",\n        },\n\"All benchmark sets were derived from the Rfam database ( Nawrocki et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1249,\n            'f': \"1249\",\n        },\n\"Here a subalignment is considered to be a subset of an Rfam seed alignment.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1250,\n            'f': \"1250\",\n        },\n\"For each species other than human, exact matches of the organism\\u2019s sequences contained in the input Rfam seed alignment are searched in the regions orthologous to the human neighborhood.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1251,\n            'f': \"1251\",\n        },\n\"Collecting the subalignments for all Rfam families yields the complete dataset named Rfam-ome .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1252,\n            'f': \"1252\",\n        },\n\"natans , L. vacuolata , L. oceanica , and A. amoebiformis against the Rfam CM database ( Nawrocki and Eddy 2013 ; Kalvari et al.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1253,\n            'f': \"1253\",\n        },\n\"Then we calculated a confusion matrix for this prediction with the Rfam secondary structure annotation taken as the ground truth and used the confusion matrix to plot the precision-recall curve.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1254,\n            'f': \"1254\",\n        },\n\"t-SNE clusters of embeddings of RNA sequences created by PredPair tend to contain embeddings from particular Rfam families, supporting the predictions of PredPair being in line with biological classification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1255,\n            'f': \"1255\",\n        },\n\"We used RNA sequences from seed alignments of 2,147 Rfam families ( Kalvari et al., 2018 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1256,\n            'f': \"1256\",\n        },\n\"The split on train, validation, and test was performed in so that all members of one Rfam family were assigned to one set.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1257,\n            'f': \"1257\",\n        },\n\"The same procedure with the Rfam secondary structure annotation as the ground truth was used to obtain the precision-recall curve for PredPair and SPOT-RNA predictions.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rfam\"],\n [{\n            'v': 1258,\n            'f': \"1258\",\n        },\n\"WMoTaNbV refractory high-entropy alloys (RHEAs) have received widespread attention due to their excellent low-temperature toughness, hardness, and wear resistance.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1259,\n            'f': \"1259\",\n        },\n\"In recent years, the rapid development of surface modification technology represented by laser cladding has provided a new technological path for RHEA surface forming, and at the same time put forward higher requirements for raw material powder.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1260,\n            'f': \"1260\",\n        },\n\"In this study, WMoTaNbV RHEA spherical powder was prepared by radiofrequency plasma spheronization, and then WMoTaNbV RHEA coating was prepared on the surface of Ti6Al4V (TC4) alloy by laser cladding technique.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1261,\n            'f': \"1261\",\n        },\n\"This experimental result shows that the surface hardness and wear resistance of WNbMoTaV RHEA coating can be effectively improved by precisely regulating the laser power, thus improving the surface hardness and friction and wear properties of TC4 titanium alloy.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1262,\n            'f': \"1262\",\n        },\n\"Among them, refractory high-entropy alloys (RHEAs) are a high-entropy alloy material composed of high-melting-point metal elements such as W, Mo, Ta, Nb, V, Ti, Cr, Hf, Zr, and so on as the main element, or an additional small amount of B, Si, Al, and so on [ 19 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1263,\n            'f': \"1263\",\n        },\n\"Refractory high-entropy alloys (RHEAs) have been of great interest due to their excellent mechanical properties at elevated temperatures.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1264,\n            'f': \"1264\",\n        },\n\"Here, we investigate lattice thermal conductivity of MoWTaTiZr RHEAs using the equilibrium molecular dynamics (EMD) method.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1265,\n            'f': \"1265\",\n        },\n\"Finally, by tuning the elemental concentrations in RHEAs, the influence of each composition on the lattice thermal conductivity is studied.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1266,\n            'f': \"1266\",\n        },\n\"Chemical ordering in RHEAs indicates that Ti-Ti pairs tend to form bonds, and increasing Ti concentration is more likely to form Ti-rich clusters.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1267,\n            'f': \"1267\",\n        },\n\"This research is conducive to understanding the thermal behaviors in RHEAs and promoting the applications of RHEAs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1268,\n            'f': \"1268\",\n        },\n\"This is a correction to: Domagoj Eljuga, Rhea Marie Muzar, Josip Jaman, Ksenija Eljuga, Goranka Rafaj, Zlatko Vlajcic, TDAP flap in reconstruction of a severe postburn contracture of the axillary region\\u2014a case report, Journal of Surgical Case Reports , Volume 2025, Issue 2, February 2025, https://doi.org/10.1093/jscr/rjaf080\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1269,\n            'f': \"1269\",\n        },\n\"We utilized longitudinally collected data from 467 mother-child pairs in the Rhea study.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1270,\n            'f': \"1270\",\n        },\n\"Additionally, an exposome-based study, including a subsample of the Rhea cohort, found that exposure to organochlorine compounds was associated with decreased externalizing problems in children aged 3 to 7 years, but this was mainly observed among women with insufficient gestational weight gain (GWG).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1271,\n            'f': \"1271\",\n        },\n\"In contrast, null associations have been previously reported in the Rhea cohort between prenatal POP levels and ADHD symptoms in preschool-aged children.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1272,\n            'f': \"1272\",\n        },\n\"44 To address this, we aimed to investigate whether gestational exposure to POPs (i.e., HCB, DDE, and PCBs) influences the developmental trajectories of emotional and behavioral symptoms from early childhood to adolescence (ages 4, 6, 11, and 15 years), utilizing data from the Rhea mother-child cohort in Crete, Greece.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1273,\n            'f': \"1273\",\n        },\n\"Participants in the present study were part of the Rhea cohort, a longitudinal mother-child study based in Crete, Greece.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1274,\n            'f': \"1274\",\n        },\n\"Isaac Rhea: Supervision.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1275,\n            'f': \"1275\",\n        },\n\"The He 2+ irradiation-induced mechanical and microstructural evolutions were studied in Nb 25 Mo 25 Ta 25 W 25 (at.%) and Nb 20 Mo 20 Ta 20 W 20 Re 20 (at.%) refractory high-entropy alloys (RHEAs) films, respectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1276,\n            'f': \"1276\",\n        },\n\"The addition of Re reduces the yield stress, while improves the ductility in as-deposited NbMoTaW RHEA film.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1277,\n            'f': \"1277\",\n        },\n\"After He 2+ irradiation at room temperature, grain boundary brittleness is much severe in NbMoTaW RHEA film than in NbMoTaWRe RHEA film.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1278,\n            'f': \"1278\",\n        },\n\"The probes were incubated with various concentrations of RheA in 20 \\u03bcL of reaction buffer containing 20 mM Tris-HCl (pH 7.5), 1 mM dithiothreitol (DTT), 5 mM MgCl 2 , 0.5 mg/ml bovine serum albumin (BSA), and 5% glycerol.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"Rhea\"],\n [{\n            'v': 1279,\n            'f': \"1279\",\n        },\n\"We apply our methods to abstracts at PubMed scale to create a draft map of enzyme functions in literature to guide curation efforts in UniProtKB and the reaction knowledgebase Rhea.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1280,\n            'f': \"1280\",\n        },\n\"We apply our methods to abstracts at PubMed scale to create a draft map of enzyme functions in literature to guide curation efforts in UniProtKB and the reaction knowledgebase Rhea.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Uniprot\"],\n [{\n            'v': 1281,\n            'f': \"1281\",\n        },\n\"Expert curated knowledgebases such as the UniProt Knowledgebase (UniProtKB) 14 , 15 , Rhea 16 , MetaCyc 17 , KEGG 18 , BRENDA 19 , SABIO-RK 20 , Reactome 21 and the Gene Ontology (GO) 22 capture knowledge of enzymes and the reactions they catalyze from peer reviewed publications using human- and machine-readable chemical ontologies and cheminformatics descriptors in forms that are Findable, Accessible, Interoperable, and Reusable (FAIR) 23 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1282,\n            'f': \"1282\",\n        },\n\"Expert curated knowledgebases such as the UniProt Knowledgebase (UniProtKB) 14 , 15 , Rhea 16 , MetaCyc 17 , KEGG 18 , BRENDA 19 , SABIO-RK 20 , Reactome 21 and the Gene Ontology (GO) 22 capture knowledge of enzymes and the reactions they catalyze from peer reviewed publications using human- and machine-readable chemical ontologies and cheminformatics descriptors in forms that are Findable, Accessible, Interoperable, and Reusable (FAIR) 23 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"UniProt\"],\n [{\n            'v': 1283,\n            'f': \"1283\",\n        },\n\"Expert curated knowledgebases such as the UniProt Knowledgebase (UniProtKB) 14 , 15 , Rhea 16 , MetaCyc 17 , KEGG 18 , BRENDA 19 , SABIO-RK 20 , Reactome 21 and the Gene Ontology (GO) 22 capture knowledge of enzymes and the reactions they catalyze from peer reviewed publications using human- and machine-readable chemical ontologies and cheminformatics descriptors in forms that are Findable, Accessible, Interoperable, and Reusable (FAIR) 23 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"KEGG\"],\n [{\n            'v': 1284,\n            'f': \"1284\",\n        },\n\"Expert curated knowledgebases such as the UniProt Knowledgebase (UniProtKB) 14 , 15 , Rhea 16 , MetaCyc 17 , KEGG 18 , BRENDA 19 , SABIO-RK 20 , Reactome 21 and the Gene Ontology (GO) 22 capture knowledge of enzymes and the reactions they catalyze from peer reviewed publications using human- and machine-readable chemical ontologies and cheminformatics descriptors in forms that are Findable, Accessible, Interoperable, and Reusable (FAIR) 23 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MetaCyc\"],\n [{\n            'v': 1285,\n            'f': \"1285\",\n        },\n\"Expert curated knowledgebases such as the UniProt Knowledgebase (UniProtKB) 14 , 15 , Rhea 16 , MetaCyc 17 , KEGG 18 , BRENDA 19 , SABIO-RK 20 , Reactome 21 and the Gene Ontology (GO) 22 capture knowledge of enzymes and the reactions they catalyze from peer reviewed publications using human- and machine-readable chemical ontologies and cheminformatics descriptors in forms that are Findable, Accessible, Interoperable, and Reusable (FAIR) 23 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 1286,\n            'f': \"1286\",\n        },\n\"Expert curated knowledgebases such as the UniProt Knowledgebase (UniProtKB) 14 , 15 , Rhea 16 , MetaCyc 17 , KEGG 18 , BRENDA 19 , SABIO-RK 20 , Reactome 21 and the Gene Ontology (GO) 22 capture knowledge of enzymes and the reactions they catalyze from peer reviewed publications using human- and machine-readable chemical ontologies and cheminformatics descriptors in forms that are Findable, Accessible, Interoperable, and Reusable (FAIR) 23 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SABIO-RK\"],\n [{\n            'v': 1287,\n            'f': \"1287\",\n        },\n\"Expert curated knowledgebases such as the UniProt Knowledgebase (UniProtKB) 14 , 15 , Rhea 16 , MetaCyc 17 , KEGG 18 , BRENDA 19 , SABIO-RK 20 , Reactome 21 and the Gene Ontology (GO) 22 capture knowledge of enzymes and the reactions they catalyze from peer reviewed publications using human- and machine-readable chemical ontologies and cheminformatics descriptors in forms that are Findable, Accessible, Interoperable, and Reusable (FAIR) 23 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Reactome\"],\n [{\n            'v': 1288,\n            'f': \"1288\",\n        },\n\"Expert curated knowledgebases such as the UniProt Knowledgebase (UniProtKB) 14 , 15 , Rhea 16 , MetaCyc 17 , KEGG 18 , BRENDA 19 , SABIO-RK 20 , Reactome 21 and the Gene Ontology (GO) 22 capture knowledge of enzymes and the reactions they catalyze from peer reviewed publications using human- and machine-readable chemical ontologies and cheminformatics descriptors in forms that are Findable, Accessible, Interoperable, and Reusable (FAIR) 23 .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"GO\"],\n [{\n            'v': 1289,\n            'f': \"1289\",\n        },\n\"We queried the UniProt SPARQL endpoint ( https://sparql.uniprot.org/ ) to identify papers that provided experimental evidence used to link protein sequence records from UniProtKB/Swiss-Prot to reactions from Rhea (specifically those reactions that involve only small molecules, excluding papers linked to Rhea reactions that involve proteins and other macromolecules) (Fig.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1290,\n            'f': \"1290\",\n        },\n\"We queried the UniProt SPARQL endpoint ( https://sparql.uniprot.org/ ) to identify papers that provided experimental evidence used to link protein sequence records from UniProtKB/Swiss-Prot to reactions from Rhea (specifically those reactions that involve only small molecules, excluding papers linked to Rhea reactions that involve proteins and other macromolecules) (Fig.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"UniProt\"],\n [{\n            'v': 1291,\n            'f': \"1291\",\n        },\n\"Positive training examples for LitSuggest consisted of abstracts from papers that provided experimental evidence used to annotate enzymes in UniProtKB/Swiss-Prot with Rhea reactions (dataset created November 7 th , 2020).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1292,\n            'f': \"1292\",\n        },\n\"Positive training examples for LitSuggest consisted of abstracts from papers that provided experimental evidence used to annotate enzymes in UniProtKB/Swiss-Prot with Rhea reactions (dataset created November 7 th , 2020).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"UniProt\"],\n [{\n            'v': 1293,\n            'f': \"1293\",\n        },\n\"As with the EnzChemRED dataset, we defined papers that provided experimental evidence as those linked to an evidence tag with an experimental evidence code from the Evidence and Conclusions Ontology (ECO), such as \\u201cECO:0000269\\u201d, and excluded abstracts of papers linked to Rhea reactions that involve proteins and other macromolecules, such as DNA.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1294,\n            'f': \"1294\",\n        },\n\"For instance, the Rhea database [ 11 ] only contains about 21 thousand EC-reaction entries, whereas UniProt [ 12 ] contains > 250 thousands reviewed EC-enzyme sequence entries.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1295,\n            'f': \"1295\",\n        },\n\"Rhea [ 11 ] is a commonly used database dedicated for reaction and enzyme mapping, which comprises only about 21 thousand reaction-enzyme pairs with annotated EC numbers.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1296,\n            'f': \"1296\",\n        },\n\"Recently, a much larger reaction-EC dataset called ECREACT [ 26 ] has been collected by combining data from Rhea, BRENDA [ 27 ], PathBank [ 28 ], and MetaNetX [ 29 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1297,\n            'f': \"1297\",\n        },\n\"Recently, a much larger reaction-EC dataset called ECREACT [ 26 ] has been collected by combining data from Rhea, BRENDA [ 27 ], PathBank [ 28 ], and MetaNetX [ 29 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BRENDA\"],\n [{\n            'v': 1298,\n            'f': \"1298\",\n        },\n\"Recently, a much larger reaction-EC dataset called ECREACT [ 26 ] has been collected by combining data from Rhea, BRENDA [ 27 ], PathBank [ 28 ], and MetaNetX [ 29 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"MetaNetX\"],\n [{\n            'v': 1299,\n            'f': \"1299\",\n        },\n\"The top reaction returned by REME is \\u2018( l )-aspartate + ATP = ADP + ( l )-aspartyl-4-phophate\\u2019 (RHEA:23776, EC:2.7.2.4), aligning with expectations as these two reactions are both phosphorylation reaction and malate is an isostere of aspartate (Figure 2B ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1300,\n            'f': \"1300\",\n        },\n\"As expected, \\u2018( l )-aspartyl-4-phosphate + NADPH + H+ = ( l )-aspartate-4-semialdehyde + Pi + NADP+\\u2019 (RHEA:24284, EC: 1.2.1.11) ranked first when we searched the reaction using REME (Figure 3B ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1301,\n            'f': \"1301\",\n        },\n\"The top reaction returned is \\u2018(L)-aspartate-4-semialdehyde + NADH + H+ = ( l )-homoserine + NAD+\\u2019 (RHEA:15757, EC:1.1.1.3).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1302,\n            'f': \"1302\",\n        },\n\"Interestingly, among the similar reactions provided by REME, the reaction (RHEA:123948) \\u2018succinic semialdehyde + NADH + H+ = 4-hydroxybutyrate + NAD+\\u2019 ranked second.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1303,\n            'f': \"1303\",\n        },\n\"Specifically, all surveyed amino acids (both nEAAs and EAAs) exhibited connections with high reciprocity scores (\\u22652), i.e., compounds and annotated genes are both linked to the same reactions or metabolic pathways from the consulted databases RheA [ 65 ] or MetaCyc [ 66 ].\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1304,\n            'f': \"1304\",\n        },\n\"We have embedded the Rhea reaction visualisation tool into the website to enable users to view the catalytic activity of enzyme complexes.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1305,\n            'f': \"1305\",\n        },\n\"Rhea ( 9 ) is a curated resource describing, from literature, enzyme-catalysed and spontaneously occurring biological reactions which utilises ChEBI references.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1306,\n            'f': \"1306\",\n        },\n\"Rhea cross-references, new at the time of our previous publication, have continued to be added to catalytically active complexes to describe reaction participants, their chemical structures and chemical transformations, thus providing a more granular description of the enzyme/substrate interaction.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1307,\n            'f': \"1307\",\n        },\n\"In September 2023, the Complex Portal embedded a visualisation widget developed by the Swiss Institute of Bioinformatics (SIB) to visualise reactions from Rhea.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1308,\n            'f': \"1308\",\n        },\n\"This has allowed us to display Rhea reactions cross-referenced to complexes as part of the Catalytic Activity section of an entry.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1309,\n            'f': \"1309\",\n        },\n\"Enzymatic reactions catalyzed by the protein are associated with the entries of the Rhea database [6] , which classifies enzymatic reactions by their reaction participants (i.e., their substrates and products) and assigns a unique ID (Rhea ID) to each class of the reaction.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Rhea\"],\n [{\n            'v': 1310,\n            'f': \"1310\",\n        },\n\"Patient demographics, preoperative laboratory measurements, and RRs were compared between patients with single-gland disease (SGD) versus multigland disease (MGD).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1311,\n            'f': \"1311\",\n        },\n\"The predictive threshold for SGD was subsequently validated on the following cohort of 115 patients.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1312,\n            'f': \"1312\",\n        },\n\"Of 2368 patients included, 1585 (66.9%) patients had SGD, and 783 (33.1%) had MGD.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1313,\n            'f': \"1313\",\n        },\n\"Patients with SGD had higher median (IQR) RRs than the MGD group (0.8 [0.5-1.3] vs 0.4 [0.3-0.7], P <.001).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1314,\n            'f': \"1314\",\n        },\n\"After adjusting for age, preoperative calcium and PTH, reoperative parathyroidectomy, and gland weight, the RR was an independent predictor (OR 2.155, P <.001) of SGD.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1315,\n            'f': \"1315\",\n        },\n\"Submarine groundwater discharge (SGD) is a nutrient source to coastal waters.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1316,\n            'f': \"1316\",\n        },\n\"However, most SGD estimates are restricted to a local scale and hardly distinguish contributions from fresh (FSGD) and recirculated (RSGD) SGD.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1317,\n            'f': \"1317\",\n        },\n\"Here, we compiled data on radium/radon of groundwater ( n ~ 2000) and seawater ( n ~ 10,000) samples along ~18,000 km of China\\u2019s coastal seas to resolve large scale FSGD and RSGD and their associated nutrient loads.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1318,\n            'f': \"1318\",\n        },\n\"Nearshore-scale FSGD ( ~ 3.56 \\u00d7 10 8 m 3 d \\u22121 ) was only 2% of the total SGD but comparable to RSGD in terms of nutrient loads.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1319,\n            'f': \"1319\",\n        },\n\"Despite large uncertainties quantified via Monte Carlo simulations, SGD was a dominant contributor to China\\u2019s coastal nutrient budgets, with dissolved inorganic nitrogen, phosphorus and silicate fluxes of ~395, 2.9, and 581 Gmol a \\u22121 , respectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1320,\n            'f': \"1320\",\n        },\n\"This study sought to quantify uptake rates of non-invasive prenatal screening for de novo single-gene disorders (NIPS-SGD) in pregnant subjects whose reproductive partner is of advanced paternal age (APA) and to determine individual parameters associated with higher test uptake rates.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1321,\n            'f': \"1321\",\n        },\n\"A cross-sectional study was performed of pregnant subjects who received prenatal genetic counseling at a mid-size tertiary care center and were offered NIPS-SGD for APA (defined as 45 or older at delivery) between June 1, 2017 and April 13, 2021.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1322,\n            'f': \"1322\",\n        },\n\"The outcome was measured as subjects who elected to do NIPS-SGD versus subjects who declined.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1323,\n            'f': \"1323\",\n        },\n\"186 subjects were offered NIPS-SGD and met inclusion criteria.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1324,\n            'f': \"1324\",\n        },\n\"AUC for the final regression model predicting NIPS-SGD uptake was 0.79.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1325,\n            'f': \"1325\",\n        },\n\"In this economic evaluation of a simulated cohort of adult patients in Singapore, LVAD's cost per quality-adjusted life-year gained was 106 458 in Singapore dollars (SGD; US $79 446) for inotrope-dependent patients and SGD 174 798 (US $130 446) for inotrope-independent patients, with 59% and 19% probabilities of attaining cost-effectiveness, respectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1326,\n            'f': \"1326\",\n        },\n\"Costs were estimated (in 2023 Singapore dollars [SGD]) using cohort billing data from 2017 to 2022 and National Heart Centre Singapore LVAD charges.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1327,\n            'f': \"1327\",\n        },\n\"Health care costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER) evaluated against a threshold of SGD 114 000 (US $85 075) per QALY gained.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1328,\n            'f': \"1328\",\n        },\n\"In the base case analysis, LVAD yielded an additional 3.45 QALYs at an incremental cost of SGD 404 678 (US $301 999), producing an ICER of SGD 117 370 (US $87 590) per QALY gained for the transplant-ineligible population.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1329,\n            'f': \"1329\",\n        },\n\"The ICER differed for inotrope-use subgroups at SGD 106 458 (US $79 446) per QALY gained for inotrope-dependent patients and SGD 174 798 (US $130 446) per QALY gained for inotrope-independent patients (with 59% and 19% probabilities, respectively, of attaining high value).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1330,\n            'f': \"1330\",\n        },\n\"SGD chromatin was prepared with recombinant yeast histone octamers at a high nucleosome density (histone-to-DNA ratio = 0.8) and incubated with the TF Reb1 and/or the indicated remodelers, leading to the formation of distinct nucleosome density profiles.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1331,\n            'f': \"1331\",\n        },\n\"This has been most clearly demonstrated in studies based on reconstitution of yeast chromatin with the salt gradient dialysis (SGD) method ( Figure 1B ) or histone chaperone-based chromatin assembly systems.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1332,\n            'f': \"1332\",\n        },\n\"However, the incubation of SGD chromatin with yeast whole-cell extract and ATP does result in a typical in vivo -like nucleosome positioning pattern [ 35 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1333,\n            'f': \"1333\",\n        },\n\"In M. speciosa , a single protein localization assay in yeast revealed that MspSGD was localized in the nucleus and MspTHAS candidates were localized in the cytoplasm.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1334,\n            'f': \"1334\",\n        },\n\"This may be required to promote the re-localization of the HpaTHAS gene towards the nucleus to interact with HpaSGD , as occurs at the protein level in M. speciosa [ 19 ] when expressed in yeast and C. roseus cells [ 16 ].\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SGD\"],\n [{\n            'v': 1335,\n            'f': \"1335\",\n        },\n\"Gene ( S. cerevisiae ) HRD1 Saccharomyces Genome Database (SGD) ( Wong et al., 2023 ) YOL013C\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1336,\n            'f': \"1336\",\n        },\n\"Gene ( S. cerevisiae ) HRD3 Saccharomyces Genome Database (SGD) ( Wong et al., 2023 ) YLR207W\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1337,\n            'f': \"1337\",\n        },\n\"Gene ( S. cerevisiae ) USA1 Saccharomyces Genome Database (SGD) ( Wong et al., 2023 ) YML029W\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1338,\n            'f': \"1338\",\n        },\n\"Gene ( S. cerevisiae ) DER1 Saccharomyces Genome Database (SGD) ( Wong et al., 2023 ) YBR201W\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1339,\n            'f': \"1339\",\n        },\n\"Gene ( S. cerevisiae ) YOS9 Saccharomyces Genome Database (SGD) ( Wong et al., 2023 ) YDR057W\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1340,\n            'f': \"1340\",\n        },\n\"Therefore, we attempted to uncover genes within S. cerevisiae which may have a role in genome stability by screening the Saccharomyces Genome Database (SGD) for genes that are involved in DNA replication, meiosis, or decreased resistance to genotoxins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1341,\n            'f': \"1341\",\n        },\n\"\\u201cMito\\u201d function in SGD description: Whether or not the Saccharomyces Genome Database description of the gene\\u2019s function includes the words \\u201cmitochondria\\u201d, \\u201cmitochondrial\\u201d, or \\u201crespiration\\u201d, or other closely related term (e.g., \\u201coxidative phosphorylation\\u201d would be considered a closely-related term).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1342,\n            'f': \"1342\",\n        },\n\"To accommodate and curate these reference-orientated resource, the Saccharomyces Genome Database (SGD, https://www.yeastgenome.org ) ( 6 ) was developed >25 years ago and continued serving the yeast community ( 7 ), providing encyclopedic information regarding the genome, genes, proteins and other encoded features of S. cerevisiae .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1343,\n            'f': \"1343\",\n        },\n\"Compared with the classic yeast genomics databases such as SGD ( 6 ) and YGOB ( 11 ), ScRAPdb shines with its unique emphasis on population-scaled pangenome characterization and multi-omics integration.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1344,\n            'f': \"1344\",\n        },\n\"This detailed information is sourced from the most recent comprehensive datasets available in the Saccharomyces Genome Database (SGD), which can be further explored at http://www.yeastgenome.org .\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1345,\n            'f': \"1345\",\n        },\n\"The process begins with obtaining GO annotations from the SGD for a given yeast dataset.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1346,\n            'f': \"1346\",\n        },\n\"SGD ( https://www.yeastgenome.org/ ) and BioGRID 4.4 ( https://thebiogrid.org/ ) were both initially examined for Prs/Prs interactions.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1347,\n            'f': \"1347\",\n        },\n\"SGD ( https://www.yeastgenome.org/ ) and BioGRID 4.4 ( https://thebiogrid.org/ ) were both initially examined for Prs/Prs interactions.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioGRID\"],\n [{\n            'v': 1348,\n            'f': \"1348\",\n        },\n\"SGD and BioGRID databases were systematically scrutinized by selecting interactions of yeast Prs with other Prs proteins and seemingly unrelated proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1349,\n            'f': \"1349\",\n        },\n\"SGD and BioGRID databases were systematically scrutinized by selecting interactions of yeast Prs with other Prs proteins and seemingly unrelated proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"BioGRID\"],\n [{\n            'v': 1350,\n            'f': \"1350\",\n        },\n\"All data about auxotrophic experiments were downloaded from The Saccharomyces Genome Database (SGD, https://www.yeastgenome.org/ ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1351,\n            'f': \"1351\",\n        },\n\"As one of the first model organism knowledgebases, Saccharomyces Genome Database (SGD) has been supporting the scientific research community since 1993.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SGD\"],\n [{\n            'v': 1352,\n            'f': \"1352\",\n        },\n\"In the decapod crustacean Ucides cordatus , the model used in this study, we described three categories of hemocytes: hyaline cells, semigranular, and granular hemocytes (Chaves da Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1353,\n            'f': \"1353\",\n        },\n\"Additionally, Chaves da Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1354,\n            'f': \"1354\",\n        },\n\"( 2011 ) suggested that cells circulating in the hemolymph, and not cells from other tissues, were attracted to the neural stem-cell niche in vitro, displaying an important role in regenerative processes of the crustacean central nervous system (Chaves da Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1355,\n            'f': \"1355\",\n        },\n\"The three types of hemocytes, previously described in this crab (Chaves da Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1356,\n            'f': \"1356\",\n        },\n\"In\\u00eas J\\u00falia Ribas Wajsenzon, Elizabeth Giestal-de-Araujo, and Silvana Allodi conceived and designed the experiments.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1357,\n            'f': \"1357\",\n        },\n\"Concept and design: Ana Sofia Silva, Sofia Reis, Ros\\u00e9lia Lima, Guilherme Jesus, L\\u00edgia R. Santos\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1358,\n            'f': \"1358\",\n        },\n\"Acquisition, analysis, or interpretation of data: Ana Sofia Silva, Sofia Reis, Ros\\u00e9lia Lima, Guilherme Jesus, L\\u00edgia R. Santos\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1359,\n            'f': \"1359\",\n        },\n\"Drafting of the manuscript: Ana Sofia Silva, Sofia Reis, Ros\\u00e9lia Lima, Guilherme Jesus, L\\u00edgia R. Santos\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1360,\n            'f': \"1360\",\n        },\n\"Critical review of the manuscript for important intellectual content: Ana Sofia Silva, Sofia Reis, Ros\\u00e9lia Lima, Guilherme Jesus, L\\u00edgia R. Santos\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1361,\n            'f': \"1361\",\n        },\n\"Supervision: Ana Sofia Silva, Sofia Reis, L\\u00edgia R. Santos\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1362,\n            'f': \"1362\",\n        },\n\"2016 , 2018 ), collared peccaries (Da Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1363,\n            'f': \"1363\",\n        },\n\"2016 ); (Da Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1364,\n            'f': \"1364\",\n        },\n\"( 2016 ) and Da Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1365,\n            'f': \"1365\",\n        },\n\"In the vitrification of pubescent collared peccary testicles, it was observed that the DMSO/EG association provided better preservation of the testicular structure (tubular lumen, cell junctions and cell membrane integrity), as well as the proliferative capacity of spermatogonia and Sertoli cells (Da Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1366,\n            'f': \"1366\",\n        },\n\"Comparison of CABO-16S with SILVA 138.2 results in equivalent taxonomic classification of mock communities and increased classification of diverse environmental samples.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1367,\n            'f': \"1367\",\n        },\n\"With the CABO-16S (Combined Archaeal, Bacterial, and Organelle for 16S) database, we combine the bacterial and archaeal sequences from SILVA with the 16S sequences of plastids and other organelles from PR2 to enable efficient identification of all 16S sequences.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1368,\n            'f': \"1368\",\n        },\n\"A framework and clearly annotated scripts are provided for CABO-16S to be updated with future releases of SILVA and PR2, or users can include sequences particular to their own area of interest.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1369,\n            'f': \"1369\",\n        },\n\"Martin Sellier Silva est un assistant de recherche r\\u00e9cemment dipl\\u00f4m\\u00e9 et un ancien pair aidant \\u00e0 l\\u2019Universit\\u00e9 McGill.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1370,\n            'f': \"1370\",\n        },\n\"The SM was synthesized using the methodology of Silva et al., and the thermal annealings were performed at 250 \\u00b0C/1 h and 500 \\u00b0C/h, forming SM/ZnO NCPs containing the following composition: 40SM/60 and 30SM/70ZnO, respectively.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1371,\n            'f': \"1371\",\n        },\n\"In addition, the investigation of the optical, structural, morphological, and photocatalytic performances was made by Silva et al.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1372,\n            'f': \"1372\",\n        },\n\"J\\u00e9ssyka Noronha, Juliana Fernandes, Julia Colares, and Gisele Guimar\\u00e3es performed the experiments; J\\u00e9ssyka Noronha and Juliana Fernandes carried out the laboratory analyses; Francisco Rodrigues, J\\u00e9ssyka Noronha, and Juliana Fernandes operated the histological processing; L\\u00facia Silva was responsible for project supervision and coordination; J\\u00e9ssyka Noronha and L\\u00facia Silva wrote the manuscript; and Herlon Silva and L\\u00facia Silva were responsible for the final review of the manuscript.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1373,\n            'f': \"1373\",\n        },\n\"CABO-16S combines bacterial and archaeal sequences from the SILVA database with 16S rRNA sequences of plastids and other organelles from the PR2 database to enable identification of all 16S rRNA sequences.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 1374,\n            'f': \"1374\",\n        },\n\"The SILVA database (v138.2) [ 34 ] contains a comprehensive record of 16S rRNA gene sequences and is continuously updated to include recently identified taxa from novel environments; however, only broad identification of chloroplasts is possible with no ability to provide further taxonomic identification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 1375,\n            'f': \"1375\",\n        },\n\"Concept and design: Flavia M. Bandeira, Camila A. Mesquita, Kallic B. Fonseca, Sandro Artur F. Silva, Fernando S. Silva\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1376,\n            'f': \"1376\",\n        },\n\"Acquisition, analysis, or interpretation of data: Flavia M. Bandeira, Camila A. Mesquita, Kallic B. Fonseca, Helena P. Magalh\\u00e3es, Sandro Artur F. Silva, Fernando S. Silva\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1377,\n            'f': \"1377\",\n        },\n\"Critical review of the manuscript for important intellectual content: Flavia M. Bandeira, Camila A. Mesquita, Kallic B. Fonseca, Helena P. Magalh\\u00e3es, Sandro Artur F. Silva, Fernando S. Silva\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1378,\n            'f': \"1378\",\n        },\n\"Author Contributions: Conceptualization: de Souza Bett G, Fernandes BB, da Silva LS, da Silva MR, Rezin GT, Trevisol DJ, Schuelter-Trevisol F, do Nascimento RR.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1379,\n            'f': \"1379\",\n        },\n\"Data curation: de Souza Bett G, Fernandes BB, da Silva LS, da Silva MR, Rezin GT, Trevisol DJ, de Azevedo Traebert ES, Traebert JL.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1380,\n            'f': \"1380\",\n        },\n\"Formal analysis: de Souza Bett G, Fernandes BB, da Silva LS, da Silva MR, Rezin GT, Trevisol DJ.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1381,\n            'f': \"1381\",\n        },\n\"Investigation: de Souza Bett G, Fernandes BB, da Silva LS, da Silva MR.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1382,\n            'f': \"1382\",\n        },\n\"Writing - original draft: de Souza Bett G, Fernandes BB, da Silva LS, da Silva MR.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1383,\n            'f': \"1383\",\n        },\n\"Juliana de Souza Fernandes, J\\u00e9ssyka Ara\\u00fajo Noronha, and Gisele Karla Sena Guimar\\u00e3es performed the experiments; Juliana de Souza Fernandes and J\\u00e9ssyka Ara\\u00fajo Noronha carried out the laboratory analyses; Francisco Denilson Rodrigues Gomes, Juliana de Souza Fernandes, and J\\u00e9ssyka Ara\\u00fajo Noronha operated the histological processing; Bruna Farias Brito performed all statistical analyses; L\\u00facia Daniel Machado da Silva was responsible for project supervision and coordination; Juliana de Souza Fernandes and L\\u00facia Daniel Machado da Silva wrote the manuscript; Herlon Victor Rodrigues Silva, Leda Maria Costa Pereira Bersano, and L\\u00facia Daniel Machado da Silva were responsible for the final review of the manuscript.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1384,\n            'f': \"1384\",\n        },\n\"In the present study, we chose to use the chronic protocol with a low dose of reserpine ( Silva et al., 2024 ; Leao et al., 2015 ; Leal et al., 2016 ; Fernandes et al., 2012 ) because the progressiveness of motor alterations is more likely to show long-term effects of potential neuroprotective treatments ( Peres et al., 2018 ; Peres et al., 2016 ; Silva-Martins et al., 2021 ; Beserra-Filho et al., 2022 ; Sarmento-Silva et al., 2014 ; Brandao et al., 2017 ; Lins et al., 2018 ; Beserra-Filho et al., 2019 ; Custodio-Silva et al., 2024 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1385,\n            'f': \"1385\",\n        },\n\"This protocol produces gradual motor impairments in both rats ( Silva et al., 2024 ; Cunha et al., 2022 ; Santos et al., 2013 ; Lima et al., 2021 ) and mice ( Lopes-Silva et al., 2024 ; Beserra-Filho et al., 2022 ; Campelo et al., 2017 ), and rodents submitted to this protocol develop non-motor signs ( Santos et al., 2013 ; Sarmento-Silva et al., 2014 ; Lima et al., 2021 ; Campelo et al., 2017 ), inflammatory reactions ( Cunha et al., 2022 ), oxidative impairment ( Silva-Martins et al., 2021 ; Fernandes et al., 2012 ; Leao et al., 2017 ) and neurotransmitter impairments ( Cunha et al., 2022 ; Lopes-Silva et al., 2024 ; Santos et al., 2013 ; Lima et al., 2021 ; Campelo et al., 2017 ) similar to those observed in PD patients ( Silva et al., 2024 ) .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1386,\n            'f': \"1386\",\n        },\n\"This study systematically evaluates 57 commonly used 16S rRNA primer sets through in silico PCR simulations against the SILVA database.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 1387,\n            'f': \"1387\",\n        },\n\"Our findings reveal: (1) significant limitations in widely used \\u201cuniversal\\u201d primers, often failing to capture microbial diversity due to unexpected variability in conserved regions, (2) substantial intergenomic variation, even within traditionally conserved regions of the 16S rRNA gene, as demonstrated by Shannon entropy analysis, and (3) discrepancies between intergenomic patterns in NCBI and SILVA databases, highlighting the impact of database choices on taxonomic classification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 1388,\n            'f': \"1388\",\n        },\n\"Our findings reveal: (1) significant limitations in widely used \\u201cuniversal\\u201d primers, often failing to capture microbial diversity due to unexpected variability in conserved regions, (2) substantial intergenomic variation, even within traditionally conserved regions of the 16S rRNA gene, as demonstrated by Shannon entropy analysis, and (3) discrepancies between intergenomic patterns in NCBI and SILVA databases, highlighting the impact of database choices on taxonomic classification.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 1389,\n            'f': \"1389\",\n        },\n\"The SILVA database, which includes Bacteria, Archaea, and Eukaryota, is curated through phylogenetic analysis of small subunit rRNAs (16S and 18S) using the SINA alignment tool ( Quast et al., 2013 ).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 1390,\n            'f': \"1390\",\n        },\n\"The 16S rRNA gene sequences of the core gut microbiome were initially downloaded separately from the NCBI and SILVA databases, and each dataset was further analyzed for the intergenomic patterns using multiple sequence alignments and Shannon entropy graph analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 1391,\n            'f': \"1391\",\n        },\n\"The 16S rRNA gene sequences of the core gut microbiome were initially downloaded separately from the NCBI and SILVA databases, and each dataset was further analyzed for the intergenomic patterns using multiple sequence alignments and Shannon entropy graph analysis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"NCBI\"],\n [{\n            'v': 1392,\n            'f': \"1392\",\n        },\n\"TestPrime 1.0 3 ( Klindworth et al., 2013 ) was then used to assess in silico performance of each primer pair against the SILVA SSU Ref NR 16S rRNA gene database (release 138.1), which contains 510,495 sequences (>1,200\\u202fbp for Bacteria/Eukaryota, >900\\u202fbp for Archaea).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SILVA\"],\n [{\n            'v': 1393,\n            'f': \"1393\",\n        },\n\"Concept and design: Catarina Santos Reis, Bernardo Fernandes, Pedro Lisboa Gon\\u00e7alves, Ricardo Neto, Roberto Silva, Isabel Cam\\u00f5es\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"SILVA\"],\n [{\n            'v': 1394,\n            'f': \"1394\",\n        },\n\"A nonlocal string order parameter detecting topological order and deconfinement has been proposed by Fredenhagen and Marcu (FM).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1395,\n            'f': \"1395\",\n        },\n\"However, due to the lack of exact internal symmetries for lattice models and the nonlinear dependence of the FM string order parameter on ground states, it is a priori not guaranteed that it is a genuine order parameter for topological phase transitions.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1396,\n            'f': \"1396\",\n        },\n\"In this work, we find that the FM string order parameter exhibits universal scaling behavior near critical points of charge condensation transitions, by directly evaluating the FM string order parameter in the infinite string-length limit using infinite Projected Entangled Pair States (iPEPS) for the toric code in a magnetic field.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1397,\n            'f': \"1397\",\n        },\n\"Our results thus demonstrate that the FM string order parameter represents a quantitatively well-behaved order parameter.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1398,\n            'f': \"1398\",\n        },\n\"We find that only in the presence of an emergent 1-form symmetry the corresponding FM string order parameter can faithfully detect topological transitions.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1399,\n            'f': \"1399\",\n        },\n\"The narrow lumen of the duodenal bulb and the high tension of the mucosa posed a significant challenge for suturing the defect.To overcome this, we employed a modified purse-string suture technique ( Video 1 ).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1400,\n            'f': \"1400\",\n        },\n\"2 b ), secured the nylon string to the edge of the defect, and gently pulled the dental floss.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1401,\n            'f': \"1401\",\n        },\n\"Modified endoscopic purse-string suture with dental floss traction has been effectively utilized in the management of duodenal defects.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1402,\n            'f': \"1402\",\n        },\n\"The purse-string suture technique has proven effective in closing gastrointestinal tract defects, especially in challenging anatomical areas 1 2 .\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1403,\n            'f': \"1403\",\n        },\n\"In contrast to the conventional purse-string suture technique, our innovative approach, characterized by dental floss traction, mitigates the risk of inadvertent inversion of clips into the wound during nylon tightening ( Fig.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1404,\n            'f': \"1404\",\n        },\n\"To evaluate the safety and comfort of ureteral stents with extraction strings during modified split-leg prone percutaneous nephrolithotomy (PCNL).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1405,\n            'f': \"1405\",\n        },\n\"Patients were randomized into two groups: 50 with extraction-string stents and 50 without.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1406,\n            'f': \"1406\",\n        },\n\"The extraction-string group demonstrated significantly lower pain scores during stent removal (0.86 \\u00b1 0.62 vs. 5.23 \\u00b1 1.74, p < 0.05) and shorter stent indwelling time (16.06 \\u00b1 4.48 vs. 60.54 \\u00b1 20.4 days, p < 0.05).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1407,\n            'f': \"1407\",\n        },\n\"The incidence of hematuria (8 vs. 29 cases) and flank pain (7 vs. 22 cases) was notably lower in the extraction-string group ( p < 0.05).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1408,\n            'f': \"1408\",\n        },\n\"The amino acids and cyclohexenimine ring are analogous to the string and button of a button-on-a-string spinner, otherwise known as button whirligigs.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1409,\n            'f': \"1409\",\n        },\n\"Thus, we refer to the ring-rotating nonradiative decay of porphyra-334 as a button-on-a-string mechanism.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1410,\n            'f': \"1410\",\n        },\n\"We will refer to the ring rotation decay as a \\u201cbutton-on-a-string\\u201d mechanism later, in order to distinguish it from the previously proposed mechanism of swinging the out-of-ring amino acids (\\u201carm-swing\\u201d mechanism, Figure b).\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1411,\n            'f': \"1411\",\n        },\n\"We will show that the button-on-a-string mechanism can conserve the hydrogen bonds due to the structural flexibility of the out-of-ring amino acids of porphyra-334.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1412,\n            'f': \"1412\",\n        },\n\"(c) Schematic representation of button-on-a-string spinner.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1413,\n            'f': \"1413\",\n        },\n\"Finally, STRING can provide information on functional enrichment and pathway analysis for each cluster.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1414,\n            'f': \"1414\",\n        },\n\"The Search Tool for the Retrieval of Interacting Genes/Protein (STRING) database (RRID: SCR_005223) ( https://string-db.org/ ), which allows the visualization of complex networks (through clustering analysis), was used to retrieve the predicted interactions for the identified proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1415,\n            'f': \"1415\",\n        },\n\"We used the following settings for STRING analysis: full STRING network as the network type, in which edges indicate both functional and physical protein associations; evidence as the meaning of the network edges; different types of interaction sources, such as text-mining, neighborhood, experiments, co-occurrence, and more; and a medium confidence cut-off of 0.400 as the minimum required interaction score to highlight the more significant interactions.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1416,\n            'f': \"1416\",\n        },\n\"The STRING database is also linked to the SMART database ( http://smart.embl-heidelberg.de/ ) (RRID: SCR_005026), which allowed us to compare different protein domains of proteome data of H. tubulosa and compare them with domains present in the human species.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1417,\n            'f': \"1417\",\n        },\n\"The STRING database is also linked to the SMART database ( http://smart.embl-heidelberg.de/ ) (RRID: SCR_005026), which allowed us to compare different protein domains of proteome data of H. tubulosa and compare them with domains present in the human species.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"SMART\"],\n [{\n            'v': 1418,\n            'f': \"1418\",\n        },\n\"Besides the STRING \\u201cclustering\\u201d function, the \\u201chomology search\\u201d function (string- db.org/cgi/proteinhomology) was used to calculate the percentage of protein sequence similarity between different species.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1419,\n            'f': \"1419\",\n        },\n\"As presented in the brief review above, other studies involving automatic excitation of string instruments have focused either on complex, elaborate systems aimed at studying human-instrument interactions or on single-purpose mechanisms applied in well-defined problems.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1420,\n            'f': \"1420\",\n        },\n\"Simulation models of the interaction of the pick with the string used in sound synthesis use, among others, beam mechanics subject only to transverse displacements.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1421,\n            'f': \"1421\",\n        },\n\"If human factors influencing the path of a guitar pick were eliminated, it would be possible to study the string-excitation phenomenon using a plectrum in such a way as to obtain more information about the pick-string interaction.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1422,\n            'f': \"1422\",\n        },\n\"In this study, we explored the interaction between letter and letter string processing.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"STRING\"],\n [{\n            'v': 1423,\n            'f': \"1423\",\n        },\n\"STRING network analysis revealed functional interactions between SQLE and ten proteins involved in ergosterol biosynthesis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1424,\n            'f': \"1424\",\n        },\n\"Tools such as I-Mutant, DynaMut2, ConSurf, HOPE, AlphaFold, STRING, and molecular docking were employed to predict the impact of mutations on protein stability, structural integrity, evolutionary conservation, and protein-protein interactions.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1425,\n            'f': \"1425\",\n        },\n\"Tools such as I-Mutant, DynaMut2, ConSurf, HOPE, AlphaFold, STRING, and molecular docking were employed to predict the impact of mutations on protein stability, structural integrity, evolutionary conservation, and protein-protein interactions.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"AlphaFold\"],\n [{\n            'v': 1426,\n            'f': \"1426\",\n        },\n\"STRING analysis identified interactions between SQLE and ten other proteins involved in the ergosterol biosynthesis pathway.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1427,\n            'f': \"1427\",\n        },\n\"6 STRING-based protein-protein interaction network centered on SQLE (TERG_05717), showing its connections with key enzymes involved in ergosterol biosynthesis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1428,\n            'f': \"1428\",\n        },\n\"STRING-based protein-protein interaction network centered on SQLE (TERG_05717), showing its connections with key enzymes involved in ergosterol biosynthesis.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1429,\n            'f': \"1429\",\n        },\n\"To further investigate these interactions, we analyzed relevant pathways in the Reactome database for Asian seabass, humans, and zebrafish, constructed a protein-protein interaction (PPI) network using STRING database, and identified hub genes using six different algorithms.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1430,\n            'f': \"1430\",\n        },\n\"To further investigate these interactions, we analyzed relevant pathways in the Reactome database for Asian seabass, humans, and zebrafish, constructed a protein-protein interaction (PPI) network using STRING database, and identified hub genes using six different algorithms.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"Reactome\"],\n [{\n            'v': 1431,\n            'f': \"1431\",\n        },\n\"To establish the protein-protein interaction (PPI) network, the online tool STRING ( https://string-db.org/ (accessed on 7 January 2025) was used with a high confidence interaction score of 0.7 and a medium FDR stringency of 5%.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1432,\n            'f': \"1432\",\n        },\n\"Subsequently, we constructed a protein-protein interaction (PPI) network for Asian seabass using the STRING database and performed clustering to identify groups of interacting proteins.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1433,\n            'f': \"1433\",\n        },\n\"Figure S1: Melt curve analysis of the RT-qPCR validation; Table S1: Primers used for identifying ISKNV in this study; Table S2: Homology analysis and gene list for segregation in REACTOME; Table S3: DEGs in the spleen of Asian seabass infected with ISKNV; Table S4: DEGs segregated according to the biological pathways using the Reactome server; Table S5: String interactions for the 31 shared immune genes; Table S6: String interactions of the genes in the IFN pathway; Table S7: String MCL clusters for the IFN signal; Table S8: String interactions of the genes in the TLR pathway; Table S9: String MCL clusters for TLR signal; Table S10: String interactions of the genes in endocytosis pathway; Table S11: String MCL clusters for the endocytosis signal; Table S12: String interactions for cell-cell communication; Table S13: String MCL clusters for cell-cell communication; Table S14: String interactions for PCD; Table S15: String MCL clusters for PCD; Table S16: String interactions for cell cycle arrest; Table S17: String MCL clusters for cell cycle arrest; Table S18: String interactions of the genes in the PI3K pathway; Table S19: String MCL clusters for PI3K signal.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1434,\n            'f': \"1434\",\n        },\n\"Protein-protein interactions (physical and functional) networks were illustrated via String database 12.0 [ 18 ] setting the following parameters (organism: Rattus norvegicus ; minimum required interaction score: high confidence 0.700; false discovery rate stringency: high, 1%; protein-protein interaction, PPI, enrichment p-values were also reported for each comparison).\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1435,\n            'f': \"1435\",\n        },\n\"The proteins visualized via String database 12.0 were also enriched for biological processes and pathways by combining the information obtained from ShinyGO 0.80 [ 19 ] (species Rattus norvegicus with ENSEMBL as source; the top 20 pathways with a minimum size of 2 were shown; pathways were filtered by FDR cutoff 0.05 and sorted by fold enrichment, FE; GO Biological Process and KEGG pathway databases were interrogated) and a manual search through the published literature.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"],\n [{\n            'v': 1436,\n            'f': \"1436\",\n        },\n\"(C, D) String network (String 12.0) of the significant, up (C) and down (D) regulated proteins in ADCTL/AGCTL.\",\n{\n            'v': 1,\n            'f': \"1\",\n        },\n\"STRING\"]],\n        columns: [[\"number\", \"index\"], [\"string\", \"paragraph_text\"], [\"number\", \"label\"], [\"string\", \"matched_term\"]],\n        columnOptions: [{\"width\": \"1px\", \"className\": \"index_column\"}],\n        rowsPerPage: 25,\n        helpUrl: \"https://colab.research.google.com/notebooks/data_table.ipynb\",\n        suppressOutputScrolling: true,\n        minimumWidth: undefined,\n      });\n\n      function appendQuickchartButton(parentElement) {\n        let quickchartButtonContainerElement = document.createElement('div');\n        quickchartButtonContainerElement.innerHTML = `\n    <div id=\"df-8da49fd7-e0ed-4202-8717-70964204589e\">\n      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-8da49fd7-e0ed-4202-8717-70964204589e')\"\n                title=\"Suggest charts\"\n                style=\"display:none;\">\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n     width=\"24px\">\n    <g>\n        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n    </g>\n</svg>\n      </button>\n\n<style>\n  .colab-df-quickchart {\n      --bg-color: #E8F0FE;\n      --fill-color: #1967D2;\n      --hover-bg-color: #E2EBFA;\n      --hover-fill-color: #174EA6;\n      --disabled-fill-color: #AAA;\n      --disabled-bg-color: #DDD;\n  }\n\n  [theme=dark] .colab-df-quickchart {\n      --bg-color: #3B4455;\n      --fill-color: #D2E3FC;\n      --hover-bg-color: #434B5C;\n      --hover-fill-color: #FFFFFF;\n      --disabled-bg-color: #3B4455;\n      --disabled-fill-color: #666;\n  }\n\n  .colab-df-quickchart {\n    background-color: var(--bg-color);\n    border: none;\n    border-radius: 50%;\n    cursor: pointer;\n    display: none;\n    fill: var(--fill-color);\n    height: 32px;\n    padding: 0;\n    width: 32px;\n  }\n\n  .colab-df-quickchart:hover {\n    background-color: var(--hover-bg-color);\n    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n    fill: var(--button-hover-fill-color);\n  }\n\n  .colab-df-quickchart-complete:disabled,\n  .colab-df-quickchart-complete:disabled:hover {\n    background-color: var(--disabled-bg-color);\n    fill: var(--disabled-fill-color);\n    box-shadow: none;\n  }\n\n  .colab-df-spinner {\n    border: 2px solid var(--fill-color);\n    border-color: transparent;\n    border-bottom-color: var(--fill-color);\n    animation:\n      spin 1s steps(1) infinite;\n  }\n\n  @keyframes spin {\n    0% {\n      border-color: transparent;\n      border-bottom-color: var(--fill-color);\n      border-left-color: var(--fill-color);\n    }\n    20% {\n      border-color: transparent;\n      border-left-color: var(--fill-color);\n      border-top-color: var(--fill-color);\n    }\n    30% {\n      border-color: transparent;\n      border-left-color: var(--fill-color);\n      border-top-color: var(--fill-color);\n      border-right-color: var(--fill-color);\n    }\n    40% {\n      border-color: transparent;\n      border-right-color: var(--fill-color);\n      border-top-color: var(--fill-color);\n    }\n    60% {\n      border-color: transparent;\n      border-right-color: var(--fill-color);\n    }\n    80% {\n      border-color: transparent;\n      border-right-color: var(--fill-color);\n      border-bottom-color: var(--fill-color);\n    }\n    90% {\n      border-color: transparent;\n      border-bottom-color: var(--fill-color);\n    }\n  }\n</style>\n\n      <script>\n        async function quickchart(key) {\n          const quickchartButtonEl =\n            document.querySelector('#' + key + ' button');\n          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n          quickchartButtonEl.classList.add('colab-df-spinner');\n          try {\n            const charts = await google.colab.kernel.invokeFunction(\n                'suggestCharts', [key], {});\n          } catch (error) {\n            console.error('Error during call to suggestCharts:', error);\n          }\n          quickchartButtonEl.classList.remove('colab-df-spinner');\n          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n        }\n        (() => {\n          let quickchartButtonEl =\n            document.querySelector('#df-8da49fd7-e0ed-4202-8717-70964204589e button');\n          quickchartButtonEl.style.display =\n            google.colab.kernel.accessAllowed ? 'block' : 'none';\n        })();\n      </script>\n    </div>`;\n        parentElement.appendChild(quickchartButtonContainerElement);\n      }\n\n      appendQuickchartButton(table);\n    "
          },
          "metadata": {},
          "execution_count": 18
        }
      ],
      "source": [
        "import pandas as pd\n",
        "\n",
        "infile = \"training_set_sentences.full.csv\"\n",
        "# infile = 'train_split.csv'\n",
        "df = pd.read_csv(infile)\n",
        "df = df[[\"paragraph_text\", \"label\", \"matched_term\"]]\n",
        "df\n"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "00f44c55",
      "metadata": {
        "id": "00f44c55"
      },
      "source": [
        "## ðŸ§  Tokenize and Split"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from datasets import Dataset, DatasetDict\n",
        "from transformers import AutoTokenizer\n",
        "tokenizer = AutoTokenizer.from_pretrained(\"allenai/scibert_scivocab_uncased\")\n",
        "\n",
        "# 1. Convert to Hugging Face dataset\n",
        "dataset = Dataset.from_pandas(df)\n",
        "\n",
        "# 2. Define tokenizer (with chunking logic)\n",
        "def tokenize(batch):\n",
        "    # input_texts = [text + \" [SEP] \" + alias for text, alias in zip(batch[\"paragraph_text\"], batch[\"matched_term\"])]\n",
        "\n",
        "    encodings = tokenizer(\n",
        "        # input_texts,\n",
        "        batch[\"matched_term\"],\n",
        "        batch[\"paragraph_text\"],\n",
        "        return_overflowing_tokens=True,\n",
        "        truncation=True,\n",
        "        stride=128,\n",
        "        padding=\"max_length\",\n",
        "        max_length=512\n",
        "    )\n",
        "\n",
        "    # Expand the labels to match the number of chunks per example\n",
        "    new_labels = []\n",
        "    for i in range(len(encodings[\"input_ids\"])):\n",
        "        example_idx = encodings[\"overflow_to_sample_mapping\"][i]\n",
        "        new_labels.append(batch[\"label\"][example_idx])\n",
        "\n",
        "    return {\n",
        "        \"input_ids\": encodings[\"input_ids\"],\n",
        "        \"attention_mask\": encodings[\"attention_mask\"],\n",
        "        \"label\": new_labels,\n",
        "    }\n",
        "\n",
        "# 3. Tokenize and remove non-input columns\n",
        "tokenized_dataset = dataset.map(tokenize, batched=True, remove_columns=dataset.column_names)\n",
        "print(tokenized_dataset)\n",
        "\n",
        "# 4. Split\n",
        "encoded_dataset = tokenized_dataset.train_test_split(test_size=0.2)"
      ],
      "metadata": {
        "id": "v7pHH8CO80ds",
        "outputId": "edcdb52f-3443-4379-855e-03ca9a9bb8ce",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 117,
          "referenced_widgets": [
            "e15294301e7b4fddabce57f4cec6f1f8",
            "a5c5cd5f1d294ca59e39ad0b90fe5a3d",
            "0dd8a3c28c85442d807aeb81e7ea832d",
            "08bb1bc0b43a4af0b7e78d6fd23a8ceb",
            "9fa764b4babd4b6d984d43a486f782b2",
            "ce4480b9325c4bcca9e46339506ad201",
            "3d42610f7de64bf493c526a3a210f57a",
            "ac13b8eb681041abad01106bb240070b",
            "1a05238936eb437b95f76f3f675871ab",
            "798795ec377249de9766afe115d3666d",
            "6ba0ff9c9b5d4b4797e3fe335d1a6f73"
          ]
        }
      },
      "id": "v7pHH8CO80ds",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Map:   0%|          | 0/1437 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "e15294301e7b4fddabce57f4cec6f1f8"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Dataset({\n",
            "    features: ['label', 'input_ids', 'attention_mask'],\n",
            "    num_rows: 1452\n",
            "})\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(encoded_dataset)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Dnj8ysWY67FL",
        "outputId": "cca66e55-a726-45c3-a181-b33b4ec2f294"
      },
      "id": "Dnj8ysWY67FL",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "DatasetDict({\n",
            "    train: Dataset({\n",
            "        features: ['label', 'input_ids', 'attention_mask'],\n",
            "        num_rows: 1161\n",
            "    })\n",
            "    test: Dataset({\n",
            "        features: ['label', 'input_ids', 'attention_mask'],\n",
            "        num_rows: 291\n",
            "    })\n",
            "})\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "id": "a7b531d9",
      "metadata": {
        "id": "a7b531d9"
      },
      "source": [
        "## ðŸš€ Fine-Tune SciBERT"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n"
      ],
      "metadata": {
        "id": "_ieLb7O4VsQy"
      },
      "id": "_ieLb7O4VsQy",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": 17,
      "id": "9c791f0e",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9c791f0e",
        "outputId": "341dd238-312b-4c99-a7c7-7575a395930f"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Some weights of BertForSequenceClassification were not initialized from the model checkpoint at allenai/scibert_scivocab_uncased and are newly initialized: ['classifier.bias', 'classifier.weight']\n",
            "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
          ]
        }
      ],
      "source": [
        "from transformers import AutoModelForSequenceClassification, TrainingArguments, Trainer\n",
        "from sklearn.metrics import accuracy_score, precision_recall_fscore_support\n",
        "\n",
        "model = AutoModelForSequenceClassification.from_pretrained(\"allenai/scibert_scivocab_uncased\", num_labels=2)\n",
        "\n",
        "def compute_metrics(eval_pred):\n",
        "    logits, labels = eval_pred\n",
        "    preds = logits.argmax(axis=-1)\n",
        "\n",
        "    precision, recall, f1, _ = precision_recall_fscore_support(labels, preds, average=\"binary\")\n",
        "    acc = accuracy_score(labels, preds)\n",
        "\n",
        "    return {\n",
        "        \"accuracy\": acc,\n",
        "        \"precision\": precision,\n",
        "        \"recall\": recall,\n",
        "        \"f1\": f1,\n",
        "    }\n",
        "\n",
        "training_args = TrainingArguments(\n",
        "    output_dir=\"./scibert_resource_classifier\",\n",
        "    eval_strategy=\"epoch\",\n",
        "    save_strategy=\"epoch\",\n",
        "    learning_rate=2e-5,\n",
        "    per_device_train_batch_size=8,\n",
        "    per_device_eval_batch_size=8,\n",
        "    num_train_epochs=4,\n",
        "    weight_decay=0.01,\n",
        "    report_to=\"none\",\n",
        ")\n",
        "\n",
        "trainer = Trainer(\n",
        "    model=model,\n",
        "    args=training_args,\n",
        "    train_dataset=encoded_dataset[\"train\"],\n",
        "    eval_dataset=encoded_dataset[\"test\"],\n",
        "    compute_metrics=compute_metrics\n",
        ")\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "trainer.train()"
      ],
      "metadata": {
        "id": "GZkaL7dgWHlD"
      },
      "id": "GZkaL7dgWHlD",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "metrics = trainer.evaluate()\n",
        "print(metrics)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 74
        },
        "id": "jjZi3eeuVFD6",
        "outputId": "3ccfa29b-95e4-46b2-8041-6aafd9e9ce33"
      },
      "id": "jjZi3eeuVFD6",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='37' max='37' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [37/37 00:07]\n",
              "    </div>\n",
              "    "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{'eval_loss': 0.07801998406648636, 'eval_accuracy': 0.9862542955326461, 'eval_precision': 0.9845360824742269, 'eval_recall': 0.9947916666666666, 'eval_f1': 0.9896373056994818, 'eval_runtime': 8.2603, 'eval_samples_per_second': 35.229, 'eval_steps_per_second': 4.479, 'epoch': 4.0}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "id": "396eb7a9",
      "metadata": {
        "id": "396eb7a9"
      },
      "source": [
        "## ðŸ’¾ Save Trained Model"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "abac023b",
      "metadata": {
        "id": "abac023b",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 697
        },
        "outputId": "524fc3f7-1586-4798-ebc7-a3890f734c27"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "  adding: scibert_resource_classifier/ (stored 0%)\n",
            "  adding: scibert_resource_classifier/checkpoint-584/ (stored 0%)\n",
            "  adding: scibert_resource_classifier/checkpoint-584/training_args.bin (deflated 52%)\n",
            "  adding: scibert_resource_classifier/checkpoint-584/config.json (deflated 49%)\n",
            "  adding: scibert_resource_classifier/checkpoint-584/model.safetensors (deflated 7%)\n",
            "  adding: scibert_resource_classifier/checkpoint-584/trainer_state.json (deflated 70%)\n",
            "  adding: scibert_resource_classifier/checkpoint-584/optimizer.pt (deflated 24%)\n",
            "  adding: scibert_resource_classifier/checkpoint-584/scheduler.pt (deflated 56%)\n",
            "  adding: scibert_resource_classifier/checkpoint-584/rng_state.pth (deflated 25%)\n",
            "  adding: scibert_resource_classifier/tokenizer_config.json (deflated 74%)\n",
            "  adding: scibert_resource_classifier/config.json (deflated 49%)\n",
            "  adding: scibert_resource_classifier/model.safetensors (deflated 7%)\n",
            "  adding: scibert_resource_classifier/special_tokens_map.json (deflated 42%)\n",
            "  adding: scibert_resource_classifier/checkpoint-292/ (stored 0%)\n",
            "  adding: scibert_resource_classifier/checkpoint-292/training_args.bin (deflated 52%)\n",
            "  adding: scibert_resource_classifier/checkpoint-292/config.json (deflated 49%)\n",
            "  adding: scibert_resource_classifier/checkpoint-292/model.safetensors (deflated 7%)\n",
            "  adding: scibert_resource_classifier/checkpoint-292/trainer_state.json (deflated 62%)\n",
            "  adding: scibert_resource_classifier/checkpoint-292/optimizer.pt (deflated 24%)\n",
            "  adding: scibert_resource_classifier/checkpoint-292/scheduler.pt (deflated 56%)\n",
            "  adding: scibert_resource_classifier/checkpoint-292/rng_state.pth (deflated 25%)\n",
            "  adding: scibert_resource_classifier/tokenizer.json (deflated 71%)\n",
            "  adding: scibert_resource_classifier/checkpoint-146/ (stored 0%)\n",
            "  adding: scibert_resource_classifier/checkpoint-146/training_args.bin (deflated 52%)\n",
            "  adding: scibert_resource_classifier/checkpoint-146/config.json (deflated 49%)\n",
            "  adding: scibert_resource_classifier/checkpoint-146/model.safetensors (deflated 7%)\n",
            "  adding: scibert_resource_classifier/checkpoint-146/trainer_state.json (deflated 58%)\n",
            "  adding: scibert_resource_classifier/checkpoint-146/optimizer.pt (deflated 24%)\n",
            "  adding: scibert_resource_classifier/checkpoint-146/scheduler.pt (deflated 56%)\n",
            "  adding: scibert_resource_classifier/checkpoint-146/rng_state.pth (deflated 25%)\n",
            "  adding: scibert_resource_classifier/checkpoint-438/ (stored 0%)\n",
            "  adding: scibert_resource_classifier/checkpoint-438/training_args.bin (deflated 52%)\n",
            "  adding: scibert_resource_classifier/checkpoint-438/config.json (deflated 49%)\n",
            "  adding: scibert_resource_classifier/checkpoint-438/model.safetensors (deflated 7%)\n",
            "  adding: scibert_resource_classifier/checkpoint-438/trainer_state.json (deflated 66%)\n",
            "  adding: scibert_resource_classifier/checkpoint-438/optimizer.pt (deflated 24%)\n",
            "  adding: scibert_resource_classifier/checkpoint-438/scheduler.pt (deflated 56%)\n",
            "  adding: scibert_resource_classifier/checkpoint-438/rng_state.pth (deflated 25%)\n",
            "  adding: scibert_resource_classifier/vocab.txt (deflated 52%)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Javascript object>"
            ],
            "application/javascript": [
              "\n",
              "    async function download(id, filename, size) {\n",
              "      if (!google.colab.kernel.accessAllowed) {\n",
              "        return;\n",
              "      }\n",
              "      const div = document.createElement('div');\n",
              "      const label = document.createElement('label');\n",
              "      label.textContent = `Downloading \"${filename}\": `;\n",
              "      div.appendChild(label);\n",
              "      const progress = document.createElement('progress');\n",
              "      progress.max = size;\n",
              "      div.appendChild(progress);\n",
              "      document.body.appendChild(div);\n",
              "\n",
              "      const buffers = [];\n",
              "      let downloaded = 0;\n",
              "\n",
              "      const channel = await google.colab.kernel.comms.open(id);\n",
              "      // Send a message to notify the kernel that we're ready.\n",
              "      channel.send({})\n",
              "\n",
              "      for await (const message of channel.messages) {\n",
              "        // Send a message to notify the kernel that we're ready.\n",
              "        channel.send({})\n",
              "        if (message.buffers) {\n",
              "          for (const buffer of message.buffers) {\n",
              "            buffers.push(buffer);\n",
              "            downloaded += buffer.byteLength;\n",
              "            progress.value = downloaded;\n",
              "          }\n",
              "        }\n",
              "      }\n",
              "      const blob = new Blob(buffers, {type: 'application/binary'});\n",
              "      const a = document.createElement('a');\n",
              "      a.href = window.URL.createObjectURL(blob);\n",
              "      a.download = filename;\n",
              "      div.appendChild(a);\n",
              "      a.click();\n",
              "      div.remove();\n",
              "    }\n",
              "  "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Javascript object>"
            ],
            "application/javascript": [
              "download(\"download_cc30f389-90a3-4f71-912b-9348c4465137\", \"scibert_resource_classifier.zip\", 4722522285)"
            ]
          },
          "metadata": {}
        }
      ],
      "source": [
        "model.save_pretrained(\"scibert_resource_classifier\")\n",
        "tokenizer.save_pretrained(\"scibert_resource_classifier\")\n",
        "\n",
        "!zip -r scibert_resource_classifier.zip scibert_resource_classifier\n",
        "from google.colab import files\n",
        "files.download(\"scibert_resource_classifier.zip\")\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!ls -lh"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "e21_NUe2aO7-",
        "outputId": "dd67c0bb-6b11-4e0f-9659-2ae02876bda9"
      },
      "id": "e21_NUe2aO7-",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "total 4.4G\n",
            "drwxr-xr-x 1 root root 4.0K Jun 17 13:37 sample_data\n",
            "drwxr-xr-x 6 root root 4.0K Jun 19 13:14 scibert_resource_classifier\n",
            "-rw-r--r-- 1 root root 4.4G Jun 19 13:34 scibert_resource_classifier.zip\n",
            "-rw-r--r-- 1 root root 366K Jun 19 12:48 training_set_sentences.full.csv\n"
          ]
        }
      ]
    }
  ],
  "metadata": {
    "language_info": {
      "name": "python"
    },
    "colab": {
      "provenance": [],
      "gpuType": "T4"
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "accelerator": "GPU",
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "e15294301e7b4fddabce57f4cec6f1f8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_a5c5cd5f1d294ca59e39ad0b90fe5a3d",
              "IPY_MODEL_0dd8a3c28c85442d807aeb81e7ea832d",
              "IPY_MODEL_08bb1bc0b43a4af0b7e78d6fd23a8ceb"
            ],
            "layout": "IPY_MODEL_9fa764b4babd4b6d984d43a486f782b2"
          }
        },
        "a5c5cd5f1d294ca59e39ad0b90fe5a3d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ce4480b9325c4bcca9e46339506ad201",
            "placeholder": "â€‹",
            "style": "IPY_MODEL_3d42610f7de64bf493c526a3a210f57a",
            "value": "Map:â€‡100%"
          }
        },
        "0dd8a3c28c85442d807aeb81e7ea832d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ac13b8eb681041abad01106bb240070b",
            "max": 1437,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_1a05238936eb437b95f76f3f675871ab",
            "value": 1437
          }
        },
        "08bb1bc0b43a4af0b7e78d6fd23a8ceb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_798795ec377249de9766afe115d3666d",
            "placeholder": "â€‹",
            "style": "IPY_MODEL_6ba0ff9c9b5d4b4797e3fe335d1a6f73",
            "value": "â€‡1437/1437â€‡[00:01&lt;00:00,â€‡1366.28â€‡examples/s]"
          }
        },
        "9fa764b4babd4b6d984d43a486f782b2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ce4480b9325c4bcca9e46339506ad201": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3d42610f7de64bf493c526a3a210f57a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "ac13b8eb681041abad01106bb240070b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1a05238936eb437b95f76f3f675871ab": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "798795ec377249de9766afe115d3666d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6ba0ff9c9b5d4b4797e3fe335d1a6f73": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}